LETTER FROM THE CHAIRMAN

02/26/2008

To the Infirmary Family:

The 2005-2006 Annual Report of the Department of Ophthalmology of The New York Eye and Ear Infirmary covers activities of our 186 years of continuous service. This report attests to the continuing fulfillment of the mission embarked upon by our founders, Dr. John Kearney Rodgers and Dr. Edward Delafield, in 1820 – to bring quality eye services to all through patient care, education and research.

We hope that this report rekindles fond memories of your time at the Infirmary. It represents the work and dedication of many who contribute their time, treasure and talent.

Please remember The New York Eye and Ear Infirmary Department of Ophthalmology in your charitable donations. We are in the early stages of establishing an endowment so that those who follow may benefit from the same opportunities that were available to us.

Sincerely,

Joseph B. Walsh, MD, FACS, FRCOphth Professor & Chair Department of Ophthalmology The New York Eye & Ear Infirmary New York Medical College

1

TABLE OF CONTENTS

LETTER FROM THE CHAIRMAN 1 OPHTHALMOLOGY DEPARTMENTAL ADMINISTRATION 4 THE NEW YORK EYE AND EAR INFIRMARY MEDICAL BOARD COMMITTEES 5 AMBULATORY CARE SERVICE 7 COMPREHENSIVE OPHTHALMOLOGY SERVICE 17 CORNEA AND REFRACTIVE SERVICE 19 GLAUCOMA SERVICE 23 NEURO-OPHTHALMOLOGY SERVICE 37 OCULAR TUMOR SERVICE 39 OCULOPLASTIC AND ORIBITAL SURGERY SERVICE 41 OPHTHALMIC PATHOLOGY SERVICE 45 PEDIATRIC OPHTHALMOLOGY AND ORTHOPTICS 47 EYE TRAUMA SERVICE 51 RETINA SERVICE 53 ABORN-LUBKIN EYE RESEARCH LABORATORY 57 THE NEW YORK EYE AND EAR INFIRMARY OPHTHALMOLOGY ASSOCIATES, P.C. 63 BETH ISRAEL MEDICAL CENTER AFFILIATION 71 RESIDENT TRAINING AND EDUCATION 75 NYEEI OPHTHALMOLOGY DEPARTMENT HOUSE STAFF 77 GRAND ROUNDS 82 RESIDENT/FELLOW RESEARCH DAY 2005 88 RESIDENT/FELLOW RESEARCH DAY 2006 90 PUBLICATIONS 2005 92 PUBLICATIONS 2006 96 PRESENTATIONS 2005 102 PRESENTATIONS 2006 106 NYE&E ARVO BIBLIOGRAPHY 2005 114 NYE&E ARVO BIBLIOGRAPHY 2006 117 NY MEDICAL COLLEGE BIBLIOGRAPHY 2005 120 INSTITUTIONAL REVIEW BOARD SUMMARY 2005 121 INSTITUTIONAL REVIEW BOARD SUMMARY 2006 135 APPOINTMENTS, HONORS, AWARDS, FELLOWSHIPS 152 DONATIONS 158 DEPARTMENT OF OPHTHALMOLOGY EXECUTIVE OVERVIEW 2005 161 EXECUTIVE COMMITTEE RESIDENCY REVIEW 2006 167 VISION CORRECTION CENTER 175 OPHTHALMOLOGY DEPARTMENTAL ADMINISTRATION

The Board of Directors of The New York Eye & Ear Infirmary has entrusted the administration of the Department of Ophthalmology to the Chair of Ophthalmology, who by consent, concurrently serves as Chair of the Department of Ophthalmology of New York Medical College. The Chair, therefore, is selected by and reports directly to the Board of Directors of The New York Eye & Ear Infirmary and New York Medical College. The Chair is ably assisted by:

DIRECTORS OF CLINICAL SERVICES:

Ophthalmic Plas tic, Orb ital & Reconstructive Surgery Service ...... Robert C. Della Rocca, MD* ...... Assistant: Elizabeth Maher, MD* Glaucoma Service ...... Robert H. Ritch, MD* ...... Assistant: Celso Tello, MD* Retinovitreal Service ...... Thomas O Muldoon, MD* ...... Assistant: Jeanne L. Rosenthal, MD* Comprehensive Ophthalmology ...... Paul A. Sidoti, MD* Corneal & External Service ...... John A. Seedor, MD* ...... Assistant: David Ritterband, MD Vision Correction Center Co-Directors ...... Barrie Soloway, MD ...... Advisor: Richard Keates, MD Pediatric & Motor Anomaly Service ...... Lisabeth Hall, MD* Ocular Oncology ...... Paul Finger, MD ...... Consultant: David H. Abramson, MD Low Vision Service ...... Benjamin Freed, OD Tissue Culture Laboratory ...... Dan-Nang Hu, MD Ocular Trauma Service Co-Directors ...... John Aljian*, MD, Ronald C. Gentile, MD* Neuro-Ophthalmology Service ...... Mark J. Kupersmith, MD* ...... Assistant: Hilary Fazzone, MD Ocular Pathology ...... Steven McCormick, MD Uveitis Service ...... Paul Latkany, MD ...... C. Michael Samson, MD* Beth Israel Affiliation ...... H. Jay Wisnicki, MD* Aborn Eye Research Institute ...... Greg Bennett, MD

OPHTHALMOLOGY ADMINISTRATIVE FACULTY

Program Director & Director Resident Services ...... Richard B. Rosen, MD* Medical Student Education: ...... Lois McNally, MD* Coordinator Retina- Education: ...... Ronald C. Gentile, MD* Coordinator Refraction Service: ...... David Krumholz, OD

ELECTED STAFF REPRESENTATIVES-AT-LARGE

Jeanne L. Rosenthal*, MD, Kenneth Felder*, MD, Elliott Fienman, MD*, C. Michael Samson, MD Medical Director ...... Douglas F. Buxton, MD (06)Alumni Alumni Association, President ...... Jeanne L. Rosenthal, MD*(05/00) Medical Director ...... Robert Rosenthal, MD (05)

CHIEF RESIDENTS*

(07/05 - 06/06) ...... Jon Page, MD, Natalie Rodriguez, MD (07/06 - 06/07) ...... Michael Bannitt, MD, Samuel Barone, MD

*The above listed individuals* collectively form the Executive Committee of the Department of Ophthalmology. This committee forms a collegial body wherein activities related to education, clinical care and research are discussed. Resident evaluations are performed and past departmental policies are evaluated and mortified and new policies formulated and promulgated

4 OPHTHALMOLOGY DEPARTMENTAL ADMINISTRATION THE NEW YORK EYEAND EAR INFIRMARY MEDICAL BOARD COMMITTEES 2005-2006

BYLAWS COMMITTEE R.C. Della Rocca, MD N. Mehta, MD J.R. Rosenthal, MD K. Felder, MD

MEDICAL LIBRARY COMMITTEE J. Liebmann, MD R.B. Rosen, MD J.B. Walsh, MD

CPR COMMITTEE R. Durell, MD

CREDENTIALS COMMITTEE M. Behette, MD R. Lester, MD R. Ritch, MD R. Della Rocca, MD E. Maher, MD J.B. Walsh, MD J. Galst, MD J. McDermott, MD P. Weseley, MD H. Hedaya, MD

OPERATING ROOM COMMITTEE D. Buxton, MD T. Muldoon, MD P. Sidoti, MD W. Kestin, MD R. Rosen, MD C. Tello, MD J. Liebmann, MD J. R. Rosenthal, MD J.B. Walsh, MD C. Locke, MD J. Seedor, MD

SURGICAL CASE REVIEW COMMITTEE B. Datta, MD S. McCormick, MD J.R. Rosenthal, MD J. Liebmann, MD R.B. Rosen, MD J.B. Walsh, MD A. Weseley, MD

INSTITUTIONAL REVIEW BOARD R. Andrew S. McCormick, MD S. Schantz, MD G. Caponong, MSW D. Ritterband, MD E. Schleider E. Ilitchev, MD R.B. Rosen, MD S. Tennaro, EdD L. James, RPh H. Savage, Ph.D J.B. Walsh, MD R. Bakin, PhD

TELEINFORMATICS COMMITTEE J. Liebmann, MD R. Ritch, MD J.B. Walsh, MD

QUALITY MANAGEMENT COMMITTEE R. Della Rocca, MD J.B. Walsh, MD A. Weseley, MD S. McCormick, MD

THE NEW YORK EYEAND EAR INFIRMARY MEDICAL BOARD COMMITTEES 5

AMBULATORY CARE SERVICE

he Division of Ambulatory Care Services is comprised of eight clinical departments, Ambulatory Care Revenue Management and the Language Assistance Program. T The clinical areas include: Ophthalmology Otolaryngology Glau coma Retina Orthoptics Pediatric Ophthalmology Urgent Care Services Control.

This report presents statistical summaries that include patient visits, staffing, Employee Health Service needle sticks, sharps and splash injuries, major achievements for 2006 and goals for 2007.

SCOPE OF SERVICES AND STATISTICAL OVERVIEW

The Ambulatory Care Division of The New York Eye & Ear Infirmary provides a comprehensive range of outpatient and referred ambulatory services for the diagnosis and treatment of patients with conditions related to ophthalmology, otolaryngology and their related specialties. Below are statistics for 2006 indicating the visits in all ambulatory care areas as they compare to the visits for 2005.

OPHTHALMOLOGY

The tables on the following pages reflect the yearly activity for years 2004 – 2005 for the Ophthalmology Services.

Ann Marie Palladino, Division Director

AMBULATORY CARE SERVICE 7 COMPARATIVE STATISTICS

SPECIALTY 2004 2005 % CHANGE 2005 2006 % CHANGE

Ophthalmology 86,827 86,088 (1)% 86,088 86,879 0.92% Otolaryngology 32,006 31,138 (2.7)% 31,138 27,480 -11.75%7 Specialty Services 2,978 3,135 5% 3,135 2,435 -22.33% Referred 8,421 9,197 9% 9,197 9,853 7.13% TOTALS 130,232 130,297 0% 130,297 126,647 -2.80%

VISIT TYPE 2004 2005 % CHANGE 2005 2006 % CHANGE

New 17,610 17,920 .02% 17,920 16,497 -7.94%

Revisit 95,329 94,579 (1)% 94,579 91,006 -3.78% Emergency 8,437 8,601 .02% 8,601 9,291 8.02% Referred 8,856 9,197 .04% 9,197 9,853 7.13% TOTALS 130,232 130,297 0% 130,297 126,647 -2.80%

OPHTHAMOLOGY

FINANCIAL CLASS 2004 2005 % CHANGE 2005 2006 % CHANGE

MC 21,786 21,567 1% 21,567 20,202 -6.33%

MA 21,190 18,539 (13)% 18,539 16,649 -10.19% BC 1,388 2,013 45% 2,013 917 -54.45% COMM’L. 1,437 1,554 8% 1,554 1,292 -16.86% HMO 22,998 24,234 5% 24,234 27,616 13.96% PPO 8,636 8,821 2% 8,821 9,339 5.87% COMP 205 307 50% 307 306 -0.33% SP 8,902 8,822 (.08)% 8,822 10,302 16.78% FREE 283 231 (18)% 231 256 10.82%

8 THE NEW YORK EYEAND EAR INFIRMARY OPHTHALMOLOGY ASSOCIATES COMPARATIVE STATISTICS

SPECIALTY SERVICES

FINANCIAL CLASS 2004 2005 % CHANGE 2005 2006 % CHANGE

MC 770 765 (.06)% 765 620 -19%

MA 986 755 (23)% 755 613 -19% BC 12 26 116% 26 10 -62% COMM’L. 18 10 (44)% 10 23 130% HMO 317 382 21% 382 374 -2% PPO 188 162 (14)% 162 173 7% COMP* 2 0 0 0 1 100% SP 682 1,033 51% 1,033 620 -40% FREE 3 2 (33)% 2 1 -50%

AMBULATORY CARE SERVICE 9 COMPARATIVE STATISTICS

OVERALL SUMMARY

Visits in 2006 decreased by almost 3% as compared to 2005. There was a 9% increase in ophthalmology visits, a 12% decrease in otolaryngology visits, and a 22% decrease in specialty visits. The urgent/emergent care visits increased by 8% and there was a 13% increase in referred ambulatory patients visits.

The decreasing trend in free passes continued during 2006 with an 8% decrease in the number of free passes given to patients.

The percentage of straight Medicaid visits as compared to total visits for 2006 continues to decrease although at a slower rate, now that significantly more patients have been moved into Medicaid managed care. The decrease was 6% for Ophthalmology, 14% for Otolaryngology and 19% for Specialty Services. The increase in HMO visits for 2006 was 14% for ophthalmology, 3% for otolaryngology and a 2% for the specialty services. The percentage of managed care patients continues to present many challenges to the ambulatory care department due to the extra work required to ensure that the Infirmary receives payment for all services provided.

Throughout the year, there was considerable effort given to ambulatory care revenue cycle and in trying to improve processes, coding and data entry in order to maximize revenue. An Ambulatory Care Revenue Manager was hired in April who is responsible for overseeing these processes. Midway during the year, the coding function was transferred to Medical Records while the data entry piece remained in ambulatory care, under the supervision of the Ambulatory Care Revenue Manager. It was evident that there was much confusion over what reports needed to be run, reviewed and worked on in order for an accurate bill to drop, in a timely manner. The agreed upon report that would serve to correct all outstanding accounts is the Service Verification Report; which is to be run daily. Corrections to accounts appearing on this report need to be made in order to finalize the ambulatory care portion of the billing process.

10 THE NEW YORK EYEAND EAR INFIRMARY OPHTHALMOLOGY ASSOCIATES COMPARATIVE STATISTICS

OPHTHALMOLOGY SERVICE

SPECIALTY 2004 2005 2006 % CHANGE

Contact lens 1,032 1,020 938 -8.04%

Cornea 2,301 2,193 1,925 -12.22% Cornea Modeling 40 6 0 -100.00% ERG 174 149 133 -10.74% Eye – New 9,025 8,956 8,398 -6.23% Eye RV 17,766 17,078 18,050 5.69% Eye Emerg. – New 4,768 5,013 5,526 10.23% Eye Emerg. – RV 1,838 1,906 2,146 12.59% Eye Plastic 1,402 1,532 1,481 -3.33%

Fluorescein Angiography 1,686 1,481 1,371 -7.43% Fundus Photo 1,319 1,483 1,645 10.92% Glaucoma 10,272 10,387 10,318 -0.66% Glaucoma Laser 647 669 718 7.32% Humphrey Visual Fields 3,588 3,271 3,464 5.90% Laser Clinic 7,246 7,323 6,835 -6.66% Laser Argon 1,197 1,169 1,172 0.26% Laser Yag 44 43 54 25.58% Laser Return Visit 252 157 48 -69.43% Low Vision – New 370 367 371 1.09% Low Vision – Return 135 152 149 -1.97% Minor Surgery Eye 285 266 281 5.64% Neuro-Ophthalmology 641 683 866 26.79%

Oncology 558 569 562 -1.23% Orthoptics/Peds.Ophthalmology 6,376 6,202 6,013 -3.05% Prosthetics 218 205 146 -28.78% Refraction 5,309 5,059 4,039 -20.16% Retina 5,425 5,702 6,870 20.48% Specular Microscopy 16 1 (94)% Uveitis 1,932 2,120 10% Visual Fields 960 923 (4)% TOTALS 86,822 86,088 (.08)%

AMBULATORY CARE SERVICE 11 COMPARATIVE STATISTICS

SPECIALTY SERVICES

The New York Eye and Ear Infirmary provide specialty services related to ophthalmology and ototolaryngology including medical, neurology and plastic cosmetic services. There was an overall decrease of 22% in specialty visits mainly attributable to plastic cosmetic clinic that had a 51% decrease in patient visits in 2006 as compared to 2005. This is a significant change in this service considering that there was a 76% increase in visits in 2005 over 2004.

SPECIALTY 2003 2004 2005 % CHANGE 2004 2005 2006 % CHANGE

Diabetic* 263 238 208 (13)%

Medical 1,816 1,831 1,661 (9)% 1,831 1,661 1,574 -5.24% Employee Medical 63 90 43% 63 90 124 37.78%

Neurology 454 384 364 (5)% 384 364 342 -6.04% Plastic Cosmetic 435 462 812 76% 462 812 395 -51.35% TOTALS 3,006 2,978 3,135 5% 2,978 3,135 2,435 -22.33%

Diabetic clinic was closed on 10/1/05 and patients were referred to medical clinic.

STAFFING

The FTE staffing to support the Ambulatory Care Division is as follows:

DEPARTMENT FTE’S PT PERDIEM TOTAL 2005 FTE’S PT PERDIEM TOTAL 2006

Physician Assistant ENT 3.0 0 0 3.0 3.0 0 0 3.0

Orthoptics 4.0 1.6 0 5.6 4.0 1.6 0 5.6 Glaucoma 7.0 0 0.24 7.24 7.0 0 0.24 7.24 Clinic Receptionists* 14.9 0 4.06 18.96 12.0 0 5.10 17.10

Nursing** 26.0 0.2 3.14 29.34 26.0 0.2 3.14 29.34 Retina 11.0 0.8 1.0 12.8 12.0 0.6 0 12.6 TOTALS 65.90 2.6 8.44 76.94 64.00 2.4 8.48 74.88

* 2 FTE receptionists were added – 1 additional in the Phone Bank and 1 to do authorizations.

** 1 FTE IC/EHS Coordinator added to staffing

12 THE NEW YORK EYEAND EAR INFIRMARY OPHTHALMOLOGY ASSOCIATES COMPARATIVE STATISTICS

ACHIVEMENTS FOR 2006

• Form Fast implemented in Orthoptics and Ophthalmology

• Resident appointment schedules revised to better meet the demand for appointments

• Encouraged patients to make appointments instead of walking in to be seen without an appointment.

• Obtaining pre certifications on all patients prior to surgery.

• Surgical schedulers using MMF to send patient documents to admitting.

• Pediatric crash carts added to department’s emergency equipment.

• Implemented facility billing.

• Software for Infection Control (AICE) and EHS (RESPOND) obtained in order to have information organized and the ability to obtain statistical reports. Software creates interface with safety and human resources so that data is consistent.

• Language Assistance Program formalized and federal/state mandates implemented.

• Increased administration of flu vaccine doses by 100% over 2005.

• Restructured EHS resulting in improved confidentiality for employees.

GOALS FOR 2007

• Be able to focus more on clinical and operational issues.

• Implement Form Fast in ENT and Glaucoma.

• Develop Electronic Medical Record

• Continue to work with nursing staff to improve nursing documentation.

• Hire RN to oversee nursing clinical practice and patient discharge process in ophthalmology area A.

• Continue improvement of ophthalmology surgical scheduling processes.

• Complete entering data for AICE and RESPOND.

• Change remote sign language interpretation vendor.

AMBULATORY CARE SERVICE 13 COMPARATIVE STATISTICS

PERFORMANCE IMPROVEMENT

SUMMARY FOR 2006

• Laser procedures and documentation compliance in Glaucoma and Retina continue to be monitored.

• Medication reconciliation process for pre op patients continues...

• Monthly monitoring for hand hygiene compliance is being performed.

• Continued to monitor multi dose eye drops for contamination.

PLANS FOR 2007

• Improve process for Continuous Survey Readiness for JCAHO

• Develop criteria to determine which patients should see an RN prior to discharge from ambulatory care area.

• Improve nursing documentation

• Develop nursing research projects

Reports from Glaucoma, Ophthalmology, Orthoptics, Otolaryngology, Retina, Infection Control and Ambulatory Care Revenue Management are attached.

14 THE NEW YORK EYEAND EAR INFIRMARY OPHTHALMOLOGY ASSOCIATES AMBULATORY CARE SERVICE 15

COMPREHENSIVE OPHTHALMOLOGY SERVICE

he Comprehensive Ophthalmology (General) Service runs 11 clinic sessions (including Saturday morning) and five surgical sessions each week. Patients are seen on both a walk-in T and appointment basis for a wide variety of ophthalmic conditions, both emergent and routine. After being assessed in the Comprehensive Clinic, patients with complex conditions are sent for further evaluation in our subspecialty clinics. 5 to 12 resident physicians staff clinic sessions and 2 to 4 attending physicians, including an Associate Clinical Director who is responsible for supervising patient care as well as administrative and teaching activities.

Attending physicians serve as the backbone for the patient care and resident teaching performed in the Comprehensive Clinic. They continue to maintain the Infirmary as a world-class institution for resident education and ophthalmic medical and surgical care. In addition to their clinic responsibilities, attending physicians staff resident surgical cases on a rotational basis.

In 2006, nearly 26,000 outpatient visits occurred through the Comprehensive Ophthalmology Service. Over 670 surgical procedures were performed including 530 cataract extractions, 110 pterygium excisions, secondary intraocular lens insertions, and YAG laser posterior capsulotomies. In addition, 281 procedures were performed in the clinic’s minor surgical suite.

In 2005, over 30,000 outpatient visits took place through the Comprehensive Ophthalmology Service. Over 700 surgical procedures were performed including 620 cataract extractions, secondary intraocular lens placements, 80 pterygium excisions, and YAG laser posterior capsulotomies. In addition, 266 procedures were performed in the clinic’s minor surgical suite.

A variety of clinical research projects has been conducted through the Paul A. Sidoti, MD Comprehensive Service. Participation in clinical trials of new medical and surgical therapies helps to maintain the Infirmary on the cutting edge of eye care and enhances resident education. ADMINISTRATIVE DIRECTOR ASSISTANT DIRECTOR COORDINATOR Paul A. Sidoti, MD Anne Ko, M.D. Annemarie Dahl

ASSOCIATE CLINICAL DIRECTORS John M. Aljian, MD Steven P. Koenig, MD Peter Schwartz, MD Abha Amin, MD Richard D. Lester, MD Glenn Silbert, MD Neal H. Brown, MD Richard B. Rosen, MD Jeffrey Spitzer, MD Elliott M. Feinman, MD Lois M. McNally, MD Edward A. Griggs, MD Michael E. Rosenberg, MD ATTENDING SURGEONS Therese Alban, M.D. Douglas Grayson, M.D. Mark Reynolds, M.D. Jessica L. Barest, MD Jack Greenberg, M.D. Alexander Ricci, M.D. Barbara Barker, M.D. Robyn Horowitz, M.D. Allen Rubin, M.D. Anna Boyman, M.D. Terry Kaiura, M.D. C. Michael Samson, M.D. Peter Breingan, M.D. Noah Klein, M.D. Susan Schneider, M.D. Douglas Buxton, M.D. Richard Koplin, M.D. Marc Sirota, M.D. Phillip J. Calenda, M.D. Oscar Kranz, M.D Marla Sultan, M.D. Roberto Cavalieros, M.D. Stephen Kronenberg, M.D. Mark Tannenbaum, M.D. Nancy Coles, M.D. Sean Lalin, M.D. Theresa Tretter, M.D. Richard Deluca, M.D. Joan Li, M.D. Joseph Walsh, M.D. Harry Faivus, M.D. Seth Meskin, M.D. Dina Weintraub, M.D. Howard Fiedler, M.D. Henri Michaud, M.D. Jonathan Weyne, M.D. Gregory Gallousis, M.D. Liselotte Pieroth, M.D. Sherry Yang, M.D. Jay Galst, M.D. Alfonso Ponce, M.D. Alyson Yashar, M.D. Andrew Gewirtz, M.D. Almerindo Portfolio, M.D. Rumei Yuan, M.D

COMPREHENSIVE OPHTHALMOLOGY SERVICE 17

CORNEA AND REFRACTIVE SURGERY SERVICE

The Cornea and Refractive Surgery Service at The New York Eye and Ear Infirmary provides clinical, research, and training programs on a number of levels to attending staff, T fellows, residents, and medical students. The Infirmary has the therapeutic and diagnostic capabilities to manage all disorders pertaining to the anterior segment of the eye. All aspects of anterior segment imaging are available such as corneal topography (Orbscan and Tomey), high frequency ultrasound biomicroscopy, digital specular microscopy and pachymetry, optical coherence tomography, and confocal microscopy. Management of patients with infectious of the eye is an important function of the service and patients are referred to us from all parts of the north- east and beyond. We are currently involved in numerous clinical trials of new therapies and antimicrobials for the treatment of infectious diseases of the eye. The microbiology laboratory, under the direction of Mr. Mahendra Shah, is one of the most active in the country and is able to handle diagnostic specimens for all infectious diseases of the eye. Our surgeons undertake complex and tertiary care of patients with anterior segment disorders such as penetrating and lamellar keratoplasty, high-risk keratoplasty, complications from cataract surgery, trauma, and anterior segment reconstruction. Newer techniques such as the artificial cornea and keratoprosthesis, limbal stem cell trans- plantation, deep lamellar keratoplasty and intracorneal rings (Intacs) are routinely performed. A newly formed Dry Eye John A. Seedor, MD Clinic will provide patients with this very common disorder the latest in diagnostic and therapeutic modalities. Educational programs on the basic sciences in corneal and refractive surgery are scheduled throughout the year for both residents and attending physicians. A schedule of these lectures can be obtained through the Resident Education Office.

RESIDENT TRAINING

Cornea, External Disease, and Refractive Surgery Clinics are conducted three half-days per week concurrently with a Contact Lens Clinic. Approximately 2,500 patients are seen per year in the Cornea Clinic, and 1,500 patients in the Contact Lens Clinic. Resident clinics and surgery are staffed at all times by an attending physician. All of our attending staff has completed fellowship training in corneal and refractive surgery. Instruction in the surgical treatment of corneal diseases includes lectures and wet-lab courses given in our microsurgical laboratory. Non-emergent corneal surgery is regularly scheduled one day per week. Residents also receive external, extensive training in Laser Vision Correction, including lectures and attendance at laser and keratome courses throughout the year. Residents will have the opportunity to perform laser vision correction procedures, and will achieve certification in these techniques prior to the end of their residency.

Residents and fellows are encouraged to initiate and complete research projects in either the clinical or basic sciences. Numerous abstracts, presentations, and manuscripts are generated annually and accepted in peer review journals.

The Cornea and Refractive Surgery Service also sponsors a series of 16 one-hour lectures covering all areas of the specialty. Following this series of lectures, an examination prepared by the attending staff is administered to each resident and reviewed individually. In addition, a Cornea Service conference is held once monthly where case presentations and OKAP review is undertaken. All educational activities and schedules pertaining to the Cornea Service can be accessed on the Infirmary website or at www.nyeecorneaservice.com.

CORNEAAND REFRACTIVE SURGERY SERVICE 19 FELLOWSHIP

The Cornea and Refractive Surgery Service accepts one or two Clinical Fellow(s) per year who must have satisfactorily completed an accredited ophthalmology residency program. The fellow participates in the clinical and surgical practice of cornea, external disease, and refractive surgery and is involved in the Cornea and Refractive Surgery Research Program.

CORNEA AND REFRACTIVE SURGERY SERVICE Director Assistant Director John A. Seedor, MD David C. Ritterband, MD

ATTENDING STAFF John Aljian, MD Abha Amin, MD Anna Boyman, MD Mary Davidian, MD Maria Hernandez, OD Anne Ko, MD Evan Kaplan, OD Robert Latkany, MD Joan Li, MD Sid Mandelbaum, MD Kira Manusis, MD Richard Najac, MD Jai Parekh, MD Tal Raviv, MD Michael Rosenberg, MD Daniel Shapiro, MD Mark Speaker, MD Laurence Sperber, MD Anthony Terraciano, MD Terry Kaiura, MD

20 THE NEW YORK EYEAND EAR INFIRMARY CORNEAAND REFRACTIVE SURGERY SERVICE 21

GLAUCOMA SERVICE

n 2006, the Glaucoma Service, under the direction of Robert Ritch, MD, Professor of Clinical Ophthalmology and Chief of the Glaucoma Service, and Celso Tello, MD, I Assistant Professor of Clinical Ophthalmology and Associate Director, continued its local, national and international leadership in research, education, advancing diagnostic and treatment modalities for all forms of glaucoma.

GLAUCOMA SERVICE PERSONNEL

Facility

Robert Ritch, MD Professor of Clinical Ophthalmology Chief, Glaucoma Service Surgeon Director, New York Eye and Ear Infirmary New York Medical College

Celso Tello, MD Assistant Professor of Clinical Ophthalmology Associate Director, Glaucoma Service New York Eye and Ear Infirmary New York Medical College

Robert Ritch, MD ADULT GLAUCOMA CLINIC ATTENDING PHYSICIANS AND SURGEONS 2005-2006 2006-2007 Abha Amin, MD Abha Amin, MD Gregory Gallousis, MD Natalia Elkin, MD Lisa Gamell, MD Lisa Gamell, MD Ronald Hagadus, MD Ronald Hagadus, MD Kerline Marcellin, MD Kerline Marcellin, MD John McDermott, MD John McDermott, MD Seth Potash, MD Seth Potash, MD Morris Podolsky, MD Morris Podolsky, MD Robert F. Rothman, MD Robert Ritch, MD Robert Rothstein,MD Robert F. Rothman, MD Ed Schottenstein, MD Robert Rothstein,MD Paul Sidoti, MD Ed Schottenstein, MD Kevin Stewart, MD Paul Sidoti, MD Mark Tannenbaum, MD Kevin Stewart, MD Celso Tello, MD Mark Tannenbaum, MD Thaddeus Wandel, MD Celso Tello, MD Celso Tello, MD David Witzel, MD David Witzel, MD

PEDIATRIC GLAUCOMA CLINIC ATTENDING PHYSICIANS AND SURGEONS 2005-2006 2006-2007 Paul Sidoti, MD Steven Kane,MD Celso Tello, MD Paul Sidoti,MD Celso Tello, MD

GLAUCOMA SERVICE 23 GLAUCOMA SERVICE

CLINICAL FELLOWS

June 2005-June 2006 June 2006-June 2007 Edgar Espana, MD Gaurang Trivedi, MD Noga Harizman, MD Miguel Unzueta, MD William Kelly, MD Bonnie Woo, MD Michael Pro, MD Maher Zbeity, MD

RESEARCH FELLOWS Rodrigo Barros, MD Syril Kumar Dorairaj, MD Tomas Grippo, MD – 2004-2006 Fabio Kanadani, MD Boonchai Wangsupadilok, MD

CLINICAL FELLOWS AT COMPLETION OF TRAINING

July 2005 July 2006 Dr. Yaniv Barkana Edgar Espana, MD Assistant Professor of Ophthalmology at Ophthalmology Residency, Tel-Aviv University and Attending Surgeon at University of Mississippi Asaf-Harofe Hospital in Israel Noga Harizman, MD Dr. Jashua Kim Fellowship in Cornea and Refractive Surgery, Joined private practices in Sarasota Florida New York Eye and Ear Infirmary Dr. Wisam Shihadeh William Kelly, MD Accepted position as a Cornea and Refractive Joined a Private Practice in Boca Raton, Florida Fellow at Tulane University Michael Pro, MD Joined the Faculty Practice of Wills Eye Hospital, Philadelphia

INTERNATIONAL FEDERATION OF OPHTHALMOLOGICAL SOCIETIES/INTERNATIONAL COUNCIL OF OPHTHALMOLOGY FELLOWS

2005-2006 2006-2007 Zhang Chun, MD, PhD, Beijing, China Saulius Galgauskas, Vilnius, Lithuania Wisam Shihadeh, MD, Irbid, Jordan Sergiu Gribonosov, Tirapol Moldavia Nazrul Islam, Bangladesh Bruno Figueiredo, Brazil Zia Aamoon, Afghanistan Nilo FlorCruz II, Philippines Balt Javzandulam, Mongolia Zia Aamoon, MD, Mazar-i-Sharif, Afghanistan INTERNATIONAL OBSERVERSHIPS

2005-2006 2006-2007 Konacio Manzitti, MD Tutul Chakravarti, MD Buenos Aires, Argentina, Jan-Feb 2005 Kolkata, India, Jan 2006 Nazrul Islam, MD Salem Abu Al Ghanam, MD Dhaka Bangladesh, August 2005 Amman, Jordan, March 2006

24 THE NEW YORK EYEAND EAR INFIRMARY GLAUCOMA SERVICE

INTERNATIONAL OBSERVERSHIPS

2005-2006 2006-2007 – IFOS/ICO, Sept – Dec 2005 Jemaima Binti Che Hamzah, MD Kuala Lumpur, Malaysia, May – June 2006 Carlos Biancietto, MD Ciudad Rivadavia, Argentina, July 2006 Alberto Chocron, MD Caracas, Venezuela, August 2006

MEDICAL STUDENTS THAT ROTATED THROUGH GLAUCOMA SERVICE

2005-2006 2006-2007 Inna Zhitomirsky Jack Manns NYU School of Medicine Albert Einstein College of Medicine Yevgeniy Shildkrot Siddhart Mehta NYU School of Medicine St. George’s University Grenada, West Indies School of Medicine Nikola Ragusa Danli Xing New York Medical College Robert Wood Johnson Medical School, NJ Ross Blair Lawson MacIntyre Swathi Reddy New York Medical College New York Medical College, Valhalla, NY Sanaz Harirchian NYU School of Medicine Isaac Ezon NYU School of Medicine Josh Chung Chi Yu Albert Einstein College of Medicine Kin K. Yee St. George's University S.O.M., Grenada Robert James Peralta NYU School of Medicine Sushma Kandula Northeastern Ohio University College of Medicine Nicole Hauptman NYU School of Medicine Allen Chang NYU School of Medicine

DIRECTOR OF CLINICAL RESEARCH

2005-2006 2006-2007 Elena Ilitchev, MD Elena Ilitchev, MD

RESEARCH FELLOWS

June 2005-June 2006 June 2006-June 2007 Rodrigo Barros, MD Stella Arthur, MD Syril Kumar Dorairaj, MD Syril Kumar Dorairaj, MD Tomas Grippo, MD Alexander Llinas, MD Fabio Kanadani, MD Boonchai Wangsupadilok, MD

GLAUCOMA SERVICE 25 GLAUCOMA SERVICE

NATIONAL INSTITUTE OF HEALTH CLINICAL TRIALS/COORDINATORS

2005-2006 2006-2007 African Descent and Glaucoma Evaluation Study African Descent and Glaucoma Evaluation Study (ADAGES) (ADAGES) Oliver Anteguera, MD • Oliver Anteguera, MD • Janice Wen, BS • Yokasta Abrev, MD Ocular Hypertension Treatment Study (OHTS) Ocular Hypertension Treatment Study (OHTS) • Jean Walker, BS, COA • Jean Walker, BS, COA • Nina Mondoc, MD • Nina Mondoc, MD CD – 44 Receptor In Aqueous Humor In Glaucoma CD – 44 Receptor In Aqueous Humor In Glaucom • Nina Mondoc, MD • Nina Mondoc, MD • John Purcell, BA Mechanical Interaction between Aqueous Humor and Iris Mechanical Interaction between Aqueous Humor • Syril Kumar Dorairaj, MD and Iris • Syril Kumar Dorairaj, MD

DIRECTOR OF CLINICAL RESEARCH

Elena Ilitchev, MD

SURGICAL TRIALS/COORDINATORS

2005-2006 2006-2007 CAT, SLT/MEDs SOLX Laser, SOLX Laser, SOLX Gold Shunt SOLX Gold Shunt • Oliver Anteguera, MD • Ricardo Mora, MD Genetic studies Genetic studies Stem cells studies Stem cells studies • Nina Mondoc, MD • Nina Mondoc, MD • John Purcell, BA

INDUSTRY SPONSORED STUDIES/COORDINATORS

2005-2006 2006-2007 Memantine study (Allergan) Xalacom study ( Pfizer) Xalacom study (Pfizer) • Nina Mondoc, MD • Nina Mondoc, MD • John Purcell, BA Inspire Study Genentech • John Purcell, BA Anecertave Study • John Purcell, BA • Jean Walker, BS, COA.

26 THE NEW YORK EYEAND EAR INFIRMARY GLAUCOMA SERVICE

STUDIES SUPPORTED BY NEW YORK GLAUCOMA RESEARCH INSTITUTE (NYGRI)

All studies conducted by research and clinical fellows (see below).

IMAGING STUDIES/COORDINATORS

2005-2006 2006-2007 GDx and OCT in Neuro-ophthalmology GDx and OCT in Neuro-ophthalmology Other imaging studies Other imaging studies • Auris Brown, MD • Auris Brown, MD Ultrasound Biomicroscopy studies • Syril Kumar Dorairaj, MD

DIRECTOR, GLAUCOMA TECHNICAL SERVICES

2005-2006 2006-2007 Arthur Tortorelli Arthur Tortorelli

SCOPE OF SERVICE OFFERED

The Glaucoma Services Department provides a full range of services for the diagnosis, treatment, and management of glaucoma for adult and pediatric patients. The services include examination in the glaucoma clinic, visual field tests utilizing the Humphrey Field Analyzer and the Goldmann Perimeter, and laser surgery utilizing the Novus 2000 Nd: YAG 7901 combined Argon/YAG laser, which was replaced with the Nidek YC1800/GYC-1000 argon/YAG combo laser in December. Select Laser Trabeculoplasty (SLT) is also offered as a laser treatment option. However, because of space limitations, the laser is located in the Retina Center.

STATISTICS

16,191 patient visits were made to the department during 2006. The statistical analysis for 2006 is listed below along with data for 2005 for comparison purposes.

2005 2006

GLAUCOMA CLINIC 10,373 10,182 GLAUCOMA LASER 666 716 HUMPHREY V.F.

Clinic 3,287 3,442 Private referred 331 231

House Cases 3 3 TOTAL 3,621 3,678 GOLDMANN V.F.

Clinic 912 1,159 Private referred 385 456

House Cases 3 2 TOTAL 1,300 1,615 DEPARTMENT TOTAL 15,960 16,191

GLAUCOMA SERVICE 27 GLAUCOMA SERVICE

MAJOR ACHIEVEMENTS FOR 2006

• Dr. Natalia Elkin was hired as a full time attending physician in the glaucoma clinic, sharing leadership responsibilities with Dr. Kevin Stewart. • Hired a per diem ophthalmic technician to perform Goldmann visual fields. • Re-established the Glaucoma Surgical Evaluation clinic.

MAJOR GOALS FOR 2007

• Continue to hire full and part time attending physicians to staff the glaucoma clinic. The department continues to experience attending physician issues including adequate coverage on certain days. • Our most important goal, however, remains continuing to find ways to increase production while decreasing expenses. The goals listed above are intended to help achieve this. • Established the first outside program use of the Jorge N. Buxton, M.D. Microsurgical Laboratory.

PERFORMANCE IMPROVEMENT ACTIVITIES FOR 2006

• Revised the glaucoma patient schedule to reduce and eliminate add-on appointments. • Hired another full time attending physician to oversee all clinical activities and to stabilize the glaucoma clinic Attending staff. • Hired a per diem ophthalmic technician to address the nine week backlog of Goldmann visual fields patients. This resulted in reducing the backlog to no more than a one week period. In addition, the number of patients seen for this test by more than 24% compared to 2005. • Established new ear surgery, head and neck anatomy and sinus surgery courses in the new microsurgical laboratory. • Conducted the first post graduate ear surgery course since 1995. • Revised the ophthalmology resident’s eye surgery-training program. • Revised the pictorial of medications to facilitate patient use of multiple anti-glaucoma- tous medications. • Replaced the glaucoma clinic laser with a state of the art combo laser.

PERPERFORMANCE IMPROVEMENT ACTIVITES PLANNED FOR 2007

• Hire another full time attending physician to supervise clinical activities and further stabilize the Glaucoma clinic attending physician staff. This will improve the continuity of patient care and level of residency education. • Establish an SLT laser clinic on a permanent basis. Perhaps relocate the laser from the Retina Center to the Glaucoma Clinic • Continue to expand microsurgical course activities for post-graduate education in otolaryngology, ophthalmology and plastic surgery. • Continue to expand the Laboratory activities for outside programs to utilize the facility for a fee. • Continue performance improvement activities related to patient care services and insure that all Joint Commission National Patient Safety Goals are addressed.

28 THE NEW YORK EYEAND EAR INFIRMARY GLAUCOMA SERVICE

RESIDENT EDUCATION

Glaucoma comprises a group of related disorders that are diagnosed and differentiated based upon particular characteristics of the slit-lamp examination, anterior chamber angle architecture, optic nerve head appearance, visual function and other clinical findings. At the core of the clinical teaching program is the emphasis on the residents becoming facile with the techniques of gonioscopy, slit-lamp examination, stereo disc ophthalmoscopy and imaging of the anterior chamber angle, optic nerve and nerve fiber layer. The Infirmary Glaucoma Clinic continues to be a major referral center for congenital glaucoma, juvenile glaucoma and all other forms of unusual forms of glaucoma. Ophthalmology residents are introduced to complicated glaucoma and more unusual, difficult surgical procedures such as trabeculectomy with mitomycin C, non-penetrating viscocanalostomy, angle surgery (Goniotomy and Trabeculotomy) and glaucoma implant surgery. The glaucoma lecture series was extremely effective in attracting top quality lecturers from both within the New York Eye and Ear Infirmary and from outside institutions. Sixteen separate topics were covered including basic anatomy, ocular physiology, and glaucoma detection, review of glaucoma clinical trials and screening and approaches to surgery. The glaucoma section of the Infirmary's Ophthalmology Knowledge Assessment Program Board Review Course was well received. Our residents had the opportunity to participate in national and local glaucoma meetings which were organized and directed by members of the glaucoma service. The Glaucoma Visiting Professor Lecture Series were well attended and it gave the opportunity to general ophthalmologist, ophthalmology residents, glaucoma specialist and ophthalmic technologist to review the most updated information on basis sciences, research and clinical and surgical treatment of glaucoma. Other meetings that our residents had the opportunity to participate include the Association for Research in Vision and Ophthalmology, Pan-American Academy of Ophthalmology and the American Academy of Ophthalmology. In these meeting, our Resident had the opportunity to present their research carried out through out the Academic year and also attend several lectures and courses related to underlying pathophysiology of the glaucoma and other topics about medical and surgical treatment of glaucoma. The wet-lab in our facility is used to introduce and train our second year residents prior real surgery takes place during their third year of training. Our Glaucoma Fellows also had the opportunity to utilize the wet-lab facility to train routine glaucoma surgery as well as to be introduced and trained in new surgical procedures to control glaucoma

GLAUCOMA CLINICS

Glaucoma Clinic is held seven sessions weekly and is staffed by three residents on rotation and two or three attending physicians. The second and third year residents remain on the service for six consecutive weeks. First-year residents rotate throughout the year. The Glaucoma Clinic functioned smoothly throughout the year in Area B. In 2005, 10,373 glaucoma patients were examined and treated. In 2006, 10,182 glaucoma patients were examined and treated. Pediatric glaucoma clinic, under the supervision of Drs. Sidoti and Tello continues to attract a wide range of patient pathology and provides a continuous flow of congenital glaucoma which

GLAUCOMA SERVICE 29 GLAUCOMA SERVICE

enhances resident education. The concentration of these patients in a subspecialty clinic allows for continuity of care and increased attention to the myriad refractive, motility, and other problems these children face. All emergency cases on the glaucoma service have been successfully cared for by our on-call team: Drs: Lisa Gamell, Robert Ritch, Paul Sidoti, Kevin Stewart, Celso Tello and David Witzel.

RESIDENT GLAUCOMA SURGERY

The second year resident assigned to the glaucoma clinic performs glaucoma clinic laser surgery. Elective surgery is scheduled for Monday afternoons and is supervised by an attending surgeon. More than 700 glaucoma laser surgeries were performed in 2005 consisting of laser iridectomy, trabeculoplasty, and iridoplasty. In 2006, more than 800 glaucoma laser surgeries were performed, primarily: laser iridotomy, trabeculoplasty, and iridoplasty. The senior resident assigned to the glaucoma service performs intraocular glaucoma surgery. During 2005, over 300 surgeries were performed, in 2006 over 350 surgeries were performed which consisted primarily of filtering surgery with or without antifibrosis chemotherapy, seton implantation, cyclodestructive procedures, combined cataract and glaucoma surgery, angle surgery (trabeculotomy and goniotomy), transconjunctival needling revisions and clear corneal cataract extraction in the presence of a filtering bleb with or without antifibrosis therapy

GLAUCOMA TECHNICAL SERVICES

Glaucoma technical services, directed by Mr. Arthur Tortorelli, continue to expand in the numbers of services provided and performed. At the current time two Goldmann and two Humphrey perimeters run full-time, 6 days per week. In 2005, 3,621 computerized fields and 1,300 Goldmann visual fields were obtained, continuing the shift towards automation and computerization. In 2006, 3,678 computerized fields and 1,602 Goldmann visual fields were obtained, continuing the shift towards automation and computerization. Currently, besides Mr. Tortorelli, the glaucoma technical staff consists of three full-time technicians, Mrs. Sarah Nunez, Ms. Kim Ramsauer, Mrs. Patricia Wong. An additional full time position is currently being recruited. In addition, one per diem technician, Ms. Jean Walker, recently joined the team.

BASIC RESEARCH

Isolation of cell lines from ocular tissues from eyes with exfoliation syndrome, three-dimensional tissue culture of Tenon’s capsule fibroblasts, and biochemical analysis of the exfoliation material was a collaborative work with the laboratory of Jorge A. Ghiso, PhD, Associate Professor, Department of Pathology, New York University School of Medicine. Other collaborations involved study of concentration of cytokines in aqueous humor in glaucoma, with Paul Knepper, MD, Northwestern University School of Medicine, Chicago, and isolation of stem cells from human trabecular meshwork in collaboration with Ting Xie, PhD, Associate Scientist at Stowers Institute, Kansas City. Our comprehensive glaucoma genetics program (Studies of Hereditary Eye Diseases) accelerated in the last several years. This included collaborations with Julia Richards, PhD (University of Michigan, Ann Arbor), Mansoor Sarfarazi, PhD (University of Connecticut, Storrs), Simon John, PhD (The Jackson Laboratory at the Howard Hughes Medical Institute, Bar Harbor,

30 THE NEW YORK EYEAND EAR INFIRMARY GLAUCOMA SERVICE

ME), Michael Walter, PhD, (University of Alberta, Edmonton) Calvin Pang, MD (Chinese University of Hong Kong, China), Vincent Raymond, PhD (Laval University, Quebec City), and Ernst Tamm, MD, PhD (University of Erlangen-Nürnberg, Germany). More than 800 were enrolled in genetic studies designed to search for the genes responsible for various glau- coma.

OCULAR IMAGING

Ultrasound biomicroscopy, optical coherence tomography, scanning laser ophthalmoscopy and scanning laser polarimetry are providing the basis for a better understanding of the glaucoma. The results of numerous research projects have been presented in the United States and worldwide. The results of these studies helped to optimized software in imaging equipment and to create new, more efficient versions of software and new imaging machines. Clinical human studies and basic science studies using cadaver and chick eyes using ultrasound biomicroscopy have made the Infirmary the international leader in this technology. Key projects have involved the pathophysiology and treatment of angle-closure glaucoma, pigment dispersion syndrome, ocular tumors, ocular trauma, ciliary body architecture, and uveitis. Quantitative evaluation of ultrasound biomicroscopic images, including in vivo angle configuration, iris volume, and tissue density, is rapidly evolving. Drs. Cristiano De Oliviera and Syril Kumar Dorairaj were the research fellows in charge of ultrasound biomicroscopy.

NATIONAL EYE INSTITUTE COLLABORATIVE, MULTI-CENTER, CLINICAL TRIALS

OCULAR HYPERTENSION TREATMENT STUDY (OHTS)

The OHTS, chaired by Dr. Michael Kass, St. Louis, Missouri, randomizes patients with newly diagnosed ocular hypertension (defined as elevated IOP, normal visual fields, and normal optic nerve) to either close observation or medical therapy to lower IOP. The goal of the project was to determine whether early treatment of ocular hypertension prevents or delays the onset of glaucoma. This multi-center project began recruitment in March 1994 and will last approximately 15 years. The total of 1636 patients had been enrolled in this trial. Dr. Liebmann is the principal investigator and Drs. Ritch and Tello are the Co-investigators at NYEEI site. A number of manuscripts have been published from this study. The five years follow up concluded that reduction of IOP in OHT does prevent or delay the development of POAG by 50%. It was found that baseline age, vertical and horizontal cup-disk ratio, pattern standard deviation, intraocular pressure are good predictors for the onset of POAG. Central corneal thickness was found to be a powerful predictor for the development of POAG. The study will continue for several more years to further determine the long-term effect of lowering IOP in preventing or delaying POAG in patients with OHT.

ANCILLARY OHTS: CONFOCAL SCANNING LASER OPHTHALMOSCOPY OF THE OPTIC DISC (OHTS-CSLO/HRT).

AFRICAN AMERICANS WITH GLAUCOMA: STRUCTURE AND FUNCTION (AAG)

This multi-site study, chaired by Dr. Pamela Sample, University of California, San Diego, is designed to obtain visual function and optic nerve structure data on eyes of African Americans

GLAUCOMA SERVICE 31 GLAUCOMA SERVICE

and Caucasians. Glaucoma is the leading cause of irreversible blindness in African Americans and occurs at least 5 times more often in African Americans than in Caucasians. Dr.Jeffrey Liebmann is the Principal Investigator in this study at NYEEI and Drs.Ritch and Tello are co- investigators. The recruitment in this multi-center clinical trial started in February 2003. More than 600 patients and normal volunteers had been enrolled up-to-date at NYEEI site. The enrollment is almost completed. The study will continue for a few more years.

MECHANICAL INTERACTION BETWEEN AQUEOUS HUMOR AND IRIS

In this study a series of UBM experiments on the dynamic effect of accommodation on iris contour in eyes with convex irides (pupillary block) and concave irides (pigment dispersion syndrome) will be performed. During 2005 we continued to enroll patients and collect in this NIH sponsored clinical trial, our collaborative project with Dr.Victor Barocas, Assistant Professor of Biomedical Engineering and Director of Graduate Studies for Biomedical Engineering at University Of Minnesota, Minneapolis, MN.

OTHER COLLABORATIVE MULTI-CENTER CLINICAL TRIALS:

1. Ancillary OHTS: Confocal Scanning Laser Ophthalmoscopy of the Optic Disc (OHTS-CSLO/HRT).

2. CD-44 Receptor in Aqueous Humor in Glaucoma

3. The International Collaborative Exfoliation Syndrome Treatment Study (ICEST).

4. A multi-center, randomized open label study to compare subconjunctival injections of CAT-152 human anti – GFB2 monoclonal antibody with an intraoperative sponge application of 5-FU following first time trabeculectomy was completed in 2005.

5. Accumap Glaucoma Detection study helped to collect data for developing new version of AccuMap in Australia.

6. Initial Treatment For Open Angle Glaucoma: A prospective Randomized Clinical

7. Trial Comparing Topical Medical Therapy with Selective Laser Trabeculoplasty.

8. Titanium sapphire laser trabeculoplasty is a multi-center FDA control study to evaluate a new laser for glaucoma treatment.

Many studies designed and conducted by research and clinical fellows under Drs. Ritch, Liebmann and Tello supervision were sponsored by the New York Glaucoma Research Institute. A lot of data were collected and analyzed.

THESE CONTINUOUS STUDIES INCLUDE:

1. Intraocular Pressure and Ocular Pulse Amplitude Measurements in Patients with Thin and Thick Corneas Using Pascal Dynamic Contour Tonometer.

2. Is Measurement Of Eye Axial Length In Patients Who Have Undergone Trabeculectomy More Accurate With The Non-Contact IOL-Master Compared With Ultrasound Biometry.

3. The effect Of Intra Ocular Pressure Changes on Optic Disc Topography and Retinal Nerve Fiber Layer Thickness.

32 THE NEW YORK EYEAND EAR INFIRMARY GLAUCOMA SERVICE

4. Evaluation of patients with optic nerve head drusen (ONHD) using both functional and structural tests. Dr.Ritch and research fellows are working on organizing International ONHD Society.

5. Functional and Structural Testing For Optic Nerve Disease.

8. A Prospective Assessment of Nerve Fiber Layer Thickness in Subjects with Unilateral Pseudoexfoliation Syndrome.

9. Evaluation of Patients with Normal Field Studies and Nerve Fiber Layer Imaging.

11 Biometric Evaluation of Iridocorneal Angle and Ciliary Body of Patients with Narrow Angles.

12 Diagnosis of Exfoliation Syndrome by Imaging Exfoliation Material on Zonules Using Ultrasound Biomicroscopy in Patients with Poor Pupil Dilation.

13 Glaucomatous Damage in Patients Performing Yoga in the Inverted position.

One of the imaging studies “Scanning Laser Polarimetry (GDx) And Optical Coherence Tomography (OCT3) to detect changes in the Peripapillary Nerve Fiber Layer With Optic Nerve Damage” designed in collaboration with Dr. Kupersmith (Department of Neuro-oph- thalmology) was completed in 2005.

ELECTROPHYSIOLOGY AND GLAUCOMA.

Several important studies on Multifocal VEP visual field were done in very productive collab- oration with Donald Hood, PhD, Columbia University, and Vivienne Greenstein, PhD, New York University School of Medicine. The results were presented at ARVO, AAO and International conferences.

DRUG STUDIES

Ongoing clinical drug trials include evaluation of beta-blockers, prostaglandins, neuron protec- tors and alpha-agonists. In “Memantine” multi-center study “A 48-month Multi-Center, Randomized, Double-Masked Placebo- Controlled, Clinical Study to Evaluate the Effectiveness and Safety of Oral Memantine in Daily Doses of 20mg and 10mg in Patients with Chronic Open-Angle Glaucoma at Risk for Glaucomatous Progression” we are on the second place for enrollment in the world and on the first place in USA. This multi-center international clinical trial spon- sored by Allergan, Inc. is one of the biggest in ophthalmology. The project started at NYEEI in 1999. During 2005 the majority of the enrolled patients completed their 5-years participa- tion in this study.

GLAUCOMA SCREENINGS/PUBLIC SERVICE

New screening techniques for glaucoma was initiated at the Infirmary and preliminary results presented and published nationally. By adding a slit-lamp examination and visual Field (FDP) to glaucoma screening, the rate of detection of persons needing either treatment or continued follow-up was doubled. This finding has potentially important long-term implications for both cost effectiveness and preventive medicine in the area of glaucoma.

GLAUCOMA SERVICE 33 GLAUCOMA SERVICE

APPOINTMENTS AND AWARDS

Dr. Ritch was appointed Chairman of the Education Distribution Task Force and Member of the International Assistance Steering Committee at the American Academy of Ophthalmology. He also presented the Irving Leopold Lecture in Irvine, CA. He was Honorary President of the Beijing International Glaucoma Congress, Beijing, China, April 9-11, 2004, and Organizing Chairman of the Eleventh International Think Tank on Optic Nerve Rescue and Regeneration, New York, NY, Sept 10-11, 2004. He was appointed to the Advisory Board of the Association of ASEAN Eye Hospitals, the Executive Board of Faculty Advisors of Unite for Sight and the Board of Directors of the New York Eye and Ear Infirmary.

Dr. Tello was appointed Program Chairman of The New York Society for Clinical Ophthalmology and Editor for the Glaucoma Section of Techniques in Ophthalmology.

Dr. Tello also is a board member of the Education Distribution Task Force Committee at the American Academy of Ophthalmology.

34 THE NEW YORK EYEAND EAR INFIRMARY GLAUCOMA SERVICE

GLAUCOMA SERVICE 35

NEURO-OPHTHALMOLOGY SERVICE

Mark J. Kupersmith, MD

he Neuro-ophthalmology Service has approximately 1200 outpatient visits per year. This service diagnoses and manages most of these cases. The Service is responsible for more T than 100 patient admissions to the Infirmary and Beth Israel Hospital. Data from ongoing projects are being analyzed and abstracts from our investigations have and will be presented at national and international forums. Numerous manuscripts have been accepted for publication, submitted for publication, and are in preparation. Presentations and invited lectures have been made this year at the AAN, AAO, NANOS, EUNOS, ARVO in addition to lectures at hospitals and universities. Hilary Fazzone, MD joined the in the fall of 2005, establishing a second Neuro-ophthalmology clinic, in-patient teaching resident rounds, and significantly increasing the number of patients and consults

.

NEURO-OPHTHALMOLOGY SERVICE 37

OCULAR TUMOR SERVICE

s Chief of the Ocular Tumor Service of The New York Eye and Ear Infirmary, Dr. Paul T. Finger continues to bring established, new and innovative treatments for A patients with eye cancer. Since 1989, when he established The Ocular Tumor Service, we have become licensed to use radioactive ophthalmic plaques to treat intraocular tumors, employed chemotherapy for conjunctival neoplasia, and have pioneered new imaging techniques for intraocular, adnexal tumors and systemic cancers. 1995 saw the introduction of the ‘Finger Iridectomy Technique” used for anterior segment tumor biopsy, small (1 mm) incision iridectomy and Iridotomy. We also published on new “Finger-tip” cryotherapy probes used to treat conjunctival and corneal cancers, to extract orbital tumors and to aid enucleation surgery. The New York Eye and Ear Infirmary’s Ocular Tumor Service has taken the lead in the use of whole body FDG- PET/CT imaging stage patients with choroidal melanoma. These scans fuse the anatomic information provided by CT with the physiologic information seen with PET. For the first time, PET/CT puts form and function on the same diagnostic page. This technology is rapidly becoming the standard for staging patients with malignant melanoma. Our close associations with the Departments of Radiation Oncology of St. Vincent’s Medical Center and the Departments of Medical Oncology Paul T. Finger, MD, F.A.C.S. and Radiation Therapy of Beth Israel Medical Center continue to grow. Dr. Aaron Rauson provides pediatric oncology care for our children with retinoblastoma and other pediatric tumors. Drs. Hu, Tena and Ng offer excellence in radiation oncology. Drs. Iacob and McCormick provide education in review of cytology, histopathology and immuno- histochemical analysis. In close consultation with physicians within these departments, we have coordinated multi-specialty, state-of-the-art care for our eye cancer patients. But, most importantly, our mission is to teach. Under the direct supervision of Dr. Finger, our second year residents attend a 2-month rotation within the Ocular Tumor Service. During that time they examine, diagnose, and care for a variety of patients with ocular tumors. Each patient generates a discussion concerning the diagnosis and treatment of ocular tumors. We also discuss the elements of informed consent, which becomes very important in treatment of rare disorders. In addition, there are 5 hours of didactic lectures followed by a formal examination. Residents are expected to form a differential diagnosis, describe how that differential was made, and suggest and perform treatments. Patients with tumors of the conjunctiva, cornea, iris, retina, choroid, and optic nerve are treated within the Ocular Tumor Service. We see more than 23 patients on a typical, weekly, half-day session. Residents learn biopsy techniques, laser photocoagulation, cryotherapy, local resection, enucleation, intravitreal injection, vitrectomy, and ophthalmic radiation therapy. Dr. Finger is interested in promoting resident and fellow research activities. Manuscripts have been generated from unusual cases, reviews and basic science studies. Residents can become involved in one of the many original investigational protocols within the Ocular Tumor Service. The Ocular Tumor Service is looking forward to continued growth in our clinical volume, educational program, and research activities in 2007

Chief of Service Paul T. Finger, M.D., F.A.C.S.

OCULAR TUMOR SERVICE 39

OCULOPLASTIC AND ORBITAL SURGICAL SERVICE

he oculoplastic and orbital service has had an excellent and long tradition at New York Eye and Ear Infirmary. Indeed this subspecialty in ophthalmology began at the Infirmary under the lead- T ership of Dr. Maynard Wheeler in 1936 and continued with great distinction and guidance of Dr. Wendell Hughes, then Drs J Gordon Cole and John Simonton and while continuing under it present leadership since 1982. Dr. Bryon Smith, a resident and fellow at the Infirmary is a most distinguished alumnus at the Infirmary and legendary teacher of oculoplastic surgery. The mission of the New York Eye and Ear Infirmary of providing outstanding specialty care, resident and fellowship training has been effectively implemented on this service. We are pleased that 35 National fellows and over 65 international fellows have been trained at the Infirmary during the past thirty-five years. The great majority of international fellows have superb achievements as clinicians and directors of service in their respective countries. Over thirty-five countries have been represented by our international fellowship program. The national and international fellowship programs at the Infirmary remain vigorous and superb. In recent years several new attendings on the service are making positive contri- butions as teachers and clinicians. They include Drs. Debra Kroll, David Della Rocca and Keyvan Keyhani. The continued extraordinary contributions of the attendings and fellows on the service serves as a “beacon” of hope and care for many with complicated oculoplastic and orbital diseases and injuries. The com- plexity of patients’ disease and treatment is challenging and rewarding to all attendings, residents and fellows. We are grateful to clinic personnel for their dedication and support for the service. The dynamic mission of our service par- Robert Della Rocca, MD allels the Infirmary. We plan to increase availability and enhance web based teaching to international sites and institutions, implement expansion of the clinic “footprint” to develop a clinical information center and availability of imaging procedures within the clinic. The management of oculoplastic and orbital diseases and trauma is strengthened by interdisciplinary cooperation. In 2007 a textbook, “Atlas of Lacrimal Surgery” published by Springer, was edited by Drs Robert Della Rocca and Steve Schaeffer, chairman of Otolaryngology and Colleagues form Germany. David Della Rocca and Syed Ahmad fellow contributed to this work. A quarterly Journal Facial Plastic Surgery invited David Della Rocca to co-edit a quarterly edition for the Journal of Facial Plastic Surgery on the subject Ophthalmic Plastic Surgery. Many members of the service wrote articles for this Journal which was published in October 2007. Dr Anthony Sclafani of the Otolaryngology department is the editor of the journal. The positive association with the pathology, radiology and otolaryngology departments is meaningful to all. Frozen section technique developed by Dr. Steven McCormick has been most important in the treatment of malignant eyelid and adnexal tumors. We are a referral cen- ter for the treatment of these tumors. This cooperative work has led to recent completion and submis- sion of a paper “Excision of Periocular Basal Cell Carcinoma with Stereoscopic Microdisection of sur- gical Margins for Frozen Section Control: Report of 200 cases”, to the Journal of Ophthalmology after presentation was featured at the AAO in 2005. The service also looks forward to accumulation of the final data in the study of adiponectin levels in the various stages of thyroid related eye disease. Attendings and past fellows have continued to conduct prominent courses at the American Academy of Ophthalmology including Surgical Anatomy of the Eyelids and Surgical Anatomy of the Orbit and Lacrimal Systems. These courses have been presented for over ten years consecutively.

We can add as a final note that for the past 15 years many of the services’ attendings and fellows have worked diligently and faithfully in medical mission work in Ophthalmology with the Volunteer Health Program in the Dominican Republic and or at St John’s Eye Hospital in Jerusalem. We are humbled and honored to be part of these worthy efforts.

The present and future of New York Eye and Ear Infirmary and the members of our service are hon- ored to be part of it.

OCULOPLASTICAND ORBITAL SURGICAL SERVICE 41 OCULOPLASTIC AND ORBITAL SURGICAL SERVICE

TEACHING CURRICULUM

The Oculoplastic and Orbital Clinic meet weekly for a four-hour session. One resident from each class spends approximately eight weeks on rotation with the Oculoplastic Service. Patients are evaluated with the assistance of the fellow and then presented to the attendings for discussion of the appropriate management. The two-month rotation allows for continuity of patient care and effective academic and surgical experience for the residents. The senior resident has block surgical time every week to complete approximately 35 major cases with assigned members of the Oculoplastic Service.

During academic clinical session, 1,275 patients have annual visits and 235 major surgical procedures are preformed. Many of the major procedures are quit complex, dealing with tumors of the eyelids and orbits, trauma, congenital and acquired abnormalities. The residents evaluate additional patients who present to the Emergency Room with orbital trauma and other urgent oculoplastic problems. A rotating schedule of oculoplastic trauma attendings assures that senior staff members are available in cases that require immediate surgery. During the second year, the residents rotate through Beth Israel Medical Center and are often called to evaluate and treat patient with orbital and oculoplastic problems. An additional 350 minor surgical procedures are preformed in the clinic. The residents are involved with the management of eyelid malposition, orbital and eyelid neoplasms, blowout and tripod fractures, and a significant number of anophthalmic socket problems. They also commonly see systematic illnesses that may affect the orbit, including thyroid disease and lymphproliferative disorders. The residents receive consultations from and work closely with their otolaryngology colleagues. The didactic program of the Oculoplastic and Reconstructive Surgery Service at The New York Eye and Ear Infirmary includes 14 formal lectures covering various topics in this subspecialty. The lectures are given during the second six months of each academic year followed by a compre- hensive written examination that is graded and reviewed with the residents. Lecture topics are updated yearly. By the completion of the rotation, the residents become proficient in nasolacrimal duct probing and intubation, dacrycystorhinostomy, entropion and ectropion repair, eyelid laceration repair, enucleation, blepharoplasty, and ptosis repair. CT and MRI studies are reviewed weekly with the Chief of Radiology. The residents also have the opportunity to examine the histopatholo- gy from all surgical cases and may participate in clinical research with the attendings.

Chief of Service Asst Chief of Service Coordinator of Trauma Service Robert Della Rocca, MD Elizabeth A. Maher, MD Janet Roen, MD

Attending Surgeons Fellows Int’l Fellows 2006-2007 James Milite, MD Syed Ahmed, MD Alessandro David Bruce Moskowitz, MD Gary Lelli, MD (Milan Italy) David A. Della Rocca, MD Bacjeet Purawal, MD Gary Bunagan Deborah Knoll, MD (Phillipines)

42 THE NEW YORK EYEAND EAR INFIRMARY OCULOPLASTIC AND ORBITAL SURGICAL SERVICE

OCULOPLASTICAND ORBITAL SURGICAL SERVICE 43

OPHTHALMIC PATHOLOGY SERVICE

he Department of Pathology and Laboratory Medicine continued its steady pattern of growth in 2006, with a 6% increase in specimen accessions which numbered 12,500 cases. T This was mainly due to an increase in eye pathology consultation specimens sent from out- side the facility as well as increased head and neck cancer work at NYEEI. Of these 12,500 cases, 7,500 are from ocular and peri-ocular sources, making the NYEEI Eye Pathology the largest and busiest in the world. This large volume of specimens has necessitated professional staff expan- sion. We now employ a full-time staff of three fellowship trained eye pathologists (Drs. McCormick, Iacob and Milman) and one general pathologist (Dr. Schulz) in the Department. Drs. Perry and McNally continue to assist with the multi- faceted teaching programs in the Department. Drs. Hu, Huang and Savage continue their respective active research programs in a variety of sub-disci- plines.

A Diagnostic Molecular Pathology was officially inaugurated in 2006 with the recruitment of a full-time molecular technologist, Jane Mo. We are in the throes of obtaining NYS certification for a variety of molecular-based clinical tests, most of which will begin to be offered in 2007.

Residents in ophthalmology continued their traditional rotations through the department, under the direction of Dr. Milman. They are joined by residents from the programs at Northshore and LIJ. Steven McCormick, MD DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE

Diagnostic Anatomic & Clinical Pathology, Fine Needle Biopsy Service Clinical & Basic Science Research, and Education for Residents and Practitioners Tatyana Milman, MD, FAAO Director of Eye Pathology Education Steven A. McCormick, M.D., FCAP Director John Protic, MD, FCAP Thomas J. Snopek, MD, PhD, FCAP Codrin Iacob, MD, FCAP Co-Directors of Molecular Pathology Thadeus Schulz, MD, FCAP Lois McNally, MD, FCAP, FAAO Raul Chiesa, M.D Tatyana Milman, MD, FAAO Henry D. Perry, M.D. Surgical Pathologists Eye Pathology Consultants

Steven A. McCormick, MD, FCAP Dan-Ning Hu, M.D. Codrin Iacob, MD, FCAP Director, Tissue Culture Center

Howard E. Savage, Ph.D. Cell Biology/Immunology

Steven A. McCormick, M.D., FCAP Associate Professor of Pathology, Ophthalmology, and Otolaryngology/Head & Neck Surgery, New York Medical College Director of Pathology & Laboratory Medicine, NYEEI

OPHTHALMIC PATHOLOGY SERVICE 45

PEDIATRIC OPHTHALMOLOGY AND ORTHOPTICS

he main mission of the Pediatric Ophthalmology / Orthoptic Department is the specialized evaluation and treatment of all eye problems in children. These problems are mostly related T to strabismus and amblyopia which is most prevalent in a pediatric population. In the last few years the scope of our services have grown especially in the pediatric area, which now also include administering to pediatric patients with cataracts, glaucoma, cornea problems, retinal problems and pediatric trauma patients. The close monitoring of the patients and specialized care necessary to deal with children with these particular eye problems and parents has made our work more rewarding but more complicated.

With the aging population we now also are seeing adults patients with binocular/ sensory problems (diplopia) caused by systemic and neurological problems. Evaluating and treating adult with diplopia is another aspect of our work to improve the quality of life issue for this older population. Patients are referred not just from our hospital ophthalmic population but also consist of direct referrals to our Department from private physicians and several social agencies.

Because of the advanced training of our highly trained Orthoptists/ Ophthalmic Technologists, the Department also is able to do specialized evaluations and treatments. The specialized testing include low vision, specialized color vision testing especially aimed toward civil service employees along with other ophthalmic Lisabeth S. Hall, MD patients, screening for learning disabilities and Botox injections for patients with bleparospasm and strabismus. Statistics for 2006 For 2006 our statistics maintained its high level in spite in this climate of continuing changing medical coverage and due to sickness in our Department. Trying to maintain our patient contacts with 8 months of reduced staff has been a difficult experience. Approximately 6400 patients received services from our Department in 2006. MAJOR ACHIEVEMENTS

A major achievement in 2006 has been to continue providing a high quality of patient care in spite of increased efforts and limitations as related to managed care. In 2006 we continues to reorganized the effectiveness of our information system program for more efficient appoint- ment scheduling to maximize patient encounters and have incorporated ARM registration and referral linking to maximize patient encounters. We have also reorganized other aspects of the information system to better reflect the activities of the Department and are working on instituting Forms Fast. We have reviewed and continue to revise our encounter forms to be more comprehensive in reflecting the work accomplished.

In response the suggestions from the JCAH survey (2003) we have devised a more aggressive approach to verifying immunization records of our pediatric patients and verifying the social and educational work we do with this group of patients. Our results show that most of our patients have the immunization records as part of their chart.

The managed care changes continue to impact on our scheduling of the numerous types of appointments and surgeries. The emphasis in the managed care area is not only to inform the patient of the appropriate referral but to educate the patient on how to obtain the referral, how to understand the information on the referral with the help of the ARM system

PEDIATRIC OPHTHALMOLOGYAND ORTHOPTICS 47 OPEDIATRIC OPHTHALMOLOGY AND ORTHOPTICS

The Department continues to spread the name of the infirmary by presenting a paper at regional meetings. This paper reported the incidents of in children with eye complaints.

We are also able to offer an art therapy program for children with visual impairment though our department’s fundraising efforts

The Allied Health School for Orthoptics is has a graduating student this year who now is working in the department. We have had three international fellows observe throughout the year.

The Medical Director, Lisabeth Hall MD, has made changes in our operation and has expanded our work into other areas of Pediatric Ophthalmology. We continue taking a more aggressive role with babies with congenital cataracts and care of pediatric trauma patients. Our collabo- ration with the Children’s Aid Society continues to be strong. This collaboration has been very successful but involves a significant input of time and effort by the whole staff because these patients have special needs.

Lastly on a continuing basis we reassessed the coding system for diagnosis and procedures for billing to be sure we are accurately and methodically completing the forms with the attending physicians. We continue to do this as reimbursement policies change.

MAJOR GOALS FOR 2007

Our major goals for 2007 again in this setting of increased managed care is to try to keep ahead and anticipate the changes that managed care will bring in our patient setting. We continue our work helping patients to continue their treatment at NYEE by informing them and their primary care physicians of the services and outstanding care done by the Pediatric Ophthalmology Department

We also continue to try to understand the appointment, registration and billing system to maximize patient appointment, patient satisfaction and payments.

We are also reviewing our patient care approaches with all our Attendings to evaluate a consis- tent and specialized approach to pediatric problems.

PEDIATRIC OPHTHALMOLOGY FACULTY Chief, Pediatric Ophthalmology and Strabismus Lisabeth S. Hall, M.D. Professor of Ophthalmology

Pediatric Ophthalmology Attending Physicians and Surgeons Brian Campolattaro, MD Steven Rosenberg, MD H. Jay Wisnicki, MD Kenneth Cohen, MD Harvey Rosenblum, MD Sherry Yang, MD John Flanagan, MD Ronald Schechter, MD Jay Galst, MD Peter Schwartz, MD Lisabeth Hall, MD Dovelet Shashou, MD Eric Lichtenstein, MD Ivy Shen, MD Marc Lustig, MD Mark Steele, MD Madelyn Pullman, MD Frederick Wang, MD

48 THE NEW YORK EYEAND EAR INFIRMARY OPEDIATRIC OPHTHALMOLOGY AND ORTHOPTICS

ORTHOPTICS DEPARTMENT Sara Shippman, CO, Director Suzanne Schudel, CO, Assistant Director

Orthoptists Administrative Staff Annette Grant, CO Wendy Vasquez Larisa Heiser, CO Samantha Peruyero

PEDIATRIC OPHTHALMOLOGYAND ORTHOPTICS 49

EYE TRAUMA SERVICE

he mission of the Eye Trauma Service is to provide acute, comprehensive ophthalmic medical and surgical care for severe eye, orbital, and ocular adnexal injuries. T Expedient management of devastating eye injuries is often beyond the capability of many general hospitals and university medical centers. The vast resources of The New York Eye & Ear Infirmary including the physical plant-access, application of state-of-the-art medical technology, and expert subspecialty surgical attending staff make it uniquely qualified to main- tain a service dedicated to eye trauma.

The Eye Trauma Service is an integrated multi-specialty service with over 25 Board Certified eye surgeons representing the Infirmary’s Anterior Segment, Retina, and Oculoplastic Services. Coverage is 24-hours a day, with a triage officer represented by the Senior House Staff. Patients are referred from the tri-state area, as well as from around the world for primary and secondary repair of complex ocular injuries.

The New York Eye & Ear Infirmary has been selected as the Eye Injury Registry of the State of New York as a member of the United States Eye Injury Registry. This will enable the Infirmary to collect eye injury date in a standardized fashion facilitating ana- lytical epidemiological research, the development of preventive strategies, the develop- ment of clinical trials, and optimizing treatment modalities.

Ronald Gentile, MD The Trauma Service holds conferences monthly where complex cases are presented and discussed amongst the entire staff.

ANTERIOR SEGMENT TRAUMA SURGEONS

Chief of Service John Aljian, MD Abha Amin, MD David Gorman, MD Paul Sidoti, MD Douglas Buxton, MD Harvey Rosenblum Jeffrey Spitzer, MD Kenneth Cohen, MD Richard DeLuca, MD Gregory Gallousis, MD Jonathan Ellant, MD Edward Schottenstein, MD Robert Cavalieros MD John Flanagan, MD Peter Schwartz, MD Lawrence Jacobson, MD Peter Breingnan, MD C. Michael Samson, MD

POSTERIOR SEGMENT TRAUMA SURGEONS Chief of Service Ronald Gentile, MD Alan Dayan, MD Richard Rosen, MD Belinda Shirkey, MD John Aljian, MD Paul Latkany, MD Jeanne Rosenthal, MD Joseph B. Walsh, MD Thomas Muldoon, MD Uri Shabto, MD Peter Weseley, MD Aryeh Pollack, MD Juan Romero, MD

OCULOPLASTIC TRAUMA SURGEONS Chief of Service Elizabeth Maher, MD Bruce Moskowitz, MD Janet Roen, MD Robert C. Della Rocca, MD James Milite, MD

EYE TRAUMA SERVICE 51

RETINA SERVICE

he Retina Center is a specialized eye care unit committed to providing our patients with comprehensive outpatient and state-of-the-art medical/surgical care in the disciplines of T Retinal, Vitreoretinal, Ocular Tumor, Uveitis and related ophthalmic disorders, in a warm and caring environment. In addition, we teach Residents, Fellows and Medical Students medical and surgical techniques in the disciplines of Retinal, Vitreoretinal, Ocular Tumor and Uveitis. The Center is opened Monday – Friday, from 7: 30- 5:00 P.M. and typically conducts 43 half-day sessions per week in addition to the Special Testing unit, which operates 5 full days per week. Sixteen Retina Surgical and Medical, two Uveitis, one Oncology, three Electrophysiolgy, eight Laser, one Vascular (stroke prevention) and ten Private Referred half-day sessions comprise our clinic complement. The Retina Medical and Surgical sessions, provide surgical and medical evaluation, laser treatment, special treatment for macular degeneration, postoperative care and diagnostic testing to persons with diseases and/or injuries to the Retina. The Uveitis clinic provides medical and surgical care to persons having inflammation of the Uvea and systemic diseases stemming from or related to the Uvea. The Oncology clinic provides medical and surgical care to persons with ocular tumors and related problems. The Vascular clinic provides care to patients who have a proclivity to becoming Thomas O. Muldoon, MD stroke victims. The Physicians Referred Retina Center serves private physicians and their patients, by provid- ing diagnostic testing for patients and is available to Physicians whose patients require laser procedures. In addition to Electrophysiology Testing, the Center’s Special Testing Unit offers the following diagnostic tests: Fluorescein and Indocyanine Green Angiography, Fundus Photos, Ultrasounds, Ocular Coherent Tomography, Heidelberg Retina Tomography, Heidelberg Retina Angiography, Scanning Laser Ophthalmoscopy, Ocular Coherent Tomography with Scanning Laser Ophthamoscopy and Retinal Thickening Analyzation. These special tests benefit not only patients with diseases/injuries to the Retina, but also to patients with many other ophthalmic conditions. STATISTICS

The Retina Center has historically experienced a steady increase in patient volume/procedures. In the past decade (1996-2005) patient volume/procedures have increased by 21,583 (144%). Since year-end 2002, our last year in the old Retina Center volume increased by 14,029 or 62%. For the 12 months ended December 31, 2006, the Center provided medical, surgical and diagnostic treatment to 39,101 patients as opposed to 36,574 patients for the same peri- od in year 2005, an increase of 2,527 patients/procedures or 6.9%. STAFF The Retina office staff consists of twelve full time and one part-time staff members, which include the Department Director, Assistant Director, 4 Registrar/Receptionists, 2 Receptionists, 3 Special testing technicians, 1 Surgical Coordinator and 1 Receptionist Clerk. Most staff members are multi-functional and are required to Register patients, code bills, make appointments and assist in managed care services when necessary. In addition to the office staff, each clinic session is supervised by one or more Attendings and is staffed by one or more Residents, one or more Retina Fellows, 1 Assistant Nursing Coordinator, two Registered Nurses and 3 or 4 Licensed Practical Nurses and/or a nursing assistant and 2 -3 Medical Photographers.

RETINA SERVICE 53 RETINA SERVICE

MAJOR ACHEIVEMENTS FOR 2006 The Retina Department has achieved the following for the year 2006.

• Added 2 new Laser Attendings. • Doctors and Administrative Staff united to improve patient flow( Retina Flow Committee) • Hired a Surgical Coordinator to book and pre-certify all Retina cases. • Hired a new Ophthalmic Imaging Specialist • Hired a new Assistant Director • Patient scheduling changes have resulted in increased patient/procedure volume and patient flow. • Educational materials on various ophthalmic and related diseases have been procured and expanded for distribution to our patients. • Began using Imitrieve to scan all Referred patient orders

MAJOR GOALS FOR 2007 The Retina Center expects to achieve the following goals in 2007.

• Continue to monitor and change Attending/Patient schedules. • Increase efforts to ensure patients provide us with lists of all medications and dosages, including vitamins. • Monitor Patient Problem lists. • Obtain time clocks in order to conduct efficient patient flow studies. • Obtain the services of two full time volunteers to perform certain clerical functions, errands and assist the nursing staff. • Expand ANKA to capture all Imaging done on the 8th fl. • Create a Surgery scheduling system in Meditech. • Expand materials available for patient education including VCRs or CDs explaining surgical procedures in layman’s language.

PERFORMANCE IMPROVEMENT ACTIVITIES PLANNED FOR 2007

• Increased patient flow and satisfaction will be achieved through the work of The Retina Center Flow committee. • Obtain Laser Utility cabinets to ensure proper maintenance of laser Equipment. • Work with MIS in providing all Attendings and residents access to all Infirmary Documents/forms in Forms Fast. • Ensure that all Private Referred Special Testing patients have appropriate orders and consents and those private physicians using the Center are compliant with policies and procedures. • The use of time clocks for patient flow studies will accurately track patient flow through the clinic, enabling administrators to recognize where backlogs occur and correct those situations. This will enable the department to improve patient flow efficiency and decrease the amount of time patients spend in the clinic. • Adding another registration Window to allow for quicker registration times. to assist in directing patients to exam rooms and testing areas.

54 THE NEW YORK EYEAND EAR INFIRMARY RETINA SERVICE

PERFORMANCE IMPROVEMENT ACTIVITIES PLANNED FOR 2007 (CONT.)

• Insurance Verification to be done 2 days prior to visit to allow for faster registration. • Continue to monitor Overnight access to the Retina Center in order to assure patient/procedure compliance and proper use of equipment. • Nursing staff will continue to monitor problem lists and medication lists and document in patient charts. • Continue to procure the service of at least 2 volunteers to assist in directing patients to exam rooms and testing areas.

Director Associate Director Thomas O. Muldoon, MD Jeanne L. Rosenthal, MD Director of Research Educational Coordinator Richard B. Rosen, MD Ronald C. Gentile, MD Associate Director Emeritus Seymour Fradin, MD Attendings Louis S. Angioletti, MD Ronald Gentile, MD Uri Shabto, MD Allesandra Bertolucci, MD Paul Latkany, MD Belinda Shirkey, MD Alan Dayan, MD Juan Romero, MD Joseph Walsh, MD Seymour Fradin, MD Richard Rosen, MD Peter Weseley, MD Retinal Fellows Eric Fitz, MD Sean Lalin, MD

Research Fellows Mirjiam Von Velthoven, M.D. Renata Canovas, M.D. Stylianos Geogoulas, MD

Uveitis Co-Directors C. Michael Samson, MD Paul Latkany, MD Ocular Oncology Paul T. Finger, MD Electrophysiology Allesandra Bertolucci, MD Sheila Margolis, MD Photography Robert Masini Nancy Gonzalez Kenneth Boyd Noelle Valet Administration Edward Jordan

RETINA SERVICE 55

ABORN-LUBKIN EYE RESEARCH LABORATORY

he Aborn-Lubkin Eye Research Center at The New York Eye and Ear Infirmary has been in existence since 1978, and founded by the late Virginia Lubkin, M.D. Over the years T the scope of the laboratory has included innovative clinical research in ophthalmology and has incorporated bioengineering and modern technology. The first modern system of corneal topography was developed in the early years at the Aborn Eye Research Center and we strive to continue the tradition with the development of new exciting ophthalmic technology and clinical research in the field.

COMPUTERIZED STEREOCAMPIMETER TO MEASURE CENTRAL SCOTOMA

We are continuing with the design and development of an automated stereocampimeter to accurately outline and map central scotomas within 300 and capability to test out to 600 in the field of vision, and completed a Phase 1 and Phase II NEI/STTR grant study in collaboration with Opticology Inc. The device uses a novel binocular stereoscopic technique that enables a patient with central visual field defects to maintain central fixation with unprecedented accuracy, using the untested eye to aid with fixation. One eye is under test while the other eye is presented a similar pattern, yielding a stereoscopic effect. Software for the device is PC driv- en and generates a chart on a computer screen, various test patterns, eye- tracking, and voice prompting in several languages. Our NEI Phase II study was designed to assist in development of the automated stereo- campimeter allowing for improvements in the design and technology. We studied 35 subjects with various retinal pathologies and compared the data from the stereocampimeter to testing with the Humphrey Field AnalyzerTM and the scanning laser ophthalmoscope (SLO), Rodenstock, Germany (no longer commercially available). Our study showed that the Greg Bennett, MD automated stereocampimeter was more accurate than the scanning laser ophthalmoscope (SLO), outlining scotomas that was missed totally or mapped incompletely by the manual test- ing (SLO). We also showed scotomas that were outlined and mapped by the stereocampime- ter and totally missed or inaccurately depicted by standard automated perimetry. The difference between the tested methods is evident, where we were able to show that the stereocampime- ter software program actually outlines and draws the shape, size and location of the central field defect as the patient clinically “sees it”. Commercially available visual field machines (perime- ters) can only provide data detecting light sensitivities (grayscale printouts) and probabilities of defects in the visual field, and not outlined maps of the actual shape and size of a scotoma, as with the stereocampimeter. Perimeters are also traditionally monocular testing devices, whereas the stereocampimeter, using a binocular stereoscopic technique for testing and more accurate fixation, can map central scotomas located directly in the center of fixation, even with bilateral disease. This is accomplished with the aid of an external bright light source over the fixation point of the untested eye, and was found to be effective even in subjects with severe bilateral central field disease and vision as poor as 20/400. We also produced preliminary evi- dence of repeatability and sensitivity of the data using the stereocampimeter, following several subjects at multiple visits. All patients were referred from the retina clinic and private patients from retina specialists at the New York Eye and Ear Infirmary. We are now in development phase of a second-generation prototype machine, which is a more compact device compared to the first generation prototype. The second-generation device includes more advanced upgraded technology, allowing for more features and accuracy. Age-related macular degenera- tion (AMD) is the leading cause of blindness in the western world among individuals older than 50 years of age. Approximately 200,000 new cases of neovascular AMD develop each year in the USA. With new anti-VEGF drugs available for the treatment of neovascular AMD, there

ABORN-LUBKIN EYE RESEARCH LABORATORY 57 ABORN-LUBKIN EYE RESEARCH LABORATORY

is a need for a method for early detection and monitoring patient treatments. The automated stereocampimeter is a visual field testing method that accurately provides an actual map of cen- tral scotomas, which will allow for the following of the clinical progress of new treatments and the disease process in patients with AMD. We are currently seeking additional funding for completion of the second-generation machine and a final third generation device for FDA approval. We are continuing with Phase III sensitivity and repeatability studies with plans for a study trial following pre and post anti-VEGF treatment neovascular AMD patients. We pre- sented a poster presentation of our Phase II NEI study at ARVO in May 2006.

A 90 Patient Phase IIb FDA Study Trial On The Safety And Efficacy Of Topical Ophthalmic 17 beta-Estradiol 0.05% And 0.1% Vs. Placebo Using A New Vehicle To Carry The Drug for the Treatment of Postmentopausal Dry Eye Syndrome. (To Be Followed By A Multi-Center Phase III Double-Masked Study On The Safety And Efficacy Of 0.1% Topical Ophthalmic 17beta-Estradiol Vs. Placebo).

An estimated 60 million people in the United States have dry eye symptoms. It is reported that between 3-4 million American women over the age of 50 suffer from dry eye syndrome. Postmenopausal dry eye syndrome is a debilitating disease which has frustrated clinicians, patients and researchers for years because of the difficulty in assessing efficacy of treatment modalities and unsuccessful treatments available. The pathogenesis of dry eye syndrome though still under debate, is better elucidated today. Experimentally induced dry eye was found to cause apoptosis of cells in ocular surface tissues, which causes a rapid turnover of epithelial cells leaving the ocular surface with an immature set of surface cells without a mucous coating. Researchers believe that inflammatory mediators released from damaged surface cells in a dry hyperosmolar environment influence the cell . Also, a significant increase in T lympho- cytes in the conjunctiva of Sjogren’s and non-Sjogren’s keratoconjunctivitis sicca is felt to con- tribute to ocular surface inflammation. Various studies have also shown that postmenopausal dry eye is not limited to only aqueous deficiency and inflammatory changes of the ocular sur- face and lacrimal gland, but those hormones, particularly the sex steroids, most likely have a role in the pathogenesis of dry eye syndrome. Clinical observations that dry eye is most preva- lent in the menopausal and peri-menopausal population as well as in those women on birth control pills suggests estrogen as a possible modulating factor. Estrogen deficiency has been shown to lead to alteration of the sebaceous glands and dysfunction of the meibomian glands, causing further destabilization of the tear film. Estrogen receptor mRNA has been found throughout the eye, in the lacrimal gland, meibomian gland, lid, palpebral and bulbar conjunc- tiva, cornea and other anterior ocular surfaces. Our early study results revealed a strong trend for topical estradiol eye drops to significantly improve several objective testing parameters and hallmark symptoms. We completed a FDA Phase I and Phase IIA double-masked clinical trial of 44 patients using concentrations of 0.25% and 0.1% Estradiol vs. Placebo. We are now con- ducting an out-of-state Phase IIb FDA clinical pilot study of 90 moderate to severe dry eye patients. This is a single-centered, randomized, vehicle-controlled, double-masked study, with

58 THE NEW YORK EYEAND EAR INFIRMARY ABORN-LUBKIN EYE RESEARCH LABORATORY

30 patients in each of three arms, and each arm receiving either a new vehicle without drug, or one of two doses of either a lower 0.05% dose or 0.1% 17 beta-estradiol as the active phar- maceutical ingredient. The Aborn-Lubkin Eye Center is the primary consultant to the study. Upon completion of the phase IIb pilot study, we plan to proceed with a multi-center phase III FDA trial. The study is sponsored by Nascent Pharmaceuticals Inc.

DEVELOPMENT OF A CHEMICAL SENSOR TECHNOLOGY NANOLITER TEAR OSMOMETER FOR THE DETECTION OF THE PRESENCE AND SEVERITY OF DRY EYE SYNDROME.

We are completing Phase I development of a Surface Plasmon Resonance (SPR) Nanoliter Tear Osmometer. The technology uses a chemical sensor technology that uses light from a laser diode that interacts with a sensing surface and tears film to determine the fractional change in osmolarity. The prototype uses an electronic detector to sense changes in image characteristics when solutions of different osmolarity are applied to the sensing surface. One of the major appeals of this type of system is the inherent sensitivity of the measurement. Changes in meas- urements are detected to less than a few microns. Tear osmolarity is an expression of the total concentration of dissolved particle (salt) in tears without regard to size, density, configuration or electrical charge. Early studies show that dry eye states result in hyperosmolarity of the tear film and that an abnormal elevation of tear film osmolarity produces morphologic changes at a cellular and cytoplasmic level in the cornea and conjunctiva. The problem in attempting to measure tear osmolarity has been that available commercial devices can only measure large mil- liliter sized samples of a solution instead of the small nanoliter scaled measurements needed to determine tear osmolarity. Old technology attempting to measure nanoliter tear samples using freezing-point depression techniques has been plagued with many problems for clinical use. In diagnosing, following and evaluating the success of new treatments in dry eye syndrome, the lack of a gold standard test has remained a problem. The diagnosis rate of dry eye is predicted at only 20% with current methods. Tear osmolarity has been recognized as the most reliable objective test for diagnosing aqueous deficient dry eye states. In collaboration with Opticology Inc., we’ve developed a first generation prototype tear osmometer using SPR technology with inherent sensitivity of measurements, provides measurements and data instantaneously upon contact of the solution with the sensing surface, and simple cost effective components that can be made compact easily. We received a Phase I NEI STTR small business grant along with Opticology Inc. and have successfully tested both known laboratory made salt solutions and human tear samples for osmolarity using a relative calibration approach in the early prototype machine. We have devoted a large part of the phase I study to implementing a final calibration design and techniques. The second-generation osmometer design is a portable hand-held device. With further funding we plan to conduct a clinical study trial to evaluate the SPR tear osmometer versus the Clifton freeze-point osmometer in both dry eye patients and a normal control group. We are currently continuing with calibration technique development, repeata- bility studies and fundraising. We were invited to present the SPR osmometer at the Global Innovation Competition at the University of California San Francisco, to an audience of

ABORN-LUBKIN EYE RESEARCH LABORATORY 59 ABORN-LUBKIN EYE RESEARCH LABORATORY

biotechnology industry investors and entrepreneurs in April 2006 and presented on “Nanoscale Methods for Analysis of Tears and Aqueous” at The Glaucoma Foundation’s Twelfth Annual Think Tank Meeting, September 2005.

STUDYING CORNEAL BIOMECHANICAL PROPERTIES USING PIEZOELECTRICITY

A study of the Piezoelectric behavior of the human cornea and possible clinical applications in collaboration with Rutgers University, Polymer Electroprocessing Laboratory, College of Engineering. Piezoelectricity refers to the generation of an electric signal in response to a change in pressure. The electric signal is generated from an applied stress or strain of the piezo- electric material. Corneal mechanics has evolved from being a topic of scientific curiosity to one of growing interest among ophthalmic researchers based on new appreciation of the cornea’s biomechanical properties and possible relevance in a variety of clinical applications. A better understanding of corneal elasticity and strain may allow for more predictable outcomes after incisional and photoablative corneal surgery, help in identifying patients at risk for ecta- sia and lead to developing methods for more accurate measurement of IOP. Researchers have recently looked at using high-speed optical coherence tomography (OCT) and software to measure and map the magnitude and direction of tissue displacements within the layers of the cornea and strain intensity within corneal tissue. In 1979, the assumed piezoelectric response of collagen was demonstrated in the sclera at the Aborn Eye Laboratory for the first time. In 1998 we showed there were significant differences in the piezoelectric effects between the human and bovine eyes as well as in the values obtained from different sections of the sclera. More recently we studied the mechanical and piezoelectric response of the human cornea and showed that the human cornea exhibited remarkably higher piezoelectric responses compared to human scleral tissue and enormous mechanical anisotropies. We recently studied the mechanical behavior of the human cornea as observed by the change in elastic response (Youngs modulus) upon drying of the corneal tissue, which may be useful clinically in diag- nosing and/or following certain dry eye conditions such as observed in post-LASIK procedures and found in keratoconjunctivitis sicca. Speculation on the conceivable clinical utilization of these concepts leads to the possible use of a piezo-electrometer for the measurement of intraoc- ular pressures as well as in determining or following the pathogenesis of corneal disease states such as keratoconus. We are also evaluating the data of the piezoelectric effects of 95 diseased human corneal specimens collected at the New York Eye and Ear Infirmary and comparing these effects to normal human corneal piezoelectric and elastic response measurements.

60 THE NEW YORK EYEAND EAR INFIRMARY ABORN-LUBKIN EYE RESEARCH LABORATORY

DEVELOPMENT OF A COMPUTERIZED EIKONOMETER TO DETECT ANISEIKONIA

A true three-dimensional (projection) space eikonometer is the only clinical device that can provide accurate information about the patient’s relationship to space and its distortion caused by aniseikonia. Aniseikonia is a difference of (perceived) image size or shape between the two eyes, and is important in binocular function. We showed in early studies that symptomatic ani- seikonia is common in pseudophakia (intraocular lens implantation after cataract extraction), and that unilateral pseudophakia has the higher degrees of aniseikonia, and is at a greater risk of loss of binocularity and of asthenopia. The availability of a reliable space eikonometer is war- ranted to test for aniseikonia. The Essilor Space Eikonometer (no longer commercially avail- able), a projection device requiring distance stereopsis was the only true space eikonometer that measured aniseikonia by projecting a three- dimensional box to be viewed at six meters. We are in the development stages of a prototype modern automated compact space eikonometer to detect and treat aniseikonia.

Submitted to Experimental Eye Research, “Mechanical and Piezoelectric Response of the Human Cornea”, Bennett, Kramer, Lubkin, Scheinbeim, and Ghosh.

Poster presentation: ARVO, “Development of an Automated Stereocampimeter to Measure Central Scotomas”, Bennett, Kramer, Lubkin, Cappo, Orr, Rosen

Presentation at the Twelfth Annual Glaucoma Foundation Optic Nerve Rescue and Restoration Think Tank Conference, “Nanoscale Methods for Analysis of Tears and Aqueous”, G. Bennett, The Ritz Carlton, N.Y., September 2005.

ABORN-LUBKIN EYE RESEARCH LABORATORY 61

THE NEW YORK EYE AND EAR INFIRMARY OPHTHALMOLOGY ASSOCIATES, PC

he New York Eye & Ear Infirmary Ophthalmology Associates Professional Corporation (PC) is a legal for-profit business entity that maintains a cooperative relationship with T the hospital but is legally separate and distinct from the New York Eye & Ear Infirmary. PURPOSE:

The development of the PC model was driven by the desire to enhance the educational expe- rience by increasing attending physician participation in the teaching program and continuity in the delivery of patient care.

GOVERNANCE:

The PC is governed by an advisory committee that is composed of:

President – (By-laws appoint Chairman of Department to serve in this capacity)

Chief Administrative Officer – (only member of leadership team that is full time PC employee)

Chiefs of Service (the directors of major services)

Director of Residency training

At large representatives (6 elected by peers to serve two year terms)

RELEVANT RULES & STRUCTURE…

All physicians who work with the residents in any capacity (provide clinical instruction, OR training and supervision, lecture, or take trauma call) must be Lloyd Stanford credentialed and approved by the Advisory Committee. Exceptions are made for guest lectur- ers. Approval of applications for membership is generally based on clinical need, credentials, prior academic experience, and recommendations.

FACULTY PRACTICE PLAN:

The faculty practice is a completely separate operation with its own administrative and opera- tional infrastructure. The faculty practice plan (FPP) sees only “private” patients and does not pilfer from the clinics.

There are no funds co-mingled or exchanged between the PC and the FPP. Residents do not rotate through the FPP offices.

PHYSICIAN STAFF

All PC physicians serve in a part-time per diem capacity. 95% are voluntary, 5% are full time faculty, 83% are recognized as independent contractors (1099’s), 17% are recognized as PC employees (w-2’s).

THE CLINICAL EXPERIENCE & EDUCATION:

All clinics are manned by attending physicians who serve as instructors. All patients seen in the sub-specialty clinics, are seen by an attending physician (as well as a resident and a mem- ber of the nursing and/or technical staff). Most patients seen in the comprehensive eye area, interface with an attending physician.

THE SURGICAL EXPERIENCE

All surgery is performed under direct supervision of a teaching physician.

NYEEI OPHTHALMOLOGY ASSOCIATES, PC 63 THE NEW YORK EYE AND EAR INFIRMARY OPHTHALMOLOGY ASSOCIATES, PC

PATIENT INFORMATION:

Approximately 85,000 patients per year

Demographics:

23% Medicare

46% Medicaid (fee for service)

17% Medicaid (managed care)

11% self pay / no pay (indigent)

3% Other

Reimbursement:

35% Medicare

38% Medicaid (fee for service)

19% Medicaid (managed care)

1% self pay / no pay (indigent)

7% Other

FUNDING:

Most of the operating revenue is derived from third party billing and reimbursement. Third party carriers are billed for the professional services (Part B) provided by the teaching physi- cians.

ROLE OF PC ADMINISTRATIVE OFFICE…

Responsibility for: Physician Member Relations

Credentialing, Medicare, Medicaid, &

managed care enrollment & reenrollment

Financial Management and Reporting

Operational Management

Regulatory Compliance & Risk Management

Systems Management

64 THE NEW YORK EYEAND EAR INFIRMARY

BETH ISRAEL MEDICAL CENTER AFFILIATION

PURPOSE

The close proximity of Beth Israel Medical Center to The New York Eye and Ear Infirmary has offered a convenient opportunity for an affiliation that provides a diverse training experience for residents. Beth Israel Medical Center, a large acute medical/surgical inpatient facility, complements the focused eye care training at The New York Eye and Ear Infirmary, which is primarily outpatient, with another clinical training experience - eye care services to inpatients who have other principal underlying medical diseases. Residents also receive exposure to Pediatric Ophthalmology and Strabismus, one of the main areas of the department’s outpatient activity.

The Department of Ophthalmology at Beth Israel is directed by H. Jay Wisnicki, MD, who is appointed by the Board of Trustees at Beth Israel Medical Center through the President of Beth Israel. Dr. Wisnicki is also appointed to the attending staff of The New York Eye and Ear Infirmary and serves on the Executive Committee of the NYEEI Department of Ophthalmology. Dr. Wisnicki and other Beth Israel attending ophthalmologists participate in teaching and academic activities at The New York Eye and Ear Infirmary and at Beth Israel.

CLINICAL FACILITIES

The department’s ambulatory facility includes examination and treatment rooms specifically designed for pediatric ophthalmology and strabismus as H.Jay Wisnicki, MD well as an administrative area. General ophthalmology and other subspecialty care are provided by attendings, each of which is also on staff of The New York Eye and Ear Infirmary and partic- ipate in the teaching program. The department is located in the Phillips Ambulatory Care Center Facility on Union Square. On the inpatient side, there is an inpatient ophthalmology consultation room available. The Emergency Room contains an ophthalmology room/area equipped with an examination chair and slit lamp. The close proximity of the two institutions enables the transfer of emergency eye patients who are medically stable to The New York Eye and Ear Infirmary for emergency care. Patients who are medically unstable for transport to the Infirmary are cared for on-site at Beth Israel Medical Center. Eye patients at The New York Eye and Ear Infirmary who develop medical complications can be transferred to Beth Israel for acute care. Thus, between the two institutions, patients receive the most appropriate eye care and other medical services.

RESIDENCY TRAINING EXPERIENCE

There are two primary resident rotations from The New York Eye and Ear Infirmary at Beth Israel Medical center. Residents are assigned on a two-month rotation to Pediatric Ophthalmology and Strabismus Service several sessions per week under the attending supervision of Dr. Wisnicki. This gives the resident an opportunity to be exposed to problems in pediatric ophthalmology and strabismus early in their training. Residents also work with Dr. Wisnicki in the operating room where they learn current techniques of pediatric and eye muscle surgery.

A second-year resident (PGY-3) rotates on the consultation services at Beth Israel. The resident serves as a consultant, under attending supervision, to each of the clinical departments. The consultation service involves responding to inpatient consults, weekly rounds in the Neonatal Intensive Care Unit examining premature infants for retinopathy and bi-monthly

BETH ISREAL AFFILIATION 71 BETH ISREAL AFFILIATION

sessions in the Peter Krueger Center for retinal screening of patients with AIDS. Residents are also called upon by physicians throughout Beth Israel Medical Center to answer questions on other ophthalmologic problems. This rotation includes 24-hour coverage of the Emergency Room as well as any ocular emergency anywhere in the Medical Center. The resident operates with and assists the local program chairman, Dr. Wisnicki, with pediatric and strabismus sur- gery.

OTHER EDUCATIONAL EXPERIENCES

Grand rounds which involve case presentations by the residents may include consultations on Beth Israel’s inpatients when interesting cases arise. Neuro-ophthalmology rounds are held by Mark Kupersmith, M.D. and Hiliary Fazzone, M.D., in conjunction with the Department of Neurology.

Rotating residents from The New York Eye and Ear Infirmary have access to Beth Israel’s com- prehensive medical library. This includes a full range of library services as well as a special library search service; one of the first of its kind in New York where residents and attendings can perform computerized literature searches from off-site locations by telephone at no charge. The majority of the attendings on staff at Beth Israel are also on staff at NYEEI. Beth Israel’s Podell Auditorium, which holds approximately 200 people, is available for large didactic lec- tures and CME courses

RESEARCH ACTIVITIES

The department provides support for research projects throughout the Beth Israel Medical Center. It also services as a portal for patients who may qualify for clinical trials ongoing at The New York Eye and Ear Infirmary. Special department interests include clinical strabismus and computer applications in ophthalmology.

Jay Wisnicki

72 THE NEW YORK EYEAND EAR INFIRMARY BETH ISREAL AFFILIATION

BETH ISREAL AFFILIATION 73

RESIDENT TRAINING AND EDUCATION

esident education, which integrates patient care, clinical and surgical training, introduction to clinical research, and teaching at all levels, is a primary mission of the Department of R Ophthalmology at The New York Eye & Ear Infirmary. It was initiated the Infirmary’s founding fathers and has continued to develop through the years. Our training program is integral to the daily functioning of the institution and continues to evolve to provide state-of the-art educational resources to the local, national and international ophthalmic community. By producing outstanding clinicians we help to raise the standards for ophthalmic care at all levels.

Central to the educational experience our residents receive is a diverse exposure to pathology. In the Comprehensive Eye clinic, a dedicated voluntary clinical faculty provides hands-on supervision, supported by a full complement of subspecialty clinics led by highly trained subspecialists. Residents participate in patient care at all levels and are introduced to the most sophisticated aspects of subspecialty care in an environment which encourages graduated involvement under supportive supervision. Guided by our diverse faculty, they have the oppor- tunity to see, do and teach the full spectrum of clinical ophthalmic science.

The overall curriculum is designed to incorporate all of the critical elements of the core competencies which include patient care, medical knowledge, practice-based learning and improvement, interpersonal and communication skills, professionalism, systems-based practice and surgical training. These competencies represent the codification of traditional ideals, the four A’s and one E of medical practice - availability, affability, ability, accountability, and economy.

With the advancing implementation of evidence-based and value-based R.B. Rosen, MD medical decision-making, and the shared knowledge environment of the World Wide Web it is imperative that today’s residents become comfortable with the ever expanding information environment and the advances in medical communication afforded by electronic media. Teleconferencing and internet publishing of grand rounds programs have become successfully integrated into our morning conferences and efforts are underway to expand availability of these programs to the wider ophthalmic community. These advances have come in great part from the dedicated efforts and support of the clinical teaching faculty under the direction of the Chiefs of Service lead by the Department Chair.

Our residency program is designed to provide an ongoing didactic exposure along with pro- gressive clinical and surgical responsibilities. First-year residents receive several weeks of orien- tation composed of introductory courses to prepare them prior to assuming their full clinical responsibilities. Most of the first part of the year is devoted towards mastering the basic skills of medical eye care. First year residents begin assisting in the operating room from the first week. Special courses are given in the use of instrumentation, refraction, and minor surgical procedures as well as management of ocular emergencies. The daily morning lecture series is designed to highlight basic and clinical science subjects that each service chief deems most crit- ical to clinical development. Special rotations are also provided in ophthalmic pathology, clin- ical research, and introduction to pediatrics and strabismus at Beth Israel Medical Center. In the second part of the year, clinical responsibilities expand to include in-patient management, introduction to laser surgery, and basic microsurgery.

Junior residents in the second year are responsible for the strabismus service, the laser clinics, and the consultation service at Beth Israel Medical Center, which includes coverage of neona- tology and the Krueger Clinic for Immunologic Disease. They also begin to undertake surgery for simple oculoplastics and external disease pathology. In the latter part of the year they are

RESIDENT TRAININGAND EDUCATION 75 RESIDENT TRAINING AND EDUCATION

introduced to intraocular surgery. Second-year residents are expected to assume increased lead- ership and teaching in the clinics as well as partaking in the opportunity to learn the finer points of surgical assistance in preparation for their own cases. Opportunities to participate clinical trials also become available, as competency in delivery of clinical care matures. Toward the latter portion of the second year, focused microsurgical courses are provided to teach important aspects of each major ophthalmic surgery. Concurrent with these courses, junior res- idents begin performing cataract surgery.

Senior residents, in their third year, assume greater leadership and responsibility for the oper- ation of the clinics. acquisition of surgical competency in each of the subspecialty areas, is a major focus of the third year. Surgical forums incorporated into morning conference are pro- vided to promote the maturation of skills and problem solving. Seniors present cases for dis- cussion with attendings that help analyze complications and discuss alternative approaches. In addition, there are numerous opportunities to attend and present at outside surgical confer- ences, at the American Academy of Ophthalmology, ASCRS, ARVO, and a variety national and international meetings. At the completion of the residency program, graduating seniors are expected to have developed facility in medical and surgical management of all aspects of oph- thalmic care. While as many half will go on to to fellowships in subspecialty training, each graduate must be competent to pursue a career in Comprehensive Ophthalmology.

MEDICAL STUDENT EDUCATION The New York Eye and Ear Infirmary offer an elective program for fourth-year medical students from schools throughout the United States and to international medical students and physicians. This rotation allows participants hands-on experience in clinical ophthal- mology in both the comprehensive and subspecialty clinics. Core didactic materials are supplied to each participant and a selection of multimedia materials is also available to supplement the lecture and conference series. The students are encouraged to attend all lectures and conferences and may observe surgery in the operating room and the pathology lab. In clinic, the students help work-up selected patients under the supervision and guidance of both the resident and attending staff. These interactions enhance the learning and teaching process for both the resident and the student. At the completion of the rotation, a quiz covers the core material, with immediate grading and feedback. This method maximizes learning and allows the student to address any questions and covers any addi- tional topics needed. In addition to the senior medical students, we offer rotations to affiliated institutions’ residents in emergency medicine, internal medicine, and family practice. The focus is on the appropriate management of ocular emergencies by the primary care provider. The vis- iting residents’ interaction with the Ophthalmology residents and attendings enhances the education, collegial atmosphere and common goal of quality patient care for all the resi- dents and students involved. We have continued our rotation of senior New York Medical College Students. The expansion of our medical and visiting resident programs continues the Infirmary’s long tradition of excellence in education and quality patient care, by providing training to doc- tors at all levels of their professional development.

76 THE NEW YORK EYEAND EAR INFIRMARY NEW YORK EYE AND EAR INFIRMARY HOUSE STAFF 2005

Graduates 2005 Medical School Joseph Bnevento, MD New York Medical College Marta Ponce-Contreras, MD Marrouin Unoversity, Guatemala Jose de laCruz, MD Ponce School of Medicine, Puerto Rico Gary Fishman, MD Brown University Kira Manusis, MD New York University Evin McCabe, MD SUNY, Stony Brook Michael Pro, MD Hahnemann University

3rd year Medical School Andrew Brown, MD Boston University School of Medicine Michele Ghatto, MD The Albany Medical College Joshua Hedaya, MD FUHS/ The Chicago Medical School Alex Liu, MD Tulane University School of Medicine Natalia Rodriguez, MD Wayne Sate University School of Medicine Jon, Page, MD Temple University School of Medicine Gaurang Trivedi, MD University of Rochester School of Medicine

2nd year Medical School Michael Banitt, MD Wayne State College Samuel Barone, MD Pennsylvania State University Joseph Capriotti, MD Jefferson Medical College Elad Feldman, MD SUNY Stony Brook School of Medicine Ariadna Gonzalez, MD University of Miami School of Medicine Jesse Pelletier, MD New York Medical College Ilya Rozenbaum, MD New York University School of Medicine

FIRST year Medical School Justin Anderson, MD Texas Tech University Health Sciences Jonathan Leon-Rosen, MD SUNY Downstate Medical College Boris Ovodenko, MD SUNY Downstate Medical College Anthony Panarelli, MD Albert Einstein School of Medicine Ganesh Rau, MD New Jersey Medical School Ragui Sedeek, MD Yale School of Medicine Elyse Trastman-Caruso, MD Yale School of Medicine

In-coming Residents Medical School Annie Berenbom, MD Washington University Lior Haim, MD Jefferson Medical College Paul Johnson, MD Jefferson Medical College Madhavi Kari, MD Chennai Medical College Olivia Lee, MD Baylor College of Medicine Neil Patel, MD SUNY Downstate Medical College Arlen The, MD Brown Medical School

RESIDENT TRAININGAND EDUCATION 77 NEW YORK EYE AND EAR INFIRMARY HOUSE STAFF 2006

Graduates Class 2006 Medical School Andrew Brown, MD Boston University School of Medicine Michele Gatto, MD The Albany Medical College Joshua Hedaya, MD FUHS/ The Chicago Medical School Alex Liu, MD Tulane University School of Medicine Natalia Rodriguez, MD Wayne Sate University School of Medicine Jon, Page, MD Temple University School of Medicine Gaurang Trivedi, MD University of Rochester School of Medicine

3rd year 2007 Medical School Michael Banitt, MD Wayne State College Samuel Barone, MD Pennsylvania State University Joseph Capriotti, MD Jefferson Medical College Elad Feldman, MD SUNY Stony Brook School of Medicine Ariadna Gonzalez, MD University of Miami School of Medicine Jesse Pelletier, MD New York Medical College Ilya Rozenbaum, MD New York University School of Medicine

2nd year 2008 Medical School Justin Anderson, MD Texas Tech University Health Sciences Jonathan Leon-Rosen, MD SUNY Downstate Medical College Boris Ovodenko, MD SUNY Downstate Medical College Anthony Panarelli, MD Albert Einstein School of Medicine Ganesh Rau, MD New Jersey Medical School Ragui Sedeek, MD Yale School of Medicine Elyse Trastman-Caruso, MD Yale School of Medicine

FIRST year 2009 Medical School Annie Berenbom, MD Washington University Lior Haim, MD Jefferson Medical College Paul Johnson, MD Jefferson Medical College Madhavi Kurli, MD Chennai Medical College Olivia Lee, MD Baylor College of Medicine Neil Patel, MD SUNY Downstate Medical College Arlen The, MD Brown Medical School

In-coming Residents Medical School Anisha Advani, MD Columbia College of Physicians & Surgeons Wendewessen Amde, MD UCLA School of Medicine Tomas Grippo, MD Universidad Austral Arusha Gupta, MD SUNY Stony Brook School of Medicine Julie Kim, MD New York Medical College Richard Mackool, MD New York University Julia Shulman, MD Mount Sinai School of Medicine

78 THE NEW YORK EYEAND EAR INFIRMARY NEW YORK MEDICAL COLLEGE RESIDENTS 2005

2005 Medical School Flanagan, Jessica Midwestern University (2001) Kurilec, Jeffrey NYMC (2001) Mann, Eric U of Rochester SoM/Dental (2001) Prevor, Meredith NYU SoM (2001)

2006 Medical School Chang, Steve NYMC (2002) Liu, Jeffrey Autonomous U of Guadalajara, Mexico Nichols, Neil Tufts University SoM (2002) Tao, Stanley Albany Medical College (2002)

2007 Medical School Ahn, Byung-Joon University of Vermont (2003) Cohen, Amir Robert Wood Johnson Med Scl. (2003) Gordon, Leslie NYMC (2003) Liu, Wei-Chuan University of CA Irvine (2003)

2008 Medical School Camillo, Reginald U. E. Ramon Magsaysay Mem. Med. Ctr, Quezon City, Phillippines (1997) Naadimuthu, Revathi Robert Wood Johnson Med Sch (2004) Shukla, Salil NYMC (2004)

2009 Medical School Hong, Albert NYMC (2005) Malen, Marissa SUNY Downstate Med Ctr (2005) Wu, Simon NYU Sch of Medicine (2004)

RESIDENT TRAININGAND EDUCATION 79 NEW YORK MEDICAL COLLEGE RESIDENTS 2006

2006 Medical School Chang, Steve NYMC Liu, Jeffrey Autonomous U of Guadalajara, Mexico Nichols, Neil Tufts University SoM Tao, Stanley Albany Medical College

2007 Medical School Ahn, Byung-Joon University of Vermont Cohen, Amir Robert Wood Johnson Med School. Gordon, Leslie NYMC Liu, Wei-Chuan University of CA Irvine

2008 Medical School Camillo, Reginald U. E. Ramon Magsaysay Mem. Med. Ctr, Quezon City, Phillippines Naadimuthu, Revathi Robert Wood Johnson Med School Shukla, Salil NYMC

2009 Medical School Hong, Albert NYMC Malen, Marissa SUNY Downstate Med Center Wu, Simon NYU School of Medicine

2010 Medical School Esposito, Donna Upstate Med University, Syracuse Khoramian, David Chicago Med School/RFUMS Lagonigro, Paul SUNY Downstate Nguyen, Tu Lan NYMC

2011 Medical School Hu, Sandra Mt. Sinai School of Med. NYC Luke, Priscilla Loma Linda U, CA Peragallo, Jason NYU School of Medicine NYC

80 THE NEW YORK EYEAND EAR INFIRMARY RESIDENT TRAININGAND EDUCATION 81 NYEEI OPHTHALMOLOGY GRAND ROUNDS 2005

DATE TOPIC PRESENTER RETINA ROUNDS: Dr. Muldoon, Rosen, Gentile, Walsh, Ponce, Lalin 1/7 Iris Retraction Syndrome: Post-Traumatic RD, PVR Dr. Ponce BRAO: Diabetic, Hypertensive with Sudden VA/VF LOSS Dr. Gordon Neuro-retinitis - Hepatosplenomegaly, Anemia, Etc, Dr. Papp CORNEA GRAND ROUNDS: Drs. Seedor, Ritterband, Samson , Schneider, Shapiro 1/14 Radial Neural Keratitis: Acathamoeba (Contact Lens Case Contamination) Dr. Feldman Ichthysosis:X-Linked Cornea Dots Dr. Rosenbaum Immune Related Corneal Perforations Dr. Meskin

TUMOR BOARD: Dr. Schneider, Moderator Drs. Schneider, McCormick, Hu,Finger, Moskowitz. Holliday, Jacob PRESENTATION: Diagnosis and Treatment of Sebaceous Dr. Moskowitz 1/20 CASES NEW 62 Male - Eye Lid Mass - Sebaceous Cell Ca Dr. Moskowitz Exenteration vs. Globe Sparing Surgery/Cryo Dr. McCormick 24 male Orbital Mass Solitary Fibrous Tumor CD 34+ Dr, Hu additional Treatment Post-incomplete Removalhemangio-pericytom Dr. McCormick CASES FOLLOW:UP 34 Female Multiple Bilateral Choroidal Masses Dr. Page, Adenocarcinoma Multiple Metastatic Lesions Dr. Finger primary Breast Lung Chemo and radiation, Taxol BMH 2 Hypopyon, Intraocular Tumors RB Dr. Barone Enucleated with Tumor Dr. Finger AC, Choroid, Angle, Nerve Margin Chemotherapy Radiation 2/14 Traumatic Cavernous Sinus Fistula Dr. De La Cruz Congenital Rubella Syndrome: Congenital Cataract/Glaucoma Micro-cornea Micro-ophthalmus 1/28 Corneal Myxoma Dr. Contreas 1/28 Myopia, Glaucoma, Dr. Rodriguez 1/28 Idiopathic Intracranial Hypertension 2ary Minocin Dr. Ahmad

UVEITIS GRAND ROUNDS: Dr. Samson 2/4 Recurrent Uveitis: Multiple Sclerosis Dr. Banitt Steroid Sparing Treatment in Uveitis Dr. Liu Acute Retinal Necrosis: HZV + Dr. Feldman OCULAR PLASTICS GRAND ROUNDS:DRS. Dellaroca 1/28 Tooth Abscess ' Sinusitis 'Orbital Cellulitis/Brain Dr. Aleksandrovich Abscess Rx: Endoscopic Drainage, Drain, 8 months IV Ptosis, < Elevation: Sinus Mucocele Rx. Endoscopic CAT Scan Dr. Capriotti Guided Surgery, Stent

TRAUMA CONFERENCE: Dr. Aljian, Seedor, Gentile, Ritterband, Rosen, Rosenthal, Walsh, Tello 22/18 Corneal Scleral Rupture: Beer Bottle 8 mm post limbus Dr. Pro Primary Closure, 2ary PPV, Lensectomy, SB Masonary Nail Cornea Lens Penetration Dr. Fishman Primary Repair 2andary Cataract Sulcus IOL

PEDIATRIC OPHTHALMOLOGY GRAND ROUNDS: Dr. Hall, Ms. Shippman, Ms. Strudel, Ms. Kaiserman 2/25 Bilateral Ectopic Lentis A- Dr. Gonzalez Ophthalmia Neonatorum Strep. Mitis Dr. Rosenbaum Infantile Nystagmus Syndrome (Congenital Motor) Dr. Liu 82 THE NEW YORK EYEAND EAR INFIRMARY NYEEI OPHTHALMOLOGY GRAND ROUNDS 2005

DATE TOPIC PRESENTER RETINA GRAND ROUNDS: Drs. Muldoon, Rosenthal, Rosen, Gentile, Samson, Walsh, Dyan 3/3 Retinoma vs. Astrocytic Hamartoma Dr. Feldman Tuberous Sclerosis: Multiple Retinal Hamartoma with Dr. Dresser Macular Edema Autoimmune Choroiditis Serpiginous Choroidopathy Dr. Lalin

3/9 VISITING PROFESSOR: Anthony Adamis, MD Shedding Light on Age Related Macular Degeneration Cofounder, Vice-President in Charge of Research EYETECH

Past Professor of Ophthalmology Massachusetts Eye and Ear Hospital Harvard Medical School

GLAUCOMA GRAND ROUNDS: Drs. Ritch, Sidoti, Gamell

3/10 Optic Nerve Head Drusen and Glaucoma: Drs. Shihadeh, Grippo, Harazim Management Dilemma Arcadi-Goutires and Congenital Glaucoma Dr. Banitt Lowe's Syndrome and Congenital Glaucoma Dr. Pelletier

3/18 Choroidal Mass 2 Years post-Orbital Floor Fx. Rx. Plate Dr. D Della Rocca Orbital Hemorrhage ? elevated Screw Spontaneously Resolved

3/18 Neuro-Retinitis ?Etiology NLP NVI NVG

3/18 Stage I Macular Hole s/p LPI Spontaneous Resolution Dr. Gentile

3/25 Migraine with Aura Dr. Cohen

3/25 Prophylactic Use of Povidone Iodine Dr. Capriotti

NEURO-OPHTHALMOLOGY GRAND ROUNDS STAFF

4/29 Aberrant Ocular Motor Nerve Regeneration Dr. Dresser S/p Coil for PCA Aneurysm III Nerve Ocular Motor Neuritis 10 Female Dr. Gonzalez Ocular MigraineNLP + Functional Scotoma Optic Neuritis+ Dr. Benevento Does von Wilderband's Knee Exist

OCUALR ONCOLOGY GRAND ROUNDS: Drs. McCormick, Iacob, McNally

4/8 Carcinoid Tumor of the Orbit Dr. Trivedi Plical Abscess Dr. Pelletier 4/15 OKAP

TRAUMA SERVICE: Drs. Aljian, Gentile, Buxton, Rosenthal 4/23 Pencil Injury Ruptured Globe Repair-CAT-IOL Dr. Manusis Ruptured lob Repair - Cataract IOL - Dr. Manusis Intra-lenticular FB Phaco-emulsification Dr. Pro

4/26 VISITING PROFESSOR: Dr. S.Merin Effect of an Alpha-Agonist - Brominidine on Retinal Dystrophies Professor & Former Chair Department of Ophthalmology Hadassah Medical Center Hebrew University of Jerusalem Professor St. John Eye Hospital, Jerusalem Adjunct Professor Department of University University of Illinois Eye Center

NYEEI OPHTHALMOLOGY GRAND ROUNDS 83 NYEEI OPHTHALMOLOGY GRAND ROUNDS 2005

DATE TOPIC PRESENTER UVEITIS GRAND ROUNDS: Drs. Latkany & Samson 4/29 Delayed Vascular Occlusive Disease -Beçhet's Disease Dr. M Liu Phthisis Bulbi - Uveitis - PPV, PKP, Healon % Dr. Barone Limited Wegener's Dr. Hedaya 5/6 A R V O

CORNEA GRAND ROUNDS: Drs. Seedor, Ritterband, Samson, Li 5/13 Capsule Staining Techniques Dr. Shapiro Silicone Oil Keratopathy Dr. Banitt Scleral Melt s/p Pterigium Surgery ?MMC ? Lupus Dr. Pelletier Announcement of Cornea Quiz Winners Dr. Seedor 3rd Year Dr. Benevento (first 2X winner) 2nd Year Dr. Page 1st Year Dr. Pelletier

TRAUMA SERVICE GRAND ROUNDS: Drs. Rosen, Sidoti, Samson, Seedor, Ritterband, Rosenthal, and Gentile 5/20 Corneal Decompensation s/p Phaco - Large Descemet's Dr. de la Cruz Detachment Rx: Suture, Gas Choroidal Avulsion s/p Trauma - PPV/Trans Scleral Suture Dr. Ponce Silicone Oil, Endolaser, Scleral Buckle Transient Choroidal Mass? Inflammatory? Ischemia Dr. Lalin NEURO-OPHTHALMOLOGY GRAND ROUNDS

5/27 Optic Nerve Glioma Dr. Feldman Optic Neuritis, Bilateral 2 month sequential Dr. Aleksandrovich MS, Devic's Partial III - Large Prolactenoma Dr. Gatto

6/2 SPECIAL VISITING PROFESSOR OCULAR TRUMA SERVICE DINNER Dr. J. Weiss, MD 5/27/05 OCULAR CHEMICAL BURNS: IMMEDIATE & EARLY TREATMENT PROFESSOR OF OPHTHALMOLOGY & PATHOLOGY DIRECTOR OF OCULAR PATHOLOGY KRESGE EYE INSTITUTE WAYNE STATE UNIVERSITY OCULAR PLASTICS GRAND ROUNDS: Dr. Robert C. Della Rocca

6/3 Excoriative Lid Cellulitis Presepteal Cellulitis Wound Healing Dr. Aleksandrovich 84 Male: Optic Nerve Glioma with Chisiamal Involvement Dr. Gonzalez

ION Various Presentations Acute Chronic Dr. Barone

6/9 VISITING PROFESSOR DONG FENG CHEN, M.D., PH.D. ASSISTANT SCIENTIST, SCHEPENS EYE RESEARCH INSTITUTE ASSISTANT PROFESSOR, HARVARD MEDICAL SCHOOL OPTIC NERVE REGENERATIONAND REPAIR AFTER INJURY

6/10 WHAT DOES IT TAKE TO REGENERATE AND OPTIC NERVE? 6/17 Corneal Laceration: 2ary Cataract Repair IOL Dr. de la Cruz Primary or Secondary 6/17 Resident/Fellow Research Day Dr. Trivedi M Shah, MS, D A Della Rocca, MD, R C Della Rocca, MD

84 THE NEW YORK EYEAND EAR INFIRMARY NYEEI OPHTHALMOLOGY GRAND ROUNDS 2005

DATE TOPIC PRESENTER 6/17 Resident/Fellow Research Day Dr. Feldman J Capproitti, MD, J Pelletier, MD

6/17 Resident/Fellow Research Day Dr. Fishman C Starr, MD, D. Jardin, MD, B. Soloway, MD

8/5 VISITING PROFESSOR Eduardo C. Alfonso, MD Edward D. Norton Chair, Professor Ophthalmolog,y Bascom-Palmer Eye Institute Keratoprosthesis Intralase for Lameller Surgery DESK (Descemet's Stripping Endothelial Keratoplasty)

8/13 Interstitial Keratitis, Retinal Vasculitis Dr. Rosenbaum Lues (the Great Masquerader) Herpes 16 Atypical Best's (Normal EOG) Dr. Banitt Thyroid Ophthalmopathy Dr. Gatto

8/18 VISITING PROFESSOR Dr. S. Isenberg Laraine and David Gerber Professor of Ophthalmology Jules Stein Eye Institute Chief, Ophthalmology Division LA Country Harbor David Geffen School of Medicine @ UCLA Preventing Blindness in Developing Countries

8/19 The Eye in Neonates

8/25 VISITING PROFESSOR Gerald Fishman, PhD Marion Schenk, Esq., Chair in Ophthalmology, Director, Electro- physiology Laboratory, Director, Inherited Retinal Disease Service, University of Illinois, Chicago The Importance of Electrophysiologic Testing in Patients with Retinal Disease

8/26 Rod-Cone RPE Like Dystrophy with Dr. Trivedi Inflammation, 2ary Coats' Response Edema ?myalgia >CPK ?CRV1 Stargardt's: Rod Cone Dystropyy Dr. Barone Different Phenotypes, common genotype Rod-Cone Dystrophy Drusen, Dr. Margolis Neovascularization Autosomal Dominant

9/2 SPECIAL LECTURER R. V. Ramani, MD Managing Trustee Sankara Eye Care Centre Coimbatore, India

9/8 Mission of Vision: 20/20 FOR ALL BY 2020

9/15 Choroidal Malignant Melanoma Dr. Feldman Rx: I 125 Plaque

9/15 Sympathetic Ophthalmia 2ary Perforating Dr. Gonzalez Corneal Ulcer

9/15 Multiple Choroidal Infaractions Dr. Fitz ? AION ? NAION ???

9/22 VISITING PROFESSOR Albert M. Lefkovits, MD Assistant Professor of Dermatology Mt. Sinai School of Medicine Fellow of the Royal College of Medicine Diseases of the Skin and Eye and Their Patho-physiological Relationships: Diagnosis and Therapy As Frequently Seen in Consultation

NYEEI OPHTHALMOLOGY GRAND ROUNDS 85 NYEEI OPHTHALMOLOGY GRAND ROUNDS 2005

DATE TOPIC PRESENTER 9/23 Case Presentations to Dr. Lefkovits * Chronic Recurrent Blepharitis Dr. Rodriguez * Acne Rosacae: Blepharitis, Corneal Ulcer Dr. Page

9/30 Lacrimal Gland Mass: Atypical Lymphoid Hyperlasia Dr. Ovodenko

9/30/05 Giant Cell Arteritis: , Prominent Artery Dr. Anderson + CRP + ESR + BX No Vision Changes

9/30 Lacrimal Gland Mass Dr. Rozenbaum Bx. + Chronic Inflammation 2 months steroids No response Excisional Bx; Benign Mixed Tumor (Pleomorphic Adenoma)

10/6 VISITING PROFESSOR Barry Winkler, MD Professor of Biomedical Sciences Eye Research Institute Oakland University Rochester, Michigan Retina Energy Metabolism in relation to Function: Neuron/Glial Interactions

10/7 Fundamentals of Electro-Retinography: Basic and Clinical Considerations

10/14 American Academy of Ophthalmology Annual Meeting Chicago

10/21 Community Oriented Primary Care: A Strategy for Dr. Capriotti Rural Sierra Leone

10/21 HLA-B27 Chronic Uveitis Dr. Trastman-Caruso

10/21 Intermediate Uveitis: Multiple Sclerosis: Exudative RD Dr. Panarelli

10/27 Cornea Anterior Segment Grand Rounds Drs. Seedor, Ritterband Posterior Polymorphous Corneal Dystrophy Dr. R. Yang Contact Lens Corneal Ulcer: Fusarium Dr. Rozenbaum Surgical Options for Presbyopia Dr. Pelletier

11/04 VISITING LECTURER Dimitri T. Azar, MD Senior Scientist Schepens Eye Research Institute Professor Of Ophthalmolgydirector Of Cornea & Refractive Surgery Massachusetts Eye And Ear Infirmary Harvard Medical School Corneal Angiogenesis

11/16 RETINA GRAND ROUNDS: Drs. Muldoon, Rosen, Rosenthal, Samson, Walsh, Pollack

UPDATE ON TREATMENT CNV-ARMD Dr. Lalin Past, Present (Infirmary Experience with Intravitreal Avastin: 150 cases) and Future CMV Retinitis: RD; Reoccurrence HART Failure Dr. Seek Ciliary Body Malignant Melanoma: Uveitis Masquerade Dr. Barone

12/02 Orbital Cellulitis: AML: Mucormycosis Dr. Aleksandrovich The Eye in Pregnancy: Benign Intracranial Hypertension Dr. Panarelli LASIK (2001): Trauma: Epithelial Ingrowth and Lamellar Keratitis Dr. Rodriguez Diffuse

86 THE NEW YORK EYEAND EAR INFIRMARY NYEEI OPHTHALMOLOGY GRAND ROUNDS 2005

DATE TOPIC PRESENTER

CORNEA GRAND ROUNDS Dr. Seedor, Mr. Shah

12/09 Contact Lens Keratitis: Acanthamoeba Dr. Bhargana S/P LASIK Corneal Ectasia ?Form Fruste Keratoconus Dr. Rau Ocular Flora Sierra Leone: Normal, Corneal Ulcers Dr. Capriotti

UVEITIS GRAND ROUNDS: Dr. Samson

12/16 Masquerade Syndrome: Chronic Uveitis Dr. Liu Endogenous Lysteria Endophthalmitis Dr. Trastman-Caruso Post-Colonoscopy Toxoplasmosis Retino-choroiditis Dr. Leon-Rosen

REFRACTIVE SURGERY LECTURES

7/20 Advances in Refractive Surgery: The Role of Multifocal IOL's Dr. K Rosenthal

8/3 Director Refractive Center Hermann Eye Institute Professor of Richard W Yee, MD Ophthalmology U of Texas at Houston Overview of LASIK Complication Complications and My Current Surface Ablation Technique LASIK, LASEK, PRK Epi-Delaminations

8/10 CUNY, Mt Sinai CK for Hyperopia and presbyopia, Penny Asbell, MD Dry eyes and the Refractive Surgery Patient

8/17 NYMC, NYEEI Barrie Soloway, MD Fundamentals of Wavefront Guided Excimer Surgery

8/24 NYMC, NYEEI Douglas Buxton, MD Bimanual Micro-Incision Phacoemulsification and LRI's for Astigmatism Control in Cataract Surgery

NYEEI OPHTHALMOLOGY GRAND ROUNDS 87 RESIDENT/FELLOW RESEARCH DAY JUNE 2005

Mehdi Ahmad, MD Joshua Hedaya, M.D. Cortical Blindness following Coil Embolization of Intracranial Optical Coherence Tomography (OCT) / Scanning Laser Aneurysm Ophthalmoscope (SLO) Imaging of Optic Nerve Pits and Associated Maculopathy Sarah Anis,MD Surgical Reduction of Symptomatic Filtering Blebs Vincent Hugo, MD SOLX Titanium Sapphire Laser for Trabeculoplasty Michael Banitt, MD Pars Plana Baerveldt Implantation for Childhood Glaucoma Sean Lalin, MD Predicting Visual Recovery in Central Retinal Vein Occlusions Yaniv Barkana, MD Intraocular Pressure Monitoring Outside of Normal Office Hours in Alex Liu, MD Patients With Glaucoma is Clinically Useful Survey on teaching of uveitis management in U.S. Ophthalmology residency training programs Samuel Barone, MD Survey On The Knowledge Of Immunosuppressive Agents For Kira Manusis, MD Uveitis Among Non-Uveitis Specialists Fungal Keratitis and Consecutive Endophthalmitis at The New York Eye and Ear Infirmary Joseph Benevento, MD Intraocular Pressure During 25 Gauge Vitrectomy Seth Meskin, MD Liquid Bandage(tm)(2-octyl cyanoacrylate) as a Temporary Wound Jose de la Cruz Napoli, MD Barrier in Clear Corneal Cataract Surgery In Vivo Confocal Microscopy Analysis of Corneal Layers Healthy Volunteers Ricardo Mora, MD Does Changing Eye Test Order With 24-2 SITA Standard Result In a Syril Dorairaj, MD Meaningful Change In Test Results? Genetic analysis of the CYP1B1 and MYOC genes in Indian families affected with juvenile-onset primary open-angle glaucoma Kannan Narayana, MD Immunomodulatory Therapy in Patients With Scleritis Elad Feldman, MD A Clinical Comparison Between Vigamox and Povidone Iodine Boris Ovodenko, MD (0.5%) For The Management Of Corneal Abrasions Complement activation in exfoliation syndrome

Gary Fishman, MD Jon Page, MD Results of Epi-LASIK with the Moria EpiK microkeratome Scanning laser ophthalmoscopy-optical coherence tomography (SLO- OCT) evaluation of choroidal nevi Julian Garcia, MD Dynamic 2D B-Scan Ultrasound Recording in Ophthalmology Christopher Papp, MD Anterior Chamber Paracentesis Cytology: For the Diagnosis of Patricia Garcia, MD Intraocular Lymphoma Coronal OCT Scanning of IPCV Jesse Pelletier, MD Michele Gatto, MD How long is Voriconazole Effective as a Topical Solution? A Retrospective Review of Patients with Syphilitic Uveitis Marta Ponce-Contreras, MD Ariadna Gonzalez, MD Endophthalmitis Associated With Infectious Keratitis Chronic Uveitis Following Laser Iridotomy - A Report of 5 Cases Alfonso Ponce, MD Tomas Grippo, MD Origin of Subbretinal Fluid in Optic Disc Pit Maculopathy: B-2 Optic Nerve Head Drusen and Visual Field Loss in Normotensive Transferrin Analysis and Hypertensive Eyes Michael Pro, M.D Noga Harizman, MD Imaging of the Optic Disc and Retinal Nerve Fiber Layer in Acute Can the ISNT Rule Be Applied To Patients of African Ancestry Optic Neuritis.

88 THE NEW YORK EYEAND EAR INFIRMARY RESIDENT/FELLOW RESEARCH DAY JUNE 2005

Natalia Rodriguez, MD The Long-term Effects of Ethambutol on the Optic Nerve Presentation Start/End Time: Sunday, May 01, 2005, 2:30 PM - 4:15 PM Location: Hall B/C

Ilya Rozenbaum, MD Screening for Systemic Pathology in Anterior Uveitis: Utility of Common Radiographic Studies

Daniel Shapiro, MD Liquid BandageTM Tissue Adhesive (2-octyl cyanoacrylate) to Seal Clear Corneal Cataract Wounds-A Laboratory Model

Wisam Shihadeh, MD Delayed Intraocular Pressure Elevation after Pharmacological Pupillary Dilation in Exfoliation Syndrome

Gaurang Trivedi, MD Comparison of infectious isolates associated with nasolacrimal duct obstruction between children and adults

Andrew Brown, MD Serpiginous Choroiditis, Autoimmune Thyroiditis In A Young Man With Pituitary Hyperplasia

Joseph Capriotti, MD Outcomes Of Immunomodulatory Therapy With Mycophenolate Mofetil In Patients With Severe Ocular Inflammation.

RESIDENT/FELLOW RESEARCH DAY JUNE 2005 89 RESIDENT/FELLOW RESEARCH DAY, MAY 11, 2006

Justin Anderson, MD Fabio Kanadani, MD Postoperative Astigmatism and Visual Acuity Following Implantation Structural and Functional Assessment of the Macular Region in of Foldable Intraocular Lenses in Pediatric Patients. Patients with Glaucoma

Michael Banitt, MD Sean Lalin, MD Treatment Of Choroidal Neovascular Membranes in Patient’s with Short-Term Outcomes in over 500 Intravitreal Bevacizumab Angioid Streaks With Intravitreal Bevacizumab (Avastin) Treatments for Retinal or Choroidal Vascular Disease at the New York Eye & Ear Infirmary Samuel Barone, MD The Incidence of Microbial Isolates and Sensitivities in Posterior Jonathan Leon-Rosen, MD Segment Intraocular Foreign Body Injury — A 10 Year Review Peripheral Retinal Imaging Using A Prototype Anterior Segment OCT/SLO Rodrigo Barros, MD Ocular Pulse Amplitude (OPA) in High Myopia, Glaucoma, and Alex Liu, MD Normal Subjects using Pascal Dynamic Contour Tonometer. Study in Outcomes of Sarcoid Uveitis Patients at a Tertiary Referral Center Anuj Bhargava, MD The Efficacy of Liquid Bandage (2-octyl Cyanoacrylate) as a Wound Boris Ovodenko, MD Sealant in Clear Corneal Cataract Surgery Propionibacterium Acnes Keratitis

Joseph Capriotti, MD Kannan Narayana, MD The etiology of infectious corneal ulceration in Sierra Leone Prescription and Inpatient Medication Order Errors in a Tertiary Referral Eye and Ear Center Syril Dorairaj, MD Short-Time Recovery after Accommodation-induced changes in Iris Jon Page, MD Curvature Intravitreal bevacizumab (Avastin) treatment of macular edema in retinal vein occlusions and diabetic retinopathy Edgar Espana, MD Surgical Outcomes of Baerveldt Glaucoma Implant with Silicone Boris Ovodenko, MD Tube placement in the Ciliary Sulcus Complement activation in exfoliation syndrome

Elad Feldman, MD Jon Page, MD Treatment of Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) Scanning laser ophthalmoscopy-optical coherence tomography (SLO- with Intravitreal Bevacizumab (Avastin) Appears To Decrease Retinal OCT) evaluation of choroidal nevi Thickness and Retinal Surface Contour Based SLO-OCT Imaging Anthony Panarelli, MD Eric Fritz Comparison of Ultrasound Biomicroscopy and Optical Coherence Snapshot of current resistance profiles for vitreous isolates in bacte- Tomography for Imaging of Anterior Segment Structures through an rial endophthalmitis Opacified Cornea

Michele Gatto, MD Jesse Pelletier, MD Lagophthalmos: Incidence, Associated Signs, Symptoms, and A Survey of Normal Ocular Flora in Healthy Eyes from a Rural Conditions Population in Sierra Leone

Ariadna Gonzalez, MD Ganesh Rau, MD Uveitis in Sickle Cell Trait and Sickle Cell Disease at the New York Enterococcus Keratitis: A Retrospective Case Series Eye and Ear Infirmary - a report of 4 patients Natalia Rodriguez, MD Tomas Grippo, MD Acute Post-operative Complications Following Simultaneous Comparison of Conventional and multifocal evoked potentials laten- Penetrating Keratoplasty and Glaucoma Drainage Implant Insertion cy changes secondary to Glaucomatous damage

90 THE NEW YORK EYEAND EAR INFIRMARY RESIDENT/FELLOW RESEARCH DAY, MAY 11, 2006

Noga Harizman, MD Detection of Glaucoma Using Operator-Dependent Versus Operator-Independant Classification in the HRT-III

Ragui W. Sedeek, MD (No Title) Purpose: To report the clinical risk factors for Cytomegalovirus retinitis (CMVR) among HIV+ patients

Gaurang Trivedi, MD The Use of Intravitreal Bevacizumab (Avastin) As A Pre-Surgical Adjuvant In The Treatment Of a Combined Tractional- Rhegmatogenous Retinal Detachment With Severe Retinal Neovascularization

Elyse Trastman-Caruso, MD Pterygium Surgery Response To Steroids In The Hispanic Population

Boonchai Wangsupadilok, MD A method to detect progression of glaucoma using the multifocal visual evoked potential technique

Renee Yang, MD Trends in Contact Lens Related Corneal Ulcers at the New York Eye and Ear Infirmary

RESIDENT/FELLOW RESEARCH DAY, MAY 11, 2006 91 PUBLICATIONS 2005

Brazzo, Brian, M.D. Kidney. Cancer and the Eye: Current Concepts. Kurli M, Finger PT Survey Editor, Oculoplastic Surgery Atlas. Cosmetic Facial Surgery. Gladstone GJ, of Ophthalmology 2005;50(6):507-18 Black EH, Myint S, Brazzo BG, editors. Springer-Verlag, New York, Inc. 2005. Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma: The Collaborative Ocular Finger, Paul, M.D. Melanoma Study Group Report No. 26 Arch Ophthalmol. 2005 R3D-ultrasound coronal C-scan imaging for optic nerve sheath menin- Dec;123(12):1639-1643. gioma. Garcia JP Jr, Finger PT, Kurli M, Holliday RA. Br J Ophthalmol. 2005 Feb;89(2):244-5. Renal Cancer, Eye and Orbit – A Review. Kurli M, Finger PT. In: Focus on kidney cancer research. Nunez KR (Ed.), Nova Science “Finger-tip” Cryoprobe assisted Enucleation. Finger PT. Am J Ophthalmol Publishers, Hauppage, New York, 2005 Chapter 1 pp. 1-20. 2005; 139:559-561. Laser for Intraocular Tumors – The Art of Lasers in Ophthalmology Melanocytic conjunctival tumors. Schneider, S, Finger PT In: Laser Surgery of the Eye. Boyd S, Agarwal A Kurli M, Finger PT. Ophthalmol Clin North Am. 2005 Mar; 18(1):15-24. (Eds.), Highlights of Ophthalmology – International, El Dorado, Panama. Optic nerve measurements by 3D ultrasound-based coronal "C-scan" 2005, Section 7, Chapter 35, pp. 387-392. imaging. Garcia JP Jr, Garcia PM, Rosen RB, Finger PT.Ophthalmic Surg Uveal melanoma: a model for exploring fundamental cancer biology. Lasers Imaging. 2005 Mar-Apr; 36(2):142-6. by M.J. Jager, J.Y. Niederkorn, B.R. Ksander (eds), Taylor and Francis, “Finger-tip” cryoprobe assisted orbital tumour extraction. Finger, PT. Br J London, New York, 2004 Ophthalmol 2005; 89(6):777-8. Finger P. Review: Graefes Arch Clin Exp Ophthalmol. 2005;243(1):82.

Laser photocoagulation for radiation retinopathy after ophthalmic plaque Greenbaum, Scott, M.D. radiation therapy. Finger PT, Kurli MBr J Ophthalmol 2005; 89(6):730-8. Amaurosis and anesthesia technique. J Cataract Refract Surg. 2005 Topical Mitomycin chemotherapy for conjunctival malignant melanoma Feb;31(2):256 and primary acquired melanosis with atypia: 12 years’ experience. Graefes Koplin, Richard, M.D. Arch Clin Exp Ophthalmol. 2005 Jun 7 Koplin, RS. J Cataract and Refractive Surgery. Consultation Section, Finding malignant change in a necrotic choroidal melanocytoma: a clinical Cataract Surgical Problem (edited by Samuel Masket, MD) Vol. 31, challenge. Kurli M, Finger PT, Manor T, McCormick SA, Grossniklaus HE. October, 2005 Br J Ophthalmol 2005:89:921-2. Meskin SW, Ritterband DC, Shapiro DC, Koplin, RS, et al. Liquid Bandage “Finger-tip” cryotherapy probes: treatment of squamous and melanocytic (2-Octyl Cyanoacrylate) as a Temporary Wound Barrier in Clear Corneal conjunctival neoplasia. Finger PT Cataract Surgery. Ophthalmology 2005; 112:2015-2022 Br J Ophthalmol 2005; 89:942-949. Ritterband DC, Meskin SW, Shapiro DE, Kuzmierczyk J, Seedor, JA, Koplin, The Finger iridectomy technique: small incision biopsy of anterior segment RS. Laboratory Model of Tissue Adhesive (2-Octyl Cyanoacrylate) in tumors. Finger PT, Latkany P, Kurli M, Iacob C. Brit J Ophthalmol Sealing Clear Corneal Cataract Wounds; Am J Ophthalmol. 2005 2005;89:946-949 Dec;140(6):1039-1043

Collaborative Ocular Melanoma Study Group: Second Primary Cancers Shah MK, Ritterband D, Meskin S, Koplin RS. Will the Fortification of after Enrollment in the COMS Trials for Treatment of Choroidal Optisol GS with Moxifloxacin Reduce the Contamination Rate of Cornea Melanoma. COMS Report No. 25. Archives of Ophthalmology Donor Rim Cultures? (Presented at ARVO, Ft Lauderdale, FL, Abstract, 2005:123:601-4. 2005)

Small incision surgical iridotomy and iridectomy. Finger PT. Graefes Arch Meskin S, Ritterband D, Shapiro D, Koplin RS. Tissue Adhesive as an Clin Exp Ophthalmol. 2005 Aug 2;:1-2 Adjunct Agent in Clear Corneal Cataract Wound Closure (Presented at ASCRS, Washington, DC, Abstract, 2005) "C-scan" ultrasound imaging of optic nerve extension of retinoblastoma Finger PT, Garcia, Jr JPS, Pro MJ, Rausen A, Schneider S. British Journal of Shapiro D, Ritterband D, Meskin S, Koplin RS. Tissue Wound adhesive to Ophthalmology 2005;89 1225-1226 Prevent Inflow of Ocular Surface Fluid Through a Clear Corneal Cataract Wound (Presented at ASCRS, Washington DC, Abstract, 2005) Whole body PET/CT for initial staging of choroidal melanoma. Finger PT, Kurli M, Reddy S, Tena LB, Pavlick AC. Ritterband D, Shapiro D, Meskin S, Koplin RS. Long Term Results of British Journal of Ophthalmology 2005 Oct; 89(10):1270-4. Penetrating Keratoplasty with Simultaneous Pars Plan Drainage Implants (Presented at World Cornea Congress, Washington, DC, Abstract April PET/CT imaging: detection of choroidal melanoma. Reddy S, Kurli M, Tena 2005) LB, Finger PT. British Journal of Ophthalmology 2005 Oct;89(10):1265-9. Seedor J, Ritterband D, Shapiro D, Koplin RS. Acute post-operative com- Population-Based Incidence of Uveal Melanoma in Various Races and plications following simultaneous penetrating Keratoplasty and glaucoma Ethnic Groups. Hu DN, Yu GP, McCormick SA, Schneider S, Finger PT. drainage implant insertion (Presented at the World Cornea Congress, American Journal of Ophthalmology 2005;140(4):612-617 Washington, DC, Abstract April, 2005)

92 THE NEW YORK EYEAND EAR INFIRMARY PUBLICATIONS 2005

Kupersmith, Mark J., M.D. course in patients with pigmentary glaucoma, J Glaucoma 2005;14:255- Kupersmith MJ, Ying GS. Ocular motor dysfunction in ocular myasthenia 259. gravis: effects of treatment. Br J Ophthalmol 2005;89:1330-1334 Ko ML, Peng PF, Ritch R, Chen CF: Dynamic changes of reactive oxygen Mohammed, Kupersmith MJ. Ischemic optic neuropathy after liposuction. species and antioxidant levels in retinas in experimental glaucoma, Free Neuro-ophthalmology (In Press) Radical Biol Med 2005;39:365-373.

Holmes J, Leske D, Kupersmith M. New methods for quantifying diplopia. Shildkrot Y, Liebmann J, Fabijanczyk B, Tello C, Ritch R: Central corneal Ophthalmology 2005;112:2035-2039 thickness in clinical practice. J Glaucoma 2005;14:331-336.

Stiebel-Kalish H, Kalish Y, Huna Bar-On R, Setton A, Niimi Y, Berenstein A, Konstas AGP, Koliakos GG, Liakos P, Karabatsas CH, Schlötzer-Schrehardt Kupersmith MJ. Presentation, Natural History and Management of Carotid U, Georgiadis N, Ritch R: Latanoprost therapy reduces the levels of TGF Cavernous Aneurysms. Neurosurgery 2005;57:850-857 beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma. Exp Eye Res 2005; De la Cruz J, Kupersmith M. Clinical profile of simultaneous bilateral optic neuritis in adults. Br J Ophthalmol (In press) Young MJ, Borràs T, Walter M, Ritch R: Potential applications of tissue engi- neering to glaucoma, Arch Ophthalmol 2005;123:1725-1731. Kupersmith, MJ. Are CD MRIs Compatible with Good Neurological Practice? J Neuroimaging (In Press) Lee PP, Walt JG, Doyle JJ, Kotak SV, Evans SJ, Budenz DL, Chen PP, Coleman AL, Feldman RM, Jampel HD, Katz LJ, Mills RP, Myers JS, Noecker RJ, Piltz- Luntz, Maurice H., M.D. Seymour JR, Ritch R, Schacknow PN, Serle JB, Trick GL: A multi-center, ret- Luntz,MH, TropeGE: In: Glaucoma Surgery (GE Trope editor), Ch. 2. rospective pilot study of resource utilization and costs associated with Glaucoma Surgical Anatomy pp13--15, Taylor & Francis (publ.),USA, 2005 severity of disease in glaucoma. Arch Ophthalmol, in press Ibid : Full Thickness Filtering Surgery, Ch.10, pp 93--100, 2005 Ritch R: Lowering intraocular pressure may not be the only presently avail- Ibid : How to do a Surgical Iridectomy, Ch.11 pp 101--105 ,2005 able approach to neuroprotection in the treatment of glaucoma. Arch Ophthalmol, in press. Ritch, Robert, M.D. Krupin T, Liebmann JM, Greenfield DS, Rosenberg LF, Ritch R, Yang JW, Anis S, Ritch R, Shihadeh W, Liebmann J: Surgical reduction of circumferen- Low-pressure Glaucoma Study Group. The Low-pressure Glaucoma tial filtering blebs. Arch Ophthalmol, in press Treatment Study (LoGTS): Study design and baseline characteristics of Barkana Y, Anis S, Liebmann JM, Tello C, Ritch R: Intraocular pressure mon- enrolled patients. Ophthalmology 2005;112:376-385. itoring outside of normal office hours in patients with glaucoma is clinical- Monemi S, Spaeth G, DaSilva A, Popinchalk S, Ilitchev E, Liebmann J, Ritch ly useful. Arch Ophthalmol, in press. R, Héon E, Pitts Crick R, Child A, Sarfarazi M: Identification of a novel adult- Oliveira C, Liebmann JM, Dodick JM, Ritch R: Identification of a retained onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Molec nucleus fragment in the posterior chamber. Am J Ophthalmol, in press. Genet 2005;14:725-733. Ritch R: Complementary and alternative therapy for glaucoma. Fishman GR, Pons ME, Seedor JA, Liebmann JM, Ritch R: Central corneal Ophthalmol Clin NA, in press thickness measurement by optical coherence tomography (OCT3) versus standard ultrasound pachymetry and Orbscan. J Cataract Refract Surg Barkana Y, Gerber Y, Mora R, Liebmann JM, Ritch R: Eye test order does 2005;31:707-711. not affect achromatic perimetry results using the SITA-standard 24-2 algo- rithm. Arch Ophthalmol, in press. OPH05-0549 Hood DC, Xu L, Thienprasiddhi P, Greenstein VC, Odel JG, Grippo T, Liebmann JM, Ritch R: The pattern electroretinogram (PERG) in glaucoma Barkana Y, Shihadeh W, Oliveira C, Tello C, Liebmann JM, Ritch R: Angle-clo- patients with confirmed visual field deficits. Invest Ophthalmol Vis Sci sure in highly myopic eyes, Ophthalmology, in press. 2005;46:2411-2419. Tham CCY, Kwong YYY, Ritch R, Lai JSM, Lam DSC: Argon laser peripher- Shihadeh W, Ritch R: Methods to reduce pigment release in exfoliation al iridoplasty (ALPI). Techniques in Ophthalmol, in press. syndrome and in pigment dispersion syndrome. Glaucoma Today 2005;2:2- Foster PJ, Gazzard GA, Garway-Heath T, Ritch R: Pattern of trabecular sur- 15. face pigment deposition in primary angle-closure, Archives, in press. Oliveira C, Tello C, Liebmann JM, Ritch R: Ciliary body thickness increases Kanadani FN, da Silva FA, Batista WD, Ritch R: Papillorenal syndrome: A with increasing axial myopia. Am J Ophthalmol 2005;140:324-325. case report. Asian J Ophthalmol, in press. Knepper PA, Miller AM, Choi J, Wetz RD, Goossens W, Nolan MJ, Ritch R, Shihadeh WA, Ritch R, Liebmann JM: Rescue of failed filtering blebs with ab Liebmann JM, Allingham RR, Ventura A, Santiago C, Wax MB, Smolyak R, interno trephination. J Cataract Refract Surg, in press. Hasan F, Barnett T, Palmberg PF, Ishika K, Samples JR: Hypophosphorylation of aqueous humor sCD44 and primary open-angle glaucoma. Invest Dorairaj SK, Murthy KR, Ritch R: A case report of a four generation famil- Ophthalmol Vis Sci 2005;46:2829-2837. ial benign fleck retina. Retina, in press.

Reistad CE, Shields MB, Campbell DG, Ritch R, Wang JC, Wand M, Shihadeh WA, Ritch R, Liebmann JM: Hyphema during selective laser tra- American Glaucoma Society Pigmentary Glaucoma Iridotomy Study beculoplasty, Ophthalmic Lasers Surg Imaging, in press. Group: The influence of peripheral iridotomy on the intraocular pressure

93 PUBLICATIONS 93 PUBLICATIONS 2005

Oliveira C, Tello C, Liebmann JM, Ritch R: Central Corneal Thickness is Not Saffra, Norman Related to Anterior Scleral Thickness or Axial Length . J Glaucoma, in “Fibrosarcoma ” N. Saffra, D. Siracuse-Lee. Current Ocular Therapy, Vol. 6 press. no. 171.9 Book Chapter accepted 2005 Oliveira C, Schlötzer-Schrehardt U, Vieira G, Liebmann J, Ritch R: Early “Peripheral Ulcerative Keratitis in Sarcoidosis: A Case Report” D. Siracuse- diagnosis of exfoliation syndrome in children of affected patients. Acta Lee, N. Saffra. Cornea Accepted 2005 Ophthalmol Scand, in press. “Retinal Vein Thrombosis as the Presenting Symptom of Essential Ritch R, Minckler DM: Laser trabeculoplasty. In: Laser surgery: open-angle Thrombocythemia” J. Huang, N. Saffra glaucoma, Weinreb RN, Crowston JC, Kugler Pub, the Hague, 2005:21-38. The American Journal of Medical Sciences Vol. 329 #3, 139-140 March 2005 Shimmyo, Mitsugu Ritch R: Is primary angle-closure glaucoma a single disease? In: Answers in Glaucoma, Susanna R Jr, Weinreb RN eds, Culttura Médica, Rio de Janeiro, Shimmyo M, Orloff PN: Corneal Thickness and Axial Length. American 2005:175-180. Journal of Ophthalmology 2005: 139 (3):553-554. Shimmyo M, Rho DS, Hiyama F, Iizuka S. Retardation of Myopia and axial Ritch R: Why is intraocular pressure difficult to control in exfoliation syn- growth by Atropine in children. Hong Kong Journal of Ophthalmology drome? In: Answers in Glaucoma, Susanna R Jr, Weinreb RN eds, Culttura 2005:9 (1); 21-27 Médica, Rio de Janeiro, 2005:157-162. Shimmyo M: Central Corneal Thickness and Measured IOP Response to Klassen H, Young MJ, Ritch R, Richards JE, Borrás T, Levin LA: Retinal stem Topical Ocular Hypotensive Medication in the Ocular Hypertension cell research. In: Retinal Diseases, Peyman G, ed., in press. Treatment Study. Correspondence: American Journal of Ophthalmology Tham CCY, Ritch R: Narrow angles – when and how to treat? Glaucoma 2005:139 (6):1148. therapy, Francisco Lima, ed., in press Sidoti, Paul Shihadeh W, Ritch R, Liebmann JM: Salvaging the failing filtering bleb. Rodriguez N, Sidoti PA, Tello C. Anterior chamber deepening and poste- Glaucoma surgery, Tarek Shaarawy ed, in press rior lens displacement with miotics. Pan-American Congress of Ophthalmology. 2005 Ritch R, Tham CCY. Plateau iris, In: Current Ocular Therapy, 6th ed, F. Fraunfelder ed, WB Saunders Co, Philadelphia, in press Rodriguez NM, Banitt MR, Dhar S, Tello C, Liebmann JL, Sidoti PA. Pars plana Baerveldt implantation for childhood glaucoma. Annual Meeting of Ritch R, Tham CCY, Lam DSC: Argon laser peripheral iridoplasty. In: Roy the American Academy of Ophthalmology. 2005;209. and Benjamin, Surgical techniques in ophthalmology: Glaucoma. In press Speaker, Mark Tello C, Liebmann JM, Ritch R, Greenfield DS: The angle-closure glaucomas, Speaker M, Haq F, Latkany R, Reing C in: Atlas of Glaucoma, Choplin NS ed, 2d edition, Martin Dunitz Ltd, Postkeratoplasty Astigmatism London, in press. Second Addition CORNEA Vol.2 Editors, Krachmer J, Mannis M, Holland E, New York, Elsevier Mosby, 2005 Chapter 127 p.1527-1537 Ritterband, David Latkany R, Nilforoushan M, Speaker M Effect of artificial tears on visual acuity Keyhani K, Seedor JA, Shah MK, Terraciano AJ, Ritterband DC. The Accepted American Journal of Ophthalmology 2005 Incidence of Fungal Keratitis and Endophthalmitis Following Penetrating Keratoplasty. Cornea, 2005 Apr;24(3):288-291 Latkany R, Nilforoushan M, Speaker M Traumatic flap dislocation four years post Lasik. J Cataract Refract Surg Ritterband DC, Meskin SW, Shapiro DC et al. Laboratory model of tissue Aug 2005 adhesive (2-octyl cyanoacrylate) in sealing clear corneal cataract wounds. Am J Ophthalmol. 2005 Dec;140(6):1039-43. Latkany RA, Chokski AR, Speaker MG, Abramson J, Soloway BD, Yu G Intraocular lens calculations after refractive surgery. J Cataract Refract Hamrah P, Ritterband D, Seedor J, Eiferman RA. Ocular Infection Surg. 2005 Mar;31(3):562-70 Secondary to Gemella. Graefe’s Arch Clin Exp Ophthalmol. 2006 Jan:1-2. Speaker M. Refractive surgical problem Consultation – March # 4 J Rodriguez-Sains, Rene Cataract Refract Surg. 2005 Mar;31(3):465. No abstract available The Sun, The Eyelids And The Eye: 2005: The Skin Cancer Foundation Journal. XXIII; pp36-37 Zaidman, Gerald W Rosen, Richard B. Morleo, M., Pramparo, T., Perone, L., Gregato, G., LeCaignec, C., Muellar, R.F., Garcia JP Jr, Garcia PM, Rosen RB, Finger PT. Optic nerve measurements Ogata, T., Rass-Rothschild, A., deBlois, M.C., Wilson, L.C., Zuffardi, O., by 3D ultrasound-based coronal "C-scan" imaging.Ophthalmic Surg Lasers Ballabio, A., Franco, B., Zaidman, G.W.: Microphthalmia with Linear Skin Imaging. 2005 Mar-Apr;36(2):142-6. defects (MLS) syndrome: clinical, cytogenetic and molecular characteriza- Rosen RB, Will D, Garcia PM Dunne S Fisher, Y, Podoleanu A Gh: “OCT tion of 11 cases. American Journal of Medical Genetics Association August Ophthalmoscope” in Age-Related Macular Degeneration: A 30, 2005; 137(2): 190-8. Comprehensive Textbook, Lippincott Williams and Wilkins, 2005 Kinn, S.K., Quinn, C.E., Zaidman, G.W., Orlin, S.E.: Congenital Hyperplastic Rosen RB, “Overview of the Residency” in the Ophthalmology Program Persistent Pupillary Membranes: A conservative approach in management. Directors Handbook ed. Volpe N, Aaron, MM, Brooker, G, Association of JAAPOS, 9: 391-3, 2005. University Professors in Ophthalmology publication,2005

94 THE NEW YORK EYEAND EAR INFIRMARY PUBLICATIONS 2005

Zaidman, G.W.: Opacification of IOL’s: A problem often misdiagnosed. Eyenet, September, 2005. Zaidman, G.W., Mondino, B.J.: Mooreu’s Ulcer. In Cornea. Krachmer, J., Mannis, M., Holland, E. (eds). Elsevier, Mosby, Philadelphia, 2005. Pp. 1241-1244

PUBLICATIONS 95 PUBLICATIONS 2006

P. ASBELL, MD Brazzo, B, MD Intrastromal Corneal Ring Implantation (360 Degrees Ring) for Lacrimal Surgery: Diagnosis and Treatment. Cohen AJ, Mercandetti Myopia: A 5-Year Follow-up. Shwartz A.P., Tinio B.O., Babayán A., M, Brazzo BG, editors. Springer-Verlag, New York, Inc. 2006. Naikoo H.N., Robert B., Asbell P.A. Eye Contact Lens. 2006; 32(3):121-123. Charles, N, MD Charles NC, Lisman RD, Mittal KR. Carcinoma of the lacrimal Fluorophotometry as a diagnostic tool for the evaluation of dry eye canaliculus masquerading as canaliculitis. Arch Ophthalmol. 2006; disease. Fahim MM, Haji SA, Koonapareddy CV, Fan VC, Asbell PA. 124:414-416. BioMed Central Ophthalmol. 2006; 6:20, 10.1186/1471-2415-6-20. http://www.biomedcentral.com/1471-2415/6/20/ Charles NC. Ganciclovir Implant. [letter] Ophthalmology 2006; 113:888. Efficacy of Cobalt Chelate CTC-96, Against Adenovirus in a Rabbit Model and against Adenovirus Keratoconjunctivitis in a Rabbit Barker-Griffith AE, Streeten BW, Charles NC. Moll gland neoplasms Model. Epstein SP,Pashinsky YY, Gershon D, Winicov I, Srivilasa C, of the eyelid: A clinical and pathological spectrum in 5 cases. Arch Kristic KJ, Asbell PA. BioMed Central Ophthalmol. 2006; 6:22, Ophthalmol 10.1186/2415-6-22. 2006; 124:1645-1649. http://www.biomedcentral.com/1471-2415/6/22 Finger, Paul, MD Susceptibility Testing of Clinical Isolates of Pseudomonas Aeruginosa Small incision surgical iridotomy and iridectomy. Finger PT. to Levofloxacin, Moxifloxacin and Gatifloxacin. Epstein SP, Bottone Graefes Arch Clin Exp Ophthalmol. 2006 Mar; 244(3):399-400. 2005 EJ, Asbell PA. Eye and Contact Lens. 2006; Sep; 32(5):240-244. Aug 2; 1-2

Increasing Importance of Dry Eye Syndrome and the Ideal Artificial Anterior Chamber Paracentisis cytology (cytospin technique): For Tear: Consensus views from a roundtable discussion. Asbell PA. the diagnosis of intraocular lymphoma Finger PT, Papp C, Latkany P, Current Medical Research and Opinion. 2006; 22(11): 2149-2157. Kurli M, Iacob C. Br J Ophthal 2006; 90:690-692. Barile, G, MD Ober MD, Barile GR, Tari SR, Tossi GM, Schiff WM, Chang S. Early ocular prosthesis insertion improves quality of life after enucleation. Measurement of the actual dose of triamcinolone acetonide deliv- Chin K, Margolin CB, Finger PT.Optometry. 2006 Feb; 77(2):71-5. ered by common techniques of intravitreal injection. Am J Reactive lymphoid hyperplasia 1 month after LASIK surgery. Ophthalmol. 2006 Oct; 142(4):597-600. Reddy S, Finger PT, Chynn EW, Iacob CE. Greafes Archive of Clinical Hwang JC, Barile GR, Schiff WM, Ober MD, Smith RT, Del Priore LV, and Experimental Ophthalmology 2006; 244:262-4. Turano MR, Chang S. Optical coherence tomography in asteroid hyalosis. Retina. 2006 Jul-Aug; 26(6):661-5. Peribulbar Oncocytoma: High Frequency Ultrasound with Histopathologic Correlation. Chiang MF, Starren J, Du YE, Keenan JD, Schiff W, Barile GR, Li J, Kurli M, Finger PT, Garcia Jr. JPS, Schneider S. Ophthalmic Surgery, Johnson RA, Hess DJ, Flynn JT. Remote image-based retinopathy of Lasers and Imaging 2006; 37:154-156. prematurity diagnosis: a Receiver Operating Characteristic (ROC) analysis of accuracy. Br J Ophthalmol. 2006 Oct; 90(10):1292-6. Dynamic ultrasound movements of the eye and orbit Garcia JPS, Garcia PMT, Finger PT British Journal of Ophthalmology 2006; Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, 90:426. http://bjo.bmjjournals.com/video/collection.dtl Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR. Upregulation of RAGE and its ligands in pro- Bilateral epibulbar granulocytic sarcomas: a case of an 8-year-old girl liferative retinal disease. Exp Eye Res. 2006 May; 82:807-15. with acute myeloid leukemia.

Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, Rosenberg C, Finger PT, Furlan L, Iacob CE. Graefes Arch Clin Exp Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, AMD Clinical Ophthalmol. 2006 Apr 27; [Epub ahead of print] Genetics Study Group, Hageman GS, Dean M, Allikmets R. Variation Giant Secondary Conjunctival Inclusion Cysts A Late Complication in factor B (BF) and complement component 2 (C2) genes is associ- of Strabismus Surgery. Song JJ, Finger PT, Kurli M, Wisnicki HJ, Iacob ated with age-related macular degeneration. Nat Genet 2006 Apr; CE. Ophthalmology 2006 Apr 20; [Epub ahead of print] 38(4):458-62. Eyelid-sparing adjuvant radiation therapy for renal cell carcinoma. Chiang MF, Keenan JD, Starren J, Du YE, Schiff WM, Barile GR, Li J, Kurli M, Finger PT, Schneider S, Tena LB. Ophthalmologica 2006; Feb; Johnson RA, Hess DJ, Flynn JT. Accuracy and reliability of remote 124(2):226-38. retinopathy of prematurity diagnosis. Arch Ophthalmol 2006 Mar; 124(3):322-7.

96 TTHEHE NNEWEWYYORKORK EEYEANDYEAND EEARAR IINFIRMARYNFIRMARY PUBLICATIONS 2006

Escitalopram-induced Uveal Effusions and Bilateral Angle Closure Galst, JM, MD Glaucoma. Zelefsky JR, Fine HF, Rubinstein VJ, Hsu IS, Finger PT. Galst, J.M., The Gonin Medal – The Nobel Prize of Ophthalmology. American Journal of Ophthalmology 2006; 141:1144-1147. Scope, Vol. 10, Issue 1, of the American Academy of Ophthalmology, spring 2006 Guest Editorial: Topical mitomycin chemotherapy for malignant con- junctival and corneal neoplasia. Jelks, G, MD Finger, PT British Journal of Ophthalmology 2006; 90:807-809. Jelks, G.W., Jelks, E.B., Aston, S.J., Capel, B., and Chiu, E.S.: Succesful Management of Orbital Cellulitits and Temporary Visual Loss after Circumpapillary Choroidal Melanoma. Finger PT, Perry HD, Russell S, Blepharoplasty. Plastic and Reconstructive Surgery. Volume 118, No. Packer S Clinical and Surgical Ophthalmology 2006; 24(6):232-237. 3, September 2006.

Topical Mitomycin Chemotherapy for malignant conjunctival and Liebmann, Jeffrey M. MD corneal neoplasia. Finger PT Cioffi GA, Liebmann JM, Weinreb RN. Peer-Reviewed promises: British Journal of Ophthalmology 2006 Jul; 90(7):807-9. Moving forward with JoG. J Glaucoma 2006; 15:1 (editorial). 18-Fluorine-labelled 2-deoxy-2- fluoro-D-glucose positron emission tomography/computed tomography standardized uptake values: a Shihadeh WA, Ritch R, Liebmann JM. Rescue of failed filtering blebs non-invasive biomarker for the risk of metastasis from choroidal with ab interno trephination. J Cataract Refract Surg 2006; 32:918-22. melanoma. Oliveira C, Tello C, Liebmann JM, Ritch R. Central corneal thickness Finger PT, Chin K, Iacob, C is not related to anterior scleral thickness or axial length. British Journal of Ophthalmology, 2006 Oct; 90(10):1263-6. Epub J Glaucoma 2006; 15:190-4. 2006 Jul 12. Anis S, Ritch R, Shihadeh W, Liebmann J. Surgical reduction of symp- Whole-Body Positron Emission Tomography / Computed tomatic circumferential, filtering blebs. Arch Ophthalmol 2006; Tomography Imaging and Staging of Orbital Lymphoma. Roe RH, 15:890-4. Finger PT, Kurli M, Tena LB, Iacob CE. Ophthalmology 2006 Oct; Barkana Y, Anis S, Liebmann J, Tello C, Ritch R. Clinical utility of 113(10):1854-8. Epub 2006 Jul 24. intraocular pressure, monitoring outside of normal office hours in Metachronous ipsilateral conjunctival then choroidal melanoma. patients with glaucoma. Arch Ophthalmol 2006; 124:793-7. Finger PT, Iacob CE, McCormick SA. British Journal of Barkana Y, Gerber Y, Mora R, Liebmann JM, Ritch R. Effect of eye Ophthalmology 006; Oct; 90(10):1322-3. testing order on automated perimetry results using the Swedish Orbital brachytherapy for extrascleral extension of choroidal melanoma Interactive Threshold Algorithm standard 24-2. Arch Ophthalmol Lin KL, Tena LB, Finger PT Br J Ophthalmol 2006; 90 1438-1439 2006; 124:781-84.

Conjunctival Malignant Melanoma-Associated Pseudomelanoma of Medeiros FA, Sample PA, Zangwill LM, Liebmann JM, Girkin CA, the Apposing Tarsal Conjunctiva Weinreb RN. A statistical approach to the evaluation of covariate Reddy S, Finger PT, Kurli M, Bui A, Iacob CE Cornea 2006 effects on the received operating characteristic curves of diagnostic Oct;25(9):1121-1123. tests in glaucoma. Invest Ophthalmol Vis Sci 2006: 47:2520-7.

Development of Metastatic Disease After Enrollment in the COMS Rodarte C, Hood DC, Yange EB, Grippo T, Greenstein VC, Liebmann Trials for Treatment of Choroidal Melanoma: JM, Ritch R. The effects of glaucoma on the latency of the multifocal Collaborative Ocular Melanoma Study Group: Collaborative Ocular visual evoked potential. Br J Ophthalmol 2006; 90:1132-6. Melanoma Study Group Report No. 26. Arch Ophthalmol 2006; Oliveira C, Liebmann JM, Dodick JM, Topilow H, Cykiert R, Ritch R. 124(2):226-242. Identification of retained nucleus fragment in the posterior chamber Quality of life after iodine 125 brachytherapy vs enucleation for using ultrasound biomicroscopy. Am J Ophthalmology 2006; 14:964-6. choroidal melanoma: 5-year results from the Collaborative Ocular Damji KF, Konstas AG, Liebmann JM, Hodge WG, Ziakas NG, Melanoma Study: Collaborative Ocular Melanoma Study Group: Giannikakis S, Minsioulis G, Merkin A, Pan YI, Ritch R. Intraocular Melia M, Moy CS, Reynolds SM, Hayman JA, Murray TG, Hovland KR, pressure following phacoemulsification in patients with and witout Earle JD, Kurinij N, Dong LM, Miskala PH, Fountain C, Cella D, exfoliation syndrome: A two-year prospective study. Br J Mangione CM; Collaborative Ocular Melanoma Study-Quality of Life Ophthalmol 2006; 90:1014-18. Study Group.COMS QOLS Report No. 3. Arch Ophthalmol. 2006 Feb; 124(2):226-38. Barkana Y, Shihadeh W, Oliveira C, Tello C, Liebmann JM, Ritch R. Angle closure in highly myopic eyes. Ophthalmology 2006; 113:247-54. The COMS randomized trial of iodine 125 brachytherapy for Thienprasiddhi P, Greenstein VC, Chu DH, Xu L, Liebmann JM, Ritch choroidal melanoma: V. twelve-year mortality rates and prognostic R, Hood DC. Detecting early functional damage in glaucoma suspects factors: Collaborative Ocular Melanoma Study Group. and ocular hypertensive patients with the multifocal VEP technique. COMS report No. 28. Arch Ophthalmol. 2006 Dec; 124(12):1684-93. J Glaucoma 2006; 5:321-27. Retinal Physician: A New Technique for 25-g Iridotomy, Iridectomy and Tumor Biopsy http://www.retinalphysician.com/article.aspx?article=100205

PUBLICATIONS 97 PUBLICATIONS 2006

Oliveira C, Schlotzeer-Schrehardt, Vieira G, Liebmann J, Ritch R. Tools of the Anterior Segment Trade. Ocular Surgery News. Early diagnosis of exfoliation syndrome in the offspring of affected February 15, 2006. Page 12 patients. Acta Ophthalmologica Scandinavica 2006; 84:512-5. Point-Counterpoint: ReSTOR. Eye World. February 2006, page 85 Harizman N, Zelefsky JR, Ilitchev #, Tello C, Ritch R, Liebmann JM. Detection of glaucoma using operator-dependent versus operator- All About The Latest IOL’s. Eye World. February 2006, pages 90, 92-95 independent classification in the HRT-III. Br J Ophthalmol 2006; Cataract Surgical Problem. Journal of Cataract and Refractive 90:1390-2. Surgery (Consultation Section). Volume 32. No. 2, February 2006, Oliveira C, Harizman N, Girkin CA, Xie A, Tello C, Liebmann JM, Pages 192-199 Ritch R. Axial length and optic disc size in normal eyes. Br J ReSTOR: A Patient’s Perspective. Outcomes in Ophthalmic Surgery, Ophthalmol 2006; Sept 20. (E publication ahead of print) Volume II, Number 1, Winter 2006

Espana E, Ioannidis A, Tello C, Liebmann JM, Foster PJ, Ritch R. Exploring and Understanding the Benefits of Torsional Urrets-Zavaliia syndrome as a complication of argon laser peripheral Phacoemulsification. EyeWorld Supplement, March 2006 iridoplasty. Br J ophthalmol, 2006, Sept 10. (e-pub ahead of print). Torsional Phaco “Has Flat Learning Curve”. EyeWorld, March 1, Barkana Y, Harizman N, Gerber Yl, Liebmann JM, Ritch R. 2006, Page 164 Measurements of optic disk size with HRT II, Stratus OCT, and fun- duscopy are not interchangeable. Am J Ophthalmol 2006; 42:375-80. Right Patient Wrong Lens. EyeNet. March 2006 43-47

Pro MJ, Pons Me, Liebmann JM, Ritch R, Zafar S, Lefton D, Intraocular Lens Power Calculation After Laser In-Situ Kupersmith MI. Imaging of the optic disc and retinal nerve fiber Keratomileusis: The Aphakic Refraction Technique. Mackool RJ, Ko, layer in acute optic neuritis. J Neurol Sci 2006; 250: 114-9. Mackool R.J. Cataract Refract Surg - 2006; 32:435-437

Shihadeh WA, Ritch R, Liebmann JM. Hyphema occurring during Intraoperative Retinsocopy. J. Cataract Refract Surg 2006. Mackool, selective laser trabeculoplsty. Ophthalmic Surg Lasers Imaging 2006; RJ, 32: 548-549 37:432-3. Exploring and Understanding the Benefits of Torsional Anis S, Ritch R, Shihadeh W, Liebmann J. Sutureless revision of over- Phacoemulsification. Asia-Pacific handing filtering bldbs. Arch Ophthalmol 2006; 124:1317-20. EyeWorld Supplements, March 2006, Pages 1-11 Kanadani FN, Hood DC, Grippo TM, Wangsupadilok B, Harizman N, The Science of Torsional Phacoemulsification. Supplement to Ocular Greenstein VC, Liebmann JM, Ritch R. Structural and functional Surgery News, July 1, 2006, Pages 1-15. assessment of the macular region in patients with glaucoma. Br J Ophthalmol 2006. epub ahead of print. ECP at Time of Phaco Effectively Lowers IOP. Excerpts Included in Article by Mark Packer, MD. Ophthalmology Times, July 15, 2005 Zelefsky JR, Harizman N, Mora R, Ilitchev E, Tello C, Ritch R, Page 8 Liebmann JM. Assessment of a race-specific normative database on the ability of the HRT-III to differentiate glaucomatous from normal Torsional Phaco Provides Benefits. EyeWorld, July 2006, Page 25 eyes. J Glaucoma 2006, 15:548-51. Recurrent Iritis After Implantation of An Iris-Fixated Phakic Harizman N, Oliveira C, Chiang A, Tello C, Marmor M, Ritch R, Intraocular Lens for the Correction of Myopia. Kleinmann G., Apple Liebman JM. The ISNT rule and differentiation of normal from glau- D., Mackool R.J., J. Cataract Refract Surg, Volume 32, August 2006, comatous eyes arch. Ophthalmol 2006; 124:1579-83. Pages 1385-1387.

Oliviera C, Tsai JC, Liebmann JM, Ritch R. Angle-closure caused by an Assessing the Value of ECP. Ophthalmology Management. August anterior segment membrane. Eye 2006. (Epub 11/16/06) 2006, Pages 18-20, 22, 24-25

Lissauer, B, MD Here’s Another Way To Calculate IOL Power After Lasik. EyeWorld, August 2006, Pages 46, 48 The treatment of eyelid malposition following septal reset blepharo- plasty. Lissauer B, Barbarino S, Aesthetic Surgery Journal. 2006 Jul; Pearls In Refractive Cataract and Corneal Surgery. Second Edition, 26(4):476-478.Volume 26, Issue 4. Chapter 16 (8 Pearls For Challenging Cases in Cataract Extraction). Pages 119-130. Edited by Melki and Azar, Slack Incorporated 2006 McKool, RJ, MD IOLs for Cataract Refractive Surgery. Introducing Apodized Viscodissection During Phaco Reduces Posterior Capsule Rupture. Diffractive IOLs Into Your Practice. Ocular Surgery News Ocular Surgery News, Pages , 30. September 15, 2006 Supplement, January 1, 2006, Pages 1-15 Eye On Excellence: Separating Fact From Fiction. Eurotimes The New Multifocals: Better Sight, Right Now. Ophthalmology Supplement, Supplement 2006. Management, January 2006, Page 16-18, 21-22.

98 THE NEW YORK EYEAND EAR INFIRMARY PUBLICATIONS 2006

Capsule Stabilization Devices Letter to Editor). J. Cataract Vincent AL, Billingsley G, Priston M, Glaser T, Oliver E, Walter MA, Refractive Surgery. Volume 32, October 2006, Page 1592 Ritch R, Levin AV, Héon E: Further support of the role of CYP1B1 in patients with Peters’ anomaly. Molec Vis 2006;12;506-510. Removal of Lens Epithelial Cells to elay Anterior Capsule-Intraocular Lens Adherence. J. Cataract Refractive Surgery. R. Mackool MD, R.J. Rodarte C, Hood DC, Yang EB, Grippo T, Greenstein VC, Liebmann Mackool, MD., Volume 32. Page 1766-1767 JM, Ritch R: The effects of glaucoma on the latency of the multifocal visual evoked potential. Br J Ophthalmol 2006;90:1132-1136. Explanation of An Acrysof Natural Intraocular Lens Because of A Color Vision Disturbance. American Journal of Ophthalmology, Barkana Y, Harizman N, Liebmann JM, Ritch R: Measurements of optic November 2006, Vol. 142, Page 890 disc size with HRT II, OCT 3, and funduscopy are not interchange- able. Am J Ophthalmol 2006; Thermal Comparison of the Bausch and Lomb Mellennium, Alcon Advan Tec Legacy, and the AMO Sovereign WhiteStar Oliveira C, Schlötzer-Schrehardt U, Vieira G, Liebmann J, Ritch R: Phacoemulsification Systems (Letter to the Editor). J. Cataract Early diagnosis of exfoliation syndrome in children of affected Refractive Surgery, Volume 32, No. 11, November 2006, Pages 1896- patients. Acta Ophthalmol Scand 2006; 84: 512-515. 1897. Anis S, Ritch R, Shihadeh W, Liebmann J: Surgical reduction of cir- Pearls For CTR Use With Subluxated Cataracts. EyeWorld, cumferential filtering blebs. Arch Ophthalmol 2006; 124:890-894. November 2006, Pages 668-669 Barkana Y, Gerber Y, Mora R, Liebmann JM, Ritch R: Effect of eye test- Torsional Technology Fast, Safe. EyeWorld, November 2006, Pages 85, 90 ing order on automated perimetry results using the Swedish Interactive Thresholding Algorithm. Arch Ophthalmol 2006; 124:781-786. Nightingale, J, MD Nightingale, Jeffrey "Intraocular epinephrine eases cataract Barkana Y, Anis S, Liebmann JM, Tello C, Ritch R: Intraocular pressure surgery with floppy iris syndrome." Ocular Surgery News. monitoring outside of normal office hours in patients with glaucoma 2006:24(7): 5 is clinically useful. Arch Ophthalmol 2006; 124:793-799.

Ritch, R, MD Oliveira C, Tello C, Liebmann JM, Ritch R: Central Corneal thickness Konstas AGP, Koliakos GG, Liakos P, Karabatsas CH, Schlötzer- is not related to anterior scleral thickness or axial length . J Schrehardt U, Georgiadis N, Ritch R: Latanoprost therapy reduces Glaucoma 2006; 15:190-194. the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma. Exp Eye Res 2006:82:319-322. Thienprasiddhi P, Greenstein VC, Chu DH, Xu L, Liebmann JM, Ritch R, Hood DC: Detecting early glaucomatous damage in glaucoma sus- Lee PP, Walt JG, Doyle JJ, Kotak SV, Evans SJ, Budenz DL, Chen PP, pect and ocular hypertensive patients with the multifocal visual Coleman AL, Feldman RM, Jampel HD, Katz LJ, Mills RP, Myers JS, evoked potential technique. J Glaucoma 2006; 15:321-327. Noecker RJ, Piltz-Seymour JR, Ritch R, Schacknow PN, Serle JB, Trick GL: A multi-center, retrospective pilot study of resource utilization Vieira GM, Oliveira HB, de Andrade DT, Battaro M, Ritch R: and costs associated with severity of disease in glaucoma. Arch Intraocular pressure variation during weight lifting. Arch Ophthalmol Ophthalmol 2006;124:12-19. 2006; 124:1251-1254.

Barkana Y, Shihadeh W, Oliveira C, Tello C, Liebmann JM, Ritch R: Shihadeh WA, Ritch R, Liebmann JM: Rescue of failed filtering blebs Angle-closure in highly myopic eyes, Ophthalmology 2006;113:247- with ab interno trephination. J Cataract Refract Surg 2006; 32:918-922. 254. Foster PJ, Gazzard GA, Garway-Heath T, Ritch R: Pattern of trabecu- Pang CP, Fan BJ, Canlas O, Wang DY, Tam POS, Lam DSC, Fan DSP, lar surface pigment deposition in primary angle-closure Lam CY, Ritch R. A Genome-wide Scan Maps Juvenile-onset Primary (Photoessay). Arch Ophthalmol 2006; 124:1062. Open Angle Glaucoma to Chromosomes 13q and 5q, Molec Vis Shihadeh WA, Ritch R, Liebmann JM: Hyphema occurring during 2006; 12:85-92. selective laser trabeculoplasty, Ophthalmic Lasers Surg Imaging 2006; Kanadani FN, da Silva FA, Batista WD, 37:432-433. Ritch R: Papillorenal syndrome: A case report. Asian J Ophthalmol Grassi MA, Fingert JH, Sheetz TE, Roos BR, Ritch R, West SK, 2006; 8:31-34. Yamamoto T, Shire AM, Mullins RF, Stone EM: Ethnic variation in Oliveira C, Liebmann JM, Dodick JM, Topilow H, Cykiert R, Ritch R: AMD-associated complement factor H polymorphism Y402H. Identification of a retained nucleus fragment in the posterior chamber. Human Mutation 2006;0:1-5. Am J Ophthalmol 2006;142:964-966. Harizman N, Zelefsky JR, Ilitchev E, Tello C, Ritch R, Liebmann JM: Damji KF, Konstas AGP, Liebmann JM, Hodge WG, Ziakas NG, Detection of glaucoma using operator-dependent versus operator- Giannikakis S, Minstioulis G, Merkur A, Pan Y, Ritch R: Intraocular independent classification in the HRT-III. Br J Ophthalmol 2006; pressure reduction following phacoemulsification cataract surgery in 90:1390-1392. patients with and without exfoliation syndrome: A two-year prospective Konstas AGP, Tsironi S, Ritch R: Current concepts in the pathogene- study. Br J Ophthalmol 2006;90:1014-1018. sis and management of exfoliation syndrome. Comprehensive Ophthalmol Update 2006; 7:131-141.

PUBLICATIONS 99 PUBLICATIONS 2006

Kanadani FN, Hood DC, Grippo TM, Wangsupadilok B, Harizman N, Ritch R: Exfoliation syndrome: what we know now. Glaucoma: Topics Greenstein VC, Liebmann JM, Ritch R: Structural and functional and Trends 2006; 4:1-4 assessment of the macular region in patients with glaucoma. Br J Ophthalmol 2006; 90:1393-1397. Musch DC, Gillespie BW, Niziol LM, Janz NK, Wren PA, Rockwood EJ, Lichte PR, CIGTS Group: Cataract extraction in the Collaborative Barkana Y, Harizman N, Gerber Y, Liebmann JM, Ritch R: Initial Glaucoma Treatment Study: Incidence, risk factors, and the Measurement of disc size with HRT II, Stratus OCT and fundoscopy effect of cataract progression and extraction on clinical and quality- are not interchangeable. Am J Ophthalmol 2006; 142; 375-380. of-life outcomes. Arch Ophthalmol 2006; 124:1694-1700.

Anis S, Ritch R, Shihadeh W, Liebmann JM: Sutureless revision of Dorairaj SK, Murthy KR, Ritch R: A case report of a four generation overhanging filtering blebs. Arch Ophthalmol 2006; 124:1317-1320. familial benign fleck retina. Retina, in press.

Oliveira C, Harizman N, Girkin CA, Xie A, Tello C, Liebmann JM, Barkana Y, Liebmann JM, Ritch R: Thou shalt measure disc size. Ritch R: Axial length and optic disc size in normal eyes. Br J Glaucoma Today, in press. Ophthalmol, e—pub Sept 20, 2006. 2007;91:37-39. Dorairaj SK, Robin A, Shihadeh W, Greenberg S, Liebmann JM, Ritch Espana EM, Ioannidis A, Tello C, Liebmann JM, Foster P, Ritch R: R: Phenotypic variability iof pigment dispersion syndrome in children. Urrets-Zavalia syndrome as a Arch Ophthalmol, in press. complication of argon laser peripheral iridoplasty. Br J Ophthalmol, e-pub Sept 20,2006. Espana EM, Tello C, Mora R, Dorairaj S, Liebmann JM, Ritch R: Cyclodialysis cleft secondary to Pro MJ, Pons ME, Liebmann JM, Ritch R, Zafar S, Lefton D, removal of an anterior chamber phakic intraocular lens. J Cataract Kupersmith M, : Imaging of the optic Refract Surg, in press. disc and retinal nerve fiber layer in acute optic neuritis. J Neurol Sci 2006; Epub ahead of print Ovodenko B, Rostagno A, Neubert TA, Shetty V, Thomas S, Yang A, Liebmann JM, Ghiso J, Ritch R, Proteomic analysis of lenticular exfoli- Hood DC, Chen JY, Yang EB, Rodarte C, Grippo TM, Odel JG, Ritch ation deposits. Invest Ophthalmol Vis Sci, in press. R: The Role of the Multifocal Visual Evoked Potential (mfVEP) in Understanding Optic Nerve and Retinal Diseases. Trans Am Dorairaj SK, Ritch R, Tello C, Liebmann JM: Why is the superior angle Ophthalmol Soc 2006;104:71-77. narrower than the inferior angle in patients with narrow angles? Arch Ophthalmol, #OPH06-0496R2, in press Kanadani FN, Dorairaj S, Langlieb AM, Tello C, Liebmann JM, Ritch R: Ultrasound biomicroscopy in asymmetric pigment dispersion syn- Ritch R, Tham CCY, Lam DSC: Argon laser peripheral iridoplasty drome and pigmentary glaucoma. Arch Ophthalmol 2006; 124:1573- (ALPI) – Update 2006. Surv Ophthalmol, in press. 1576. Espana EM, Mora R, Liebmann JM: Ritch R: Bilateral prominent Harizman N, Oliveira C, Chiang A, Tello C, Liebmann JM, Ritch R: The Schwalbe’s ring in the anterior chamber in a patient with Rieger syn- ISNT rule can help differentiate normal from glaucomatous eyes. drome and megalocornea. Cornea, in press. Arch Ophthalmol 2006; 124:1579-1583. Hood DC, Harizman N, Kanadani FN, Grippo TM, Baharestani S, Oliveira C, Tsai JC, Liebmann JM, Ritch R: Angle--closure caused by Greenstein VC, Liebmann JM, Ritch R: Retinal nerve fiber thickness an anterior segment membrane. Eye 2006;18:Epub 11/16/06 measured with optical coherence tomography (OCT) accurately detects confirmed glaucomatous damage. Br J Ophthalmol, in press Zelefsky JR, Harizman N, Mora R, Ilitchev E, Tello C, Ritch R, Liebmann JM: Assessment of a race-specific normative database on Tham CCY, Kwong YYY, Lai JSM, Lam DSC, Ritch R: Surgical manage- the ability of the HRT-III to differentiate glaucomatous from normal ment of chronic angle-closure glaucoma. Hong Kong J Ophthalmol, in eyes. J Glaucoma 2006; 15:548-551. press.

Chen HSL, Ritch R, Krupin T, Hsu WC: Control of filtering bleb Tham CCY, Kwong YYY, Lai JSM, Lam DSC, Ritch R: Surgical manage- structure through tissue bioengineering: An animal model. Invest ment of chronic angle-closure glaucoma. Expert Review Ophthalmol, Ophthalmol Vis Sci 2006; 47:5310-5314. in press.

Grippo TM, Hood DC, Kanadani FN, Ezon I, Greenstein VC, Ritch R: Natural compounds – Evidence for a protective role in eye Liebmann JM, Ritch R: A comparison between multifocal and conven- disease. Canad J Ophthalmol, in press. 06-313 tional VEP latency changes secondary to glaucomatous damage. Ritterband, D, MD Invest Ophthalmol Vis Sci 2006; 47:5331-5336. Hamrah P, Ritterband D, Seedor J, Eiferman RA. Ocular Infection Greenfield DS, Liebmann JM, Ritch R, Krupin T, and the Low-Pressure Secondary to Gemella. Graefe’s Arch Clin Exp Ophthalmol. 2006 Glaucoma Study Group: Visual field and intraocular pressure asym- Jan:1-2. metry in the Low-Pressure Glaucoma Treatment Study. Ritterband D. Herpes Simplex keratitis:classification, pathogenesis Ophthalmology, 2006; Nov Epub ahead of print and therapy. Expert Rev. Ophthalmol 2006;1:241-256

100 THE NEW YORK EYEAND EAR INFIRMARY PUBLICATIONS 2006

Ritterband D, Seedor J, Shah M. Fungal keratitis at the New York Eye and Ear Infirmary. Cornea. 2006 Apr;25(3):264-7

Shimmyo Shimmyo M, Kitaichi N, Ohno S: Current state of insurance coverage of ophthalmic cares in USA. Nippon no Ganka (Japanese Ophthalmology) 2006:77(2) 233-234.

Rosen, Richard B. Hvan Velthoven ME, Verbraak FD, Yannuzzi LA, Rosen RB, Podoleanu AG, de Smet MD.

Imaging the retina by en face optical coherence tomography.Retina. 2006 Feb;26(2):129-36.

Cucu RG, Podoleanu AG, Rogers JA, Pedro J, Rosen RB. Combined confocal/en face T-scan-based ultrahigh-resolution optical coherence tomography in vivo retinal imaging.Opt Lett. 2006 Jun 1;31(11):1684-6.

Garcia JP Jr, Garcia PM, Muldoon TO, Rosen RB. Surface rendering of 3D ultrasound images in ophthalmology. Ophthalmic Surg Lasers Imaging. 2006 Jul-Aug;37(4):347-51

Rosen, RB, Muldoon TO, Garcia,PM. Evaluating Retinal Thickness During Pegaptanib Sodium Therapy. Retinal Physician Oct 2006 35-38

Rosen RB, Dunne S, Podoleanu A Gh Garcia PM: “OCT Ophthalmoscopy” in Posterior Segment Imaging of the Eye, ed. Huang, D. Elsevier, 2006

PUBLICATIONS 101 PRESENTATIONSLECTURES 2005

Brazzo, Brian, M.D. Finger PT. NYU Grand Rounds I: Resident Cases and Research New York University School of Medicine New York City, New York 4-12-05 Oral Therapy and Eyecare: Dermatologic Disorders of the Eye (Part 1), at The New Jersey Academy of Optometry Summer Seminar, Jamesburg, Finger PT. Innovations for the Diagnosis of Ocular Tumors Albert Einstein New Jersey, August 24, 2005. – Montefiore Department of Ophthalmology New York City, New York 4-15-05 Oral Therapy and Eyecare: Dermatologic Disorders of the Eye (Part 2), at The New Jersey Academy of Optometry Summer Seminar, Jamesburg, Finger PT. NYU Grand Rounds: Innovations for the Diagnosis New Jersey, August 24, 2005. and Treatment of Ocular Tumors. New York University School of Medicine New York City, New York. 4-19-05 Orbital Trauma and Imaging, at The New Jersey Academy of Optometry Summer Seminar, Jamesburg, New Jersey, August 24, 2005. Whole-Body PET / CT for Initial Staging of Choroidal Melanoma Tena LB, Reddy S, Kurli M, Finger PT Tearing: Evaluation, Diagnosis and Treatment, at The New Jersey Academy of Association for Research in Vision and Ophthalmology Annual Meeting, Optometry Summer Seminar, Jamesburg, New Jersey, August 24, 2005. Fort Lauderdale, FL, May 2005 Invest Ophthalmol Vis Sci 46:4297.

Evaluation of Ptosis, at The New Jersey Academy of Optometry Summer Whole-Body PET / CT Imaging Staging for Orbital Lymphoma Seminar, Jamesburg, New Jersey, August 24, 2005. Roe RH, Kurli M, Trivedi G, Iacob C, Tena LB, Finger PT. Association for Research in Vision and Ophthalmology Annual Meeting, Fort Lauderdale, Lumps and Bumps: A Review for the Primary Eyecare Provider, at The FL, May 2005 Invest Ophthalmol Vis Sci 46:4313. New Jersey Academy of Optometry Summer Seminar, Jamesburg, New Jersey, August 24, 2005. Ultrasound Biomicroscopy in the Evaluation of Giant Conjunctival Inclusion Cysts. Song JJ, Kurli M, Schneider S, Finger PT Association Anatomy of the Midface, at Cosmetic Blepharoplasty, Endoscopic Forehead for Research in Vision and Ophthalmology Annual Meeting, Fort Lift & Mid-Face Surgery. William Beaumont Hospital, Royal Oak, Michigan, Lauderdale, FL, May 2005 Invest Ophthalmol Vis Sci 46:4299. April 8-10, 2005. Course co-director and instructor. Cytological Evaluation in the Management of Ocular Surface Neoplasia. Blepharoplasty marking and Anesthesia, at at Cosmetic Blepharoplasty, Schneider S, Kurli M, Finger PT Association for Research in Vision and Endoscopic Forehead Lift & Mid-Face Surgery. William Beaumont Hospital, Ophthalmology Annual Meeting, Fort Lauderdale, FL, May 2005, Invest Royal Oak, Michigan, April 8-10, 2005. Course co-director and instructor. Ophthalmol Vis Sci 46:5396. Finger, Paul, M.D. Finger Iridectomy Technique (FIT): For Minimally Invasive Iris Biopsy Finger PT. Photography and Angiography of Ocular Tumors. NYEE Finger PT, Latkany P, Kurli M, Iacob CE Association for Research in Vision Resident Lecture Series. New York City, New York 1-26-05 and Ophthalmology Annual Meeting, Fort Lauderdale, FL, May 2005 Invest Ophthalmol Vis Sci 46:5397. Finger PT. Ophthalmic Ultrasonography. NYEE Resident Lecture Series. New York City, New York 2-2-05 Resident Research Day – NYEE Papp C, Finger PT et al. AC Tap for the Diagnosis of Intraocular Lymphoma. Garcia J. Finger PT et al. Dynamic Finger PT. Imaging of Ocular Tumors: CT, MRI, PET and PET/CT. NYEE Ultrasound Imaging. New York City, New York 6-14-05 Resident Lecture Series. New York City, New York 2-9-05 Finger PT. Introduction to The Ocular Tumor Service NYU Incoming Finger PT, Eyelid and Conjunctival Tumors. New York University School Resident Lecture NYU Medical Center, New York City. 7-05 of Medicine – Resident Education. New York City, New York 2-11-05 St. Vincent’s Medical Center – Grand Rounds Ophthalmic Oncology: Finger PT. Interesting Ocular Tumor Cases, Studies and Research. Imaging and FIT. 10-26-05 Resident Lecture Series NYEE. New York City, New York 2-16-05 Interdisciplinary Melanoma Group Meeting NYU Medical Center Finger PT. Introduction to Ophthalmic Ultrasonography. NYU- Resident Combined Conference – Dermatology and Oncology “Ocular Lecture Series. New York City, New York 2-25-05 Melanoma” 12-07-05

Finger PT. “Eye Cancer”Ophthalmic Technologists and Operating Room Whole Body PET/CT Imaging of Choroidal Melanoma Staff NYEE. New York City, New York 3-05-05 Finger PT, Kurli M, Reddy S, Tena L The Retina Society The 38th Annual Scientific Meeting Coronado, Finger PT. Photography and Angiography in the Diagnosis and Treatment California, September 16th, 2005 pp 102. of Ocular Tumors. NYU Resident Lecture Series. New York City, New York 3-18-05 Small Incision Iridectomy, Iridotomy and Tumor Biopsy Finger PT, Latkany P, Kurli M, Iacob CE American Academy of Finger PT. The Treatment of Retinoblastoma and Choroidal Melanoma. Ophthalmology – Free Papers, NYU Resident Lecture Series New York City, New York 3-25-05 Chicago, Illinois October 2005

Dynamic 2D B-scan ultrasound recording in ophthalmology. Whole Body PET/CT Imaging of Choroidal Melanoma Garcia JPS, Garcia P, Finger PT Finger PT, Kurli M, Reddy S, Tena L Presented as a paper at the annual meeting of the International Society American Academy of Ophthalmology – Free Papers, Chicago, Illinois for Imaging of the Eye in Fort Lauderdale, Florida on April 29, 2005. October 2005

102 TTHEHE NNEWEWYYORKORK EEYEANDYEAND EEARAR IINFIRMARYNFIRMARY PRESENTATIONSLECTURES 2005 2005

Galst, Jay M., M.D. Ritch R: Exfoliation syndrome and its systemic implications. Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, April 30, 2005 Cogan Ophthalmic History Society Meeting, Duke University Eye 2005. Center, Durham, North Carolina: The Gonin Medal-The Nobel Prize Of Ophthalmology. April 9, 2005. Pang C, Fan BJ, Canlas O, Wang DY, Tam POS, Lam DSC, Fan DSP, Lam CY, Raymond V, Ritch R; A Novel Locus for Juvenile-Onset Primary 2005 Ocular Heritage Society Meeting, The Duke Mansion, Charlotte, Open-Angle Glaucoma Maps at Chromosome 5q. Association for North Carolina: The O.H.S. Spectacle Coin And Medal Exhibit. April 30, Research in Vision and Ophthalmology, Fort Lauderdale, FL, May 2005. 2005. 487. Anis SN, Shihadeh W, Kim J, Tello C, Liebmann JM, Ritch R: Greenbaum, Scott, M.D. Surgical Reduction of Symptomatic Filtering Blebs. Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, May 2005. The History and Development of Sub-Tenon's Anesthesia, The Peking UniversityEye Center- Beijing, China. 8/5/05 Tello C, Shihadeh W, Grippo T, Schargus M, Gramer E, Liebmann J, Ritch R: Optic Nerve Head Drusen and Visual Field Loss in Normotensive and Parabulbar and Posterior Sub-Tenon's Anesthesia, Department of Hypertensive Eyes. Association for Research in Vision and Ophthalmolology, Chinese University of Hong Kong, Hong Kong, China. Ophthalmology, Fort Lauderdale, FL, May 2005. 8/9/05 Monemi S, Spaeth G, DaSilva A, Ilitchev E, Liebmann J, Ritch R, Héon E, Koplin, Richard, M.D. Crick RP, Child A, Sarfarazi M; Identification of WDR36 as a Novel Gene Grand Rounds: St. Vincent’s Medical Center, New York: Technology for Adult-Onset Primary Open Angle Glaucoma (POAG) at the GLC1G Innovation: APersonal Journey, Dec. 14, 2005 Locus on 5q22.1. Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, May 2005. Phaco Forum: Cataract Teaching Forum New York Eye and Ear Infirmary, New York, New York: Fundamentals of Phaco-emulsification Surgery, Liebmann JM, Greenfield D.S., Piltz-Seymour J, Ritch R, Krupin T: Baseline October, 2005 Intraocular Pressure, Visual Function, and Disc Hemorrhage in the Low- Pressure Glaucoma Treatment Study. Association for Research in Vision Introduction to Phaco-emulsification Cataract Surgery: Laboratory and Ophthalmology, Fort Lauderdale, FL, May 2005. Course, New York Eye and Ear Infirmary, New York, New York: June 2005 Rezaie T, Child A, Popinchalk S, Krupin T, Ritch R, Liebmann J, Ilitchev E, Phaco Forum: Cataract Teaching Forum New York Eye and Ear Infirmary: Crick R, Sarfarazi M: Large-Scale Sequencing of the Optineurin Gene in Complications of Phaco-emulsification Surgery, April, 2005 Familial and Sporadic Cases With Primary Open-Angle Glaucoma. Association for Research in Vision and Ophthalmology, Fort Lauderdale, Grand Rounds: St. Vincent’s Medical Center: Innovations in Cataract FL, May 2005. Closure Systems; March 12, 2005 Schargus M, Grippo T, Ritch R, Gramer E: Stage of Visual Field Loss in Phaco Forum: Cataract Teaching Forum New York Eye and Ear Infirmary: Relation to the Appearance of the Optic Disc in 144 Eyes of Patients Advanced Techniques in Phaco-emulsification Surgery, February, 2005 With Drusen of the Optic Disc. Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, May 2005. Ritch, Robert, M.D. Greenfield DS, Liebmann JM, Ritch R, Krupin T: Visual Field Asymmetry Is Unrelated to Intraocular Pressure Asymmetry in the Low-Pressure Grippo T, Hood DC, Ritch R: Latency delays in visual evoked potentials of Glaucoma Treatment Study. Association for Research in Vision and patients with glaucomatous defects present in automated perimetry and Ophthalmology, Fort Lauderdale, FL, May 2005. mfVEP. Pan-American Congress of Ophthalmology, Santiago, Chile, March 18-21, 2005. Mora R, Barkana Y, Tello C, Liebmann JM, Ritch R: Does Changing Eye Test Order With 24-2 SITA Standard Result in a Meaningful Change in Test 481. Oliveira C, Liebmann JM, Ritch R: Correlation between Results? Association for Research in Vision and Ophthalmology, Fort Central Corneal Thickness, Scleral Thickness and Refractive Error. Pan- Lauderdale, FL, May 2005. American Association of Ophthalmology, Santiago, Chile, March 18-21, 2005. Chu DH, Greenstein VC, Thienprasiddhi P, Hood DC, Liebmann JM, Ritch R: Structure and Function in Normal versus High Tension Glaucoma. Ritch R: The Zonular apparatus in exfoliation syndrome - the broken Association for Research in Vision and Ophthalmology, Fort Lauderdale, window frame. Moorfields Bicentennial Scientific Meeting, London, UK, FL, May 2005. March 19, 2005. Hood DC, Xu L, Grippo T, Chen J, Greenstein VC, Liebmann JM, Ritch R: Seedor J, Ritterband D, Trubnik V, Meskin S, Seedor J, Koplin R, Shabto U, Factors Involved in the Failure of the Photopic Negative Response Liebmann J, Tello C, Ritch R: Acute post-operative complications follow- (PhNR) and Pattern Electroretinograms (PERG) to Detect ing simultaneous penetrating keratoplasty and glaucoma drainage implant Glaucomatous Damage in Some Patients. Association for Research in insertion. World Cornea Congress, Washington DC, April 14, 2005. Vision and Ophthalmology, Fort Lauderdale, FL, May 2005.

Ritterband D, Shapiro D, Trubnik V, Meskin S, Seedor J, Koplin R, Shabto Rodarte C, Yang EB, Grippo T, Greenstein VC, Liebmann JM, Ritch R, U, Liebmann J, Tello C, Ritch R: Long-term results of penetrating kerato- Hood DC: Evaluation of Multifocal Visual Evoked Potential Latency in plasty with simultaneous pars plana glaucoma drainage implants. World Glaucoma. Association for Research in Vision and Ophthalmology, Fort Cornea Congress, Washington DC, April 14, 2005. Lauderdale, FL, May 2005.

PRESENTATIONS 103 PRESENTATIONSLECTURES 2005 2005

Kelly WJ, Harizman N, Oliveira C, Liebmann JM, Ritch R, Tello C: Disc Ritterband, David, M.D. Area in High Myopia. Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, May 2005. Royal County of Queens and Brooklyn Pharmacists Society. The Pharmacology of the Fluoroquinolones: Brooklyn, New York Jan. 12, 2005 Stein J, Girkin CA, Harizman N, Arthur S, Chiang A, Ortega JD, Liebmann JM, Tello C, Ritch R: A Comparison of False-Positive Test Results Between Alcon Local Summit, Cataract Surgery and Infection Prevention. the Stratus OCT III and the GDx-VCC. Association for Research in Syracuse, NY Jan. 20, 2005 Vision and Ophthalmology, Fort Lauderdale, FL, May 2005. Current Concepts in Ophthalmology-Winter Meeting, Dorado, Puerto Ovodenko B, Rostagno A, Liebmann JM, Bley LM, Jofe MA, Smolyak RM, Rico (Faculty) Feb.11-14, 2005 Pinhas D, Ghiso JA, Ritch R: Complement Activation in Exfoliation Syndrome. Association for Research in Vision and Ophthalmology, Fort ASCRS/Alcon Booth-Antiseptics, Antibiotics, and Wound Barriers in the Lauderdale, FL, May 2005. Prevention of Endophthalmitis. April 19, 2005

Oliveira C, Harizman N, Ortega JD, Arthur S, Girkin CA, Tello C, Fluoroquinolone and Nevanac Advisory Summit Faculty: Las Vegas, NV Liebmann JM, Ritch R: Axial Length and Optic Disc Size in Normal Eyes. Alcon Laboratory June 17-18, 2005 Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, May 2005. Tissue Adhesives in Ophthalmology-Catholic Medical Ctr-Grand Rounds July 13, 2005 Harizman N, Chiang A, Oliveira C, Liebmann CA, Liebmann JM, Ritch R: Can the ISNT Rule Be Applied To Patients of African Ancestry. Endophthalmitis Prevention-Suffolk County Surgery Center Grand Association for Research in Vision and Ophthalmology, Fort Lauderdale, Rounds Aug 4, 2005 FL, May 2005. Alcon Booth Lecture-American Academy of Ophthalmology Meeting- Shihadeh W, Ritch R, Scharf B, Liebmann JM: Delayed Intraocular Pressure Target Specific Therapeutics (Nevanac and Vigamox) Oct. 16, 2005 Elevation After Pupillary Dilation in Exfoliation Syndrome. Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, May 2005. Resident Lectures-NYEEI Herpes Simplex Keratitis-March 2005

Barkana Y, Anis SN, Kim J, Tello C, Liebmann JM, Ritch R: Is Intraocular Resident Lectures-NYEEI OKAP-Review-Cornea Exam-April, 2005 Pressure (IOP) Monitoring Outside of Normal Office Hours Clinically Useful? Association for Research in Vision and Ophthalmology, Fort Cornea Conference:Residents NYEEI Lauderdale, FL, May 2005. Faculty Moderator:First Thursday AM-Monthly

Harizman N, Oliveira C, Tello C, Liebmann JM, Ritch R: Can we apply the ISNT rule using the scanning laser ophthalmoscope? Int Soc Imaging Eye, Romero, Juan M., M.D. Sarasota, FL, May 2005.

Ritch R: Exfoliation syndrome – a systemic disease. World Glaucoma Vitrectomia 25-Gauge: El "Faco" del Cirujano de Retina? (25-gauge vit- Congress, Vienna, Austria, July 7, 2005. rectomy: the "phaco" of the retina surgeon?) Instituto Barraquer de Colombia, Bogotá. June 24, 2005 Ritch R: Exfoliation syndrome: How early can it be diagnosed? Eur Ophthalmol Soc, Berlin, Germany, Sept 27, 2005. Basics in retina imaging: fundus photography, fluorescein angiography, and ICG angiography. New Jersey Society of Optometric Physicians. Grippo TM, Rodarte C, Liebmann J, Ritch R, Hood D. Multifocal (mfVEP) September 21, 2005 versus conventional (cVEP) visual evoked potential measures of latency changes secondary to glaucomatous damage. Am Acad Ophthalmol, Rosen, Richard B., M.D. Chicago, IL Oct 14, 2005.

Teekhasaenee C, Ritch R: Combined phacoemulsification, posterior Photonics West Bios 2005, “Simultaneous OCT/ICG Fluorescense chamber IOL implantation and goniosynechialysis in the treatment of Imaging System for Investigations of the Eye Fundus,” San Jose 1/28/05 residual synechial angle-closure glaucoma. Asian Angle-Closure Glaucoma Society. Taipei, Taiwan, Oct 22, 2005. International Society For Imaging Of The Eye, Garcia JPS, Richard B. Rosen, Justin Pedro, Patricia M.T. Garcia, Kenneth M. Boyd, Robert Masini, Teekhasaenee C, Ritch R: Goniosynechialysis following unsuccessful pha- Adrian Gh. Podoleanu, “A New Technique of Retinal Thickness Mapping coemulsification in residual synechial angle-closure glaucoma. Asian Using the OCT Ophthalmoscope (OCT~SLO,” Poster session Ft. Angle-Closure Glaucoma Society. Taipei, Taiwan, Oct 22, 2005. Lauderdale, Fla. 4/23-24/05

Islam, MN, Dorairaj SK, Ritch R: Ultrasound biomicroscopy – a study of ARVO 2005 T.O. Muldoon, J.P.Garcia, P.M.T. Garcia, R.B. Rosen.Rendering 69 patients. 3rd Annual Scientific Congress, Bangladesh Acad Ophthalmol, of 3D Ultrasound Images in Ophthalmology 5/3/2005 Dacca, Bangladesh, Nov 17, 2005. ARVO 2005 S.C. Lalin, R.C. Gentile, J.P. S.Garcia, J.M. Romero, R.B. Rosen Can Foveolar Choroidal Blood Flow in Central Retinal Vein Occlusions Predict VisualRecovery? Wednesday, May 4 2005

104 TTHEHE NNEWEWYYORKORK EEYEANDYEAND EEARAR IINFIRMARYNFIRMARY PRESENTATIONSLECTURES 2005 2005

ARVO 2005 P.M. Garcia, D.V. Will, A.Ponce,J.P. S. Garcia, R.B. Panelist,”New Frontiers in Clinical Glaucoma II”, a Continuing Medical Rosen.Coronal OCT Education program by Department of Ophthalmology, Columbia Scanning of Idiopathic Polypoidal Choroidal Vasculopathy(IPCV) Using University College of Physicians and Surgeons, held at The new York the OCT/SLO May 4 2005 Academy of Medicine, Nov 11-12, 2005

ARVO 2005 R.E. Rosenbaum, P.M. T. Garcia, J.P. S. Garcia, R.B.Rosen A Comparison of Leakage by FA With Retinal Thickness Using Talia's Sidoti, Paul A., M.D. Anatomy Imager in Patients Aqueous Shunts With Diabetic Retinopathy, May 4 2005 Ophthalmology Resident Conference New York University Medical Center, New York, NY March 7, 2005 ARVO 2005 J. Hedaya, P.M. T. Garcia, R.C.Gentile, R.B. Rosen OCT/SLO Evaluation of Optic Nerve Pits Wednesday, May 4, 2005 Pediatric Glaucoma Ophthalmology Resident Conference ARVO 2005 J.P. Page, P.M. T. Garcia,S.Schneider, R.B. Rosen, Scanning Laser New York Eye and Ear Infirmary, New York, NY October 26, 2005 Ophthalmoscopy-Optical Coherence Tomography (OCT/SLO) Evaluation of Choroidal Nevi Wednesday, May 4 2005 Sims, Leslie M., M.S.P.H., M.D. American Society Of Retina Specialists, R Rosen, TO Muldoon, P Garcia, “Imaging the Occult with the Combined ICG/OCT/SLO,” Montreal, Univeristy of Nebraska Medical Center at Omaha, Omaha, NE 7/2005 Departmentof Ophthalmology-Residents Grand Rounds "Orbital Disorders: Diagnosis and Treatment" "The Lacrimal System: Evaluation American Society Of Retina Specialists, TO Muldoon, R and Associated Disorders" 12/2005 Rosen,“OCT/SLO Topographic Mapping of Macugen Therapy,” Montreal, 7/2005 The Brooklyn Hosital Center, Brooklyn, NY, Department of Medicine- Residents Grand Rounds, "Eyelid Pathology", 10/2005 Shimmyo, Mitsugu, M.D. Zaidman, Gerald W., M.D. Pathogenesis of myopia and retardation of myopia and axial growth in children with Muscarinic inhibitor treatment. Invited lecturer, at the Best for the Treatment of Group B Streptococcus. Poster annual meeting of Myanmar ophthalmological Society, Rangon, Myanmar Presentation at World Cornea Congress, Washington, D.C., April, 2005. (Burma), January 3, 2005 Complications of the Phakic 6 Angle-Supported Phakic Anterior Shimmyo M: Comparison of intraocular pressure measurements by Chamber Intraocular Lens. Presentation at World Cornea Congress, Reichert’s Ocular Response Analyzer, Pascal Dynamic Contour Washington, D.C., April, 2005. Tonometry and Goldmann Applanation Tonometry corrected for central corneal thickness. Oral presentation (March 31,2005) at the Scientific Delayed Opacification of the Memory Lens IOL and Difficulties in its Session of the 5th International Glaucoma Symposium, Cape Town, South Diagnosis. Presentation at World Cornea Congress, Washington, D.C., Africa, March 30 – April 2, 2005. April, 2005.

Shimmyo M: Comparison of intraocular pressure measurements by Cataract: IOL's. Presentation at World Cornea Congress, Washington, Reichert’s Ocular Response Analyzer, Pascal Dynamic Contour D.C., April, 2005. Tonometry and Goldmann Applanation Tonometry corrected for central corneal thickness. A poster presentation (April 15, 2005) at the World LASIK to Correct Refractive Errors after Radial Keratotomy. Cornea Congress and Annual Meeting of American Society of Cataract Presentation at World Cornea Congress, Washington, D.C., April, 2005. and Refractive Surgery, Washington, D. C., April 14 – 20,2005. What is the Best Animal Model for Group B Streptococcus Corneal Shimmyo M, Orloff PN: Clinical comparison of IOP measurements by Ulcers. Presentation at Ocular Microbiology & Immunology Group, Goldmann Applanation Tonometry, Reichert’s Ocular Response Analyzer Chicago, Illinois, October, 2005. and Pascal Dynamic Contour Tonometry. Scientific Poster (May 5, 2005), Association for Research in Vision and Ophthalmology What is the Best Antibiotic for the Treatment of Group B Streptococcus Keratitis? ARVO, Ft. Lauderdale, Florida, May, 2005. Shimmyo M: Accuracy of IOP measurements by Goldmann Applanation Tonometry, Reichert’s Ocular Response Analyzer and Pascal Dynamic In Vitro Sensitivity of Group B Streptococcus to Topical Ophthalmic Contour Tonometry. Scientific Poster # 1482, European Society for Antibiotics. ARVO, Ft. Lauderdale, Florida, May, 2005. Cataract and Refractive Surgery, Lisbon, Portugal, September,11-13, 2005. Long Term Visual Prognosis in Children with Clear Grafts after Corneal Shimmyo M: Current Practice Patterns in Medicine in the United States Transplant Surgery for Peters Anomaly Type I. ARVO, Ft. Lauderdale, of America, an invited guest lecturer, at the annual meeting of the Florida, May, 2005. Japanese Society of Clinical Ophthalmology, October 6-9, 2005, Sapporo, Japan, October 8,2005 Posterior Amorphous Corneal Dystrophy or Dysgenesis. ARVO, Ft. Lauderdale, Florida, May, 2005. Shimmyo M, Orloff PN:Accuracy of IOP measurements by Goldmann Applanation Tonometry, Reichert’s Ocular Response Analyzer and Pascal Guest Lecturer. Grand Rounds, Department of Ophthalmology, Dynamic Contour Tonometry. Scientific Poster (PO 080), American St. Vincent's Medical Center. January, 2005. Academy of Ophthalmology, Chicago, Il, October 16, 2005.

PRESENTATIONS 105 PRESENTATIONS 2006

Amin, A, MD Barile, G, MD Herpes Simplex Keratitis, Women's Ophthalmology Meeting, New York, The Rage Axis: A Neurovascular Therapeutic Target In Diabetic Ny, March 23, 2006 Retinopathy at Macula 2006, New York, New York, 1/14/06.

Asbell, P, MD Rage In Retinal Disease At Kentucky Lions Eye Center, University Of Louisville, Louisville, Kentucky, 3/24/06. “Intacs For Keratoconus”, At Ophthalmic Laser And Surgery Society, New York, New York, January 17, 2006. Age-Related Macular Degeneration 2006 At Suny Downstate 34th “Non-Laser Treatments Of Presbyopia: Conductive Keratoplasty” Alumni (Didactic And Live Surgery, Visiting Professor), At Pundacion Sante Fe De Ophthalmology Update, Brooklyn, New York, 6/8/06. Bogota, Bogota, Columbia, January 21, 2006. “Vision: Seeing Is Believing”, Roundtable Discussion For The Phizer Avastin At New York Ophthalmological Society, New York, New York, Journal, February 2-3, 2006. 5/8/06. “Endpoints In Dry Eye - Clinical Trials: Corneal Permeability Testing” At The World Ophthalmology Conference, Sao Paulo, Brazil, February 19- Age-Related Macular Degeneration At Lancaster Course In 24, 2006. Ophthalmology; “Keratitis And Glaucoma” At The World Ophthalmology Conference, Colby College, Warerville, Maine, August 1, 2006. Sao Paulo, Brazil, February 19-24, 2006. “Trust Data: Fluoroquinolone Resistance In Usa Over Past Decade” At Presented: Second American-French Ophthalmology Symposium “How The World Ophthalmology Conference, Sao Paulo, Brazil, February 19- Can You Easily Switch From Conventional (Co-Axial) To Bi-Manual (Bi- 24, 2006. Axial) Phacoemulsification?” Hilton, Ny, 8.5 Hours Cme, Category I June “Ocular Surface Disease And Antibiotics”, At The World Ophthalmology 2nd-3rd Conference, Sao Paulo, Brazil, February 19-24, 2006. “Intacs Roundtable”, At The Annual Meeting Of The American Society Of Organized, Sponsored And Hosted: “Anterior Segment Refractive Cataract And Refractive Surgery (Ascrs), San Diego, California, March 21, Lecture Series Ii”, Weekly Refractive Lecture Series For Nyeei 2006,. Ophthalmology Residents. July 12th-August 23rd “Effects On Preservatives On The Ocular Surface”, At The 6th International Symposium On Ocular Pharmacology And Therapeutics Brazzo, B, MD (Isopt), Berlin, Germany, March 31, 2006. “Lumps And Bumps: Diagnosis Of Eyelid Lesions,” At Current Concepts In Ophthalmology, New Jersey Academy Of Optometry Continuing “Fluorophotometry In Dry Eye Disease”, At The 6th International Education Seminar, West Orange, New Jersey, September 20, 2006. Symposium On Ocular Pharmacology And Therapeutics (Isopt), Berlin, Germany, April 2, 2006. “Ophthalmic Cosmetic And Reconstructive Surgery,” At New Jersey Academy Of Optometry Continuing Education Seminar, Paramus, New “The Pathway Of New Treatments”, At The New York City Regional Jersey, May 3, 2006. Conference Of The Sjogren’s Syndrome Foundation, New York, New York, June 10, 2006. “Evaluation Of Ptosis And Other Facial Disorders - Video Rounds,” At New York Academy Of Optometry, New “Following The Escrs Endophthalmitis Study: How To Optimize The Use York, New York, March 21, 2006. Of Levofloxacin In Cataract Surgery.” At The Annual Meeting Of The European Society Of Cataract And Refractive Surgery (Escrs), London, Buxton, D, MD England, September 12, 2006. Proctored: Amo Residents’ Microphaco Course, Nyeei, Jnbmsec April 9th “Academic Appointments And Promotions.” At The Mount Sinai Presented: “Elestat: A Comprehensive Approach To Allergic Adolescent Health Center (Ahc), New York, New York, November 30, Conjunctivitis”, Sponsored By Inspire, Pharmaceuticals, Blue Water Grill, 2006. NY May 17th Presented: “The Use Of Xibrom In Cme Prevention” Xibrom Lecture, La “The Need For An Alternative Preservative In Intra-Ocular Pressure- Marmite Restaurant, NY. July 13th Lowering Medications”, At The Glaucoma Bak Free Meeting, Melville, New York, November 30, 2006. Finger, Paul, MD “Seed-Guide Inserts” Standardize Seed Position Within Eye Plaques: “Current Diagnosis And Treatment: Bacterial Conjunctivitis”, At The Clinical Experience. Annual Meeting Of The American Academy Of Ophthalmology, Las Vegas, Finger Pt, Szechter A, Astrahan Ma. Nevada, November 11-14, 2006. Association For Research In Vision And Ophthalmology (Arvo), Ft. Lauderdale, Florida, Poster (2263/B1006), May 1, 2006. “New Innovations In Intraocular Lenses For Cataract Surgery”, At The Annual Meeting Of The American Academy Of Ophthalmology, Las Vegas, Second Primary Cancers Discovered By Whole Body Fdg-Pet/Ct Imaging Nevada, November 11-14, 2006. For Uveal Melanoma. Chin K, Kurli M, Tena L, Reddy S, Finger Pt. “Safety And Effectiveness Of The Hoya Blue Blocker Acrylic Intraocular Lens Results From 12-Month Follow-Up”, At The Annual Meeting Of The Association For Research In Vision And Ophthalmology (Arvo), Ft. American Academy Of Ophthalmology, Las Vegas, Nevada, November 11- Lauderdale, Florida, Poster (2261/B1004), May 1, 2006. 14, 2006.

106 THE NEW YORK EYEAND EAR INFIRMARY PRESENTATIONS 2006

Discrimination Between Choroidal Nevi And Melanoma Using The Jelks, GW, MD Combination Oct/Slo. Garcia Pm, Van Velthoven Me, Finger Pt, Schneider Anatomy: Muscles Of Facial Expression. New Horizons In Cosmetic S, Garcia Jps, Jr., Rosen Rb.Association For Research In Vision And Surgery. Indian Wells, California. January 2006. Ophthalmology (Arvo), Ft. Lauderdale, Florida, Poster (2258/B1001), May 1, 2006. Upper Lid Blepharoplasty In Patients With Levator Ptosis: Technique- 5 Consecutive Cases. New Horizons In Cosmetic Surgery. Indian Wells, Positron Emission Tomography / Computed Tomography Imaging Of California. January 2006. Choroidal Melanoma: Pathology And Ultrasound Correlation. Finger Pt, Iacob Ce American Academy Of Ophthalmology – Poster 199, Challenges In Lower Lid Blepharoplasty: Management Of Lower Lid Pg. 250 Las Vegas, Nevada, November 2006 Laxity And Technique Of Canthal Support: Importance Of Orbital Morphology. New Horizons In Cosmetic Surgery. Indian Wells, California. High-Frequency Ultrasound Biomicroscopy Features Of 25 Iris And January 2006. Iridociliary Melanomas: Before And After Plaque Radiation Therapy. Reddy S, Chin K, Tena Lb, Finger Pt. American Academy Of Panelist Lower Lid/Mid-Face Junction: Restoration Of Volume/Ablation Of Ophthalmology – Poster 195, Pg. 250 Las Vegas, Nevada, November 2006 The Tear Trough. New Horizons In Cosmetic Surgery. Indian Wells, California. January 2006. 1- 2006 - Macula 2006, New York City Section On Choroidal Melanoma Pet/Ct Imaging For Detection Of Intraocular And Metastatic Disease Comprehensive Facial Rejuvenation. New Horizons In Cosmetic Surgery. Indian Wells, California. January 2006. 2-01-06 Nyee Resident Lecture Series Photography And Angiography Of Ocular Tumors Periorbital Rejuvination: Approaches To Lid Anchoring Orbicularis 2-08-06 Nyee Resident Lecture Series Ultrasound Imaging I Preservation And Fat Manipulation. 40th Baker Gordon Symposium. Miami, Florida. February 2006. 2-10-06 Nyu Resident Lecture Series Photography And Angiography Of Ocular Tumors Moderator Mid-Facelift: Transtemporal Vs. Transpelepbral Five Consecutive Cases-Which Is Best? Is There A Difference? Asaps Annual 2-21-06 Nyu Grand Rounds Case Presentations: Ultrasound Meeting. Orlando Florida. April 2006 Biomicroscopy For Anterior Segment Tumors, Bilateral Epibulbar Granulocytic Leukemia In And 8 Year Old, Management Of An Iridociliary Panelist Resect, Retain, Reposition-Management Of Lower Lid Fat. Asaps Melanoma In A Patient With Choroideremia, Brachytherapy Implants For Annual Meeting. Orlando, Florida. April 2006. Extrascleral Extension Of Choroidal Melanoma The Anatomical Basis For Advanced Blepharoplasty. Ucsf Plastic Surgery. 2-22-06 Nyee Resident Lecture Series “Ocular Surface Tumors” San Mateo, California. April 2006.

2-24-06 Nyu Resident Lecture Series “Ocular Surface Tumors” Panelist Reconstructive Issues In Facial Plastic Surgery: Reconstruction Of The Nasal Ala, Eyelid Defects And The Lip. 9th International 3-01-06 Nyee Resident Lecture Series“Retinoblastoma” Symposium Of Facial Plastic Surgery. Las Vegas, Nevada. May 2006.

3-03-06 Nyu Resident Teaching Lecture “Retinoblastoma” The No-Touch Blepharoplasty. 10th Emerging Technologies And Techniques In Plastic Surgery. New York, New York. May 2006. 3-23-06 Nyu Resident Teaching Lecture “Ophthalmic Ultrasound” “The “No Touch” Blepharoplasty.” Current Prospectives In Plastic 3-14-06 Okap Review Course Surgery: Point-Counterpoint By The Experts. Washington, Dc. June 2006. “Melanocytic, Metastatic And Panelist No Touch Blepharoplasty With Lateral Canthopexy And Vascular Intraocular Tumors” Transpalpebral Corrugator Resection. 2006 Madrid Internaionl 4-18-06 Nyu Grand Rounds Iconfrence On Plastic Surgery. Madrid, Spain. March 2006. “Modern Ocular Imaging At The New York Eye Cancer Center” Panelist Blepharoplasty In The Male Patient. 2006 Madrid Internaionl 6-08-06 Downstate 34th Annual Alumni Update Meeting Iconfrence On Plastic Surgery. Madrid, Spain. March 2006. “Imaging For Choroidal Melanoma: Pet / Ct And Treatment” 7-10-06 Nyu Department Of Ophthalmology “No Touch” Lower Lid Blepharoplasty. 2006 Michigan Academy Of Plastic “Introduction To Ocular Oncology” Surgery Meeting. Mackinac Island, Michigan. July 2006. 7-26-06 Nyee Department Of Ophthalmology “Introduction To The Ocular Tumor Service” Moderator Blepharoplasty In The Asian Patient. America Society Of 10-3-06 Winthrop University Hospital, Department Of Ophthalmology Plastic Surgery 2006. San Francisco, Califotnia. October 2006. “Imaging Of Ocular Tumors And Treatment Of Radiation Retinopathy” Panelist Preoperative Evaluation Of The Blepharoplasty Patient. Advances Galst, J, MD In Aesthetic Plastic Surgery: The Cutting Edge Vi. New York, Ny. 2006 2006 Ocular Heritage Society Meeting At Alcon Museum Of Panelist Correction Of Lower Lid Malposition With Mid-Face And Cheek Ophthalmology, Ft. Worth, Texas: Rehabilitation Of The Blind On Medals. Suspension. Advances In Aesthetic Plastic Surgery: The Cutting Edge Vi. April 22, 2006. New York, NY. 2006 Ocular Heritage Society Exhibit At Alcon Museum Of Ophthalmology, Ft. Blepharoplasty On A Male Patient. 5th Frankfurter Live –Op Kurs Worth Texas: Coins, Medals And The Ability To “See”. July 2005 – April Asthetic Surgery Of The Male. Frankfurt,Germany December 2006. 2006.

PRESENTATIONS 107 PRESENTATIONS 2006

Instructlonal Courses Wangsupadilok, Greenstein Vc, Liebmann Jm, Ritch R, Hood Dc. Arvo Eyelid And Periorbital Reconstruction. 9th International Symposium Of Scientific Poster Presentation, Ft. Lauderdale, Florida, April 20, 2006. Facial Plastic Surgery. Las Vegas, Nevada. May 2006. A Method To Detect Progression Of Glaucoma Using The Multifocal Advanced Blepharoplasty. American Society Of Plastic Surgery 2006. San Visual Evoked Potential Technique – Wangsupadilok B, Kanadani, Fn, Francisco, California. October 2006. Grippo Tm, Greenstein Vc, Ilitchev E, Ritch R, Liebmann Jm, Hood, Dc. Arvo Scientific Poster Presentation, Fr. Lauderdale, Florida, May 1, 2006. Live Surgical Demonstrations Ocular Pulse Amplitude (Opa) In High Myopia, Glaucoma, And Normal Live Surgery. Upper And Lower Blepharoplasty, Transpalpebral Subjects – Barros Ra, Kanadani Fn, Pro M, Shimmo M, Malhotra V, Tello C, Corrugator Resection, Retinacular Canthopexy. 40th Baker Gordon Liebmann Jm, Ritch R. Arvo Scientific Poster Presentation, Ft. Lauderdale, Symposium. Miami, Florida. February 2006. Florida, May 1, 2006.

Live Surgery. Upper Eyelid Entropian And Ptosis Correction. 2006 Madrid Assessment Of A Race-Specific Normative Database On The Ability Of International Iconference On Plastic Surgery. Madrid, Spain. March 2006. The Hrt-Iii To Differentiate Glaucomatous From Normal Eyes – Mora R, Harizman N, Zelefsky Jr, Ilitchev E, Wen J, Tello C, Ritch R, Liebmann Jm. Live Surgery. Aesthetic No Touch Blepharoplasty-Lateral Canthopexy And Arvo Scientific Poster Presentation, Ft. Lauderdale, Florida, May 2, 2006. Transpalpebral Corrugator Resection. 2006 Madrid International Iconference On Plastic Surgery. Madrid, Spain. March 2006. Normal Tension Glaucoma: A Stage Related Evaluation In 381 Patients – Gramer E, Wettengel A, Ritch R, Liebmann Jm, Gramer G. Arvo Scientific Live Surgery. Correction Of Bilateral Lower Lid Retraction With Cheek Poster Presentation, Fr. Lauderdale, Florida, May 2, 2006. Suspension, Mitek Screw Fixation And Lateral Canthoplasty. 2006 Madrid International Iconference On Plastic Surgery. Madrid, Spain. March 2006. Iris Contour Changes During Accommodation – Dorairaj Sk, Oliveira C, Barrocs V, Ragusa N, Tello C, Liebmann, Ritch. Arvo Scientific Poster Live Surgery. Lateral Retinacular Suspension. Advances In Aesthetic Presentation, Ft. Lauderdale, Florida, May 3, 2006. Plastic Surgery Surgery: The Cutting Edge Vi. New York, Ny. November 2006. Detection Of Glaucoma Using Operator-Dependent Versus Operator- Independent Classification In The Hrt-Iii – Harizman N, Zelefsky Jr, Live Surgery. Upper And Lower Eyelid Blehpahroplasty. 5th Frankfurter Ilitchev E, Anteqera O, Tello C, Ritch R, Liebmann Jm. Arvo Scientific Live –Op Kurs Asthetic Surgery Of The Male. Frankfurt,Germany Poster Presentation, Ft. Lauderdale, Florida, May 3, 2006. December 2006. Ocular Coherence Tomography (Oct) On Glaucoma Patients With Visual Field Defects Confirmed On Both Conventional Perimetry And Scientific Posters Multifocal Visual Evoked Potentials (Mfvep) – Arvo Scientific Poster When Must A Lateral Canthoplasty Be Done? A Precise Evaluation Of Presentation, Ft. Lauderdale, Florida, May 3, 2006. The Lower Eyelid For An Algoritham To Select The Most Appropriate Canthoplasty Technique – Nyu Medical Center, New York. American Structural And Functional Assessment Of The Macular Region In Patients Society Of Plastic Surgeons 2006. San Francisco, California. October With Glaucoma – Kanadani Fn, Grippo Tm, Wangsupadilok B, Harizman 2006. N., Greenstein Vc, Hood Dc, Liebmann Jm, Ritch R. Arvo Scientific Poster Presentation, Ft. Lauderdale, Florida, May 3, 2006. Liebmann, Jeffrey M., MD Multifocal And Conventional Visual Evoked Potentials Latency Detecting And Monitoring Progression Of Visual Field Defects In Measurements In Patients With Optic Disc Drusen - Grippo T, Ezon I, Glaucoma Suspects With The Mfvep: A Longitudinal Study – Greenstein Kanadani F, Wangsupadilok B, Greenstein V. Tello C, Liebmann Jm, Ritch R, Vc, Zhang X, Wangsupadilok, Rtch R, Liebmann J, Gripppo Tm, Hood, Dc. Hood D. Scientific Paper, World Congress Of Ophthalmology, Sao Paulo, Arvo Scientific Poster Presentation, Ft. Lauderdale, Florida, May 3, 2006. Brazil, February 19-24, 2006. Measurements Of Optic Disc Size With Hrt Ii, Oct3 And Funduscopy An Evaluation Of Implicit Time In Patients With Optic Nerve Head Are Not Interchangeable – Barkana Y, Harizman N, Liebmann Jm, Riitch Drusen With Multifocal And Conventional Visual Evoked Potentials – R. Arvo Scientific Poster Presentation, Ft. Lauderdale, Florida, May 3, Grippo Tm, Ezon I, Kanadani, F, Wangsupadilok B, Liebmann Jm, Ritch R, 2006. Hood D. Scientific Poster, American Glaucoma Society, Charleston, Sc, March 3-7, 2006. The Effect Of Trabeculectomy On Intraocular Pressure (Iop) Of The Contralateral Eye – Espana Em, Kanadani Fn, Berke Sj, Tello C, Caronia Does Changing Eye Test Ordder With 24-2 Sita Standard Result In A Rm, Sturm Rt, Liebmann Jm, Ritch R. Arvo Scientific Poster Presentation, Meaningful Change In Test Result? Barkana Y, Mora R, Tello C, Liebmann Ft. Lauderdale, Florida, May 3, 2006. Jm, Ritch R. Scientific Paper, Israeli Association For Eye And Vision Research, Neve Han, Israel, March 9, 2006. Why Is The Superior Angle Narrower Than The Inferior Angle In Eyes With Narrow Angles? – Riitch R, Dorairaj Sk, Tello C, Liebmann Jm. Arvo Intraocular Pressure (Iop) Monitoring Outside Of Normal Office Hours Scientific Poster Presentation, Ft. Lauderdale, Florida, May 4, 2006. Clinically Useful? Barkana Y, Anis Sn, Kim J, Tello C, Liebmann Jm, Ritch R. Scientific Paper, Israeli Association For Eye And Vision Research, Neve Corneal Graft Survival In Ice Syndrome With Coexisting Glaucoma- Han, Israel, March 9, 2006. Drainage Implants In The Vitreous Cavity – Harizman N, Ritterband D, Schneider L, Chiu E, Liebmann J, Ritch R, Seedor J. Aao Scientific Paper, Optical Coherence Tomography Can Detect Retinal Nerve Fiber Defects Cornea Society, Las Vegas, NV, November 11, 2006. In Patients With Optic Nerve Head Drusen – Grippo Tm, Kanadani Fn, Ezon I, Harizman N,

108 THE NEW YORK EYEAND EAR INFIRMARY PRESENTATIONS 2006

Lippman, J, MD Torsional Phacoemulsification: Advantages, Techniques And Parameters. Presented At The Annual Tri-State Meeting Of The Arizona, Nevada And New York Eye And Ear Infirmary, New York, NY. Phaco Forum: “Avoiding New Mexico Ophthalmological Societies. May 20th, 2006, Sedona, And Managing Cataract Surgical Complications”. January 30, 2006 Arizona Annual Meeting Of The American Society Of Cataract And Refractive Surgery, San Francisco, Ca. Instructor: Advanced Phaco Lab. March 19, Foldable Iol Removal: Anticipation, Timing And Techniques. Presented At 2006 The Annual Tri-State Meeting Of The Arizona, Nevada And New Mexico Ophthalmological Societies. May 20th, 2006, Sedona, Arizona New York Eye And Ear Infirmary, New York, Ny. Phaco Forum: “Introduction To Modern Cataract Surgery”. August 21, 2006 Iol Options With Zonular Weakness. Presented At The Storm Eye/Ascrs Annual Meeting Of The American Academy Of Ophthalmology, Las Vegas, Clinical Update, Kiawah, South Carolina. June 1, 2006. Nevada. Senior Instructor: Phacoemulsification Skills Transfer Lab 338a. November 13, 2006 Rezoom/Restor Mix And Match. Presented At The Storm Eye/Ascrs Clinical Update, Kiawah, South Carolina. June 3, 2006. Mackool, R, MD New Modalities For Cataract Extraction And Lens Implantation. Wherefore Art Thou Astigmatism (Discussion Of Non-Corneal Hawaiian Eye 2006. January 15, 2006, Grand Wailea Resort, Maui, Astigmatism). Presented At The Storm Eye/Ascrs Clinical Update, Hawaii. Kiawah, South Carolina. June 4, 2006.

Torsional Phacoemulsification: The Elimination Of Lens Chattering And Adopized Diffractive Iol’s: Results And Caveats. Presented At The Asian Reduction Of Heat Generation. Hawaiian Eye 2006. January 16, 2006. Pacific Academy Of Ophthalmology Symposium, Singapore, June 9th, 2006 Grand Wailea Resort, Maui, Hawaii. Torsional Ultrasound Technology. Presented At The Asian Pacific Removable Anterior Lens Opacity. Vascularized Anterior Lens Capsule. Academy Of Ophthalmology Symposium, Singapore, June 9th, 2006 Presented During Panel Discussion - Cataract Surgery Complications. Hawaiian Eye 2006. January 17, 2006, Grand Wailea Resort, Maui, Hawaii. Evolution In Ultrasound Based Lens Removal. Presented At The Asian Pacific Academy Of Ophthalmology Symposium, Singapore, June 11th, Cataract Surgery Update And Review Of Complications. Suny 2006 Downstate Department Of Ophthalmology/Brooklyn Ophthalmology Society Meeting, Suny Downstate Medical Center, Brooklyn, NY January Adopized Diffractive Iol’s: Results And Caveats. Presented At The Asian 26, 2006 Pacific Academy Of Ophthalmology Symposium, Singapore, June 11th, 2006 Torsional Phacoemulsification: Clinical Perspective. 28th Annual Current Concepts In Ophthalmology Meeting, Johns Hopkins Wilmer Eye The Natural And Restor Intraocular Lenses. Presented At Zhongshan Institute, Hyatt Dorado Hotel, Puerto Rico, February 10, 2006. Eye Center, Guangzhou, China, June 14th, 2006

Wild Stuff (Stuff You Don’t See Very Often). 28th Annual Current “Mix And Match” Comparison: Results After Randomized Insertion Of Concepts In Ophthalmology Meeting. Johns Hopkins Wilmer Eye Restor An Rezoom Intraocular Lens Implants In Contralateral Eyes. Institute, Hyatt Dorado Hotel, Puerto Rico, February 10, 2006. Presented At The Eye On Excellens Symposium Sponsored By Alcon Surgical, September 8th, 2006, House Of Parliament, London, England Phacoemulsification Of The Subluxated/Dislocated. 28th Annual Current Concepts In Ophthalmology Meeting. Johns Hopkins Wilmer Eye The Science And Benefits Of Torsional Phacoemulsification. Ocular Institute, Hyatt Dorado Hotel, Puerto Rico, February 10, 2006. Surgery News New York Symposium, Waldorf Astoria Hotel, New York, Ny October 15, 2006 Foldable Iol Removal. 28th Annual Current Concepts In Ophthalmology Meeting. Johns Hopkins Wilmer Eye Institute, Hyatt Dorado Hotel, Cataract Surgery In The Glaucoma Patient. Combined Ecp And Puerto Rico, February 10, 2006. Phacoemulsification. Presented At The Postgraduate Medicine Conference, “New Frontiers In Clinical Glaucoma Ii”, New York Academy The Restor Lens: Results And Caveats: 28th Annual Current Concepts In Of Medicine, New York, Ny, October 21, 2006 Ophthalmology Meeting. Johns Hopkins Wilmer Eye Institute, Hyatt Dorado Hotel, Puerto Rico, February 10, 2006. Optimizing Outcomes With Presbyopic-Correcting Iols. Innovations In Ophthalmology Symposium, Mgm Grand Garden Arena, Las Vegas, Lens Removal/Torsional Phacoemulsification: Advantages Of Nonlinear Neveda, November 12th, 2006. Ultrasound. Presented At The Annual Meeting Of The American Society Of Cataract And Refractive Surgery, March 18th, 2006, San Francisco, Ca Manusis, Kira, MD Wavefront Analysis Of The Acrysof Iq Spherical Aberration Correcting The Restor Lens. Presented At The Eye World Educational Symposium Iol Using The Tracey Itrace Aberrometer Richard E. Braunstein, Md, (Presbyopic Solutions And Patient Expectations), St. Regis Hotel, San Ankoor Shah, Bs, Kira Manusis, Md, Arvo Poster, Edward S. Harkness Eye Francisco, Ca, March 21, 2006. Institute, Columbia University Medical Center, New York, Ny; The New York Eye & Ear Infirmary, New York, NY. The Restor Lens: Results And Caveats. Presented At The Annual Tri-State Meeting Of The Arizona, Nevada And New Mexico Ophthalmological Societies. May 20th, 2006, Sedona, Arizona

PRESENTATIONS 109 PRESENTATIONS 2006

Ritch, R, MD Narrow Than The Inferior Angle In Eyes With Narrow Angles? Barros, R; Kanadani, Fn; Pro, M; Tello, C; Liebmann, Jm; Ritch, R: Ocular Association For Research In Vision And Ophthalmology, Fort Lauderdale, Pulse Amplitude Measurements In Patients With Asymmetric Glaucoma Fl, May 4, 2006. Damage Using Pascal Dynamic Contour Tonometer, World Ophthalmology Congress, Sao Paulo, Brazil, Feb. 22, 2006. Espana Em, Kanadani Fn, Berke Sj, Tello C, Caronia Rm, Sturm Rt, Liebmann Jm, Ritch R: The Effect Of Trabeculectomy On Intraocular Grippo Tm, I Ezon, F Kanadani, B Wangsupadilok, V Greenstein, C Tello, Pressure (Iop) Of The Contralateral Eye. Association For Research In Jm Liebmann, R Ritch, D Hood: Multifocal And Conventional Visual Vision And Ophthalmology, Fort Lauderdale, Fl, May 3, 2006. Evoked Potentials Latency Measurements In Patients With Optic Disc Drusen. World Ophthalmology Congress, Sao Paulo, Brazil, Feb. 20, 2006. Grippo Tm, Kanadani Fn, Ezon I, Harizman N, Wangsupadilok B, Greenstein Vc, Liebmann Jm, Ritch R, Hood Dc: Optical Coherence Kanadani, Fn; Dorairaj, Sk; Langlieb, Am; Tello, C; Liebmann Jm; Ritch R: Tomography Can Detect Retinal Nerve Fiber Defects In Patients With Ultrasound Biomicroscopy In Asymmetric Pigment Dispersion Syndrome Optic Nerve Head Drusen. Association For Research In Vision And And Pigmentary Glaucoma. World Ophthalmology Congress, Sao Paulo, Ophthalmology, Fort Lauderdale, Fl, April 30, 2006. Brazil, Feb. 22, 2006. Mora R, Harizman N, Zelefsky Jr, Ilitchev E, Wen J, Tello C, Ritch R, Kanadani, Fn; Moreira, Tc; Figueiredo, Cr; Pineda, H; Ritch, R: Ocular Liebmann Jm: Assessment Of A Race-Specific Normative Database On Perfusion Pressure And Pulsatile Ocular Blood Flow In Normal And The Ability Of The Hrt-Iii To Differentiate Glaucomatous From Normal Systemic Hypertensive Patients. World Ophthalmology Congress, Sao Eyes. Association For Research In Vision And Ophthalmology, Fort Paulo, Brazil, Feb. 23, 2006. Lauderdale, Fl, May 2, 2006.

Ritch R: When To Perform Prophylactic Laser Iridotomy And/Or Harizman N, Zelefsky Jr, Ilitchev E, Antequera O, Tello C, Ritch R, Iridoplasty. World Ophthalmology Congress, Sao Paulo, Brazil, Feb. 20, Liebmann Jm: Detection Of Glaucoma Using Operator-Dependent Versus 2006. Operator Independent Classification In The Hrt-Iii. Association For Research In Vision And Ophthalmology, Fort Lauderdale, Fl, May 3, 2006. Ritch R: Exfoliation Syndrome – New Findings, New Concepts. World Kanadani Fn, Grippo Tm, Wangsupadilok B, Harizman N, Greenstein Vc, Ophthalmology Congress, Sao Paulo, Brazil, Feb. 21, 2006. Hood Dc, Liebmann Jm, Ritch R; Structural And Functional Assessment Of The Macular Region In Patients With Glaucoma. Association For Ritch R: Mechanisms Of Causation Of Angle Closure. World Research In Vision And Ophthalmology, Fort Lauderdale, Fl, May 3, 2006. Ophthalmology Congress, Sao Paulo, Brazil, Feb. 22, 2006. Gramer E, Wettengel A, Ritch R, Liebmann Jm, Gramer G: Normal Ritch R: Oculusgen – Nanotechnology Based Glaucoma Surgery. World Tension Glaucoma: A State Related Evaluation In 381 Patients. Ophthalmology Congress, Sao Paulo, Brazil, Feb. 22, 2006. Association For Research In Vision And Ophthalmology, Fort Lauderdale, Fl, May 3, 2006. Vieira Gm, Oliveira Hb, De Andrade Dt, Marques Mb, Ritch R: Variations In Intraocular Pressure During Weight Lifting. World Ophthalmology Hood Dc, Harizman N, Kanadani Fn, Grippo Tm, Baharestani S, Congress, Sao Paulo, Brazil, Feb. 22, 2006. Greenstein Vc, Liebmann Jm, Ritch R: Ocular Coherence Tomography (Oct) On Glaucoma Patients With Visual Field Defects Confirmed On Grippo T, Hood Dc Liebmann Jm, Ritch R: Multifocal And Conventional Both Conventional Perimetry And Multifocal Visual Evoked Potentials Visual Evoked Potential Latency Measurements In Patients With Optic (Mfvep). Association For Research In Vision And Ophthalmology, Fort Disc Drusen. Am Glaucoma Soc, Charleston, Sc, March 4, 2006. Lauderdale, Fl, May 3, 2006.

Barkana Y, Harizman N, Liebmann Jm, Ritch R: Measurements Of Optic Greenstein Vc, Zhang X, Wangsupadilok B, Ritch R, Liebmann J, Grippo Disc Size With Hrt Ii, Oct3, And Funduscopy Are Not Interchangeable. Tm, Hood Dc: Detecting And Monitoring Progression Of Visual Field Israel Society For Eye And Vision Research, March 9-10, 2006. Defects In Glaucoma Suspects With The Mfvep: A Longitudinal Study. Association For Research In Vision And Ophthalmology, Fort Lauderdale, Barkana Y, Mora R, Tello C, Liebmann Jm, Ritch R: Does Changing Eye Test Fl, May 3, 2006. Order With 24 Sita-Standard Result In A Meaningful Change In Test Results?. Israel Society For Eye And Vision Research, March 9-10, 2006. Grassi Ma, Fingert Jh, Folk Jc, Scheetz Te, Shire Am, Ritch R, West Sk, Kawase K, Mullins Rf, Stone Em: Ethnic And Phenotypic Frequencies Of Dorairaj Sk, Oliveira C, Barocas V, Ragusa N, Tello C, Liebmann Jm, Ritch Complement Factor H Polymorphism Y402h. Association For Research In R: Iris Contour Changes During Accommodation. Association For Vision And Ophthalmology, Fort Lauderdale, Fl, May 3, 2006. Research In Vision And Ophthalmology, Fort Lauderdale, Fl, May 3, 2006. Barkana Y, Harizman N, Liebmann Jm, Ritch R: Measurements Of Optic Barros Ra, Kanadani Fn, Pro M, Shimmyo M, Malhotra V, Tello C, Liebmann Disc Size With Hrt Ii, Oct 3, And Funduscopy Are Not Interchangeable. Jm, Ritch R: Ocular Pulse Amplitude (Opa) In High Myopia, Glaucoma, Association For Research In Vision And Ophthalmology, Fort Lauderdale, And Normal Subjects. Association For Research In Vision And Fl, May 3, 2006. Ophthalmology, Fort Lauderdale, Fl, May 1, 2006. Ritch R: Angle-Closure: A Century Of Controversy, Nonbelievers, Missed Wangsupadilok B, Kanadani Fn, Grippo Tm, Greenstein Vc, Ilitchev E, Opportunities, And Reinventing Wheels. Assoc Int Glaucoma Socs, Ft Ritch R, Liebmann Jm, Hood Dc: A Method To Detect Progression Of Lauderdale, May 3, 2006. Glaucoma Using The Multifocal Visual Evoked Potential Technique. Association For Research In Vision And Ophthalmology, Fort Lauderdale, Hood Dc, Chen Jy, Yang Eb, Rodarte C, Grippo Tm, Odel Jg, Ritch R: The Fl, May 1, 2006. Role Of The Multifocal Visual Evoked Potential (Mfvep) In Understanding Optic Nerve And Retinal Diseases. Am Ophthalmol Soc., San Francisco, Ritch R, Dorairaj Sk, Tello C, Liebmann Jm: Why Is The Superior Angle Ca, May 21, 2006.

110 THE NEW YORK EYEAND EAR INFIRMARY PRESENTATIONS 2006

Sirampuj P, Teekhasaenee C, Ritch R: Inferior Posterior Lip Sclerectomy Successful Treatment Of Glaucoma. Indonesian Ophthalmological Society, And Anterior Chamber Inflation For Uncontrolled Total Hyphema. Int Medan, Sumatra, Aug 3, 2006. Congress Glaucoma Surg, Toronto, May 30, 2006. One Hundred Years Of Angle-Closure. Sixth International Symposium Of Teekhasaenee C, Ritch R: Goniosynechialysis (Gsl) For Chronic Angle- Ophthalmology, Hong Kong, Aug 13, 2006. Closure With Uncontrolled Intraocular Pressure (Iop) Following Phacoemulsification And Intraocular Lens (Iol) Implantation. Int Congress Challenges In Glaucoma In The Next Decade. Sixth International Glaucoma Surg, Toronto, June 1, 2006. Symposium Of Ophthalmology, Hong Kong, Aug 14, 2006.

Teekhasaenee C, Ritch R: Long-Term Follow-Up Of Combined One Hundred Years Of Angle-Closure. 20th Anniversary Symposium Of Phacoemulsification And Goniosynechialysis For Uncontrolled Angle- Tun Hussein National Eye Hospital, Kuala Lumpur, Malaysia, Sept 1, 2006. Closure. Int Congress Glaucoma Surg, Toronto, June 1, 2006. What Is Glaucoma. Thirteenth Annual Optic Nerve Rescue And Ritch R: Laser Treatment Of The Trabecular Meshwork: A Generation Of Regeneration Think Tank, New York, Ny, Sept 15, 2006. Experience. Int Congress Glaucoma Surg, Toronto, June 1, 2006. Natural Compounds: Evidence For Protective Roles In Eye Disease. Ritch R: Natural Products: Evidence For A Protective Role In Eye International Ocular Neuroprotection Symposium, Toronto, Ont, Oct 14, Disease. Int Ocular Neuroprotection Symposium, Toronto, Ont, Oct 14, 2006. 2006. Potential Applications Of Nanotechnology In Glaucoma. New Frontiers Ritch R: Exfoliation Syndrome And Pigment Dispersion Syndrome: In Clinical Glaucoma, New York, Ny, Oct 20, 2006. Paradigm Of An Overlap Syndrome. Subspecialty Day, Am Acad Ophthalmol, Las Vegas, NV, Nov 10, 2006. Alternative Therapy For Glaucoma (Neuroprotection Course With Len Levin). Am Acad Ophthalmol, Las Vegas, Nv. Nov 14, 2006. Harizman N, Ritterband D, Schneideer L, Chiu E, Liebmann J, Ritch R, Seedor J: Corneal Graft Survival In Ice Syndrome With Coexisting Management Of Advanced Glaucoma. Southeast Asian Glaucoma Interest Glaucoma-Drainage Implants In The Vitreous Cavity. Cornea Society, Las Group, Chennai, India, Dec. 1, 2006 Vegas, NV, Nov 10, 2006. Pediatric Glaucoma. Southeast Asian Glaucoma Interest Group, Chennai, Ritch R: Goniosynechialysis For Chronic Angle—Closure Glaucoma. Am India, Dec. 3, 2006. Acad Ophthalmol, Las Vegas, Nv, Nov 11, 2006. Laser Suture Lysis. Southeast Asian Glaucoma Interest Group, Chennai, Ritch R: The Role For Alternative Therapy In The West. Am Acad India, Dec. 1, 2006. Ophthalmol, Las Vegas, Nv, Nov 12, 2006. Limbus-Based Trabeculectomy. Southeast Asian Glaucoma Interest Group, Dorairaj S, Ritch R: Prevalence Of Monocular Childhood Blindness In A Chennai, India, Dec. 1, 2006. Rural Population Of Southern India (Poster). Am Acad Ophthalmol, Las Vegas, Nv, Nov 13, 2006. Laser Ablation Of Conjunctival Vessels. Southeast Asian Glaucoma Interest Group, Chennai, India, Dec. 1, 2006. Dorairaj S, Barocas V, Tello C, Liebmann Jm, Ritch R: Time Dependent Accommodation-Induced Changes In Iris Curvature. Am Soc Ophthalmic Mvr Revision Of Leaking Blebs. Southeast Asian Glaucoma Interest Ultrasound, Las Vegas, Nv, Nov 13, 2006. Group, Chennai, India, Dec. 1, 2006.

Hsu Wc, Ritch R, Krupin T, Chen Hsl: Control Of Filtering Bleb Structure Ab Interno Trephination For Failed Blebs. Southeast Asian Glaucoma Through Tissue Bioengineering: An Animal Model. Southeast Asian Interest Group, Chennai, India, Dec. 2, 2006. Glaucoma Interest Group, Chennai, India, Dec. 1, 2006. Needling Revision Of Failed Filtering Blebs. Southeast Asian Glaucoma Argon Laser Peripheral Iridoplasty. Ritch R: World Ophthalmology Interest Group, Chennai, India, Dec. 2, 2006. Congress, Sao Paulo, Brazil, Feb. 23, 2006. Argon Laser Peripheral Iridoplasty. Southeast Asian Glaucoma Interest Management Of Exfoliation Syndrome. 2nd European-American Group, Chennai, India, Dec. 2, 2006. Ophthalmology Symposium, New York, Ny, June 2, 2006. Goniosynechialysis. Southeast Asian Glaucoma Interest Group, Chennai, Exfoliation Syndrome: The Worst Open-Angle Glaucoma? Glaucoma India, Dec. 2, 2006. 2006, New York, Ny, June 10, 2006. Combined Trephination And Mvr Bleb Revision. Southeast Asian Argon Laser Peripheral Iridoplasty. Glaucoma 2006, New York, NY, June Glaucoma Interest Group, Chennai, India, Dec. 3, 2006. 10, 2006 Circumferential Bleb Reduction. Southeast Asian Glaucoma Interest Exfoliation Syndrome. Kazakhstan Ophthalmological Congress, Almaty, Group, Chennai, India, Dec. 3, 2006. Kazakhstan, July 26, 2006.

New Paradigms In The Diagnosis Of Glaucoma. Indonesian Ophthalmological Society, Medan, Sumatra, Aug 2, 2006.

PRESENTATIONS 111 PRESENTATIONS 2006

Ritterband, D, MD ARVO 2006 R.Canovas, C.Morini, P.Garcia, R.Rosen. Macular Pigment Alcon Booth Lecture-Ascrs-Target Specific Therapeutics (Nevanac And Density Measurements Using Autofluorescence Technique and Vigamox) March 18, 2006 Heterochromatic Flicker Photometry. May 3, 2006 ARVO 2006 J.P. Garcia, Jr., P.M. T. Garcia, R.B.Rosen Anterior Segment Albany County Ophthalmology Society-Endophthalmitis September 12, 2006 Imaging Using the AC Cornea OCT System May 3, 2006

Infection Prevention: New Frontiers In Glaucoma: Ny Academy Of ARVO 2006 D.Pau1, M.E. J. van Velthoven, P.M.Garcia, R.B. Rosen. Retinal Medicine Conference Oct 12-13. Saturday Oct 13, 2006 Nerve Fiber Layer Thickness Measurements: Coronal OCT/SLO versus Stratus OCT May 3,2006 ARVO 2006 A.C. Brown, S.Lalin, R.Rosen. The Clinical Role of SLO-OCT Romero, J, MD in Diagnosing and Managing Recurrent Cystoid Macula Edema in a Current Trends In Diabetic Retinopathy. Xxx Inter-American Medical Patient With Retinitis Pigmentosa Responsive to Acetazolamide Dental Congress. New York University And The Spanish American Treatment. May 3,2006 Medical Dental Society Of New York. New York, October 28, 2006 ARVO 2006 R.B. Rosen, P.M. Garcia, M.Van Velthoven, R.Canovas, S.Lalin, Rosen, Richard B. MD T.O.Muldoon, J.B. Walsh, J.Rogers,J.Pedro, R.Weitz PeripheralRetinal Imaging Using A Prototype Anterior Segment OCT/SLO Wednesday, May Atlantic Fluorescein Club, “ The Silkscreen Artist: Central Serous 3, 2006 Retinopathy Complicated by Retinal Detachment and Metastatic Lung Cancer, “ January 12, 2006 ARVO 2006 G.Trivedi, S.Lalin, J.Romero, R.Rosen. Intravitreal Injection of Bevacizumab (Avastin) as a Surgical Adjuvant in the Treatment of Retinal MACULA 2006, R Rosen, “OCT/SLO: It Matters How You Slice It”, New Neovascularization Associated With Tractional Retinal Detachment York, January13, 2006 Wednesday, May 3, 2006 Photonics West Bios 2006,AG Podoleanu, R Rosen “Simultaneous ARVO 2006 M.Banitt, S.C. Lalin, R.C.Gentile, R.B. Rosen Treatment of OCT/ICG Fluorescense Imaging System for Investigations of the Eye Choroidal Neovascular Membranes in Patients With Angioid Streaks Fundus,” San Jose 1/28/06 With Intravitreal Bevacizumab (Avastin) Wednesday, May 3,2000 World Ophthalmology Congress, R Rosen“ Advances in SLO-OCT ARVO 2006 S.C. Lalin, R.C. Gentile, P.M. Garcia, J.Dominguez, R.B. Rosen. Imaging,” Sao Paulo, Brazil, February 21,2006 Outcome and Complications of Intravitreal Bevacizumab(Avastin) in 69 World Ophthalmology Congress, R Canovas, C Morini, P Garcia, R Rosen Patients (102 injections) for Choroidal and/or Retinal VascularDisease, Wednesday, May 3, 2006 Macular Pigment Density Measurements Using Autofluorescence And Heterochromatic Flicker Photometry,” Sao Paulo, Brazil, February ARVO 2006 J.Dominguez, S.C. Lalin, R.C.Gentile, P.M. Garcia, M.E. Van 23,2006 Velthoven, J.M. Romero, R.B.Rosen. Treatment of Choroidal Neosvascularization in Myopic Degeneration With Bevacizumab (Avastin) World Ophthalmology Congress, “R Canovas, P Garcia, M Velthoven,R Appears to Improve ShortTerm Anatomic and Visual Outcomes When Rosen,” MACULAR HOLE IMAGING WITH OCT/SLO COMPARED TO Correlated With Vision and SLO-OCT Imaging Wednesday, May 3, 2006 OCT3”, Sao Paulo, Brazil, February 20,2006 ARVO 2006 E.Feldman, S.Lalin, R.Gentile, P.Garcia, R.Rosen, Treatment of World Ophthalmology Congress, M Van Velthoven, R Cucu, P Garcia, A Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) with Podoleanu, R Gentile,T Muldoon, R Rosen “Comparison Of A Broadband IntravitrealBevacizumab (Avastin) Appears To Decrease Retinal Thickness SLD-Based Ultra-High Resolution Oct/SLO System With A First and Retinal Surface Contour Based on SLO-OCT Imaging, May 4,2006 Generation Commercial OCT/SLO System For Retinal Imaging,” Sao Paulo, Brazil, February 21,2006 ARVO 2006 E.W. Fitz, M.Shaw, R.B. Rosen, R.C. Gentile, Bacterial Sensitivity to Fourth Generation Fluoroquinolones in Infectious World Ophthalmology Congress, M Van Velthoven, P Garcia, P Finger, J Endophthalmitis, May 4, 2006 Garcia, S Schneider, T Muldoon, R Rosen “Discrimination Between Choroidal Nevi And Melanoma Using Combined Coronal Oct And ARVO 2006 T.O. Muldoon, R.B. Rosen,P.Tone, D.-N.Hu Melatonin Confocal Ophthalmoscopy (OCTt/SLO),” Sao Paulo, Brazil, February Suppression of TPA-Induced VEGF Up-Regulation in Cultured Human 22,2006 Uveal Melanocytes, May 4, 2006 International Society For Imaging Of The Eye, R Rosen “Second ARVO 2006 G.H. Bennett, P.W. Kramer, V.L.Lubkin, T.Cappo, M.Orr, Generation ICG/SLO/OCT Imager,” Ft. Lauderdale, May 1, 2006 R.B.Rosen Development of an Automated Stereocampimeter to Measure Central Scotomas. May 4, 2006 ARVO 2006 S.B. Barone, S.C. Lalin, R.C.Gentile, J.Garcia, R.B. Rosen,Changes in Choroidal Blood Flow in Response to the Treatment 2nd European-American Ophthalmogy Symposium, Course Directors: P of Diabetic Macular Edema, Apr 30, 2006 Lehoang, RB Rosen, G Coscas, “Evaluation of Diabetic Maculopathy with OCT/SLO,” New York, June 5, 2009 ARVO 2006 P.M. Garcia, M.E. van Velthoven, P.T. Finger, S.Schneider, J.P. S.Garcia, Jr., R.B. Rosen, Discrimination Between Choroidal Nevi and 21st Congress of the Asia-Pacific Academy of Ophthalmology 2006, , Melanoma Using the Combination OCT/SLO, May 1, 2006 Richard B Rosen, Dennis Orlock, Adrian Gh Podoleanu ,Rishard Weitz ,Patricia M Garcia ,Mirjam Van Velthoven ,John Rogers ,Radu Cucu ARVO 2006 A.Gonzalez, K.M. Narayana, P.M.Garcia, M.E. J. Van Velthoven, OCT/SLO VS STRATUS OCT3 : IT MATTERS HOW YOU SLICE IT, June M.D. DeSmet, R.B. Rosen, C.M. Samson, Combined Optical Coherence 10,2006 Tomography and Confocal 21st Congress of the Asia-Pacific Academy of Ophthalmology 2006, , Scanning Laser Ophthalmoscope Imaging in Multifocal Choroiditis, May 2, 2006 Richard B Rosen, Dennis Orlock, Adrian Gh Podoleanu ,Rishard Weitz ARVO 2006 J.C. Nieto, P.M. T. Garcia, K.Feldhamer, J.P. S. Garcia, R.B. ,Patricia MGarcia ,Mirjam Van Velthoven ,John Rogers ,Radu Cucu Rosen. Macular Pigment Density Distribution Variability in Normal ICG/OCT/SLO for Evaluation of Occult Choroidal Neovascularization, HumanSubjects, Primary Relatives of AMD Subjects, and AMD Subjects. June 10,2006 May 3, 2006

112 THE NEW YORK EYEAND EAR INFIRMARY PRESENTATIONS 2006

Corso Avanzato di OCT, Stratigraia C-Scan OCT/SLO Possibilita attuali Ophthalmology (Arvo), Fort Lauderdale, Fl, May 1-5, 2006.Arvo Poster in clinica ed interpretazione, Course Directors- B Lumbroso, R Brancato, 4442/B201. R Rosen “Clinical Applications of OCT/SLO”, “ ICG/OCT/SLO A New Barros Ra, Kanadani Fn, Pro M, Shimmyo M, Malhotra V, Cello C, Clinical Tool, “ “OCT/SLO for Differentiation of Nevi and Melanomas” Liebmann J, Ritch R: Ocular Pulse Amplitude (Opa) In High Myopia, June 24, 2006 Glaucoma And Normal Subjects. Presentation 1800, May 1,2006, At Association For Research In Vision And Ophthalmology (Arvo), Fort International Society of Ocular Trauma, RB Rosen, B Lubroso, R Brancato Lauderdale, Fl, May 1-5, 2006. “ New OCT: OCT/SLO high Resolution” Rome, June 29,2006 Shimmyo M, Orloff Pn: Instructors, Instructional Course; How To International Society of Ocular Trauma, RB Rosen, SB Barone SC Lalin, AJ Measure And Calculate “True” Iop: Iop Correction With Cct, Corneal Terraciano, M Shah, SA McCormick, DC Ritterband, RC Gentile “ Curvature And Corneal Hysteresis: Comparisons Of Specificity And Microbial Isolates and Sensitivities in Posterior Segment Intraocular Sensitivity Of Goldmann Applanation, Dct And Reicher’s Ocular Foreign Body Injuries: A 10 year review ” Rome, June 29,2006 Response Analyzer; Monday, September 11, 1630-1730 At Xxiv Congress Of European Society For Cataract And Refractive Surgery (Escrs), 2nd Edition JAKA International Congress New Therapies in Retinal London, Uk, September 9 – 13, 2006. Diseases, R Rosen “Advances in OCT/SLO,” Rome , September 8, 2006 Shimmyo M, Orloff Pn, Hayashi Ni: Optic Nerve Morphology And Axial Length : Scientific Poster (Po 080), Nov 13, 2006 At American Academy American Society Of Retina Specialists, R Rosen, “Dualing OCT Of Ophthalmology (Aao), Las Vegas NV, Nov 11-14, 2006. Modalities: Ultrahigh Resolution OCT/SLO Spectral vs. Time Domain,” Cannes, 9/12/2006

American Society Of Retina Specialists, TO Muldoon, RB Rosen, SC Lalin, Warren, F, MD J Dominguez, RC Gentile, “Avastin for treatment of ocular neovascular- Temporal Arteritis At American Academy Of Ophthalmology Breakfast ization and macular edema, Cannes 9/11/2006 With Experts, Las Vegas, Nevada, November 14,2006.

Combined meeting Club Jules Gonin The Retina Society, RB Rosen, PM Temporal Arteritis/ Pseudotumor Cerebrii At The Greater New York Garcia, J Sebag, “Coronal Plane Imaging with Combined OCT/SLO Ophthalmology Lecture Series, New York, NY, September 3, 2006. Detect Macular Pucker in Macular Holes” 10/15/2006

American Academy of Ophthalmology: Subspecialty Day Retina 2006: "High Resolution OCT/SLO".R Rosen, Las Vegas11/07/03.

Ophthalmic Photographers Society Annual Meeting,Las Vegas, New High Resolution OCT/SLO Imaging, D Orlock, R Rosen

AAO Course , “Imaging Techniques for Ocular Tumors- OCT/SLO Techniques,” Las Vegas, P Finger, W Mieler, R Rosen

Schiller, J, MD Deepening Of The Upper Eyelid Crease After Lower Transconjunctival Blepharoplasty, At The 13th Asean Congress Of Plastic Surgery, Chiang Mai, Thailand, October 17th, 2006

Evaluation, Decision-Making, And Techniques For Asian Blepharoplasty, At The Anti-Aging World Medicine Congress, Paris, France, March 24, 2006.

Shama, M, MD New Techniques In Trabeculectomy Surgery-Review Of 100 Cases,At The Ophthalmic Laser Surgical Society,Ny,Ny. May 2006. Also Given At The Ny Glaucoma Society, June, 2006. NY, NY Morris Shamah Md Ps During This Year I Also Organized The Brooklyn Glaucoma Society. I Server As Chairman of The Society.

Shimmyo, M, MD Shimmyo M, Orloff Pn, Hayashi N: Optic Disc Area, Optic Rim Area, And Axial Length In Evaluation Of Glaucoma. Scientific Poster (P157) Annual Meeting Of American Society Of Cataract And Refractive Surgery (Ascrs), San Francisco, March 17 – 22, 2006. Shimmyo M, Orloff Pn: Specificity And Sensitivity Of Intraocular Pressure Measurements By Goldmann Applanation Tonometry, Reichert’s Ocular Response Analyzer And Dynamic Contour Tonometry. Scientific Poster Presented On May 3 At Association For Research In Vision And

PRESENTATIONS 113 NYE&E ARVO BIBLIOGRAPHY 2005

May 1 - 5, 2005 - New York, New York

SUNDAY, MAY 01, 2005 42 PO B 16 A Novel Locus for Juvenile-Onset Primary Open-Angle Glaucoma Maps at Chromosome 5q, C.Pang, B.J. Fan, O.Canlas, D.Y. Wang, P.O. S. Tam, D.S. C. Lam, D.S. P. Fan, C.Y. Lam, V.Raymond, R.Ritch 96 PO B 70 Surgical Reduction of Symptomatic Filtering Blebs,S.N. Anis, W.Shihadeh, J.Kim, C.Tello, J.M. Liebmann, R.Ritch.

658 PO B 632 Optic Nerve Head Drusen and Visual Field Loss in Normotensive and Hypertensive Eyes, C.Tello, W.Shihadeh, T.Grippo, M.Schargus, E.Gramer, J.Liebmann, R.Ritch.

MONDAY, MAY 02, 2005

PR 8:30 AM GRAND FLORIDIAN B Moderator, R.Ritch 1095 PR 8:30 AM GRAND FLORIDIAN D Identification of WDR36 as a Novel Gene for Adult-Onset Primary Open Angle Glaucoma (POAG) at the GLC1G Locus on 5q22.1, S.Monemi, G.Spaeth, A.DaSilva, E.Ilitchev, J.Liebmann, R.Ritch, E.Héo, R.P. Crick, A.Child, M.Sarfaraz 1598 PO B 367 Visible Light Toxicity of Hypericin to Human Retinal Pigment Epithelial Cells, A.R. Wielgus, C.F. Chignell, D.S. Miller, D.-N.Hu, J.E. Roberts 1304 PO B 73 Baseline Intraocular Pressure, Visual Function, and Disc Hemorrhage in the Low-Pressure Glaucoma Treatment Study, J.M. Liebmann, D.S. Greenfield, J.Piltz-Seymour, R.Ritch 1306 PO B 75 Large-Scale Sequencing of the Optineurin Gene in Familial and Sporadic Cases With Primary Open-Angle Glaucoma Treatment Study, T.Rezaie, A.Child, S.Popinchalk, T.Krupin, R.Ritch, J.Liebmann, E.Ilitchev, R.Crick, M.Sarfarazi PR 3:00 PM GRAND FLORIDIAN D Moderator, J.Liebmann

TUESDAY, MAY 03, 2005 2833 PO B 386 Immunomodulatory Therapy in Patients With Scleritis, K.M. Narayana, J.Wu, P.Latkany, S.Schwartzman, C.M. Samson 2837 PO B 390 Infliximab in the Treatment of Chronic Non-infectious Ocular Inflammation, C.A. Samson, K.M. Narayana, P.Latkany, S.Schwartzman 2843 PO B 396 Outcomes of Immunomodulatory Therapy With Mycophenolate Mofetil in Patients With Severe Ocular Inflammation, J.A. Capriotti, K.Narayana, S.Walsman, P.Latkany, S.Schwartzman, C.Samson 2847 PO B 400 Survey on the Knowledge of Immunosuppressive Agents for Uveitis Among Non-Uveitis Specialists, S.B. Barone, K.Narayana, P.Latkany, S.Schwartzman, C.M. Samson 2857 PO B 410 The Rate of Posterior Capsular Opacity With the Crystalens Accommodating IOL, I.Hsu, D.Jardim, B.Soloway, C.Starr 2579 PO B 132 Surface Rendering of 3D Ultrasound Images in Ophthalmology, T.O. Muldoon, J.P. S. Garcia, P.M. T. Garcia, R.B. Rosen 2483 PO B 36 Stage of Visual Field Loss in Relation to the Appearance of the Optic Disc in 144 Eyes of Patients With Drusen of the Optic Disc, M.Schargus, T.Grippo, R.Ritch, E.Gramer 3343 PO B 896 Presence of M1 to M5 Acetylcholine Receptors in Human Sclera: An Evidence of Local Mechanism in Control of Axial Myopia, X.Zhou, F.Lu, L.Zhang, D.Hu, H.Li, R.Xie, J.Qu 3349 PO B 902 Production of Matrix Metalloproteinases-2 and -9 by Cultured Uveal Melanocytes, D.-N.Hu, S.F. Yang, D.Wu1, X.Shen, S.A. McCormick

114 TTHEHE NNEWEWYYORKORK EEYEANDYEAND EEARAR IINFIRMARYNFIRMARY NYE&E ARVO BIBLIOGRAPHY 2005

WEDNESDAY, MAY 04, 2005 3577 PR 11:15 AM GRAND FLORIDIAN D Visual Field Asymmetry Is Unrelated to Intraocular Pressure Asymmetry in the Low-Pressure Glaucoma Treatment Study, D.S. Greenfield, J.M. Liebmann, R.Ritch, T.Krupin 4054 PO B 412 Can Foveolar Choroidal Blood Flow in Central Retinal Vein Occlusions Predict Visual Recovery? S.C. Lalin, R.C. Gentile, J.P. S. Garcia, J.M. Romero, R.B. Rosen, 4340 PO B 698 Safety and Efficacy of the Moria Epi-K for Epi-LASIK in Four Centers Worldwide, B.Soloway, M.Swanson, R.Rashid, J.Bai, C.Starr, D.Jardim, 4376 PO B 734 Comparison of the Change in Corneal Higher Order Aberrations With Wavefront-Guided Epi-LASIK versus Wavefront-Guided Conventional LASIK Using the LadarWave CustomCornea Platform, J.J. Wong, K.Masselam, D.Jardim, B.Soloway, C.Starr, 4377 PO B 735 Nomogram for the Pre-Operative Prediction of Ablation Depth With CustomCornea Refractive Surgery, K.L. Masselam, J.Wong, D.Jardim, D.Pettinelli, B.Soloway, C.Starr, 3717 PO B 75 Does Changing Eye Test Order With 24-2 SITA Standard Result in a Meaningful Change in Test Results? R.Mora, Y.Barkana, C.Tello, J.M. Liebmann, R.Ritch, 3748 PO B 106 Structure and Function in Normal versus High Tension Glaucoma, D.H. Chu, V.C. Greenstein, P.Thienprasiddhi, D.C. Hood, J.M. Liebmann, R.Ritch, 3751 PO B 109 Factors Involved in the Failure of the Photopic Negative Response (PhNR) and Pattern Electroretinograms (PERG) to Detect Glaucomatous Damage in Some Patients, D.C. Hood, L.Xu, T.Grippo, J.Chen, V.C. Greenstein, J.M. Liebmann, R.Ritch, 3753 PO B 111 Evaluation of Multifocal Visual Evoked Potential Latency in Glaucoma, C.Rodarte, E.B. Yang, T.Grippo, V.C. Greenstein, J.M. Liebmann, R.Ritch, D.C. Hood, 4277 PO B 635 Disc Area in High Myopia, W.J. Kelly, N.Harizman, C.Oliveira, J.M. Liebmann, R.Ritch, C.Tello,

3631 PR 3:00 PM GRAND FLORIDIAN D Baseline Topographic Optic Disc Measurements Are Associated With the Development of Primary Open Angle Glaucoma: The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the OHTS L.M. Zangwill1, R.N. Weinreb, J.A. Beiser, G.A. Cioffi, A.L. Coleman, G.Trick, J.M. Liebmann, M.A. Kass, M.O. Gordon, OHTS CSLO Ancillary Study Group.

3635 PR 3:00 PM GRAND FLORIDIAN D A Comparison of False-Positive Test Results Between the Stratus OCT III and the GDx-VCC J.Stein, C.A. Girkin, N.Harizman, S.Arthur, A.Chiang, J.D. Ortega, J.M. Liebmann, C.Tello, R.Ritch 3763 PO B 121 Complement Activation in Exfoliation Syndrome, B.Ovodenko, A.Rostagno, J.M. Liebmann, L.M. Bley, M.A. Jofe, R.M. Smolyak, D.Pinhas, J.A. Ghiso, R.Ritch, 4293 PO B 651 Coronal OCT Scanning of Idiopathic Polypoidal Choroidal Vasculopathy(IPCV) Using the OCT/SLO, P.M. Garcia, D.V. Will, A.Ponce, J.P. S. Garcia, R.B. Rosen, 4294 PO B 652 A Comparison of Leakage by FA With Retinal Thickness Using Talia's Anatomy Imager in Patients With Diabetic Retinopathy, R.E. Rosenbaum, P.M. T. Garcia1, J.P. S. Garcia1, R.B. Rosen, 4297 PO B 655 Whole Body PET / CT for Initial Staging of Choroidal Melanoma, L.Tena, S.Reddy, M.Kurli, P.T. Finger, 4299 PO B 657 High Frequency Ultrasound (UBM) Evaluation of Giant Conjunctival Inclusion Cysts, J.Song, M.Kurli, S.Schneider, P.T. Finger 4303 PO B 661 OCT/SLO Evaluation of Optic Nerve Pits, J.Hedaya, P.M. T. Garcia, R.C. Gentile, R.B. Rosen 4307 PO B 665 Scanning Laser Ophthalmoscopy-Optical Coherence Tomography (OCT/SLO) Evaluation of Choroidal Nevi, J.P. Page, P.M. T. Garcia, S.Schneider, R.B. Rosen, 4308 PO B 666 OCG/ICG Imaging of Choroidal Neovascular Membranes, R.B. Rosen, P.M. T. Garcia, G.M. Dobre, A.G. Podoleanu,

ARVOARVO BBIBLIOGRAPHYIBLIOGRAPHY 115 NYE&E ARVO BIBLIOGRAPHY 2005

PO B 671 Whole Body PET / CT Imaging Staging for Orbital Lymphoma, R.H. Roe, M.Kurli, G.Trivedi, C.E. Iacob, L.B. Tena, P.T. Finger,

THURSDAY, MAY 05, 2005 4804 PO B 7 Axial Length and Optic Disc Size in Normal Eyes, C.Oliveira, N.Harizman, J.D. Ortega, S.Arthur, C.A. Girkin, C.Tello, J.M. Liebmann, R.Ritch 4805 PO B 9 Can the ISNT Rule Be Applied To Patients of African Ancestry, N.Harizman, A.Chiang, C.Oliveira, C.A. Liebmann, J.M. Liebmann, R.Ritch 4883 PO B 86 Will the Fortification of Optisol GS® With Moxifloxacin Reduce the Contamination Rate of Corneal Donor Rim Cultures? M.K. Shah, D.C. Ritterband, S.M. Meskin, D.E. Shapiro, W.Perez, P.Dahl, J.A. Seedor, R.S. Koplin 5014 PO B 217 Survey on Teaching of Uveitis Management in U.S. Ophthalmology Residency Training Programs, A.C. Liu, K.Narayana, P.Latkany, S.Schwartzman, C.Samson 5068 PO B 271 Comparison of Infectious Isolates Associated With Nasolacrimal Duct Obstruction Between Children and Adults, G.Trivedi, M.Shah, R.Della Rocca, D.Della Rocca 4835 PO B 38 Delayed Intraocular Pressure Elevation After Pupillary Dilation in Exfoliation Syndrome, W.Shihadeh, R.Ritch, B.Scharf, J.M. Liebmann 4836 PO B 39 Is Intraocular Pressure (IOP) Monitoring Outside of Normal Office Hours Clinically Useful? Y.Barkana, S.N. Anis, J.Kim, C.Tello, J.M. Liebmann, R.Ritch 5099 PO B 302 Clinical Characteristics of Scleritis J.Wu, K.M. Narayana, P.Latkany, S.Schwartzman, C.M. Samson 5101 PO B 304 Chronic Uveitis Following Laser Iridotomy - A Report of 4 Cases, A.Gonzalez, K.M. Narayana, R.Rothstein, C.Tello, C.Samson 5396 PO B 599 Cytological Evaluation in the Diagnosis and Management of Ocular Surface Neoplasia, S.Schneider, M.Kurli, P.T. Finger 5397 PO B 600 The Finger Iridectomy Technique (FIT): Minimally Invasive Iris Biopsy, Iridectomy and Tumor Excision, P.T. Finger, P.Latkany, M.Kurli, C.E. Iacob

116 TTHEHE NNEWEWYYORKORK EEYEANDYEAND EEARAR IINFIRMARYNFIRMARY NYE&E ARVO BIBLIOGRAPHY 2006

Sunday, April 30, 2006 New York, New York

SUNDAY, APRIL 30, 2006 781 PO B 702 Does the Clinical Evaluation Distinguish Third Nerve Palsies Due to Ischemia from an Unruptured Posterior Communicating Aneurysm? M. J. Kupersmsith, TA Cox INN and Ophthalmology 612 PO B 533 SPostoperative Astigmatism and Visual Acuity Following Implantation of Foldable Intraocular Lenses in Pediatric Patients, J.E. Anderson, S.M. Brown, W.A. Graham

675 PO B 754 Optical Coherence Tomography Can Detect Retinal Nerve Fiber Defects in Patients With Optic Nerve Head Drusen, T.M. Grippo, F.N. Kanadani, I.Ezon, N.Harizman, B.Wangsupadilok, V.C. Greenstein, J.M. Liebmann, R.Ritch, D.C. Hood 881 PO B 802 Expression of Muscarinic Acetylcholine Receptor-1 in Human Retinal Pigment Epithelium, X.Zhou, D.Yan, J.Qu1, R.Xie, L.Zhang, D.Hu1, F.Lu1 924 PO B 991 Changes in Choroidal Blood Flow in Response to the Treatment of Diabetic Macular Edema, S.B. Barone, S.C. Lalin, R.C. Gentile, J.Garcia, R.B. Rosen 1306 PO B 75 Large-Scale Sequencing of the Optineurin Gene in Familial and Sporadic Cases With Primary Open-Angle Glaucoma Treatment Study, T.Rezaie, A.Child, S.Popinchalk, T.Krupin, R.Ritch, J.Liebmann, E.Ilitchev, R.Crick, M.Sarfarazi MONDAY MAY 01, 2006 211 PO B Nanotechnology for Drug Delivery and Tissue Bioengineering – Special Topic Session, R.Ritch. 348 PO B 1621 Inhibition of VEGF Expression and Corneal Neovascularization by siRNA Targeting the Cytochrome P450 (CYP) 4B1, M.L. Schwartzman, F.Seta, L.Bellner, A.Mezentsev, M.W. Dunn PO B 1800 Ocular Pulse Amplitude (OPA) in High Myopia, Glaucoma, and Normal Subjects, R.A. Barros, F.N. Kanadani, M.Pro, M.Shimmyo, V.Malhotra, C.Tello, J.Liebmann, R.Ritch 2031 PO B 560 The Expression of Melanin-Related Genes in Cultured Adult Human Retinal Pigment Epithelium Cells, J.Qu, D.Yan, X.Zhou, F.Lu, D.Hu. 2258 PO B 1001 Discrimination Between Choroidal Nevi and Melanoma Using the Combination OCT/SLO, P.M. Garcia, M.E. van Velthoven, P.T. Finger, S.Schneider, J.P. S. Garcia, Jr., R.B. Rosen, Jr. 2579 PO B 132 Surface Rendering of 3D Ultrasound Images in Ophthalmology, T.O. Muldoon, J.P. S. Garcia, P.M. T. Garcia, R.B. Rosen 2483 PO B 36 Stage of Visual Field Loss in Relation to the Appearance of the Optic Disc in 144 Eyes of Patients With Drusen of the Optic Disc, M.Schargus, T.Grippo, R.Ritch, E.Gramer 3343 PO B 896 Presence of M1 to M5 Acetylcholine Receptors in Human Sclera: An Evidence of Local Mechanism in Control of Axial Myopia, X.Zhou, F.Lu, L.Zhang, D.Hu, H.Li, R.Xie, J.Qu 3349 PO B 902 Production of Matrix Metalloproteinases-2 and -9 by Cultured Uveal Melanocytes, D.-N.Hu, S.F. Yang, D.Wu1, X.Shen, S.A. McCormick

MONDAY, MAY 01, 2006

6:30 PM BEACH BASH SHERATON YANKEE CLIPPER Hosted by Richard B. Rosen, MD

TUESDAY, MAY 02, 2006 2373 PO B 25 Visual Rehabilitation in Combined Cataract Extraction, IOL Placement, and Corneal Transplant, Phaco vs. ECCE, S.H. Chang, G.W. Zaidman, D.Khoramian. 2417 PO B 235 Uveitis Associated With Sickle Cell Trait: A Report Of Four Patients, C.A. Samson, J.Laio, A.Gonzalez, K.Narayana, J.Capriotti, S.Schwartzman.

ARVO BIBLIOGRAPHY 117 NYE&E ARVO BIBLIOGRAPHY 2006

TUESDAY, MAY 02, 2006 2421 PO B 239 Study in Outcomes of Sarcoid Uveitis Patients at aTertiary Referral Center, S.Schwartzman, P.Latkany, C.Samson. 2435 PO B 253 Long Term Follow Up Of Patients With Pediatric Uveitis: A Retrospective Study, W.-C.M. Liu, K.Narayana, P.Latkany, C.M. Samson. 2437 PO B 255 Medical Treatment of Uveitis With Adalimumab, I.Rozenbaum, K.Narayana, P.A. Latkany, S.Schwartzman, C.M. Samson. 2640 PO B 813 Combined Optical Coherence Tomography and Confocal Scanning Laser Ophthalmoscope Imaging in Multifocal Choroiditis, A.Gonzalez, K.M. Narayana, P.M. Garcia, M.E. J. Van Velthoven, M.D. De Smet, R.B. Rosen, C.M. Samson. 2772 PO B 298 The Role of Intraocular Pressure in Formation of the Primate Foveal Pit and Vascular Retinal Impressions, A.D. Springer, A.E. Hendrickson. 3367 PO B 900 Assessment of a Race-Specific Normative Database on the Ability of the HRT-III to Differentiate Glaucomatous From Normal Eyes, R.Mora, N.Harizman, J.R. Zelefsky, E.Ilitchev, J.Wen, C.Tello, R.Ritch, J.M. Liebmann.

WEDNESDAY, MAY 03, 2006 3891 PO B Iris Contour Changes During Accommodation, S.K. Dorairaj, C.Oliveira, V.Barocas, N.Ragusa, C.Tello, J.M. Liebmann, R.Ritch, 3557 PO B 31 Determining the Optimal Treatment for Group B Streptococcal Keratitis: An Animal Model, J.C. Liu, J.M. Kurilec, G.W. Zaidman, P.Patel, J.N. Kruh, M.E. Aguero-Rosenfeld, K.B. Juechter. 3634 PO B 235 Detection of Glaucoma Using Operator-Dependent Versus Operator-Independent Classification in the HRT-III, N.Harizman, J.R. Zelefsky, E.Ilitchev, O.Antequera, C.Tello, R.Ritch, J.M. Liebmann. 3802 PO B 664 Macular Pigment Density Distribution Variability in Normal Human Subjects, Primary Relatives of AMD Subjects, and AMD Subjects, J.C. Nieto, P.M. T. Garcia, K.Feldhamer, J.P. S. Garcia, R.B. Rosen. 4018 PO B 474 Anterior Segment Imaging Using the AC Cornea OCT System, J.P. Garcia, Jr., P.M. T. Garcia, R.B. Rosen. 4051 PO B 507 Peripheral Retinal Imaging Using A Prototype Anterior Segment OCT/SLO, R.B. Rosen, P.M. Garcia, M.Van Velthoven, R.Canovas, S.Lalin, T.O. Muldoon, J.B. Walsh, J.Rogers, J.Pedro, R.Weitz. 4255 PO B 926 Intravitreal Injection of Bevacizumab (Avastin) as a Surgical Adjuvant in the Treatment of Retinal Neovascularization Associated With Tractional Retinal Detachment, G.Trivedi, S.Lalin, J.Romero, R.Rosen. 4263 PO B 934 Treatment of Choroidal Neovascular Membranes in Patients With Angioid Streaks With Intravitreal Bevacizumab (Avastin), M.Banitt, S.C. Lalin, R.C. Gentile, R.B. Rosen. 4266 PO B 937 Short-Term Outcome and Complications of Intravitreal Bevacizumab (Avastin) in 69 Patients (102 injections) for Choroidal and/or Retinal Vascular Disease, S.C. Lalin, R.C. Gentile, P.M. Garcia, J.Dominguez, R.B. Rosen. 4347 PO B Measurements of Optic Disc Size With HRT II, OCT3 and Funduscopy Are Not Interchangeable, Y.Barkana, N.Harizman, J.M. Liebmann, R.Ritch. 4368 PO B 13 A Critical Role for Lipid Mediators in Balancing the Inflammatory Response of the Cornea, K.Gronert, I.Hassan, B.Biteman, E.Walker, M.Dunn. 4427 PO B 186 The Effect of Trabeculectomy on Intraocular Pressure (IOP) of the Contralateral Eye, E.M. Espana, F.N. Kanadani, S.J. Berke, C.Tello, R.M. Caronia, R.T. Sturm, J.M. Liebmann, R.Ritch.

118 THE NEW YORK EYEAND EAR INFIRMARY NYE&E ARVO BIBLIOGRAPHY 2006

WEDNESDAY, MAY 03, 2006 4442 PO B 201 Specificity and Sensitivity of Intraocular Pressure Measurements by Goldmann Applanation Tonometry, Reichert’s Ocular Response Analyzer and Dynamic Contour Tonometry, M.Shimmyo, P.N. Orloff

THURSDAY, MAY 04, 2006 4753 PO B Propionibacterium Acnes Keratitis, B.Ovodenko, M.Shah, R.J. Yang, D.C. Ritterband, J.A. Seedor, R.S. Koplin. 4822 PO B 80 NPD1 Promotes Survival of Retinal Ganglion Cells Following Optic Nerve Transection, Q.Qin, K.A. Patil, K.Gronert, S.C. Sharma. 4911 PO B 233 Mediation of UV Irradiation-Induced c-Jun Phosphorylation by Plk3, L.Wang, W.Dai, L.Lu. 4914 PO B 236 Heme Oxygenase-2 (HO-2) Is a Critical Component of the Acute Inflammatory and Reparative Response of the Cornea to Injury, F.Seta, L.Bellner, M.W. Dunn, N.G. Abraham, K.Gronert, M.L. Schwartzman. 5183 PO B 598 Treatment of Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) with Intravitreal Bevacizumab (Avastin) Appears To Decrease Retinal Thickness and Retinal Surface Contour Based on SLO-OCT Imaging, E.Feldman, S.Lalin, R.Gentile, P.Garcia, R.Rosen. 5470 PO B 13 Why Is The Superior Angle Narrower Than The Inferior Angle In Eyes With Narrow Angles?, R.Ritch, S.K. Dorairaj, C.Tello, J.M. Liebmann. 5624 PO B 435 Melatonin Suppression of TPA-Induced VEGF Up-Regulation in Cultured Human Uveal Melanocytes, T.O. Muldoon, R.B. Rosen, P.Tone, D.-N.Hu. 5680 PO B 774 Development of an Automated Stereocampimeter to Measure Central Scotomas, G.H. Bennett, P.W. Kramer, V.L. Lubkin, T.Cappo, M.Orr, R.B. Rosen.

ARVO BIBLIOGRAPHY 119 NY MEDICAL COLLEGE BIBLIOGRAPHY 2005

May 1 - 5, 2005 - New York, New York

SUNDAY, MAY 01, 2005

MONDAY, MAY 02, 2005 2150 PO B 919 A Novel Role for the 15-Lipoxygenase (Alox15) in Promoting Re-Epithelialization of the Mouse Cornea, I.R. Hassan1A, N.Maheshwari, N.Khan, M.Dunn, K.Gronert, 1368 PO B 137 The Corneal-Derived 12(R)-Hydroxyeicosatrienoic Acid (12-Hetre) Stimulates IL-8 Production in Microvessel Endothelial Cells, F.Seta, A.Mezentsev, M.Dunn, M.Laniado-Schwartzman, 1390 PO B 159 Resorption of Posterior Pole Drusen Following Focalargon Laser Photocoagulation Applied Anterior to the Equator, S.Kesting, D.H. Kauffmann Jokl, R.T. Smith, J.van Meurs, S.Baarsma, J.Chan, J.P. Koniarek,

TUESDAY, MAY 03, 2005 2820 PO B 373 The Corneal Epithelial CYP4B1 Produces Angiogenic Eicosanoids and Induces Inflammation of the Ocular Surface, A.V. Mezentsev, F.Seta, R.Kemp, M.W. Dunn, M.Laniado-Schwartzman 2625 PO B 178 What Is the Best Antibiotic for the Treatment of Group B Streptococcus Keratitis? J.M. Kurilec, G.W. Zaidman, J.N. Kruh, M.E. Aguero-Rosenfeld

WEDNESDAY, MAY 04, 2005 3656 PO B 14 Relationship Between Central Corneal Thickness and Refractive Error in Caucasian and African American Glaucoma Patients, N.M. Radcliffe1, J.Stein1, E.Farris, 4098 PO B 456 Clinical Comparison of IOP Measurements by Goldmann Applanation Tonometry, Reichert's Ocular Response a Nalyzer and Pascal Dynamic Contour Tonometry, D.H. Kauffmann Jokl, R.H. Silverman, S.A. Kane, M.F. Chiang, R.Lopez, S.L. Nemerofsky,

3619 PR BCD 3:00 PM BALLROOM Heme Oxygenase-2 (HO-2) Knockout Mice Display Impaired Corneal Wound Healing and Marked Corneal Neovascularization, M.Laniado-Schwartzman, A.Mezentsev, F.Seta, M.W. Dunn, N.G. Abraham, K.Gronert

THURSDAY, MAY 05, 2005 4899 PO B 102 In vitro Sensitivity of Group B Streptococcus to Topical Ophthalmic Antibiotics, J.N. Kruh, G.W. Zaidman, J.M. Kurilec, M.E. Aguero-Rosenfeld 4840 PO B 43 Clinical Comparison of IOP Measurements by Goldmann Applanation Tonometry, Reichert's Ocular Response a Nalyzer and Pascal Dynamic Contour Tonometry, M.Shimmyo, 4971 PO B 174 Long Term Visual Prognosis in Children With Clear Grafts After Corneal Transplant Surgery for Peters Anomaly Type I, J.Flanagan, G.W. Zaidman, C.Cape

THURSDAY, MAY 06, 2005 4939 PO B 142 Posterior Amorphous Corneal Dystrophy or Dysgenesis? S.H. Chang, G.W. Zaidman,

120 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD SUMMARY 2005

VOTING MEMBERS:

R. Andrew R. Rosen, MD E. Schleider M. Dodge L. James, RPh S. Schantz, MD R. Baken, PhD S. Tennaro, EdD, RN G. Caponong, MSW J. Walsh, MD l. Tiersten, MSW (alt) D. Ritterband, MD E. Ilitchev, MD P. Kennedy, LCSW H. Savage, PhD R. Jordan, admin. M. Pitman, MD(alt.) M. Potucek, RPh(alt.)

GUESTS/OBSERVERS:

L. Klingos, RN K. Tai, CRC J. Galst, MD N. Suslina, CRC J. Thomas B. Soloway, MD R. Neil, MD J. Arigo, MD G. Alexiades, MD R. Barros, MD R. Canovas, MD N Mondoc, MDF. Kanadani, MD J. Capriotti, MD J. Pelletier, MD A. Browne, MD C. Morini, MD R. MacIntyre P. Latkany, MD R. Mora, MD C.M. Samson, MD K. Narayana, MD A Palladino, RN R. Gentile, MD

MEETING DATES:

JANUARY 11 FEBRUARY 8 MARCH 8 APRIL 12 MAY 10 JUNE 14 JULY 19 SEPTEMBER 13 OCTOBER 4 NOVEMBER 15 DECEMBER 13

NEW PROTOCOLS:

05.00 Ocular Biometry In Vision Screening J. Galst, MD

05.01 How Sensitive And Specific Is The Pigment Reversal Sign For Pigment Dispersion Syndrome/Pigmentary Glaucoma? J. Liebmann, MD

05.02 Effect Of Botulinum Toxin (Botox) Treatment For Blephorospasm On the Measurement Of Intraocular Pressure R. Ritch, MD

05.03 Effect Of Pupillary Dilation On Intraocular Pressure In Exfoliation Syndrome R. Ritch, MD

05.04 Effect Of Portable Air Humidifier/Purifier On Symptoms In Dry Eye Patients R. Latkany, MD

05.05 Rapid Screening Tests For Detection Of Adenovirus In Tears D. Ritterband, MD

INSTITUTIONAL REVIEW BOARD SUMMARY 121 INSTITUTIONAL REVIEW BOARD SUMMARY 2005

DATE TOPIC PRESENTER 05.06 An Open-Label, Multicenter Extension Study To Evaluate The Safety And Tolerability Of Ranizumab In Subjects With Subfoveal Choroidal Neovascularization (CNV) Secondary To Age-Related Macular Degeneration (AMD) Who Have Completed The Treatment Phase Of A Genentech-Sponsored Ranizumab Study (FVF3426g) R. Gentile, MD

05.07 Stapedectomy In Patients Who Have Failed Reconstructive Surgery For Chronic EarDisease J. Arigo, MD

05.08 A Phase 3 Multicenter, Randomized, Double-Masked, Controlled Study Of Squalamine Lactate (MSI-1256F) For Injection For The Treatment Of Subfoveal Choroidal NeovascularizationAssociated With Age-Related Macular Degeneration R. Rosen, MD

05.09 A 12-Week Randomized, Double-Masked, Parallel Group Comparison Of Xalacom‘ Given In The Evening, Xalatan‘ Given In The Evening, And Timolol Given In The Morning In Subjects With Open Angle Glaucoma Or Ocular Hypertension J. Liebmann, MD

05.10 Comparing The Intraocular Pressure And Ocular Pulse Amplitude Measurements IN Patients With Asymmetric Glaucoma Damage Using Pascal Dynamic Contour Tonometer R. Ritch, MD

05.11 Comparing The Ocular Pulse Amplitude Measurements In Patients With Asymmetric Glaucoma Damage Using Pascal Dynamic Contour Tonometer And POBF Tonograph R. Ritch, MD

05.12 Influence Of Pilocarpine On The Postural Effect Of Intraocular Pressure J. Liebmann, MD

05.13 Randomized, Controlled, Multicenter Comparative Trial To Evaluate For The SOLX Gold Shunt For The Reduction Of Intraocular Pressure (IOP) In Glaucomatous Eyes Following Failed Medical And Conventional Surgical Treatments C. Tello, MD

05.14 Epithelial Toxicity Of 0.5% Povidone Iodine Studied By in- vivo Confocal Microscopy In Healthy Human Volunteers D. Ritterband, MD

05.15 Comparison OF OCT-Ophthalmoscope And Standard OCT Technology Instrument For The Imaging Of Macular Hole Pathology R. Rosen, MD

05.16 Multicenter Uveitis Steroid Treatment Trial (MUST) P. Latkany, MD

05.17 A Randomized, Double-Masked, Parallel Group, Multi- Center, Dose Ranging Pilot Study Of Denufosol Tetrasodium (INS37217) Intravitreal Injection In Subjects With Uveitis Associated Macular Edema C M Samson, MD

05.18 A Randomized, Double-Masked, ParallelGroup, Multi-Center, Dose Ranging Pilot Study Of Denufosol Tetrasodium (INS37217) Intravitreal Injection In Subjects With Post Cataract Extraction Macular Edem R. Rosen, MD

122 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD SUMMARY 2005

DATE TOPIC PRESENTER 05.19 A Two Year Open Label, Randomized, ParallelGroup, Blinded Assessment Ophthalmologic Safety Study Of Pramipexole IR Versus Ropinirole In Early Parkinson’s Disease Patients (protocol #248.538) A. Bertolucci, MD

05.20 Diindolymetahne As A suppressor Of Thyroid Growth And Its Effect On Urine Estrogen Metabolites In Proliferative Thyroid Disease S. Schantz, MD

05.21 Titanium Sapphire Laser Trabeculoplasty As A Primary Treatment In Open Angle Glaucoma R. Ritch, MD

05.22 Titanium Sapphire Laser Trabeculoplasty Versus Selective Laser Trabeculoplasty In Open Angle Glaucoma R. Ritch, MD

05.23 The Use Of Confocal Microscopy To Characterize Keratic Precipitates (KPs) In Sarcoidosis-Associated Uveitis C M Samson, MD

05.24 Macular Pigment Density Measurements Using Auto Fluorescence HRA Technique R. Rosen, MD

05.25 Evaluating Tear Film Dysfunction – Schirmer’s Test Vs. Tear Normalization Test R. Latkany, MD

05.26 A Three Year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial To Assess The Safety And Efficacy Of 700 µG And 350 µG Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS Applicator System) In The Treatment Of Patients With Diabetic Macular Edema R. Rosen, MD

05.27 A Natural History Study Of Macular Telangiectasia – The Mactel Study R. Rosen, MD

05.28 A Phase IIIb, Single-Masked, Multicenter, Randomized Study To Evaluate The Safety And Tolerability Of Ranibizumab In Naive and Previously Treated Subjects With Choroidal Neovascularization (CNV) Secondary To Age-Related Macular Degeneration (AMD) R. Gentile, MD

05.29 Rapid Pathogen Screening Test For Herpes D. Ritterband, MD

05.30 Determining The True Incidence Of Lagophthalmos R. Latkany, MD

05.31 Immunotherapy For Treatment Of Anterior Uveitis C M Samson, MD

EXEMPT:

Cat Scan of Orbit R. DellaRocca, MD P. Preechawai, MD RENEWALS:

02.02 Phase III Multicenter Clinical Investigation To Evaluate The Oculaid® Endocapsular Tension Ring Inserter For The Management Of Zonular Weakness And / Or Dialysis During And After Cataract Extraction And IOL Implantation K. Rosenthal, MD

INSTITUTIONAL REVIEW BOARD SUMMARY 123 INSTITUTIONAL REVIEW BOARD 2005

DATE TOPIC PRESENTER 93.01 Ocular Hypertension Treatment Study R. Ritch, MD

96.00 Blood Studies Of Hereditary Eye Diseases R. Ritch, MD

98.11 A Multi-Center, Double-Masked, Two-Arm Parallel Group Study Comparing The Effect Of Brimonidine 0.2% Versus Timolol 0.5% On Visual Field Stability In Patients With Low Pressure Glaucoma J. Liebmann, MD

99.11 A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study To Evaluate The Effectiveness And Safety Of Oral Memantine In Daily Doses Of 20 mg And 10 mg In Patients With Chronic Open-Angle Glaucoma At risk Of Glaucomatous Progression R. Ritch, MD

00.14 Endothelial Cell Counts Following Baerveldt Glaucoma Implant Surgery P. Sidoti, MD

01.02 Protein Kinase C Beta Inhibitor – Diabetic Retinopathy Study 2 (PKC-DRS2). A Phase III Clinical Trial R. Gentile, MD

02.01 Anthropometric Facial Analysis & Quantitative Measurements Of Aesthetically Pleasant Face Of A Korean American Woman A. Sclafani, MD

03.01 Decomposition Of Electromyographic Signals In Facial Paralysis C. Li, MD

03.02 Evaluation Of The Preferential Hyperactivity Perimeter (PHP) Device, For Testing Intermediate AMD Patients, During Routine Eye-Clinic Operation R. Rosen, MD

03.03 Low-Volume, High Surface Area, Cylindrical Aqueous Shunt (Wilcox Implant) Small-Diameter Aqueous Shunt Study (SAS) P. Sidoti, MD

03.07 AccuMap‚ Glaucoma Detection Study J. Liebmann, MD

03.11 A Phase III, Multi-Center, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age- Related Macular Degeneration R. Gentile, MD

03.12 Is Elevation Of Adiponectin Serologic Concentration Associated With A Flare Of Graves’ Ophthalmopathy Or Other Ocular Disease? P. Latkany, MD

03.14 A Multicenter, Randomized, Open-Label Study To Compare Subconjuctival Injection Of 100 mg CAT-152 Human Anti-TGFb2 Mononuclonal Antibody With An Intraoperative Sponge Application Of 5 - Fluorouracil Following First Time Trabeculectomy R. Ritch, MD

03.32 Macular Pigment Density In Patients With Diabetes R. Rosen, MD

03.34 An Automated 3-D Ultrasound Tool For Screening Eyes With Papilledema P. Finger, MD

04.01 Proteomic And Immunologic Analyses Of Thyroid Cancer S. Schantz, MD

124 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2005

DATE TOPIC PRESENTER 04.02 RNA Microarray Analysis Of Thyroid Cancer S. Schantz, MD

04.03 The Effects Of Alcohol And Tobacco Use On The Mutational Profiles Of People With Head And Neck Squamous Cell Carcinoma S. Schantz, MD

02.13 An Evaluation Of Efficacy AND Safety Of Posterior Juxtascleral Injections Of Anecortave Acetate 15mg (0.5ml of 30 mg/ml Anecortave Acetate Sterile Suspension) Versus VISUDYNE® in Patient With Subfoveal Exudative Age-Related Macular Degeneration (AMD) Eligible For Initial Treatment With Photodynamic Therapy (PDT) Using VISUDYNE® R. Rosen, MD R. Gentile, MD

03.04 Rituximab For Primary Ocular Adnexal Lymphomas S. Lauer, MD

03.10 Cytogenic Analysis Of Head And Neck Cancer Using Comparative Genomic Hybridization K. Hu, MD

04.07 Microcurrent Stimulation For The Improvement Of Visual Acuity In Patients With Non-Exudative Macular Degeneration (AMD) (Ciba Vision P-307-C001 IDE# Mcs 500 Sylark Device And Systems) R. Rosen, MD

04.08 An Exploratory Study Of The Safety, Tolerability And Biological Activity Of Intravenously Administered VEGF Trap In Patients With Neovascular Age-Related Macular Degeneration R. Rosen, MD

04.09 Optometrist/General Ophthalmologist-Performance in CNV Detection R. Rosen, MD

03.18 Oral Megadose Corticosteroid Therapy Of Acute Exacerbation In MS-OMEGA M. Kupersmith, MD

04.05 In Vivo Confocal Microscopy Epithelium In Healthy Volunteer J. Seedor, MD

04.10 Characteristics of patients with cochlear implants C. Linstrom, MD

00.19 Macular Genetics Study R. Rosen, MD

00.24 The International Collaborative Exfoliation Syndrome Treatment Study R. Ritch, MD

01.11 A Multicenter, Randomized, Double-Masked, Controlled Study To Evaluate The Safety And Efficacy Of An Intravitreal Fluocinolone Acetonide (0.5 Or2mg) Implant In Patients With Non Infectious Uveitis Affecting The Posterior Segment Of The Eye P. Latkany, MD

01.12 Optical Mapping Apparatus Using Optical Coherence Tomography (OCT) Equivalent To The Humphrey OCT, Which Produces Longitudinal And Transversal OCT Images Combined With Scanning Laser Ophthalmoscopy (SLO) Images Of The Retina And Macula Using A Single Superluminescent Diode Source (SLD) R. Rosen, MD

INSTITUTIONAL REVIEW BOARD SUMMARY 125 INSTITUTIONAL REVIEW BOARD 2005

DATE TOPIC PRESENTER 01.18 A Multicenter, Randomized, Masked, Controlled Study To EvaluateRetisert, An Intravitreal Fluocinolone Acetonide Implant, In the Treatment Of Patients With Diabetic Macular Edema P. Latkany, MD

04.11 A Randomized Trial To Evaluate 2 Hours Of Daily Patching For Amblyopia In Children 3 TO < 7 Years Old (ATS5) L. Hall, MD

04.12 A Randomized, Double-Masked, Placebo Controlled, Parallel Group, Multi-Center, Dose-Ranging Study Of Denufosol Tetrasodium (INS37217) Intravitreal Injection In Subjects With Rhegmatogenous Retinal Detachment R. Rosen, MD

97.11 Prophylactic Diode Laser Photocoagulation For The Prevention Of Choroidal Neovascularization In Age-Related Macular Degeneration (ARMD) R. Gentile, MD R. Rosen, MD

98.19 A Pilot Study Of Fluorescence And Non-Linear Optical Methods To Investigate Normal And Tumor Tissue H. Savage, PhD S. Schantz, MD

01.16 A Phase II/III Randomized, Double-Masked, Controlled, Dose- Ranging Multi-Center Comparative Trial, In Parallel Groups, To Establish The Safety And Efficacy Of Intravitreal Injections Of EYE001 (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks For 54 Weeks, In Patients With Exudative Age-Related Macular Degeneration (AMD) R. Rosen, MD

02.15 Multicenter Clinical Study Of The Optic Model 311 Iris Reconstruction Lens K. Rosenthal, MD

02.17 A Safety And Efficacy Assessment Of Chimeric Ribozyme To PCNA To Prevent Recurrence Of Proliferative Vitreoretinopathy R. Gentile, MD

02.18 A Phase II Randomized, Controlled, Double-Masked, Dose-Finding, Multicenter, Comparative Trial, In Parallel Groups, To Establish The Safety And Preliminary Efficacy Of Intravitreal Injections Of EYE001 (Anti-VEGF Pegylated Aptamer), Given Every 6 Weeks For 12 To 30 Weeks To Patients With Clinically Significant Diabetic Macular Edema (CSME) Involving The Center Of The Macula R. Gentile, MD

04.13 A Phase 2, Multi-Center, Randomized, Masked, Controlled Study Of MSI-1265F (Squalamine Lactate) (IND # 66,897) For The Treatment Of Choroidal Neovascularization Associated With Age-Related Macular Degeneration MSI-1256F-209 R. Rosen, MD

04.18 Diagnosis Of Exfoliation Syndrome By Imaging Exfoliation Material On Zonules Using Ultrasound Biomicroscopy In Patients With Poor Pupil Dilation R. Ritch, MD

04.19 Ocular Hypertension Treatment Study (OHTS): Ancillary Genetic Testing Study J. Liebmann, MD

126 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2005

DATE TOPIC PRESENTER 04.21 Scanning Laser Polarimetry (GDx) And Optical Coherence Tomography (OCT3) To Detect Changes In The Peripapillary Nerve Fiber Layer WithOptic Nerve Damage M. Kupersmith, MD

99.20 McGhan Medical Corporation Silicone Filled Breast Implant Adjunct Clinical Study T. Chaglassian, MD

99.22 Tube Versus Trabeculectomy (TVT) Study P. Sidoti, MD

99.28 Transpupillary Thermotherapy Of Occult Subfoveal Choroidal Neovascular Membranes In Patients With Age-Related Macular Degeneration (The TTT Study) R. Rosen, MD

01.30 CD-44 Receptor In Aqueous Humor In Glaucoma R. Ritch, MD

02.25 Analysis Of Aqueous Humor, Anterior Capsule, Iris And Trabecular Tissue In Patients With Exfoliation Syndrome R. Ritch, MD

04.22 Plasma EBV DNA In Blood As A Screening Device And Prognostic Factor In Nasopharyngeal Carcinoma J. Li, MD

04.27 Mechanical Interaction Between Aqueous Humor And Iris R. Ritch, MD

04.29 Biometric Evaluation Of Iridocorneal Angle And Ciliary Body Of Patients With Narrow Angle R. Ritch, MD

04.30 Evaluation Of Patients With Normal Tension Glaucoma (NTG) Or High Tension Glaucoma (HTG) Using Different Visual Field Studies And Nerve Fiber Layer Imaging R. Ritch, MD

04.31 A Prospective Assessment Of Nerve Fiber Layer Thickness In Subjects With Unilateral Pseudoexfoliation Syndrome R. Ritch, MD

04.33 Effect Of Laser Cautery Of Ropy Bleb Vessels On The S uccess Rate Of TransConjunctival Needle Revision R. Ritch, MD

04.35 Functional And Structural Testing For Optic Nerve Disease R. Ritch, MD

04.36 Evaluation Of Patients With Optic Nerve Head Drusen (OHND) Using Both Functional And Structural Tests R. Ritch, MD

01.35 A Multicenter, Randomized, Masked, Controlled Study To Evaluate Retisert™, An Intravitreal Fluocinolone Acetonide Implant, In The Treatment Of Patients With Diabetic Macular Edema R. Gentile, MD

02.32 A Phase I/II, Single-Masked, Multicenter Study Of The Safety, Tolerability, And Efficacy Of Multiple-Dose Intravitreal Injections Of rhuFab V2 In Combination With Verteporfin (Visudyne™) Photodynamic Therapy In Subjects With Neovascular Age-Related Macular Degeneration R. Gentile, MD

INSTITUTIONAL REVIEW BOARD SUMMARY 127 INSTITUTIONAL REVIEW BOARD 2005

DATE TOPIC PRESENTER 02.33 An Extension Study To Evaluate The Safety And Tolerability Of Multiple-Dose Intravitreal Injections Of rhuFab V2 In Subjects With Neovascular Age-Related Macular Degeneration Who Have Completed The Treatment Phase Of A Genentech-Sponsored Phase I Or Phase II/II rhuFabV2 Study R. Gentile, MD

03.26 Estrogen Metabolite Ratio Of 2-Hydroxyestrone: 16a-Hydroxyestrone As A Marker And Mechanism For Proliferative Thyroid Disease S. Schantz, MD

04.24 Efficacy Of Endoscopic Sinus Surgery Simulator As A Teaching Tool For ENT Residents S. Schaefer, MD

04.25 Motoneuron Activity In Patients With Neurological Disease S. Schaefer, MD

96.24 Computerized Stereocampimeter to Measure Central Scotoma (Comparative Study Of The Lloyd Stereo-Campimeter With Other Monocular Campimeters (Such As The Humphrey) In Charting A Central Field Of Vision.) P. Kramer, MD

03.33 Short-Term And Long-Term Efficacy Of The BAHA For Single Sided Deafness C. Linstrom, MD

03.38 Prospective, Multi-Center Clinical Trial Of The Scleral Expansion Bands (SEB) For The Treatment Of Presbyopia B. Soloway, MD

04.50 The Otologics Fully Implantable Middle Ear Transducer (MET™) Ossicular Stimulator J. Arigo, MD

96.20 Ocular Hypertension Treatment Study Ancillary Investigation: Confocal Scanning Laser Ophthalmoscopy Of The Optic Disc. J. Liebmann, MD

02.36 African Americans With Glaucoma (AAG): Structure And Function (NEI 1U0EY14267-01) J. Liebmann, MD

04.38 The Standard Care Vs. Corticosteroid For Retinal Vein Obstruction (SCORE) Study R. Rosen, MD

04.39 A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide And Laser Photocoagulation R. Gentile, MD For Diabetic Macular Edema R. Gentile, MD

04.46 An Open Label, Non-Comparative Protocol For The Use Of Pegaptanib Sodium Every 6 Weeks In Patients With Exudative Age-Related Macular Degeneration (AMD) R. Rosen, MD

04.49 Titanium Sapphire Laser Trabeculoplasty – Multi-Center Study R. Ritch, MD

AMENDMENTS TO PROTOCOLS

02.13 An Evaluation Of Efficacy AND Safety Of Posterior Juxtascleral Injections Of Anecortave Acetate 15mg (0.5ml of 30 mg/ml Anecortave Acetate Sterile Suspension) Versus VISUDYNE® in Patient With Subfoveal Exudative Age-Related Macular Degeneration (AMD) Eligible For Initial Treatment With Photodynamic Therapy (PDT) Using VISUDYNE® R. Rosen, MD

128 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2005

DATE TOPIC PRESENTER 03.38 Prospective, Multi-Center Clinical Trial Of The Scleral Expansion Bands (SEB) For The Treatment Of Presbyopia B. Soloway, MD

04.18 Diagnosis Of Exfoliation Syndrome By Imaging Exfoliation Material On Zonules Using Ultrasound Biomicroscopy In Patients With Poor Pupil Dilation R. Ritch, MD

04.35 Functional And Structural Testing For Optic Nerve Disease R. Ritch, MD

04.52 Macular Function In Glaucoma Patients: Normal Tension(NTG Vs.) Angle-Closure Glaucoma (ACG) And Or Juvenile Glaucoma (JG) A. Bertolucci, MD

01.30 CD-44 Receptor In Aqueous Humor In Glaucoma R. Ritch, MD

02.15 Multicenter Clinical Study Of The Optic Model 311 Iris Reconstruction Lens K. Rosenthal, MD

02.25 Analysis Of Aqueous Humor, Anterior Capsule, Iris And Trabecular Tissue In Patients With Exfoliation Syndrome R. Ritch, MD

03.38 Prospective, Multi-Center Clinical Trial Of The Scleral Expansion Bands (SEB) For The Treatment Of Presbyopia B. Soloway, MD

04.13 A Phase 2, Multi-Center, Randomized, Masked, Controlled Study Of MSI-1265F (Squalamine Lactate) (IND # 66,897) For The Treatment Of Choroidal Neovascularization Associated With Age-Related Macular Degeneration MSI-1256F-209 R. Rosen, MD

04.49 Titanium Sapphire Laser Trabeculoplasty – Multi-Center Study R. Ritch, MD

02.14 An Evaluation Of Efficacy AND Safety Of Posterior Juxtascleral Injections Of Anecortave Acetate 15mg (0.5ml of 30 mg/ml Anecortave Acetate Sterile Suspension) Versus VISUDYNE® in Patient With Subfoveal Exudative Age-Related Macular Degeneration (AMD) Eligible For Initial Treatment With Photodynamic Therapy (PDT) Using VISUDYNE® R. Rosen, MD 04.01 Proteomic And Immunologic Analyses Of Thyroid Cancer S. Schantz, MD

04.13 A Phase 2, Multi-Center, Randomized, Masked, Controlled Study Of MSI-1265F (Squalamine Lactate) (IND # 66,897) For The Treatment Of Choroidal Neovascularization Associated With Age-Related Macular Degeneration MSI-1256F-209 R. Rosen, MD

04.39 A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide And Laser Photocoagulation For Diabetic Macular Edema R. Gentile, MD

02.32 A Phase I/II, Single-Masked, Multicenter Study Of The Safety, Tolerability, And Efficacy Of Multiple-Dose Intravitreal Injections Of rhuFab V2 In Combination With Verteporfin (Visudyne™) Photodynamic Therapy In Subjects With Neovascular Age-Related Macular Degeneration R. Gentile, MD

INSTITUTIONAL REVIEW BOARD SUMMARY 129 INSTITUTIONAL REVIEW BOARD 2005

DATE TOPIC PRESENTER 03.11 A Phase III, Multi-Center, Randomized, Double-Masked, Sham Injection- Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration R. Gentile, MD

03.38 Prospective, Multi-Center Clinical Trial Of The Scleral Expansion Band (SEB) For The Treatment Of Presbyopia B. Soloway, MD

05.06 An Open-Label, Multicenter Extension Study To Evaluate The Safety And Tolerability Of Ranizumab In Subjects With Subfoveal Choroidal Neovascularization (CNV) Secondary To Age-Related Macular Degeneration (AMD) Who Have Completed The Treatment Phase Of A Genentech-Sponsored Ranizumab Study (FVF3426g) R. Gentile, MD

03.37 Isolation Of Stem Cells From Human Trabecular Meshwork R. Ritch, MD

04.45 Intraocular Pressure And Ocular Pulse Amplitude Measurement In Patients With Thin And Thick Corneas Using Pascal Dynamic Contour Tonometer R. Ritch, MD

05.01 How Sensitive And Specific Is The Pigment Reversal Sign For Pigment Dispersion Syndrome/Pigmentary Glaucoma? J. Liebmann,MD

98.19 A Pilot Study Of Fluorescence And Non-Linear Optical Methods To Investigate Normal And Tumor Tissue H. Savage, PhD

99.11 A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study To Evaluate The Effectiveness And Safety Of Oral Memantine In Daily Doses Of 20 mg And 10 mg In Patients With Chronic Open-Angle Glaucoma At risk Of Glaucomatous Progression R. Ritch, MD

01.18 A Multicenter, Randomized, Masked, Controlled Study To Evaluate Retisert, An Intravitreal Fluocinolone Acetonide Implant, In the Treatment Of Patients With Diabetic Macular Edema P. Latkany, MD

01.36 A 48-Month, Multi-Center, Randomized, Double-Masked, Placebo Controlled, Clinical Study To Evaluate The Effectiveness And Safety Of Oral Memantine In Daily Doses Of 20mg And 10mg In Patients With Open-Angle Glaucoma At Risk For Glaucomatous Progression P. Sidoti, MD

04.07 Microcurrent Stimulation For The Improvement Of Visual Acuity In Patients With Non-Exudative Macular Degeneration (AMD) (Ciba Vision P-307-C001 IDE# Mcs 500 Sylark Device And Systems) R. Rosen, MD

04.43 The Effect Of Intra-Ocular Pressure Changes On Optic Disc Topography And Retinal Nerve Fiber Layer Thickness R. Ritch, MD

05.08 A Phase 3 Multicenter, Randomized, Double-Masked, Controlled Study Of Squalamine Lactate (MSI-1256F) For Injection For The Treatment Of Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration R. Rosen, MD

130 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2005

DATE TOPIC PRESENTER 05.13 Randomized, Controlled, Multicenter Comparative Trial To Evaluate For The SOLX Gold Shunt For The Reduction Of Intraocular Pressure (IOP) In glaucomatous Eyes Following Failed Medical And Conventional Surgical Treatments C. Tello, MD

05.06 An Open-Label, Multicenter Extension Study To Evaluate The Safety And Tolerability Of Ranizumab In Subjects With Subfoveal Choroidal Neovascularization (CNV) Secondary To Age-Related Macular Degeneration (AMD) Who Have Completed The Treatment Phase Of A Genentech-Sponsored Ranizumab Study (FVF3426g) R. Gentile, MD

03.38 Prospective, Multi-Center Clinical Trial Of The Scleral Expansion Bands (SEB) For The Treatment Of Presbyopia B. Soloway, MD

04.13 A Phase 2, Multi-Center, Randomized, Masked, Controlled Study Of MSI-1265F (Squalamine Lactate) (IND # 66,897) For The Treatment Of Choroidal Neovascularization Associated With Age-Related Macular Degeneration MSI-1256F-209 R. Rosen, MD

05.13 Randomized, Controlled, Multicenter Comparative Trial To Evaluate For The SOLX Gold Shunt For The Reduction Of Intraocular Pressure (IOP) In Glaucomatous Eyes Following Failed Medical And Conventional Surgical Treatments C. Tello, MD

05.24 Macular Pigment Density Measurements Using Auto Fluorescence HRA Technique R. Rosen, MD

TERMINATIONS:

01.34 Collection Of Normative Values With The GDx Access™ J. Liebmann, MD

03.24 Correlation Between Central Corneal Thickness In Black And Whites With Regards To Incidence Of Juvenile Primary Open Angle Glaucoma R. Ritch, MD

00.41 A Twelve-Week, Multicenter, Double-Masked, Parallel Group, Primary Therapy Study Of The Safety And Efficacy Of BETAXON 0.5% Compared To AZOPT 1% In Pediatric Patients With Glaucoma Or Ocular Hypertension P. Sidoti, MD

03.08 A Multicenter, 2-Arm Parallel Group Study Comparing The Effect Of Repeat Argon Laser Trabeculopasty Versus Selective Laser Trabeculoplasty On Intraocular Pressure Reduction In Open-Angle Glaucoma Patients That Have Had Prior Argon Laser Trabeculoplasty J. Liebmann, MD

03.09 Analysis Of DNA In Family Members Of Patients With Exfoliation Syndrome And/Or Exfoliation Glaucoma R. Ritch, MD

04.00 Diabetic Retinopathy Clinical Research Network Protocol #1a: A Pilot Study Of Laser Photocoagulation For Diabetic Macular Edema R. Gentile, MD

INSTITUTIONAL REVIEW BOARD SUMMARY 131 INSTITUTIONAL REVIEW BOARD 2005

DATE TOPIC PRESENTER 04.04 A Masked Histological Evaluation Of Trabecular Meshwork Specimens Collected Form Trabeculectomy Patients With Primary Open-Angle Glaucoma (POAG) Treated With Bimatoprost 0.003% Ophthalmic Solution Once Daily (UD) Fro At Least Two Years Compared With POAG Patients Treated With Other Topical Ophthalmic IOP-Lowering Drugs (ALLERGAN # 192024-029-00) J. Liebmann, MD

04.06 Comparison Of The Effect Of Tight Collars And Expandable Collars On The Intraocular Pressure In Patients With Open-Angle Glaucoma R. Ritch, MD

99.14 McGhan Medical Corporation Silicone Filled Breast Implant Core Clinical Study S. Colen, MD

99.15 McGhan Medical Corporation Silicone Filled Breast Implant Adjunct Clinical Study S. Colen, MD

02.12 Assessing The Impact Of A Telephone-Based Support Group On The Quality Of Family/Caregivers Of Head and Neck Cancer Patients: A Pilot Study G. Caponong, CSW L. Tiersten, CSW

04.14 Clinical Evaluation Of EPI-K For E-LASIK Laser Vision Correction Surgery B. Soloway, MD

01.17 Ocular Manifestations in Kniest Dysplasia R. Gentile MD R. Rosen, MD

04.15 Detection Of H. Pilori Infection In Young Children With Adenotonsillar Hypertrophy (ATH) J. Dolitsky, MD

04.20 The Assessment Of Diplopia Pre And Post Treatment For Diplopia With The Cervical Range Of Motion(CROM) Device L. Hall, MD

02.16 Can Bone Marrow Aspirates Help Predict Risk Of Early Cancer Spread In Head And Neck Cancer? S. Schantz, MD

03.19 Effect Of Cold Provocation On PERG And mfVEP Responses On Patients With Open Angle Glaucoma And Normal Tension Glaucoma R. Ritch, MD

03.25 A Double-Blind Randomized Study On The Effect Of Partial Versus Total Coblation On Post-Operative Control J. Dolitsky, MD

03.29 A Phase 3 Study Assessing The Safety And Effectiveness Of The GMP Bi-Directional Glaucoma Implant In Patients With Primary Open Angle Glaucoma Who Have Failed Conventional Medical And Surgical Therapy J. Liebmann, MD

04.28 Collection Of Normative Values With The GDx VCC™ J. Liebmann, MD

04.37 An Exploratory Study Of The Safety, Tolerability And Biological Activity Of Intravenously Administered VEGF Trap In Patients With Diabetic Macular Edema R. Rosen, MD

132 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2005

DATE TOPIC PRESENTER 02.16 Can Bone Marrow Aspirates Help Predict Risk Of Early Cancer Spread In Head And Neck Cancer? S. Schantz, MD

03.19 Effect Of Cold Provocation On PERG And mfVEP Responses On Patients With Open Angle Glaucoma And Normal Tension Glaucoma R. Ritch, MD

03.25 A Double-Blind Randomized Study On The Effect Of Partial Versus Total Coblation Tonsillectomy On Post-Operative Pain Control J. Dolitsky, MD

03.29 A Phase 3 Study Assessing The Safety And Effectiveness Of The GMP Bi-Directional Glaucoma Implant In Patients With Primary Open Angle Glaucoma Who Have Failed Conventional Medical And Surgical Therapy J. Liebmann, MD

04.28 Collection Of Normative Values With The GDx VCC™ J. Liebmann, MD

04.37 An Exploratory Study Of The Safety, Tolerability And Biological Activity Of Intravenously Administered VEGF Trap In Patients With Diabetic Macular Edema R. Rosen, MD

03.39 Protocol B7A-MC-MBDL: Reduction In The Occurrence Of Center-Threatening Diabetic Macular Edema R. Gentile, MD

04.16 Oral Montelukast For Graves’ Ophthalmopathy S. Lauer, MD

04.48 Ocular Penetration Of Fourth Generation Fluoroquinolone Antibiotics In Patients With Pre-Existing Filtering Blebs J. Seedor, MD

02.13 An Evaluation Of Efficacy AND Safety Of Posterior Juxtascleral Injections Of Anecortave Acetate 15mg (0.5ml of 30 mg/ml Anecortave Acetate Sterile Suspension) Versus VISUDYNE® in Patient With Subfoveal Exudative Age-Related Macular Degeneration (AMD) Eligible For Initial Treatment With Photodynamic Therapy (PDT) Using VISUDYNE® R. Rosen, MD

03.19 Effect Of Cold Provocation On PERG And mfVEP Responses On Patients With Open Angle Glaucoma And Normal Tension Glaucoma R. Ritch, MD

INSTITUTIONAL REVIEW BOARD SUMMARY 133 134 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD SUMMARY 2006

VOTING MEMBERS:

R. Andrew R. Rosen, MD E. Schleider M. Dodge L. James, RPh S. Schantz, MD R. Baken, PhD S. Tennaro, EdD, RN G. Caponong, MSW J. Walsh, MD l. Tiersten, MSW (alt) D. Ritterband, MD E. Ilitchev, MD P. Kennedy, LCSW H. Savage, PhD R. Jordan, admin. M. Pitman, MD(alt.) M. Potucek, RPh(alt.) A. Ovchinsky (alt.)

GUESTS/OBSERVERS:

L. Klingos, RN K. Tai, CRC C. Tello, MD N. Suslina, CRC J. Thomas A. Patel, MD S. Arthur, MD P. Guerrrero, CRC G. Alexiades, MD S. Tari, MD C.M. Samson, MD R. Gentile, MD L. McNally, MD P. Sidoti, MD M. Gatto, MD A. Llinas, MD A. Panarelli, MD J. Manns, MS IV A. Browne, CRC F. Kanadani, MD S. Dorairaj, MD J. Liebmann, MD M. Cleary, PhD S. Lauer, MD J. Arigo, MD L. Heiser, CO D. Buxton, MD S. Park, MD J. Pearson, MD S. Shippman, CO

MEETING DATES:

JANUARY 10 FEBRUARY 14 MARCH 14 APRIL 11 MAY 9 JUNE 6 JULY 18 AUGUST (no meeting) SEPTEMBER 12 OCTOBER 10 NOVEMBER 14 DECEMBER 12

NEW PROTOCOLS:

06.00 Hearing Results In Single Versus Staged Tympanomastoidectomy For Chronic Ear Disease G. Alexiades, MD

06.01 Amblyopia Treatment Study ATS6 – A Randomized Trial Comparing Near Versus Distance Activities While Patching For Amblyopia In Children 3 to < 7 Years Old L. Hall, MD

06.02 Amblyopia Treatment Study ATS8 – A Randomized Trial Comparing Atropine To Atropine Plus A Plano Lens For The Sound Eye As Prescribed Treatments For Amblyopia In Children 3 To < 7 Years Old L. Hall, MD

06.03 Diagnostic Imaging Using The AC Cornea OC R. Rosen, MD

06.04 Comparison Of Rates Of Epithelial Wound Healing With Gatifloxacin And Moxifloxacin Following Corneal Transplantation D. Buxton, MD

06.05 Retinal Nerve Fiber Layer Imaging P. Sidoti, MD

06.06 The Effectiveness Of Exercises And Laryngopharyngeal Reflux Therapy On Obstructive Sleep Apnea S. Park, MD

INSTITUTIONAL REVIEW BOARD SUMMARY 135 INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 06.07 Headaches In Ophthalmology S. Shippman, CO

06.08 Melatonin Levels In Macular Degeneration R. Rosen, MD

06.09 Quality Of Visual Function And Life In Uveitis Patients C. M. Samson, MD

06.10 Trans Canal Cochlear Implantation – A Simpler Technique Whose Time Has Come J. Arigo, MD

06.11 Word Identification And Memory In Children With Cochlear Implants J. Madell, PhD

06.12 Age-Related Eye Disease Study II (AREDS II): A Multi-Center, Randomized Trial of Lutein, Zeazanthin, And Long-Chain Omega-3 Fatty Acids (Docosahexaenoic Acid [DHA] And Eicosapentaenoic Acid [EPA]) In Age-Related Macular Degeneration R. Rosen, MD

06.13 A Study of The Safety And IOP Lowering Efficacy Of Anecortave Acetate (AL-3789) In Patients With Open Angle Glaucoma J. Liebmann, MD

06.14 Reproducibility And Reliability Of The Anterior Segment OCT J. Liebmann, MD

06.15 Non-Invasive, Non-Contact Imaging of The Anterior Segment By Anterior Segment OCT R. Ritch, MD

06.16 Combined Simultaneous ICG Angiography And SLO/OCVT On Patients With Central Serous Chorio-Retinopathy R. Rosen, MD

06.17 Comparing the Ocular Pulse Amplitude Measurements Before and After the Administration of Travaprost by Using the Pascal R. Ritch, MD Dynamic Contour Tonomteter J. Manns, MS IV

06.18 A Six-Week, Multicenter, Masked, Randomized Trial (With A 20-Week Masked Extension) To Assess The Safety And Efficacy Of 700 μG And 350 μG Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System Compared With Sham DEX PS DDS Applicator System In The Treatment Of Non-Infectious Ocular Inflammation Of The Anterior Segment In Patients With Anterior Uveitis C. M. Samson, MD

06.19 An Eight-Week, Multicenter, Masked, Randomized Trial (With An 18-Week Masked Extension) To Assess The Safety And Efficacy Of 700 μG And 350 μG Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System Compared With Sham DEX PS DDS Applicator System In The Treatment Of Non-Infectious Ocular Inflammation Of The Anterior Segment In Patients With Intermediate Uveitis C. M. Samson, MD

06.20 Photographic Assessment OF Eyebrow Position Range Of Moti A. Sclafani, MD

06.21 Magnetoencephalographic (MEG) Studies In Glaucoma Patients R. Ritch, MD

06.22 A Phase IV, Open Label, Multicenter Trial Of Maintenance Intravitreous Injections Of Macugen® (pegaptanib Sodium) Given Every 6 Weeks For 48 Weeks In Subjects With Subfoveal Neovascular Age-Related Macular Degeneration (AMD) Initially Treated With A Modality Resulting In Maculopathy Improvement R. Rosen, MD

136 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 06.23 Cornea Foreign Bodies: Clinical Characteristics And The Incidence Of Infectious Keratitis J. Seedor, MD

06.24 Anterior Segment Tomographic Imaging Of Post-Infectious Corneal Opacities A. Ko, MD

06.25 A study To Evaluate The Clinical And Microbial Efficacy Of 0.6% ISV-403 Compared To Vigamox™(Moxifloxacin) In The Treatment Of Bacterial Conjunctivitis L. McNally, MD

06.26 A One Year, Investigator-Masked, Randomized, Naturalistic, Observational Study Of The Safety And Efficacy Of Lumigan, Xalatan And Travatan In The Management Of Elevated IOP In Patients With Glaucoma P. Sidoti, MD

06.27 The Effect Of Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) On Corneal Thickness And Intra-Ocular Pressure J. Seedor, MD

06.28 Structural Evaluation Of The Optic Nerve In Subjects Without Glaucoma J. Liebmann, MD

06.29 African Descent And Glaucoma Evaluation Study (ADAGES): Ancillary Genetic Testing Study J. Liebmann, MD

06.30 Developing A Valid Diagnostic Ocular Rosacea Index (ORI) R. Latkany, MD

06.31 Quantification of the Effect of Free Radicals in Sera and Tear Films of Uveitic Patients C M Samson, MD

06.32 Physiological Characteristics Of The “Belt” Voice A. Lebowitz, MS R. Baken, PhD

06.33 Diintholimethane (DIM): Anti-Proliferation Agent In Thyroid Disease – Non-Surgical Protocol S. Schantz, MD P. Parmar, MD

06.34 Treatment Of Pterygia With Bevacizumab D. Ritterband, MD M. Banitt, MD

06.35 Treatment Of Vascularized Corneal Grafts With Bevacizumab (Avastin) J. Seedor, MD D. Ritterband, MD

06.36 Foveal Blood Flow Before And After Lasik R. Rosen, MD D. Ritterband, MD

06.28 Structural Evaluation Of The Optic Nerve In Subjects Without Glaucoma J. Liebmann, MD

06.37 Structural evaluation of optic nerve in subjects without glaucoma: Ancillary genetic blood testing study (version # 1 10/3/06) J. Liebmann, MD

06.38 A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Ascending Dose Study Of INS 115644 Ophthalmic Solution R. Ritch, MD In Subjects With Bilateral Ocular Hypertension Or Early A. Sclafani, MD Primary Open Angle Glaucoma S. Schantz, MD 06.39 A Double-Masked, Randomized, Multi-Center, 2-Arm Parallel Study Comparing The Safety And Efficacy Of Aquamid® And Restylane® In The Treatment Of Nasolabial Folds A. Sclafani, MD

INSTITUTIONAL REVIEW BOARD SUMMARY 137 INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 06.40 Connexin Protein Expression In Suspicious Thyroid S. Schantz, MD

EXEMPT/CHART REVIEWS:

P. Acnes Keratitis Ocular Infection D. Ritterband, MD

Steroid Responders – Pterygium Surgery D. Ritterband, MD

Study Of Patients With Failed Repeat Corneal Transplants That Have Herpes Simplex Virus In The Host Corneal Button D. Ritterband, MD

Retrospective Chart Review Of The Outcomes In Sarcoid Uveitis C. M. Samson, MD

Comparison Of SLO-OCT And Zeiss OCT For Diabetic Macular Edema B. Shirkey, MD

Single Versus Staged Surgery For Cholesteatoma In An Urban Residency Training Program G. Alexiades, MD

Review Of Culture Positive Endophthalmitis R. Gentile, MD E. Fitz, MD

Prevalence And Severity Of Neck Pain Among Ophthalmologists I. Rozenbaum, MD

Prevalence And Severity Of Neck Pain Among Ophthalmologists Anne Ko, MD I. Rozenbaum, MD

Retrospective Chart Review Of Culture Positive Endophhtalmitis Cases At The NYE&EI For The Past 5 Years R. Gentile, MD

Grave’s Ophthalmopathy – Anti-Thyroid Antibodies S. Lauer, MD This is a prospective study and requires a full IRB proposal. This is a study done on private patients at a private office

Await response from PI. – Not approved

Evaluate The Microbiology Associated With Intraocular Foreign Bodies (IOFB) S. Lalin, MD S. Barone, MD

Record review of Idiopathic Polypoidal Choroidal Vasculopathy: Rx: PPV tPA B. Shirkey, MD

Single Versus Staged Surgery For Cholesteatoma In An G. Alexiades, MD Urban Residency Training Program J. Pearson, MD

Intraocular Lens Induced Uveitis: Clinical Characteristics C. M. Samson, MD And UBM Features A. Panarelli, MD

Characteristics Of HLA-B27 Patients Treated At C. M. Samson, MD The New York Eye & Ear Infirmary D. Huie, MS

Behcet’s Disease: Case Series Describing Ocular Findings Among C. M. Samson, MD Patients Treated At A Tertiary Care Center J. Liao

Interobserver Comparison Of Fundus Photographs To Optical Coherence Tomography, Visual Evoked Potential And Humphrey Visual Field, In C. Tello, MD Patients With Visual Field Defects J. Manns, MS

Histopathological Analysis Of Vitreous Specimens And Epiretinal Membranes From Patients With Uveitis R. Gentile, MD J. Panarelli, MD

138 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER Evaluate The Microbiology Associated With Intraocular Foreign Bodies (IOFB) S. Lalin, MD S. Barone, MD

Data Base Glaucoma Drop Cultures D. Ritterband, MD

Non-Invasive, Non-Contact Imaging Of The Anterior Segment Using Anterior Segment OCT J. Seedor, MD

Clinical Significance Of Human Papilloma Virus (HPV) S. Schantz, MD In Squamous Cell Carcinoma Of The Upper Aerodigestive Tract J. Bedwell, MD

Comparison Of A Spectral OCT/SLO With The Stratus OCT And R. Rosen, MD Time-Domain OCT/SLO For Imaging Various Retinal Pathologies P. Garcia Not a retrospective study. The committee informed Dr. Rosen that this Should be re-submitted as prospective study. NOT APPROVED

RENEWALS:

02.38 A Randomized, Double-Masked, Multi-Center Trial Of The Safety, Tolerability And Pharmacokinetics Of 1 Mg/Eye And 3 Mg/Eye Intravitreal Injections Of Pegaptanib Sodium (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks For 54 Weeks, In Patients With Exudative Age-Related Macular Degeneration (AMD) R. Rosen, MD

04.47 Tissue Glue As An Enhancing Adjunct In Clear Cornea Cataract Wound Closure D. Ritterband, MD

04.51 Cellular Biology Of Cholesteatoma S. Parisier, MD

04.52 Macular Function In Glaucoma Patients: Normal Tension (NTG) Vs. Angle –Closure Glaucoma (ACG) And Or Juvenile Glaucoma (JG) A. Bertolucci, MD

93.01 Ocular Hypertension Treatment Study R. Ritch, MD

96.00 Blood Studies Of Hereditary Eye Diseases R. Ritch, MD

02.34 Glaucomatous Damage In Patients Performing Yoga In The Inverted Position R. Ritch, MD

03.01 Decomposition Of Electromyographic Signals In Facial Paralysis C. Li, MD

03.36 Electron Microscopic Examination Of Trabecular Meshwork From Primary Open Angle Glaucoma Patients With Mutations In The GLC1A (Myocilin) Gene R. Ritch, MD

03.37 Isolation Of Stem Cells From Human Trabecular Meshwork R. Ritch, MD

04.01 Proteomic And Immunologic Analyses Of Thyroid Cancer S. Schantz, MD

04.02 RNA Microarray Analysis Of Thyroid Cancer S. Schantz, MD

04.03 The Effects Of Alcohol And Tobacco Use On The Mutational Profiles Of People With Head And Neck Squamous Cell Carcinoma S. Schantz, MD

04.45 Intraocular Pressure And Ocular Pulse Amplitude Measurement In Patients With Thin And Thick Corneas Using Pascal Dynamic Contour Tonometer R. Ritch, MD 05.00 Ocular Biometry In Vision Screening J. Galst, MD

INSTITUTIONAL REVIEW BOARD 139 INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 05.01 How Sensitive And Specific Is The Pigment Reversal Sign For Pigment Dispersion Syndrome/Pigmentary Glaucoma? J. Liebmann, MD

03.10 Cytogenic Analysis Of Head And Neck Cancer Using Comparative Genomic Hybridization K. Hu, MD

03.11 A Phase III, Multi-Center, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration R. Gentile, MD

04.10 Characteristics of patients with cochlear implants C. Linstrom, MD C. Silverman, PhD

05.05 Rapid Screening Tests For Detection Of Adenovirus In Tears D. Ritterband, MD

05.06 An Open-Label, Multicenter Extension Study To Evaluate The Safety And Tolerability Of Ranizumab In Subjects With Subfoveal Choroidal Neovascularization (CNV) Secondary To Age-Related Macular Degeneration (AMD) Who Have Completed The Treatment Phase Of A Genentech-Sponsored Ranizumab Study (FVF3426g) R. Gentile, MD

99.11 A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study To Evaluate The Effectiveness And Safety Of Oral Memantine In Daily Doses Of 20 mg And 10 mg In Patients With Chronic Open-Angle Glaucoma At risk Of Glaucomatous Progression R. Ritch, MD

03.12 Is Elevation Of Adiponectin Serologic Concentration Associated With A Flare Of Graves' Ophthalmopathy Or Other Ocular Disease? P. Latkany, MD

05.07 Stapedectomy In Patients Who Have Failed Reconstructive Surgery For Chronic Ear Disease J. Arigo, MD

98.11 A Multi-Center, Double-Masked, Two-Arm Parallel Group Study Comparing The Effect Of Brimonidine 0.2% Versus Timolol 0.5% On Visual Field Stability In Patients With Low Pressure Glaucoma J. Liebmann, MD

98.19 A Pilot Study Of Fluorescence And Non-Linear Optical Methods To Investigate Normal And Tumor Tissue H. Savage, PhD

02.15 Multicenter Clinical Study Of The Optic Model 311 Iris Reconstruction Lens K. Rosenthal, MD

99.20 McGhan Medical Corporation Silicone-Filled Breast Implant Adjunct Clinical Study T. Chaglassian, M.D.

01.18 A Multicenter, Randomized, Masked, Controlled Study To Evaluate Retisert, An Intravitreal Fluocinolone Acetonide Implant, In the Treatment Of Patients With Diabetic Macular Edema P. Latkany, MD

02.25 Analysis Of Aqueous Humor, Anterior Capsule, Iris And Trabecular Tissue In Patients With Exfoliation Syndrome R. Ritch, MD

03.18 Oral Megadose Corticosteroid Therapy Of Acute Exacerbation In MS-OMEGA M. Kupersmith, MD

140 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 04.18 Diagnosis Of Exfoliation Syndrome By Imaging Exfoliation Material On Zonules Using Ultrasound Biomicroscopy In Patients With Poor Pupil Dilation R. Ritch, MD

04.19 Ocular Hypertension Treatment Study (OHTS): Ancillary Genetic Testing Study R. Ritch, MD

04.21 Scanning Laser Polarimetry (GDx) And Optical Coherence Tomography (OCT3) To Detect Changes In The Peripapillary Nerve Fiber Layer With Optic Nerve Damage M. Kupersmith, MD

04.27 Mechanical Interaction Between Aqueous Humor And Iris R. Ritch, MD

04.29 Biometric Evaluation Of Iridocorneal Angle And Ciliary Body Of Patients With Narrow Angle R. Ritch, MD

04.35 Functional And Structural Testing For Optic Nerve Disease R. Ritch, MD

04.36 Evaluation Of Patients With Optic Nerve Head Drusen (OHND) Using Both Functional And Structural Tests R. Ritch, MD

05.13 Randomized, Controlled, Multicenter Comparative Trial To Evaluate For The SOLX Gold Shunt For The Reduction Of Intraocular Pressure (IOP) In Glaucomatous Eyes Following Failed Medical And Conventional Surgical Treatments C. Tello, MD

97.11 Prophylactic Diode Laser Photocoagulation For The Prevention Of Choroidal Neovascularization In Age-Related Macular Degeneration (ARMD) R. Gentile, MD R. Rosen, MD

99.22 Tube Versus Trabeculectomy (TVT) Study P. Sidoti, MD

00.24 The International Collaborative Exfoliation Syndrome Treatment Study R. Ritch, MD

01.12 Optical Mapping Apparatus Using Optical Coherence Tomography (OCT) Equivalent To The Humphrey OCT, Which Produces Longitudinal And Transversal OCT Images Combined With Scanning Laser Ophthalmoscopy (SLO) Images Of The Retina And Macula Using A Single Super R. Rosen, MD luminescent Diode Source (SLD) R. Gentile, MD

01.30 CD-44 Receptor In Aqueous Humor In Glaucoma R. Ritch, MD

01.35 A Multicenter, Randomized, Masked, Controlled Study To Evaluate Retisert™, An Intravitreal Fluocinolone Acetonide Implant, In The Treatment Of Patients With Diabetic Macular Edema R. Gentile, MD

01.36 A 48-Month, Multi-Center, Randomized, Double-Masked, Placebo Controlled, Clinical Study To Evaluate The Effectiveness And Safety Of Oral Memantine In Daily Doses Of 20mg And 10mg In Patients With Open-Angle Glaucoma At Risk For Glaucomatous Progression P. Sidoti, MD

02.33 An Extension Study To Evaluate The Safety And Tolerability Of Multiple-Dose Intravitreal Injections Of rhuFab V2 In Subjects With Neovascular Age-Related Macular Degeneration Who Have Completed The Treatment Phase Of A Genentech-Sponsored Phase I Or Phase II/II rhuFabV2 Study R. Gentile, MD

INSTITUTIONAL REVIEW BOARD 141 INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 04.13 A Phase 2, Multi-Center, Randomized, Masked, Controlled Study Of MSI-1265F (Squalamine Lactate) (IND # 66,897) For The Treatment Of Choroidal Neovascularization Associated With Age-Related Macular Degeneration MSI-1256F-209 R. Rosen, MD

04.22 Plasma EBV DNA In Blood As A Screening Device And Prognostic Factor In Nasopharyngeal Carcinoma James Li, MD

04.24 Efficacy Of Endoscopic Sinus Surgery Simulator As A Teaching Tool For ENT Residents S. Schaefer, MD

04.25 Motoneuron Activity In Patients With Neurological Disease M. Pitman, MD

04.38 The Standard Care Vs. Corticosteroid For Retinal Vein Obstruction (SCORE) Study R. Rosen, MD

04.39 A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide And Laser Photocoagulation For Diabetic Macular Edema R. Gentile, MD

05.08 A Phase 3 Multicenter, Randomized,Double-Masked, Controlled Study Of Squalamine Lactate (MSI-1256F) For Injection For The Treatment Of Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration R. Rosen, MD

05.09 A 12-Week Randomized, Double-Masked Parallel Group Comparison Of Xalacom™ Given In The Evening, Xalatan™ Given In The Evening, And Timolol Given In The Morning In Subjects With Open Angle Glaucoma Or Ocular Hypertension J. Liebmann, MD

05.16 Multicenter Uveitis Steroid Treatment Trial (MUST) P. Latkany, MD

05.17 A Randomized, Double-Masked, Parallel Group, Multi-Center, Dose Ranging Pilot Study Of Denufosol Tetrasodium (INS37217) Intravitreal Injection In Subjects With Uveitis Associated Macular Edema C. M. Samson, MD

05.19 A Two Year Open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study Of Pramipexole IR Versus Ropinirole In Early Parkinson’s Disease Patients (protocol #248.538) A. Bertolucci, MD

05.21 Titanium Sapphire Laser Trabeculoplasty As A Primary Treatment In Open Angle Glaucoma R. Ritch, MD

05.23 The Use Of Confocal Microscopy To Characterize Keratic Precipitates (KPs) In Sarcoidosis-Associated Uveitis C. M. Samson, MD

05.24 Macular Pigment Density Measurements Using Auto Fluorescence HRA Technique R. Rosen, MD

96.20 Ocular Hypertension Treatment Study Ancillary Investigation: Confocal Scanning Laser Ophthalmoscopy Of The Optic Disc J. Liebmann, MD

03.36 Electron Microscopic Examination Of Trabecular Meshwork From Primary Open Angle Glaucoma Patients With Mutations In The GLC1A (Myocilin) Gene R. Ritch, MD

03.37 Isolation Of Stem Cells From Human Trabecular Meshwork R. Ritch, MD

142 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 05.20 Diindolymetahne As A suppressor Of Thyroid Growth And Its Effect On Urine Estrogen Metabolites In Proliferative Thyroid Disease S. Schantz, MD

05.26 A Three Year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial To Assess The Safety And Efficacy Of 700 µG And 350 µG Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS Applicator System) In The Treatment Of Patients With Diabetic Macular Edema R. Rosen, MD

05.27 A Natural History Study Of Macular Telangiectasia – The Mactel Study R. Rosen, MD

05.28 A Phase IIIb, Single-Masked, Multicenter, Randomized Study To Evaluate The Safety And Tolerability Of Ranibizumab In Naive and Previously Treated Subjects With Choroidal Neovascularization (CNV) Secondary To Age-Related Macular Degeneration (AMD) R. Gentile, MD

96.24 Computerized Stereocampimeter to Measure Central Scotoma (Comparative Study Of The Loyd Stereo-Campimeter With Other Monocular Campimeters (Such As The Humphrey) In Charting A Central Field Of Vision.) P. Kramer, MD

02.34 Glaucomatous Damage In Patients Performing Yoga In The Inverted Position R. Ritch, MD

02.36 African Americans With Glaucoma (AAG): Structure And Function (NEI 1U0EY14267-01) J. Liebmann, MD

03.38 Prospective, Multi-Center Clinical Trial Of The Scleral Expansion Bands (SEB) For The Treatment Of Presbyopia B. Soloway, MD

04.23 Uveitis Clinical Registry C. M. Samson, MD

04.47 Tissue Glue As An Enhancing Adjunct In Clear Cornea Cataract Wound Closure D. Ritterband, MD

05.31 Immunotherapy For Treatment Of Anterior Uveitis C M Samson, MD

96.00 Blood Studies Of Hereditary Eye Diseases R. Ritch, MD J. Liebmann, MD

02.36 African Americans With Glaucoma (AAG): Structure And Function (NEI 1U0EY14267-01) J. Liebmann, MD

03.33 Short-Term And Long-Term Efficacy Of The BAHA For Single Sided Deafness C. Linstrom, MD

03.38 Prospective, Multi-Center Clinical Trial Of The Scleral Expansion Bands (SEB) For The Treatment Of Presbyopia B. Soloway, MD

04.30 Evaluation Of Patients With Normal Tension Glaucoma (NTG) Or High Tension Glaucoma (HTG) Using Different Visual Field Studies And Nerve Fiber Layer Imaging R. Ritch, MD

04.33 Effect Of Laser Cautery Of Ropy Bleb Vessels On The Success Rate Of TransConjunctival Needle Revision R. Ritch, MD

INSTITUTIONAL REVIEW BOARD 143 INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 04.50 The Otologics Fully Implantable Middle Ear Transducer (MET™) Ossicular Stimulator J. Arigo, MD

04.51 Cellular Biology Of Cholesteatoma S. Parisier, MD G. Alexiades, MD

05.12 Influence Of Pilocarpine On The Postural Effect Of Intraocular Pressure J. Liebmann, MD

05.22 Titanium Sapphire Laser Trabeculoplasty Versus Selective Laser Trabeculoplasty In Open Angle Glaucoma R. Ritch, MD

AMENDMENTS TO PROTOCOLS:

01.30 CD-44 Receptor In Aqueous Humor In Glaucoma R. Ritch, MD

02.15 Multicenter Clinical Study Of The Optic Model 311 Iris Reconstruction Lens K. Rosenthal, MD

05.16 Multicenter Uveitis Steroid Treatment Trial (MUST) P. Latkany, MD

06.00 Hearing Results In Single Versus Staged Tympanomastoidectomy For Chronic Ear Disease G. Alexiades, MD

02.15 Multicenter Clinical Study Of The Optic Model 311 Iris Reconstruction Lens K. Rosenthal, MD

04.01 Proteomic And Immunologic Analyses Of Thyroid Cancer S. Schantz, MD

04.45 Intraocular Pressure and Ocular Pulse Amplitude Measurements in Patients with Primary Open-Angle Glaucoma and different Corneal Thickness using Pascal Dynamic Contour Tonometer R. Ritch, MD

05.26 A Three Year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial To Assess The Safety And Efficacy Of 700 µG And 350 µG Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS Applicator System) In The Treatment Of Patients With Diabetic Macular Edema R. Rosen, MD

05.28 A Phase IIIb, Single-Masked, Multicenter, Randomized Study To Evaluate The Safety And Tolerability Of Ranibizumab In Naive and Previously Treated Subjects With Choroidal Neovascularization (CNV) Secondary To Age-Related Macular Degeneration (AMD) R. Gentile, MD

02.36 African Americans With Glaucoma (AAG): Structure And Function (NEI 1U0EY14267-01) J. Liebmann, MD

03.38 Prospective, Multi-Center Clinical Trial Of The Scleral Expansion Bands (SEB) For The Treatment Of Presbyopia B. Soloway, MD

04.38 The Standard Care Vs. Corticosteroid For Retinal Vein Obstruction (SCORE) Study R Rosen, MD

04.45 Intraocular Pressure And Ocular Pulse Amplitude Measurement In Patients With Thin And Thick Corneas Using Pascal Dynamic Contour Tonometer R. Ritch, MD

144 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 04.13 A Phase 2, Multi-Center, Randomized, Masked, Controlled Study Of MSI-1265F (Squalamine Lactate) (IND # 66,897) For The Treatment Of Choroidal Neovascularization Associated With Age-Related Macular Degeneration MSI-1256F-209 R. Rosen, MD

03.12 Is Elevation Of Adiponectin Serologic Concentration Associated With A Flare Of Graves' Ophthalmopathy Or Other Ocular Disease? P. Latkany, MD

03.38 Prospective, Multi-Center Clinical Trial Of The Scleral Expansion Bands (SEB) For The Treatment Of Presbyopia B. Soloway, MD

05.20 Diindolymetahne As A suppressor Of Thyroid Growth And Its Effect On Urine Estrogen Metabolites In Proliferative Thyroid Disease S. Schantz, MD

05.28 A Phase IIIb, Single-Masked, Multicenter, Randomized Study To Evaluate The Safety And Tolerability Of Ranibizumab In Naive and Previously Treated Subjects With Choroidal Neovascularization (CNV) Secondary To Age-Related Macular Degeneration (AMD) R. Gentile, MD

06.06 The Effectiveness Of Tongue Exercises And Laryngopharyngeal Reflux Therapy On Obstructive Sleep Apnea S. Park, MD

06.12 Age-Related Eye Disease Study II (AREDS II): A Multi-Center, Randomized Trial Of Lutein, Zeazanthin, And Long-Chain Omega-3 Fatty Acids (Docosahexaenoic Acid [DHA] And Eicosapentaenoic Acid [EPA]) In Age-Related Macular Degeneration R. Rosen, MD

04.35 Functional And Structural Testing For Optic Nerve Disease R. Ritch, MD

02.36 African Americans With Glaucoma (AAG): Structure And Function (NEI 1U0EY14267-01) J. Liebmann, MD

04.33 Effect Of Laser Cautery Of Ropy Bleb Vessels On The Success Rate Of TransConjunctival Needle Revision R. Ritch, MD

04.39 A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide And Laser Photocoagulation For Diabetic Macular Edema R. Gentile, MD

05.06 An Open-Label, Multicenter Extension Study To Evaluate The Safety And Tolerability Of Ranizumab In Subjects With Subfoveal Choroidal Neovascularization (CNV) Secondary To Age-Related Macular Degeneration (AMD) Who Have Completed The Treatment Phase Of A Genentech- Sponsored Ranizumab Study (FVF3426g) R. Gentile, MD

06.13 A Study of The Safety And IOP Lowering Efficacy Of Anecortave Acetate (AL-3789) In Patients With Open Angle Glaucoma J. Liebmann, MD

04.36 Evaluation Of Patients With Optic Nerve Head Drusen (OHND) Using Both Functional And Structural Tests R. Ritch, MD

06.18 A Six-Week, Multicenter, Masked, Randomized Trial (With A 20-Week Masked Extension) To Assess The Safety And Efficacy Of 700 μG And 350 μG Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System Compared With Sham DEX PS DDS Applicator System In The Treatment Of Non-Infectious Ocular Inflammation Of The Anterior Segment In Patients With Anterior Uveitis C. M. Samson, MD

INSTITUTIONAL REVIEW BOARD 145 INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 06.19 An Eight-Week, Multicenter, Masked, Randomized Trial (With An 18-Week Masked Extension) To Assess The Safety And Efficacy Of 700 μG And 350 μG Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System Compared With Sham DEX PS DDS Applicator System In The Treatment Of Non-Infectious Ocular Inflammation Of The Anterior Segment In Patients With Intermediate Uveitis C. M. Samson, MD

05.27 A Natural History Study Of Macular Telangiectasia – The Mactel Study R. Rosen, MD

06.19 An Eight-Week, Multicenter, Masked, Randomized Trial (With An 18-Week Masked Extension) To Assess The Safety And Efficacy Of 700 μG And 350 μG Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System Compared With Sham DEX PS DDS Applicator System In The Treatment Of Non-Infectious Ocular Inflammation Of The Anterior Segment In Patients With Intermediate Uveitis C. M. Samson, MD

TERMINATIONS:

02.01 Anthropometric Facial Analysis & Quantitative Measurements Of Aesthetically Pleasant Face Of A Korean American Woman A. Sclafani, MD

96.16 Temporal And Spatial Characteristics Of Facial Motion In Normal Persons And Persons With Facial Paresis Or Paralysis. C. Linstrom, MD

99.19 An Analysis Of Macular Pigment Density In First Degree Relatives Of Individuals With Age Related Macular Degeneration R. Rosen, MD

01.02 Protein Kinase C Beta Inhibitor – Diabetic Retinopathy Study 2 (PKC-DRS2). A Phase III Clinical Trial R. Gentile, MD

02.02 Phase III Multicenter Clinical Investigation To Evaluate The Oculaid® Endocapsular Tension Ring Inserter For The Management Of Zonular Weakness And / Or Dialysis During And After Cataract Extraction And IOL Implantation K. Rosenthal, MD

02.35 Initial Treatment For Open Angle Glaucoma: A prospective, Randomized Clinical Trial Comparing Topical Medical Therapy With Selective Randomized Clinical Trail Comparing Medical Therapy With Selective Laser Trabeculoplasty J. Liebmann, MD

03.02 Evaluation Of The Preferential Hyperactivity Perimeter (PHP) Device, For Testing Intermediate AMD Patients, During Routine Eye-Clinic Operation R. Rosen, MD

03.03 Low-Volume, High Surface Area, Cylindrical Aqueous Shunt (Wilcox Implant) Small-Diameter Aqueous Shunt Study (SAS) P. Sidoti, MD

03.32 Macular Pigment Density In Patients With Diabetes R. Rosen, MD

03.34 An Automated 3-D Ultrasound Tool For Screening Eyes With Papilledema P. Finger, MD

146 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 04.07 Micro current Stimulation For The Improvement Of Visual Acuity In Patients With Non-Exudative Macular Degeneration (AMD) (Ciba Vision P-307-C001 IDE# Mcs 500 Sylark Device And Systems) R. Rosen, MD

04.17 The Effect Of CDP Choline On Visual Function In Open Angle Glaucoma Patients R. Ritch, MD

04.26 Concentration Of Topically Administered Moxifloxacin In Human Iris/Ciliary Body J. Seedor, MD

04.32 Effect Of Argon Laser Iridotomy (ALI) And Argon Laser Peripheral Iridoplasty (ALPI) On the Corneal Endothelium R. Ritch, MD

04.34 A Prospective Assessment Of The Effect Of Trabeculectomy With Mitomycin C Or 5-Fluorouracil On The Corneal Endothelium R. Ritch, MD

04.40 Effect Of Artificial Tears On Visual Acuity R. Latkany, MD

04.41 Comparison Of Different Preservative Free Artificial Tears On Visual Acuity R. Latkany, MD Accepted

04.42 Effect Of Artificial Tears And Punctal Plugs On Visual Acuity R. Latkany, MD

04.43 The Effect Of Intra-Ocular Pressure Changes On Optic Disc Topography And Retinal Nerve Fiber Layer Thickness R. Ritch, MD

05.02 Effect Of Botulinum Toxin (Botox) Treatment For Blephorospasm On the Measurement Of Intraocular Pressure R. Ritch, MD

05.18 A Randomized, Double-Masked, Parallel Group, Multi-Center, Dose Ranging Pilot Study Of Denufosol Tetrasodium (INS37217) Intravitreal Injection In Subjects With Post Cataract Extraction Macular Edema R. Rosen, MD

01.11 A Multicenter, Randomized, Double-Masked, Controlled Study To Evaluate The Safety And Efficacy Of An Intravitreal Fluocinolone Acetonide (0.5 Or 2mg) Implant In Patients With Non Infectious Uveitis Affecting The Posterior Segment Of The Eye P. Latkany, MD

03.04 Rituximab For Primary Ocular Adnexal Lymphomas S. Lauer, MD

03.11 A Phase III, Multi-Center, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration R. Gentile, MD

04.16 Oral Montelukast For Graves’ Ophthalmopathy S. Lauer, MD

03.07 AccuMap Glaucoma Detection Study J. Liebmann, MD

03.14 A Multicenter, Randomized, Open-Label Study To Compare Subconjuctival Injection Of 100 μg CAT-152 Human Anti-TGFβ2 Mononuclonal Antibody With An Intraoperative Sponge Application Of 5 - Fluorouracil Following First Time Trabeculectomy R. Ritch, MD

04.44 Is Measurement Of Eye Axial Length In Patients who have Undergone Trabeculectomy More Accurate With The Non-Contact IOL-Master Compared With Ultrasound Biometry? R. Ritch, MD

INSTITUTIONAL REVIEW BOARD 147 INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 05.03 Effect Of Pupillary Dilation On Intraocular Pressure In Exfoliation Syndrome R. Ritch, MD

00.14 Endothelial Cell Counts Following Baerveldt Glaucoma Implant Surgery P. Sidoti, MD

02.18 A Phase II Randomized, Controlled, Double-Masked, Dose-Finding, Multicenter, Comparative Trial, In Parallel Groups, To Establish The Safety And Preliminary Efficacy Of Intravitreal Injections Of EYE001 (Anti-VEGF Pegylated Aptamer), Given Every 6 Weeks For 12 To 30 Weeks To Patients With Clinically Significant Diabetic Macular Edema (CSME) Involving The Center Of The Macula R. Gentile, MD

02.32 A Phase I/II, Single-Masked, Multicenter Study Of The Safety, Tolerability, And Efficacy Of Multiple-Dose Intravitreal Injections Of rhuFab V2 In Combination With Verteporfin (Visudyne™) Photodynamic Therapy In Subjects With Neovascular Age-Related Macular Degeneration R. Gentile, MD

04.05 In Vivo Confocal Microscopy Epithelium In Healthy Volunteers J. Seedor, MD

05.04 Effect Of Portable Air Humidifier/Purifier On Symptoms In Dry Eye Patients R. Latkany, MD

03.26 Estrogen Metabolite Ratio Of 2-Hydroxyestrone: 16α-Hydroxyestrone As A Marker And Mechanism For Proliferative Thyroid Disease S. Schantz, MD

04.31 A Prospective Assessment Of Nerve Fiber Layer Thickness In Subjects With Unilateral Pseudoexfoliation Syndrome R. Ritch, MD

04.45 Intraocular Pressure And Ocular Pulse Amplitude Measurement In Patients With Thin And Thick Corneas Using Pascal Dynamic Contour Tonometer R. Ritch, MD

05.10 Comparing The Intraocular Pressure And Ocular Pulse Amplitude Measurements IN Patients With Asymmetric Glaucoma Damage Using Pascal Dynamic Contour Tonometer R. Ritch, MD

05.11 Comparing The Ocular Pulse Amplitude Measurements In Patients With Asymmetric Glaucoma Damage Using Pascal Dynamic Contour Tonometer And POBF Tonograph R. Ritch, MD

99.28 Transpupillary Thermotherapy Of Occult Subfoveal Choroidal Neovascular Membranes In Patients With Age-Related Macular Degeneration (The TTT Study) R. Rosen, MD

00.19 Macular Genetics Study R. Rosen, MD R. Gentile, MD

01.16 A Phase II/III Randomized, Double-Masked, Controlled, Dose-Ranging, Multi-Center Comparative Trial, In Parallel Groups, To Establish The Safety And Efficacy Of Intravitreal Injections Of EYE001 (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks For 54 Weeks, In Patients With Exudative Age-Related Macular Degeneration (AMD) R. Rosen, MD

03.27 SLO-OCT ICG Angiography R. Rosen, MD

148 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 03.29 A Phase 3 Study Assessing The Safety And Effectiveness Of The GMP Bi-Directional Glaucoma Implant In Patients With Primary Open Angle Glaucoma Who Have Failed Conventional Medical And Surgical Therapy J. Liebmann, MD

04.08 An Exploratory Study Of The Safety, Tolerability And Biological Activity Of Intravenously Administered VEGF Trap In Patients With Neovascular Age-Related Macular Degeneration R. Rosen, MD

04.09 Optometrist/General Ophthalmologist-Performance in CNV Detection R. Rosen, MD

04.11 A Randomized Trial To Evaluate 2 Hours Of Daily Patching For Amblyopia In Children 3 TO < 7 Years Old (ATS5) L. Hall, MD

04.12 A Randomized, Double-Masked, Placebo Controlled, Parallel Group, Multi-Center, Dose-Ranging Study Of Denufosol Tetrasodium (INS37217) Intravitreal Injection In Subjects With Rhegmatogenous Retinal Detachment R. Rosen, MD

05.15 Comparison OF OCT-Ophthalmoscope And Standard OCT Technology Instrument For The Imaging Of Macular Hole Pathology R. Rosen, MD

99.11 A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study To Evaluate The Effectiveness And Safety Of Oral Memantine In Daily Doses Of 20 mg And 10 mg In Patients With C hronic Open-Angle Glaucoma At risk Of Glaucomatous Progression R. Ritch, MD

02.38 A Randomized, Double-Masked, Multi-Center Trial Of The Safety, Tolerability And Pharmacokinetics Of 1 Mg/Eye And 3 Mg/Eye Intravitreal Injections Of Pegaptanib Sodium (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks For 54 Weeks, In Patients With Exudative Age-Related Macular Degeneration (AMD) R. Rosen, MD

04.46 An Open Label, Non-Comparative Protocol For The Use Of Pegaptanib Sodium Every 6 Weeks In Patients With Exudative Age-Related Macular Degeneration (AMD) R. Rosen, MD

05.14 Epithelial Toxicity Of 0.5% Povidone Iodine Studied By in-vivo Confocal Microscopy In Healthy Human Volunteers D. Ritterband, MD

05.25 Evaluating Tear Film Dysfunction – Schirmer’s Test Vs. Tear Normalization Test R. Latkany, MD

05.08 A Phase 3 Multicenter, Randomized, Double-Masked, Controlled Study Of Squalamine Lactate (MSI-1256F) For Injection For The Treatment Of Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration R. Rosen, MD

02.33 An Extension Study To Evaluate The Safety And Tolerability Of Multiple-Dose Intravitreal Injections Of rhuFab V2 In Subjects With Neovascular Age-Related Macular Degeneration Who Have Completed The Treatment Phase Of A Genentech-Sponsored Phase I Or Phase II/II rhuFabV2 Study R. Gentile, MD

INSTITUTIONAL REVIEW BOARD 149 INSTITUTIONAL REVIEW BOARD 2006

DATE TOPIC PRESENTER 04.13 A Phase 2, Multi-Center, Randomized, Masked, Controlled Study Of MSI-1265F (Squalamine Lactate) (IND # 66,897) For The Treatment Of Choroidal Neovascularization Associated With Age-Related Macular Degeneration MSI-1256F-209 R. Rosen, MD

06.18 A Six-Week, Multicenter, Masked, Randomized Trial (With A 20-Week Masked Extension) To Assess The Safety And Efficacy Of 700 μG And 350 μG Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System Compared With Sham DEX PS DDS Applicator System In The Treatment Of Non-Infectious Ocular Inflammation Of The Anterior Segment In Patients With Anterior Uveitis C. M. Samson, MD

150 THE NEW YORK EYEAND EAR INFIRMARY INSTITUTIONAL REVIEW BOARD 2006

INSTITUTIONAL REVIEW BOARD 151 APPOINTMENTS, HONORS, AWARDS, FELLOWSHIPS

2005 US NEWS AND WORLD BEST HOSPITALS (Eye Hospitals)

The New York Eye & Ear Infirmary

The Chair congratulated all and thanked all those responsible for the hard word that so many do to keep these ratings. The Committee expressed the strong warning that we much grow and build for the future for us to continue not only US News and World Report Ratings but to continue to fulfill our Mission of Patient Care, Education and Research.

US NEWS AND WORLD REPORT BEST HOSPITALS 2005

1. Bascom Palmer Eye Institute

2. Wilmer Eye Institute

3. Wills Eye Hospital

4. Massachusetts Eye & Ear Infirmary

5. Jules Stein Eye Institute, UCLA

6.University of Iowa

7. Doheny Eye Institute, USC

8. Duke University Medical Center

9. New York-Presbyterian University

10. University of California, San Francisco

11. Barnes-Jewish Hospital/Washington University

12. THE NEW YORK EYE & EAR INFIRMARY

13. Mayo Clinic

14. Cleveland Clinic

15. University of Michigan Medical Center

16. Emory University

17. Manhattan Eye & Ear Infirmary

152 THE NEW YORK EYEAND EAR INFIRMARY APPOINTMENTS, HONORS, AWARDS, FELLOWSHIPS

NEW YORK MAGAZINE BEST DOCTORS IN NEW YORK JUNE 2005/2006 ABRAMSON, David H

DELLA ROCCA, Robert C

FINGER, Paul T

FUCHS, Wayne S

GENTILE, Ronald C

HALL, Lisabeth S

HORNBLASS, Albert

KO, Wilson*

KUPERSMITH, Mark J

LIEBMANN, Jeffrey M

LIPPMAN, Jay

LISMAN, Richard S

MACKOOL, Richard J

MAGARAMM, Irene

MANDEL, Eric R

MEDOW, Norman B

MILLMAN, Arthur L.*

MULDOON, Thomas O

RITCH, Robert

ROSEN, Richard B

SHABTO, Uri R

WALSH, Joseph B

WANG, Frederick M

ZAIDMAN, Gerald W

* Added in 2006

Dr. Robert Ritch - 2005 John Kearny Rogers Physician of the Year Dr. Robert C. Della Rocca - 11/12/ 05 Invested as Knight of Justice, The Most Venerable Order of the Hospital of St. John of Jerusalem, 11/15/05 Inducted into the White Plains High School Hall of Fame

AAO HONOR AWARDS Achievement Award AAO Meeting, Chicago, October 15 – 18:

James P. Milite, MD

Jeanne L. Rosenthal, MD

Neil J. Friedman, MD R’ Ophth. ’96

APPOINTMENTS, HONORS, AWARDS, FELLOWSHIPS 153 APPOINTMENTS, HONORS, AWARDS, FELLOWSHIPS

CASTLE CONNOLLY TOP DOCTORS TENTH EDITION NEW YORK METRO AREA 2006 THE NEW YORK EYE & EAR INFIRMARY 80 listed

ABRAMSON, David H MAGRAMM, Irene ACCARDI, Frank E MAHER, Elizabeth ANGIOLETTI, Louis V MANDEL, Eric R ASBELL, Penny MANDELBAUM, Sid BARILE, Gaetano McDERMOTT, John A BARKER, Barbara Ann MACKOOL, Richard J BUXTON, Douglas F MEDOW, Norman CAMPOLATTARO, Brian MILITE, James P CHAIKEN, Barry MILLMAN, Arthur CHARLES, Norman MOSKOWITZ, Bruce K CHERN, Reily MULDOON, Thomas O CHU, Wing NEWTON, Michael COHEN, Ben NIGHTINGALE, Jeffery COHEN, Leeber PERRY, Henry CYKIERT, Robert POOLE, Thomas DELLA ROCCA, Robert C PRINCE, Andrew DINNERSTEIN, Stephen RELLAND, Maureen ESPOSITO, Donna RICHARDS, Renee FINGER, Paul T RITCH, Robert FOX, Martin L RODRIGUEZ-SAINS, Rene S FRIEDMAN, Alan J ROSEN, Richard B FRIEDMAN, Robert ROSENTHAL, Jeanne L FUCHS, Wayne ROSENTHAL, Kenneth GENTILE, Ronald C RUDICK, A Joseph GIBRALTER, Richard P SCHIFF, William M GRAYSON, Douglas SEEDOR, John A GURLAND, Judith SHABTO, Uri HALL, Lisabeth SIDENFELD, Andrew HORNBLASS, Albert SIDOTI, Paul A KELLY Stephen E SILBERT, Glenn KLEIN, Noah SOLOWAY, Barrie KO, Wilson STEELE, Mark KOPLIN, Richard S TOPILOW, Harvey KRAMER, Philip WALSH, Joseph B KUPERSMITH, Mark WESELEY, Peter E LESTER, Richard WISNICKI, H Jay LEVITZKY, Munro WONG, Raymond F LIEBMANN, Jeffrey YAGODA Arnold D LIPPMAN, Jay ZAIDMAN, Gerald W* LISMAN, Richard D ZELLNER, James H

154 THE NEW YORK EYEAND EAR INFIRMARY APPOINTMENTS, HONORS, AWARDS, FELLOWSHIPS

CLASS OF 2005 APPOINTMENTS/FUTURES

FELLOWS- NYE&EI RESIDENTS 2005 Graduates

Benevento, Joseph, MD U Chicago - Retina Contreas, Marta, MD Private Practice De La Cruz-Naploi, Jose, MD MEEI Cornea/External Diseases Fishman, Gary MD, MD NYE&EI Refractive Manusis, Kira, MD Columbia/Cornea Pro, Michael, MD Glaucoma/NYE&EI

FELLOWS- NYE&EI RESIDENTS 2005

In-coming 2005 - 2006

Cornea/External Diseases Drs. Seedor & Ritterband Bhargava, Anuj Resident U Ottawa, Future Position Cornea U. Ottawa Yang, Renee Resident U Wisconsin

In-coming 2005 - 2007

Retina Service Fitz, Eric U of Virginia

In-coming 2005 - 2006 Glaucoma Service Drs. Ritch & Tello

CLINICAL

Harizman, Noga Presently Research Fellow Kelly, William John Resident SL-R, MD – NYMC Edgar Espana Colombian University, Bogotá

RESEARCH

Barkana, Yaniv Presently Clinical Fellow in Glaucoma De Barros, Rodrigo Residency ABC School of Medicine, Santo Andre (Sao Paulo) Dorairaj, Syril Kumar Residency - Minto Regional Institute , India. Research Associate: Molecular Reproduction, Development & Genetics, Minto University (glaucoma, retino-blastoma, RP) Grippo, Thomas Presently Research Fellow

Kanadani, Fabio Nishimura Residency - Ministry of Education and Culture at Clinica de Olhos of Santa Casa Belo Hoizonte, Brazil Wangsupadilok, Boonchai Resident - Prince of Songkla Univ, Thailand

The application will be sent to the PC for further action.

APPOINTMENTS, HONORS, AWARDS, FELLOWSHIPS 155 APPOINTMENTS, HONORS, AWARDS, FELLOWSHIPS

CLASS OF 2006 APPOINTMENTS Graduates

Brown, Andrew, MD Private Practice

Chang, Steve, MD Cornea Refractive Surgery Sinskey Eye Institute

Kerry K. Assil, MD

Hedaya, Joshua, MD Retina UC San Diego

William Freeman, MD

Gatto, Michele, MD Cornea & External Disease

M. G Speaker, MD, PhD

Robert Latkany, MD

Liu, Alex, MD Oculo-plastics Beraja Medical Institute Coral Gables, FL

Liu, Jeffrey C. Private Practice, California

Page, Jon, MD Corneal & External Disease

Jules Stein/UCLA

Rodriguez, Natalia MD Private Practice

Tao, Stanley, MD Vitreal-Retinal Disease

John |E. Lynn, MD

Memphis Tennessee

Trivedi, Gaurang. MD Glaucoma, NYE&EI Drs. Ritch, Tello, Liebmann

156 THE NEW YORK EYEAND EAR INFIRMARY APPOINTMENTS, HONORS, AWARDS, FELLOWSHIPS

APPOINTMENTS, HONORS, AWARDS, FELLOWSHIPS 157 OPHTHALMOLOGY DONATIONS 2005 – 2006

ABORN-LUBKIN CENTER FOR EYE RESEARCH Anthony Anderson Harvey S. Rosenblum Nancy H. Coles Danise Weiss Karen Allison Opticology, Inc. David M. Silverberg Kenneth R. Cohen Perrin L. Blank David S. Karan Lisa M. Porche Burke Peter L. Oppenheimer Don Wise Louis H. Aborn Richard Feinbloom Edward H. Bedrossian Louis H. Aborn Foundation Roger A. Michaels Eugene Wisoff Marguerite M. Wilke Solomon H. Chafkin Gloria Leeds Marie Coleman The Wise Family Charitable Harriet R. Barry Mollie F. Kikuchi Foundation

BETH ISRAEL OPHTHALMOLOGY FUND Beth Israel Medical Center

DIANNE ANGIOLETTI MEMORIAL FUND Amy S. Decotiis Jeannene Doub Pat Montalbano Anna Brown Joel C. Friedman Patricia Malillo Barbara J. Bopp John A. Cannito Priscilla Mac Phail Barbara Taylor John N. Curcio Ralph Del Priore Brian A. Bentancourt John T. Miller Remo B. Cinquino Cynthia LaTerra John T. Volpe Richard Levine Debra A. Starr-Costa Joseph B. Walsh Richard S. Eichenbaum Donald R. Schwamb Joseph G. Meyer Robert J. Klemt Doris Schonberg Joseph P. Corcoran Ronald C. Gentile Elaine F. Gustenhoven Julia Trenkmann Ruth Bloom Ellen S. Battle Laurice A. Albed Ruthann Curley Ellen Zlotolow Linda P. Desfosses Seligman Rosenberg Frances Kraus Lisa C. McElrath Shari L. Rosenberg Francine Hartley M.J. D'Addato Stefan Rossi Fred Futterman Michael A. Freedman Steven Waldman G. Joannou Cycle Co., Inc Nancy C. Sanders Stuart Komrower Glen Rock High School Nancy Rosenthal Thomas J. Volpe Glenn Dennis Narcissa Ferri Tina Karayanis Helena Bopp Palisades Rehabilitation Center William C. Speciale Janet G. Nackson of Cresskill

GERALD G. PIERCE, MD ENDOWMENT FUND

HPB Foundation

GLAUCOMA RESEARCH AND DEVELOPMENT FUND

Bearing Point Frederick M. Wang Nicola Mullen Changing Our World Jean Rabunski Roger Thorpe Charitable Gift Fund John M. Gillen Ruby E. Morgan Douglas F. Buxton John R. Finlay Sandra E. Ward Edwin Stritzl Matilda Belley

158 THE NEW YORK EYEAND EAR INFIRMARY OPHTHALMOLOGY DONATIONS 2005 – 2006

JORGE N. BUXTON, MD MEMORIAL MICROSURGICAL EDUCATION CENTER Alcon Laboratories, Inc. Frank P. Tortorici Pannonia Foundation Ambrose Monell Foundation Frederick G. Feldman Peter Reiff Carol Moss Herbert E. Walters Robert Gross Charles & Mildred Joseph V. Arigo Steve Henninger Schnurmacher Foundation, Inc. Lenore Hecht Wyeth Douglas F. Buxton Lucien M. Cesiano Ernest T. Harper Millicent W. Simon

LIBRARY Dr. Gerald G. Pierce, MD

MIRIAM LANDAU FUND FOR RESIDENT RESEARCH AWARD The Estate of Mrs. Miriam Landau

OPHTHALMOLOGY CHAIRMAN'S RESEARCH FUND Douglas Grayson, MD Yashoda Dilwali

RETINA RESEARCH ENDOWMENT FUND Aaron Langman Herbert Krasnow Millicent W. Simon Adam Bartos Pannonia James Brinkley Norman Odlum Foundation Jean Dansker Phyllis R. Galst Al Maiolo Joseph R. Burkart Philip J. Silverstone Chase Manhattan Foundation Joseph B. Walsh Seymour Kaplan Edward J. Kuriansky Louis V. Angioletti Sheldon S. Gordon Edward J. Nowak Mr/Mrs. Justus Lawrence Shoreline Eye Group, PC Edwin Stritzl Mr/Mrs. Peter Murphy The Bendheim Family/Leon Floridalma Barreto Mr/Mrs. Roger J. King Lowenstein Foundation, Inc Frederick M. Wang Mark J. Altschuler Herbert E. Gade Mercedita Nelson

DONATIONS 159 160 THE NEW YORK EYEAND EAR INFIRMARY DEPARTMENT OF OPHTHALMOLOGY EXECUTIVE OVERVIEW 2005

RESIDENTS

FIRST YEAR RESIDENT ON-CALL REVISION/NIGHT FLOAT INSTITUTED Commencing Sunday, 01/09/05 the first year residents instituted a new on-call rotation.

Residency Interviews for the class of 2009 were held December 11 and 17, 2004. The committee members assisted by Ms. Lamm, Mr. Jordan and Mrs. Almadovar did an excellent job.

COMMITTEE MEMBERS

Richard B. Rosen, MD Abha Amin, MD Ms. Ann Brancato Neal Brown, MD Douglas F. Buxton, MD John McDermott, MD Brian Campolattaro, MD Ronald C. Gentile, MD Susan Schneider, MD Jeanne L. Rosenthal, MD Paul A. Sidoti, MD John Seedor, MD C. Michael Samson, MD Joseph Walsh, MD Sherry Yang, MD Glenn Silbert, MD

RESIDENT MATCH RESULTS - CLASS OF 2009

BERENBOM, Anne BA U. Pennsylvania MD Washington U. HAIM, Lior BS Brandies University MD Jefferson University JOHNSON, Paul B. BA John Hopkins U. MD Jefferson Medical KURLI, MaDhavi MD Chennai Med. Ophth. Wolverhampton Eye FRCOphth. LEE, Olivia L. BA Rice University MD Baylor College of Med. PATEL, Neil BS, MS Columbia Univ. MD SUNY Downstate THE, Arlene H. BA Brown University MD Brown University

RESIDENT INTERVIEWS CLASS OF 2010

Residents: 12/10, 12/16 with reception previous nights

Thanks to the reviewers who have culled 60 outstanding candidates for interviews from over 390 applica- tions. Again the quality of candidates on paper is excellent and thanks in advance to the interview team: Drs. Brown, Buxton, Gamel, Gentile, and Campolattaro, Yang, Kaiura, Ko, McDermott, Rosen, McNally, Marcelin, Samson, Sidoti, Walsh, and Mrs. Anne Brancato.

Thanks as well to Mrs. Rafaela Almodovar, assisted by Mr. Robert Jordan for all the work involved and especially in finding the 84 lost applications sent by the match to Northwestern instead of NYE&EI. RESIDENT MATCH RESULTS CLASS OF 2010

ADVANI, Anisha B. AMDE, Wendewessen GRIPPO, Tomas Mariano GUPTA, Arusha KIM, Julie Hyunjoo MACKOOL, Richard Jonathan SHULMAN, Julia Paula RESIDENT BI-ANNUAL REVIEWS

Resident reviews were conducted on February 7, 2005. Present were: Drs. Paul A. Sidoti, C. Michael Samson, Joseph B. Walsh, and Richard B. Rosen & Ronald C. Gentile. An important component is the reviews of the residents by the attendings on Web esprit and the reviews by nurses, patients and fellow residents.

DEPARTMENT OF OPHTHALMOLOGY EXECUTIVE OVERVIEW 2005 161 DEPARTMENT OF OPHTHALMOLOGY EXECUTIVE OVERVIEW 2005

JUNE 4TH NINTH ANNUAL FELLOW/RESEARCH DAY

38 Presentations covered a wide variety of areas of research

Those that attended were rewarded to most impressive presentation. Dr. Rosen and Dr. Buxton are consid- ering having the 10th Annual Resident/Fellow day to be held the same day as the Alumni/ae Dinner. This would have to be held after ARVO. Further information will be given as noted.

We wish to express appreciation the Alumni/ae Association and to the officers, Drs. Buxton, Pashcow and De Luca, for a wonderful evening at the Racquet Club on May 19. ADMINISTRATIVE CHANGE

Ms Catherine Lamm, Assistant to the Program Director, left the Infirmary on July 29, 2005 to pursue other directions. Catherine came to the Infirmary; in 1989 and has served as Secretary to the Program Director of Ophthalmology since July 1999. We wish her the best and thank her for the service she has rendered to the Infirmary. NYMC RESIDENT ROTATION

The NYMC residents, that have rotated through the Infirmary, expressed their deep appreciation to the res- idents and attendings and administration at the Infirmary for having had this most opportune and educa- tional rotation. OKAP REVIEW COURSE

Dr. Rosen stated that the Board & OKAP Course was a rousing success. After 17 years being held at BIMC, the course was held in the New York Eye Ear Infirmary North Building Conference Room that has a upgrad- ed for computer projection. CONFERENCE LECTURE SCHEDULE RESIDENCY

Need more interactive conferences, e.g., Retina and Grand Rounds

Overwhelming, for example - can have AM lectures with OKAP Review Tuesday and Thursday and MEETH Wednesday. Dr. Rosen will review hours and now that we have OKAP Review Course in-house, the dates can be set in advance (in the past, waited for BI to release dates for Podell Hall and then set lec- ture dates)

More teaching, not lectures but interactive, e.g., college and medical school less then 25% of student body attend scheduled lectures.

RRC as of now requires present system. Will consider alternative methods as allowed.

Hard to have all three years interested in lectures and to keep the level understandable for the first year and meaningful for the third. (One room schoolhouse on the prairie.)

18-month education cycle allows more flexibility in scheduling and more room for alternative educational avenues.

PCs for clinic approved for residents ANKA system all imaging including corneal modeling, confocal micro- scope, VF, OCT, FA, ICG etc. available from any PC. Digital camera donated for the Comprehensive Eye Clinic by Dr. Aljian's generosity so that residents can capture to image cases especially off hours, e.g. trau- ma.

162 THE NEW YORK EYEAND EAR INFIRMARY DEPARTMENT OF OPHTHALMOLOGY EXECUTIVE OVERVIEW 2005

ACGME REQUIRES

Basic and Clinical Sciences 360/hours over 36 months In addition 6/hr month (case presentations, Quality Attended by residents and attendings) 36 hours of laboratory experience in gross and microscopic examination of pathological specimens

OKAP now in-house 16 sessions @ 3 hours = 48 hours AM conference 9.5 months @ 4/week = 152 hours 200

Grand Rounds 9.5 months @ 1/week = 38 hours Visiting Professor 6/year 5 hours 43 hours

RRC/ ACGME OUTCOME

Emphasis moving from structure and procedure to Outcomes as is noted below.

It is incumbent upon us as medical educators to demonstrate the effectiveness of our educational programs and to be held accountable for our work. The ACGME Outcome Project is dedicated to achieving that pur- pose.

CORE COMPETENCIES

PATIENT CARE Compassionate, appropriate, effective, for the treatment and promotion of health

MEDICAL KNOWLEDGE Established and evolving biomedical, clinical and cognate sciences as well as application of this knowledge to patient care

PRACTICE-BASED LEARNING AND IMPROVEMENT Involves the investigation and evaluation of care for their patients, the appraisal and assimilation of scientific evidence and improvements in patient care

INTERPERSONAL AND COMMUNICATION SKILLS Result in the effective exchange of information and collaboration with patients, their families and other health professionals

PROFESSIONALISM As manifested through a commitment to carrying out professional responsibilities, adherence to ethical princi- pals, and sensitivity to patient diverse backgrounds (cultural sensitivity)

SYSTEMS-BASED PRACTICES Manifested by awareness of and responsiveness to the larger context and system of health, as well as the ability to call effectively on other resources in the system to provide optimal health care

CARE OF THE SURGICAL PATIENT Understanding the medical and technical knowledge and surgical skills to care for the surgical patient. This includes: Preoperative ophthalmic and general medical evaluation Risks and benefits Inter-operative skills Informed consent Anesthetic considerations

Postoperative management including systemic and ophthalmic complications associated with surgery and anesthesia.

DEPARTMENT OF OPHTHALMOLOGY EXECUTIVE OVERVIEW 2005 163 DEPARTMENT OF OPHTHALMOLOGY EXECUTIVE OVERVIEW 2005

The goal of each program is to develop objectives and then measurements of resident achieving each objective that is provable that said objectives are being meet. Also added experience in Practice management Ethics Advocacy Visual Rehabilitation Socia-economics Review www.acgme.org - great resource

In ophthalmology attempting to review residents on-line in light of above

Surgical log kept on ACGME log-on site - Working well. Hope to add program review and resident review of attendings, lectures, program, etc.

Not working well Computer program for on-call HOUR LIMITATION Conference attendances scan system APPRECIATION

OCULAR TRAMA SERVICE DINNER

The Ocular Trauma Service Dinner was held on June 2 at the Water Club and Dr. Jayne Weiss spoke on Chemical Injuries: Immediate treatment. This was a tribute to the Ocular Trauma Service, Attendings, Fellows, Residents and Fellows, which serves, so well, the Greater Metropolitan Area. John M. Aljian, Co- Director, again was the Host and MC, in his usual perceptive and generous style.

The NYE&EIOA PC and Class of 2005 Graduation Dinner was held on June 14 at the Blue Fin and cele- brated and thanked all of the attendings who work in the Clinics, OR and On call to make our program one of the best in the World, It was also a celebration, expression of thanks and extended best wishes to the Class of 2005. The PC Staff, Lloyd Stanford, Executive Administrator, and all his co-workers were especially singled out for their most professional and competent work. CONTINUING MEDICAL EDUCATION

CME DEPARTMENT

Ophthalmology GR evaluation summaries for the 2002 Grand Rounds suggestions noted: Handouts - References are given at the end of each presentation so that further information can be perused if indicated.

PCR and Techniques of Radiotherapy Techniques for Ocular Tumors are presented in the Basic Science Section of the Academic Program and are too specialized for a general audience. Tumor Conference does cover the latter to some extent.

The comment related to more questions from the audience and more case discussion by various members of the audience is a constant goal and we will reinforce this in the future.

We deeply appreciative Kimberly Corbin's support and careful analysis of the Course Evaluations so that we may continue to improve our courses in order to meet academic and clinical standards for improve- ment of ophthalmic care. We will further encourage attendings to evaluate each Grand Rounds (note response rate of 37% (212/568), as we as performing full disclosure of financial or other interests to ensure proper evaluation of the topics presented. OF NOTE - Out of 42 accredited Grand Rounds for 2002

ATTENDANCE: 560 MD's and 8 non - MDs 212 (37%) Responders GOOD TO EXCELLENT

164 THE NEW YORK EYEAND EAR INFIRMARY DEPARTMENT OF OPHTHALMOLOGY EXECUTIVE OVERVIEW 2005

SURGEON DIRECTORS

SURGEON DIRECTOR'S 2005 AND BEYOND

The feeling of the committee was that since the agreement with Continuum mentions Surgeon Directors as representatives to the Board, this title must be preserved. Chiefs of Major services must be voting members of the MB Full-time (salaried), geographic full-time, teaching faculty as well as active surgeons must have representa- tion The Medical Board of the Infirmary is the policing making body for medical activities at the Infirmary including, but not limited to:

Credentialing Quality control of Hospital and staff Monitor Educational and Research Activities at the Infirmary Forum for an interchange of ideas from all constituents at the Infirmary Train the leaders of tomorrow

The Medical Board member evaluation process must include: Devotion to the Infirmary Willingness to take on and fulfill assigned tasks from the MB Relate to and represent the full spectrum of the Medical Staff Be involved with the Infirmary: teaching, OR, On-call, VCC, etc. Have the Infirmary as his/her major ophthalmic center

OBJECTIVE MEASUREMENTS

Medical Board Meeting attendance Infirmary as major clinical base Participation in sub-committees Involvement in Departmental tasks:

Teaching Research Executive Committee Involvement in Infirmary support activities Fund Raisers Social Events, e.g., Staff & Alumni Association

SURGEON DIRECTORS SEARCH

The Infirmary Board of Directors did not approve revised Medical Board/Staff By-Laws as they felt the turn over of 4 eye surgeon at one time directors was too disruptive to hospital function.

Dr. Muldoon presented (MB 11/15/05) the By-Laws Committee recommendation of a staggered term be employed to meet the Board objections.

Present Situation SD Elected Wing Chu 1991 Robert C. Della Rocca 1982 Mark J. Kupersmith 10/02 Thomas O. Muldoon 1982 Robert Ritch 1991 Richard B. Rosen 10/02

So Dr. Muldoon noted that Drs. Chu, Della Rocca, Muldoon and Ritch

DEPARTMENT OF OPHTHALMOLOGY EXECUTIVE OVERVIEW 2005 165 DEPARTMENTALDEPARTMENT OF OPHTHALMOLOGY EXECUTIVE COMMITTEE EXECUTIVE OVERVIEW OVERVIEW 20052005

Term expires upon adoption of the new by-laws as each have served 5+ years. Each can run again if they so chose. Drs. Kupersmith and Rosen expire 10/07 so are " THE CLASS OF 2007".

The by-laws committee suggested:

Dr. Muldoon has stated he will not stand for re-election and will become Honorary Surgeon Director on the Board passage of the Bylaws.

He suggested one of the other expired SD (Drs. Chu, Della Rocca or Ritch) also step down with the option of running for another 5 year term

CLASS of 2005 CLASS OF 2006 CLASS of 2007 X X Dr. Kupersmith X X Dr. Rosen

So 2006 would serve till 2011

2007 Would serve till 2013

If a SD position were vacated, for any reason and election would be held to fill that position for the reminder of that SD five- year term

The Exec. Committee has already selected criteria for SD in Ophthalmology and the Medical Board appointed a nominating committee; (Drs. Fradin, Kupersmith, Rosen, Seedor & Walsh) ready to begin the process once the ground rules are decided upon. FACULTY

NEW FACULTY

Comprehensive Service Assistant Director

Dr. Paul A. Sidoti, Director of the Comprehensive Eye Service, announced that Anne Ko, MD R'04 upon completion of her Cornea Fellowship at Doheny Eye Institute, Keck School of Medicine-USC, assumed the position of Assistant Chief of the Comprehensive eye Service in July 2005/

NEURO-OPHTHALMOLOGY Dr. Kupersmith, Surgeon Director, announced that one of his former Fellows, Hillary E. Fazzone, and MD, presently at the University of Vermont is joining him in practice and will be active at the Infirmary in Education and patient care.

166 166 THE NEW YORK EYEAND EAR INFIRMARY EXECUTIVE COMMITTEE RESIDENCY REVIEW 2006

RRC REVIEW Resulted in CONTINUED FULL ACCEDITATION with next review scheduled for 2009.

VISION CORRECTION CENTER CLOSURE The following statement is a reiteration of the policy of the Department from the mid 1990’s.

The Department of Ophthalmology confirms that a comprehensive ophthalmology residency education pro- gram requires that Corneal Laser Surgery: Therapeutic and Refractive be taught and that each resident be exposed to the theory and practice of said surgery.

To be considered a major ophthalmology department, a Corneal Laser Center is essential. Without such a center the educational value and reputation of the Department would be diminished.

In addition, the RESIDENTS SENT A NOTE stating that the Refractive Service under Drs. Buxton & Soloway has had great resurgence. The AAO has Refractive Ophthalmology as a vita part of the Ophthalmology Educational Program. The residents are saddened, disappointed and troubled by closing the center. This center is vital for the Infirmary to remain a leading educational Institute in Ophthalmology.

The Infirmary closed the VCC with the stated reason of unsustainable financial loss.

ADMINISTRATIVE CHANGES Mr. Gregory Atwater, MS, replaced Mrs. Rafaela Almadovar as Departmental Administrator and Ms. Janell Matthews replaced Ms. Catherine Lamm as Secretary to the Program Director’

NYE&EI OA PC TRAUMA SERVICE DINNER Thursday June 15, 2006

ARVO April 30 – May 4 32 Presentations BEACH BASH MONDAY MAY 1, 2006 18:30 SHERATON YANKEE CLIPPER

BENDHEIM FAMILY RETINA CENTER Dedication on May 18, 2006. The Bendheim Family and the Löwenstein Foundation have generously supported The New York Eye & Ear Infirmary since 1949. The Recent gift of $1.5 Million was the occa- sion of the naming.

ARVO Once again the Department of Ophthalmology of NYE&EI/NYMC was well represented as posters, pre- sentations, special meetings and administrative responsibilities.

10TH ANNUAL RESIDENT/FELLOW RESEARCH DAY 05/11/06 Once again this event highlighted the quality and depth of research performed at The New York Eye & Ear Infirmary with 28 presentations (3 addition al abstracts - residents on vacation) by the residents and fellows. Thanks are also owed the many preceptors that are the framework upon which this work is per- formed. Special thanks to Dr. Rosen, moderator, Mr. Atwater and Mr. Jordan for the work that is required for arranging the program and to the Alumni/Staff Association for co-sponsoring this milestone

ANNUAL ALUMNI/AE AND STAFF ASSOCIATION DINNER 05/11/06 Congratulations to Alfonso Ponce-Lopez, MD R Ophtal. ’74, to Mahendra Shah, MS and Dr. Melissa Susan Paschow, R’ Oto. ‘80 as distinguished Honorees. Kudos to Drs. Buxton, De Luca and Scalfani for the truly historical day and most enjoyable evening that attracted alumni from far and near. The above named officers are bound to build on this event to re-invigorate the Association. Some questions to be addressed; Although, the Alumni association has graciously allows fellows to be full members, other non NYE&EI resident staff are still not allowed this privledge and at the meeting it was voted on to submit to the full membership, the granting of voting rights in the Alumni/ae Society to all non-alumni Infirmary Staff who have been active for more than five years.

Need to find away to be able to cover the cost of current residents and fellows to attend the Annual Dinner.

EXECUTIVE COMMITTEE RESIDENCY REVIEW 167 DEPARTMENTALEXECUTIVE EXECUTIVECOMMITTEE RESIDENCYCOMMITTEE REVIEW OVERVIEW 2006 2005

ADMINISTRATIVE CHIEF RESIDENTS 2006-2007 Drs. Michael Banitt and Sam Barone have been selected for the next academic year.

SURGICAL SIMULATOR Dr. Richard B. Rosen has secured the Ophthalmology Surgical Simulator Machine for a one-month trial at the Infirmary. The first resident exposure was this AM related to retinal surgery.

GRADUATION ACTIVITIES SUPPORTING RESIDENTS AND TEACHING FACULTY HELD IN JUNE

TRAUMA SERVICE DINNER (NYE&EI OA PC) & NYE&EI OPHTHALMOLOGY ASSOCIATES PC GRADUATION DINNER

NORTHERN DIVISION

WESTCHESTER MEDICAL CENTER

FORMAN, Scott HOROWITZ, Marc MARKOWITZ, Allan McKEE, Heather ZAIDMAN, Gerald W*

BERGEN

NORDAN, Richard

CLINICAL TRIALS AREA

At the September Infirmary Board of Directors’ meeting, Mrs. Judy Zesinger, announced that The New York Eye and Ear Infirmary Foundation have selected two projects to which to donate.

To help in realizing the fruition of a plan that was enacted in December 2001, the Foundation has donated $64,000.00 to the Refurbishment of part of the Old Retina center for the Clinical Trials Center.

We are most appreciative of the Foundation’s continued support.

168 168 THE NEW YORK EYEAND EAR INFIRMARY DEPARTMENTALEXECUTIVE EXECUTIVECOMMITTEE RESIDENCYCOMMITTEE REVIEW OVERVIEW 2006 2005

NECROLOGY 2005-2006

BRINKLEY, Jr. James Roy Class of 1975 March 8, 1943 - February 21, 2005 1965 BS Dickerson College, 1969 MD New York University School of Medicine 1969 - 70 Intern, UCLA affiliated Hospitals 1970 - 72 USN MC 1972 - 75 Resident in Ophthalmology, NYE&EI 1975 - 76 Vitreal-Retinal Fellow, UCSF

Jim was in private practice in Laguna Hills and Laguna Beach California. He also was Clinical Professor of Ophthalmology at USCF where he served as one of Professor Steven Ryan's first fellows.

Dr. Brinkley was a most loyal and valued member of alumni of the Infirmary. He was most supportive finan- cially and one cannot plaques in the retina center and Jorge N. Buxton Microsurgical Educational Center attesting to his generosity.

In addition for four years, he volunteered time from his private practice to teach in the Retina Clinic with the first and second year eye residents in August and was active in Medical Retina and Fluorescein Angiography, two areas of his special expertise. His lectures were insightful, knowledgeable and beautifully illustrated.

He indeed supported his alma mater by deeds and actions.

In his will, a legacy of $50,000.00 was earmarked for the Infirmary and I am sure Jim would be pleased to see these funds be used for education in Retina: two of his passions.

GOLDBERG, Bernard, MD Class of 1954 1950 MD Boston University 1950 1951 - 54 Ophthalmology Residency The New York Eye & Ear Infirmary 1954 - 05 Attending Staff The New York Eye & Ear Infirmary

Was named Honorary Attending in 2003

Dr. Goldberg was a long time attending and support of the Infirmary. In the 50's and 60's he worked with Dr. Gerald Kara on P-32 for the detection of Choroidal Melanomas.

In April of 1957, the Infirmary Radiosotope Division was successful in receiving a license from the Atomic Energy Commission to possess P32 C-14 and Tritium for animal use. In July 1957, the AEC granted a similar license to possess P-32 for human use that lead to research in the differentiation of malignant tumors from benign tumors. 1

From 1961 - 63- 183 patients (totaling 550 patient visits) were referred for radioisotope studies to help the clinician in his diagnosis of eye tumors. Of these 183 cases, 89 were studied by the external approach and 94 required the transconjunctival approach due to the posterior location of the tumor lesion. To date, 303 patients have been evaluated.

SEYMOUR GOODSTEIN MD Attending Surgeon 1952 – 1998

Dr. Goodstein was active in teaching both in the Clinic and the Operating Room and a valued member of our staff.

Other appointments Downstate Medical Center SUNY Stonybrook Long Island Jewish Medical Center Albert Einstein College of Medicine Attending of the Decade Lifetime Achievement Award

EXECUTIVE COMMITTEE RESIDENCY REVIEW 169 EXECUTIVE COMMITTEE RESIDENCY REVIEW 2006

GERALD GINGLE PIERCE, MD Class of 1963 1932 - 2005

It is with deep sadness that we announce the death of Gerald Gingle Pierce, MD. R Ophth. '63 and a val- ued attending and member of the teaching faculty from 1963 to 1998. Jerry died at 7:20 AM 9.8/05.

Dr. Pierce completed his undergraduate studies at Northwestern State College in Alva, Oklahoma and was awarded him MD from the University of Oklahoma School of Medicine. After his internship at St. Vincent's Medical Center in Manhattan he served his 2-year military service at the US Naval Air Station in Olathe Kansas. He was a resident at the Infirmary from July 1 1960 - June 20, 1963. He joined Dr. Brittain Ford Payne, R Ophth. '30 and upon Dr. Pierce's Retirement, the practice was continued by Dr. Chin Wing Chu, R Ophth. '77.

Dr. Pierce was actively involved on the teaching program at the Infirmary on the Simonton then Della Rocca Service and the Comprehensive Eye Clinic. Upon his retirement he was appointed Honorary Attending Surgeon. He was also an Attending ophthalmologist at Lenox Hill Hospital and Professor of Ophthalmology (Adjunct) at New York Medical College. He was always a true gentleman and treated each patient, as he would expect to be treated. When operating with the residents, he always saw each patient pre and post op. An example, that we should all follow.

Dr. Pierce married Belinda Bingham Jewel. Mrs. Pierce was most active on the Board of Directors and the Women's Auxiliary and was most supportive of the Infirmary before her untimely early death. His step chil- dren PJ (Pliny Jewell IV (Elizabeth) and Lucinda Jewell (Mrs. Peter Donohoe (Peter).

Jerry was a member of the New York Ophthalmology Society serving as President and of the Eye Study Club as well as other organizations such as the AAO. He was a diplomate of the American Board of Ophthalmology. In addition he was a member of the Priory in the United States of America of the Most Venerable Order of the Hospital of St. John of Jerusalem where he served as a member of the Hospitaller's Advisory Committee. In addition Dr. Pierce was a member of the Racquet and Tennis Club of New York, The PGA Club of Palm Beach Gardens, the Monmouth Boat Club of Red Bank New Jersey and the Mount Anthony Club in Vermont.

I was always honored to be in Dr. Pierce's company and his personal friendship and kindnesses will always be remembered. All of us, who had the opportunity of being trained by or working with Dr. Pierce, are bet- ter Ophthalmologists and individuals.

He indeed represented all that is good about the Infirmary, Medicine and Human Kind.

At the end of Dr. Pierce's Obituary in the September 11, 2005 NY Times is the following:A toast to his life at your convenience would be appreciated. Live is changed, it is not ended.

A Latin Choral Mass celebrating his life was conducted at the Holy Ghost Church in Denver Colorado on September 22, 2005

Dr. Pierce's family has established the Gerald Gingle Pierce, MD, Department of Ophthalmology Endowment Fund.

MR. LOU PRVITE May 24, 1933 - May 17, 2005 The New York Eye & Ear Infirmary 1957-1990

Mr. Lou Previte was a long time and valued member of The New York Eye & Ear Infirmary Family. Mr. Previte was the one called upon by all physicians and residents when there was no one else to turn to, as he was always ready, willing and able to do everything for everybody. He ran the Glaucoma Service and Tonography and Visual Field Department and, due to his hard work and innovation in tonography, these services were world-renowned. He also was in charge of the animal laboratory An the Temporal Bone Lab,

170 THE NEW YORK EYEAND EAR INFIRMARY EXECUTIVE COMMITTEE RESIDENCY REVIEW 2006

where her organized teaching courses and practice surgical courses for ENT and Eye Residents and faculty. Again using his inventive mind, he improved these courses with his inventions. In he could fix almost any piece of equipment.

His loyalty and steadfast support of the Infirmary allowed all of the residents and attendings to be better oph- thalmologists.

Lou and his wife, Barbara, moved to Phoenix in October. He became ill in early March with acute Burkitt's lym- phoma and he passed away on May 17, 2005. In addition to his wife, his son, Anthony, his daughter, Kathleen, her husband, Eugene, and their two children survive him.

All who know Lou were touched by him in a very positive manner. He spent 33 years at the Infirmary, retiring in 1990. He was truly "Mr. Infirmary." I think it is fair to say that although he left the Infirmary 15 years ago, his presence, because of all he did for everyone, is still felt today.

JAMES FRANCIS XAVIER O’ROURKE, MD March 11, 1920 – August 4, 2006

Parents not formally educated but literate and self-made and they made sure Jim and his three brothers all for- mally educated. His pride in his parents and brothers was always shown.

Dr. O’Rourke graduated from Manhattan College and Georgetown University School of Medicine in 1943. Jim worked as a dorm adviser then after he and Evelyn were married; he drove a cab each evening and Evelyn worked for the FBI to enable them to live and for school funds. He also played minor league-pro football with the Washington Presidents (owned by George Marshall) and was a champion boxer at Georgetown.

Medical School was accelerated because of WW II and he graduated at age 22. Jim then took his internship at St. Vincent’s Hospital and even found time to play in 3 exhibition games with the Giants but was cut when some of the regular players returned from the war. Many years later at an Awards Ceremony for Jim and Evelyn after Jim sang Danny Boy, Wellington Mara, Giants Owner, remarked: “Had I known he was going to turn out so well, we would not have cut him from the Giants”.

In World War II, Jim served with a Medical Unit (397 Regiment of the 199th Division, 3rd Battalion) in Europe and was awarded the Purple Heart (wounded when shrapnel hit the medical tent when he was delivering a baby) and the Bronze Star (went behind enemy lines with two buddies to rescue a wounded GI). Also he had the dis- tinction of having German Unit surrender to him as his medical unit got to the village ahead of the regular army units. Major O’Rourke Company earned the name “O’Rourke’s Raiders” for this exploit.

He found his soul and life mate in Evelyn Cook and they were married for 62 years at her death. They had 13 children and love was the order of the day for children, friends, in-laws, grandchildren and great children. He always had time for family and commonly all gathered around the piano for song and fellowship with Jim playing and leading all. He also was a top-notch tennis player and won may trophies and had many spirited family matches. I addition he coached the Pop Warner youth football team for 16 years and became local Yonkers heros when they won the Northeastern Regional championship. All his 6 boys played on the team and his daughters were cheerleaders. After bilateral hip replacements, Jim became a creditable golfer and we enjoyed great times at the Scarborough Country Club. Evelyn was his equal in brains, looks and talent (even coaching football team when Jim was not able to be there). His son Brian, at the funeral told this wonderful story to prove the point about his mother. At a gala Westchester dinner for Ronald Regan New York State Campaign for President, at the end, Jim who was a spectacular Toastmaster for the dinner turned to Evelyn and said: “Mother of 13, it is time for you to go home”. Without missing a beat, Evelyn replied: “OK father of 9, lets go home”. Her remarks broke up the audience.

EXECUTIVE COMMITTEE RESIDENCY REVIEW 171 EXECUTIVE COMMITTEE RESIDENCY REVIEW 2006

Jim’s love was for medicine but specifically ophthalmology. Eye residencies were hard to get so as he opened his general practice he constantly pushed Columbia to give him and eye residency. He always studied and took courses and finally (he wondered if because of his hard work or he wore the down) he got his wish and successfully completed his residency in ophthalmology at Columbia in 1951. In fact he did so well, he was asked to teach Physiology and when Professor A Gerald De Voe left to become Chairman of Ophthalmology at New York University, he requested Dr. O’Rourke come with him to educate the residents. All through his residency, the general practice keeps a roof over the head and food on the table for his rapidly growing family.

He maintained a most active practice with a high surgical volume and had and impeccable reputation. In 1977, he joined the Department of Ophthalmology at New York Medical College and he became Director of Ophthalmology at Westchester County Medical Center and subsequently moved his practice to WMC. He reinvigorated the Department and brought medical student and resident education to the fore and made quality patient care the only acceptable standard. He cared for each resident, attending and patient and treat- ed all equally and demanded the same of others. Jim never stopped learning ophthalmology and surgery. When he had some DCR to do, he went to Robert C. Della Rocca, Chief of Ophthalmic Plastic, Orbital and Reconstructive Surgery at NYE&EI, and updated his techniques working with Bob. Also, he was the most informed of present and past articles at monthly Journal Club and all present profited from his knowl- edge and perspective. Every resident trained by Jim, learned not only ophthalmology but also the art of being a physician and a human being. When I had the opportunity to present Jim with our Department heartfelt thanks for all his generosity of spirit and talent given to us all so freely at our Resident Graduation in 2006 at the Botanical Gardens, I ended with: “If any of us in the future wonder what we is the correct path we should take for a patient, just ask what Dr. O’Rourke would do – and we will have the answer”.

In addition to his profession, family and his faith, Jim was most active in politics serving as Mayor of Yonkers, Chair of the Republican Party of Westchester and was instrumental in having Ronald Regan run an active presidential campaign in NYS. He did this not for soliciting favors, but because he felt Regan was the best candidate. Upon President Reagan’s election, Jim served as a regent for the Armed Forces Medical School for eight years. He help found the Hudson Valley National Bank as money was need to help his beloved Yonkers and Westchester County and no banks would help.

When I am asked what are some of the good things that I have experienced since March of 1988 when I assumed the Chair of Ophthalmology at NYMC . I reply without hesitation to meet, respect and love JAMES F X O’ROURKE. We, who were fortunate enough to work with and learn from this truly remark- able multi-talented gentleman, have the responsibility to pass this wisdom to the next generation

Joseph B. Walsh, MD

August 8, 2006

SANACORE, JOSEPH A., M.D. March 10, 1922 – July 4, 2006

The New York Eye and Ear Infirmary notes with sorrow the passing of a long-time member of the Medical Staff, graduate of the Ophthalmology program, and teacher in the operating room and clinics. Our sincerest condolences to the Sanacore family.

Joseph B. Walsh, M.D. Chairman, Department of Ophthalmology

Douglas F. Buxton, M.D. President, Alumni Association

172 THE NEW YORK EYEAND EAR INFIRMARY EXECUTIVE COMMITTEE RESIDENCY REVIEW 2006

EXECUTIVE COMMITTEE RESIDENCY REVIEW 173

VISION CORRECTION CENTER

n the tradition of The New York Eye and Ear Infirmary, The Vision Correction Center is dedicated to providing the most advanced research and surgical options for patients I with refractive disorders using the most modern laser systems and equipment available. Our technician staff members are fully certified and expertly trained in the use of all the equip- ment at the center. Laser vision correction surgery continues to be the dominant procedure performed at the Vision Correction Center. Our LADARVision 4000 laser was the first in the tri-state area to be upgraded with the LADARWave wavefront measuring device in order to provide CustomCornea wavefront guided vision surgery. We also provide the full range of Visx excimer surgery and Intacs corneal implants for myopia

NATIONAL LEADERSHIP

The Vision Correction Center is recognized as one of three centers for education in LASIK with LADARVision in the United States. This distinction allows the LADARVision system at the Vision Correction Center to be the first to receive all upgrades and improvements. Certification classes directed by Dr. Barrie Soloway are held regularly for our laser and keratome systems. During 2003, over 100 ophthalmologists, residents, and fellows were certified during courses offered on our Alcon LADARVision laser, Visx Smoothscan laser, Moria CB, LSK microkeratomes, and the Summit KB microkeratome.

RESIDENT EDUCATION

The New York Eye and Ear Infirmary residents were the first ophthalmology res- Barrie Soloway, MD idents in the United States to perform LASIK refractive surgery. Residents and fellows train in Photorefractive Keratectomy (PRK), Laser Assisted in-situ Keratomilieusis (LASIK), and Intrastromal Corneal Ring Segment (Intacs) implantation. Bimonthly resident vision correc- tion conferences cover didactic and clinical training in refractive surgery concepts and delivery. Residents receive extensive training in the pre and post-operative evaluation and care of refrac- tive surgery patients. They also perform numerous refractive procedures throughout their sen- ior year. Our ophthalmology residents have the opportunity to become certified in each instru- ment at the Vision Correction Center. Many residents and fellows presented data from research projects developed at the Vision Correction Center at the American Society of Cataract and Refractive Surgery (ASCRS) and World Refractive Surgery Symposium (WRSS) annual meet- ings.

RESEARCH ACTIVITIES

FDA monitored Clinical Evaluation trials of Scleral Spacing Surgery for the treatment of pres- byopia began in 2003. Wavefront studies on normal and surgical eyes were carried out and pre- sented at the annual meetings of the American Society of Cataract and Refractive Surgery and the American Academy of Ophthalmology.

FELLOWSHIP

The Vision Correction Center and Dr. Soloway accept one clinical fellow each year. Applicants must have completed an accredited ophthalmology residency program. The fellow is mentored by Dr. Barrie Soloway in clinical and surgical care with refractive surgery. Development of a research project in refractive surgery is an important part of the fellow’s curriculum.

VISION CORRECTION CENTER 175 VISION CORRECTION CENTER

PATIENT CARE

Thousands of surgeries were performed at the Vision Correction Center in 2005. Other pro- cedures performed for vision correction included PRK, Intacs, scleral expansion for presbyopia reversal, and numerous repair surgeries for problems due to prior eye or vision surgery performed elsewhere. Patients from New York, throughout the United States and internation- ally came to the Vision Correction Center to reduce their dependence on eyeglasses and con- tact lenses.

MAJOR GOALS FOR 2004

Newer technologies for reducing risk and improving results such as surface treatment Epi-K for ELASIK will be studied in the coming year. The Scleral Spacing Procedure for the reversal of presbyopia and wavefront measurement and directed treatment research will continue to be studied during the next year. This technology promises to provide customized treatment and potential rehabilitation for patients with vision irregularities. Director Administrator Barrie Soloway, MD Michelle Sanchez, COT Resident Education Douglas Buxton, MD Barrie Soloway, MD Christopher Starr, MD

176 THE NEW YORK EYEAND EAR INFIRMARY